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ABSTRACT 
Numerous biologically active alkaloids and pharmaceuticals contain nitrogen atoms that 
are directly attached to stereogenic centers. Therefore, selective nitrogen atom transfer to readily 
available hydrocarbons through novel mechanistic pathways is an important tool for the 
synthesis of high-value functional molecules. We are interested in direct difunctionalization of 
alkenes with non-precious iron catalyst due to its advantages over well-established olefin 
aziridination and direct C-H amination methods in organic synthesis. Herein, we describe iron-
catalyzed nitrogen atom-transfer methods for stereoselective olefin difunctionalization, including 
olefin aminohydroxylation and diamination reactions. These transformations capitalize on the 
novel reactivity of iron catalysts by conveniently converting petrochemicals to highly 
functionalized building blocks that are valuable to organic synthesis, materials, and biomedical 
sciences.  
The first chapter of the dissertation gives an overview of ligand design and iron catalyst 
discovery for selective nitrogen atom-transfer to alkenes. The ligand can combine with a metal 
center through chelation to afford an asymmetric catalyst. This asymmetric catalyst can thus be 
used to transfer its chirality to its corresponding enantiopure product from achiral precursors. 
[Fe(L1)(OTf)2], [Fe(L2)(OTf)2], [Fe(L3)(OAc)2] and [Fe(L4)(NTf2)2] complexes were 
synthesized and reactivity studies of these iron complexes were performed. 
The second chapter of the dissertation describes an iron(II)-catalyzed intramolecular 
aminohydroxylation of olefins with functionalized hydroxylamines. A diastereoselective 
aminohydroxylation of olefins with a functionalized hydroxylamine is catalyzed by new iron(II) 
complexes. This efficient intramolecular process readily affords synthetically useful amino 
alcohols with excellent selectivity (dr up to > 20:1). Asymmetric catalysis with chiral iron(II) 
complexes and preliminary mechanistic studies reveal an iron nitrenoid is a possible intermediate 
that can undergo either aminohydroxylation or aziridination, and the selectivity can be controlled 
by careful selection of counteranion/ligand combinations. 
The third chapter describes an iron(II)-catalyzed asymmetric intramolecular 
aminohydroxylation of indoles. An enantioselective intramolecular indole aminohydroxylation 
reaction is catalyzed by iron(II) chiral bisoxazoline (BOX) complexes (ee up to 99%, dr > 20:1). 
This discovery enables expedient asymmetric synthesis of a series of biologically active 3-amino 
oxindoles and 3-amino indolanes.  
The fourth chapter focuses on iron(II)-catalyzed direct diazidation for a broad range of 
olefins. This novel reaction occurs at room temperature (1–5 mol% of catalysts and dr values of 
up to >20:1). This method tolerates a broad range of both unfunctionalized and highly 
functionalized olefins, including those that are incompatible with existing methods. It also 
provides a convenient approach to vicinal primary diamines as well as other synthetically 
valuable nitrogen-containing building blocks which are difficult to obtain with alternative 
methods. Preliminary mechanistic studies suggest that the reaction may proceed through a new 
mechanistic pathway in which both Lewis acid activation and iron-enabled redox catalysis are 
crucial for selective azido-group transfer.  
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transfer, Asymmetric synthesis, Aminohydroxylation and diamination, Natural product 
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1 
1 CHAPTER I     SYNTHESIS AND REACTIVITY STUDIES OF IRON COMPLEXES 
WITH LIGANDS 
 
1.1 INTRODUCTION 
1.1.1 Chiral Ligands in Asymmetric Catalysis 
Chiral ligands are specially designed and widely adapted molecules utilized for 
asymmetric synthesis. The chiral ligand which is enantiopure can coordinate with a metal center 
through chelation to afford an asymmetric catalyst. This asymmetric catalyst can thus be used to 
transfer its chirality to the reaction product in a chemical reaction. The beauty of chiral ligand in 
asymmetric catalysis is that even catalyst at low concentration is effective to turn over much 
more equivalents of reactant to its corresponding enantiopure product from the achiral precursor, 
making it superior to most chiral auxiliaries and well suited to large scale synthesis.  
1.1.2  Chiral and C2-Symmetrical Box Ligands 
Interestingly, although thousands of chiral ligands have been synthesized and screened, 
some of these are enantioselective over a wide range of different reactions. We call such 
catalysts “privileged ligands”.1 Examples of privileged chiral ligands and catalysts are listed in 
Figure 1 below. The framework of Bis(oxazoline) ligands inspired by vitamin B12, was first 
synthesized and used for enantioselective carbenoid cyclopropanation in 1984 by Brunner.
2
 
Later, in 1989, Nishiyama reported the first application of tridentate nitrogen ligand PyBox in 
transition metal catalysis.
3
 These newly designed chiral ligands were simply prepared from 2,6-
Pyridinedicarboxylic acid  and enantiopure amino alcohols, drawing significant attention due to 
2 
the ready availability of chiral precursors and their excellent performance in hydrosilylation of 
ketones, oxidative cyclization, reductive cyclization of various unsaturated alkyl halides, etc.
3-4
 
Iron-based catalysts is less explored compared with the noble metals, such as Pd, Pt, Ru as well 
as Rd. Therefore, the discovery of a novel iron-based catalyst is of great importance due to its 
high abundance, low cost, and low toxicity.
5
 Fe/PyBox complexes were developed for a broad 
range of organic transformations such as the asymmetric Nazarov cyclization,
6
 asymmetric 
aziridine formation reaction,
7
 Mukaiyama-Aldol reaction,
8
 etc. Based on the X-ray 
crystallographic analysis and reactivity studies of these Fe-PyBox complexes, we learned that the 
coordination abilities of pybox ligands to the iron center as well as the reactivities of the Fe-
PyBox complexes were dependent on the structure of the pybox ligand employed.
9
   
  
Figure 1. Privileged Chiral Ligands 
1.1.3 Expected Results  
We are interested in discovering general and selective catalytic reactions that transform 
readily available hydrocarbons to high-value functional molecules through novel mechanistic 
pathways. One of our current research focuses is to develop iron-catalyzed nitrogen atom transfer 
methods for stereoselective olefin functionalization, including olefin aminohydroxylation, and 
3 
diamination reactions. These transformations capitalize on the novel reactivity of iron catalysts 
by conveniently converting petrochemicals to highly functionalized building blocks that are 
valuable to organic synthesis, material and biomedical sciences. 
 
1.2     EXPERIMENT 
1.2.1 General Information  
General Procedures. All reactions were performed in oven-dried or flame-dried round-
bottom flasks and vials. Stainless steel syringes and cannula were used to transfer air- and 
moisture-sensitive liquids. Flash chromatography was performed using silica gel 60 (230-400 
mesh) from Sigma–Aldrich. 
Materials. Commercial reagents were purchased from Sigma-Aldrich, Fluka, EM 
Science, and Lancaster and used as received. All solvents were used after being freshly distilled 
unless otherwise noted. 
Instrumentation. Proton nuclear magnetic resonance (
1
H NMR) spectra， carbon 
nuclear magnetic resonance (
13
C NMR) spectra and fluorine nuclear magnetic resonance (
19
F 
NMR) were recorded on Bruker UltraShield-400 (400 MHz). Chemical shifts for protons are 
reported in parts per million downfield from tetramethylsilane and are referenced to the NMR 
solvent residual peak (CHCl3: δ 7.26). Chemical shifts for carbons are reported in parts per 
million downfield from tetramethylsilane and are referenced to the carbon resonances of the 
NMR solvent (CDCl3: δ 77.0). Chemical shifts for fluorine are reported in parts per million 
downfield and are referenced to the fluorine resonances of CFCl3. Data are represented as 
follows: chemical shift, multiplicity (br = broad, s = singlet, d = doublet, t = triplet, q = quartet, 
m = multiplet), coupling constants in Hertz (Hz), and integration.  
4 
The mass spectroscopic data were obtained at the Georgia State University mass 
spectrometry facility using a Micromass Platform II single quadruple instrument. Infrared (IR) 
spectra were obtained using a Perkin Elmer Spectrum 100 FT-IR spectrometer. Data are 
represented as follows: frequency of absorption (cm
-1
) and absorption strength (s = strong, m = 
medium, w = weak).  
Abbreviations used: EtOH–ethanol, EtOAc–ethyl acetate, THF–tetrahydrofuran, 
MeOH–methanol, Et2O–diethyl ether, CH2Cl2–dichloromethane, TEA–triethylamine, MeCN–
acetonitrile, MS–molecular sieves, CDI–1,1′-carbonyl diimidazole, Troc–2,2,2-
trichloroethoxycarbonyl, DCC–N,N′-dicyclohexylcarbodiimide, TLC–thin layer 
chromatography, Boc2O–di-tert-butyl dicarbonate, DMAP−4-dimethylaminopyridine. 
1.2.2  Synthesis of Fe-TetraMe PyBox Complex  
1.2.2.1 Synthesis of TetraMe PyBox Ligand 
Ligand L1 was synthesized according to a modified literature procedure:
10
 
 
 
 
Scheme 1. Synthesis of TetraMe PyBox Ligand 
 
To a 100 mL flame-dried flask charged with a stir bar and a reflux condenser was added 
2,6-pyridinedicarboxylic acid (3.34 g, 20 mmol). After the flask was evacuated and backfilled 
with N2 twice, SOCl2 (30 ml) and DMF (0.2 mL) were added. The reaction was heated under a 
5 
reflux condition for 3 h. Then the mixture was cooled to room temperature and concentrated in 
vacuo to afford the 2,6-pyridinedicarbonyl dichloride as a white solid which can be used directly 
in the next step. Under N2 atmosphere, to a solution of amino alcohol 1 (6.23g, 70 mmol) and 
Et3N (10.1g, 100 mmol) in CH2Cl2 (70 mL), were added 2,6-pyridinedicarbonyl dichloride in 
CH2Cl2 (30 mL) drop-wise at 0 °C. After the reaction mixture was stirred at room temperature 
for 16 h, the mixture was poured into an ice-water mixture (60 mL), which was then extracted 
with CH2Cl2 (60 mL × 3). The combined organic layers were washed with water (20 mL) and 
brine (20 mL), dried over anhydrous Na2SO4 and concentrated in vacuo. The residue was 
purified through a silica gel flash column (hexanes/acetone: from 10:1 to 1:1) to afford product 2 
as a white solid (3.53 g, 57% yield for 2 steps), which is a known compound.
10 
 
2 (3.09 g, 10 mmol) was dissolved in toluene (40 mL) in a 100 mL flame-dried flask 
charged with a stir bar and a reflux condenser. SOCl2 (7.14 g, 60 mmol) was added via a syringe 
and the mixture was heated under a reflux condition. The reaction was monitored by TLC. When 
the starting material disappeared, the reaction was cooled to 0 °C and quenched with a saturated 
NaHCO3 solution (30 mL). The organic layer was separated from the aqueous one which was 
then extracted with EtOAc (30 mL × 3). The combined organic layers were dried over anhydrous 
Na2SO4 and concentrated in vacuo. The residue was filtered through a short silica gel pad with 
EtOAc as an eluent and concentrated again. The obtained oil was dissolved in anhydrous THF 
(50 mL) under N2 atmosphere and cooled to 0 °C. NaH (2 g, 50 mmol, 60% in mineral oil) was 
added to the solution portion-wise and the whole mixture was then warmed up to room 
temperature and monitored by TLC until the starting material was fully consumed. The reaction 
6 
mixture was filtered through a Celite pad, concentrated and purified through a silica gel flash 
column (hexanes/acetone: from 20:1 to 2:1) to provide the ligand L1 as a white solid (2.02 g, 
74% yield for 2 steps).  
1.2.2.2 Synthesis of Fe-TetraMe PyBox complex 
 
Scheme 2. Synthesis of Fe-TetraMe PyBox Complex 
             Iron complexes 3 was prepared by stirring iron(II) triflate anhydrous and the 
corresponding PyBox ligand at a ratio of 1:1 in DCM/MeCN (50:1) at room temperature 
(Scheme 2). Upon removal of the solvent in vacuo, iron complex 3 was achieved in almost 
quantitative yield.      
1.2.3 Synthesis of Fe-TetraPh PyBox Complex 
1.2.3.1 Synthesis of TetraPh PyBox Ligand 
           Ligand L2 was synthesized according to a modified literature procedure:  
 
 
 
Scheme 3. Synthesis of TetraPh PyBox Ligand 
 
To a 100 mL flame-dried flask charged with a stir bar and a reflux condenser was added  
7 
2,6-pyridinedicarboxylic acid (3.34 g, 20 mmol). After the flask was evacuated and backfilled  
with N2 twice, SOCl2 (30 ml) and DMF (0.2 mL) were added. The reaction was heated under a 
reflux condition for 3 h. Then the mixture was cooled to room temperature and concentrated in 
vacuo to afford the 2,6-pyridinedicarbonyl dichloride as a white solid which can be used directly 
in the next step. Under N2 atmosphere, to a solution of amino alcohol 4 (6.23g, 70 mmol) and 
Et3N (10.1g, 100 mmol) in CH2Cl2 (70 mL), were added 2,6-pyridinedicarbonyl dichloride in 
CH2Cl2 (30 mL) drop-wise at 0 °C. After the reaction mixture was stirred at room temperature 
for 16 h, the mixture was poured into an ice-water mixture (60 mL), which was then extracted 
with CH2Cl2 (60 mL × 3). The combined organic layers were washed with water (20 mL) and 
brine (20 mL), dried over anhydrous Na2SO4 and concentrated in vacuo. The residue was 
purified through a silica gel flash column (hexanes/acetone: from 10:1 to 1:1) to afford product 5 
as a white solid (5.01 g, 45% yield for 2 steps), which is a known compound.
10,
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5 (5.01 g, 9 mmol) was dissolved in toluene (40 mL) in a 100 mL flame-dried flask 
charged with a stir bar and a reflux condenser. SOCl2 (6.43 g, 54 mmol) was added via a syringe 
and the mixture was heated under a reflux condition. The reaction was monitored by TLC. When 
the starting material disappeared, the reaction was cooled to 0 °C and quenched with a saturated 
NaHCO3 solution (30 mL). The organic layer was separated from the aqueous one which was 
then extracted with EtOAc (30 mL × 3). The combined organic layers were dried over anhydrous 
Na2SO4 and concentrated in vacuo. The residue was filtered through a short silica gel pad with 
EtOAc as an eluent and concentrated again. The obtained oil was dissolved in anhydrous THF 
(50 mL) under N2 atmosphere and cooled to 0 °C. NaH (1.8 g, 45 mmol, 60% in mineral oil) was 
8 
added to the solution portion-wise and the whole mixture was first warmed up to room 
temperature and then was refluxed until TLC indicated fully consumption of the starting material 
and reaction intermediate. The reaction mixture was filtered through a Celite pad, concentrated 
and purified through a silica gel flash column (hexanes/acetone: from 20:1 to 2:1) to provide the 
ligand L1 as a white solid (2.90 g, 62% yield for 2 steps).  
1.2.3.2  Synthesis of Fe-TetraPh PyBox Complex 
 
Scheme 4. Synthesis of Fe-TetraPh PyBox Complex 
   Iron complexes 6 was prepared by stirring iron(II) triflate anhydrous and the 
corresponding PyBox ligand at a ratio of 1:1 in DCM/MeCN (50:1) at room temperature 
(Scheme 4). Upon removal of the solvent in vacuo, iron complex 6 was achieved in almost 
quantitative yield.       
1.2.4 Synthesis of Fe-TetraPh Box Complex 
1.2.4.1 Synthesis of TetraPh Box Ligand 
 
 L3 was synthesized according to the literature procedures.
12
  
1.2.4.2 Synthesis of Fe-TetraPh Box Ligand 
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Scheme 5. Synthesis of Fe-TetraPh Box Complex 
Iron complexes 7 was prepared by stirring iron(II) acetate anhydrous and the 
corresponding Box ligand at a ratio of 1:2 in Tol/MeCN (50:1) at room temperature (Scheme 5). 
Upon removal of the solvent in vacuo, iron complex 7 was achieved in almost quantitative yield.   
1.2.5 Synthesis of Fe-Phenanthroline Box Complex 
1.2.5.1 Synthesis of Phenanthroline Box Ligand 
 
Scheme 6. Synthesis of Phenanthroline Box Ligand 
Ligand L4 was synthesized from 2-cyanophenanthroline.
13
 2-Cyanophenanthroline  
(4.10g, 20 mmol) was dissolved in anhydrous methanol (60 mL) in a flame-dried flask equipped 
with a stir bar. NaOMe (108 mg, 2 mmol) was added to the reaction. The reaction mixture was 
stirred at room temperature and monitored with TLC until the starting material was fully 
consumed. The reaction was then quenched with acetic acid (0.22 mL) and the mixture was 
filtered and concentrated in vacuo. The residue was dissolved in toluene (100 mL) together with 
amino alcohol 1 (1.87 g, 21 mmol) and p-TsOH∙H2O (380 mg, 2 mmol). The reaction mixture 
was then heated under a reflux condition with a DeanStark apparatus until the intermediate was 
consumed. After the reaction was cooled to room temperature, the solvent was removed in vacuo 
10 
and the residue was purified through a silica gel flash column (hexanes/acetone: from 2:1 to 1:2) 
to afford L4 as a white solid (3.6g, 65% yield).
10
  
  
1.2.5.2 Synthesis of Fe-Phenanthroline Box Complex 
 
Scheme 7. Synthesis of Fe-Phenanthroline Box Complex 
 
Iron complexes 8 was prepared by stirring iron(II) triflimide and the corresponding Box 
ligand at a ratio of 1:1 in DCM/MeCN (50:1) at room temperature (Scheme 7). Upon removal of 
the solvent in vacuo, iron complex 8 was achieved in almost quantitative yield. 
 
1.3     RESULTS 
1.3.1 Results of Fe-TetraMe PyBox Complex 
1.3.1.1 Results of TetraMe PyBox Ligand  
 
2,6-Bis(4,4-dimethyl-4,5-dihydrooxazol-2-yl)pyridine (L1): ligand L1 was further 
purified by recrystallization from a mixture of hexanes/EtOAc (9:1) as a colorless crystalline 
solid (m.p. 139141 °C). IR νmax (neat)/cm
-1
: 3423 (w), 2967 (m), 2927 (w), 2896 (w), 1641 (s), 
1573 (s), 1459 (s), 1365 (s), 1302 (s); 
1
H NMR (400 MHz, CDCl3): δ 8.22 (d, J = 7.9 Hz, 2H), 
11 
7.87 (t, J = 7.9 Hz, 1H), 4.24 (s, 4H), 1.42 (s, 12H); 
13
C NMR (100 MHz, CDCl3): δ 160.9, 
147.0, 137.1, 125.7, 79.8, 68.0, 28.4; HRMS (ESI, m/z): calcd for C15H20N3O2
+
, [M + H
+
],  
274.1550, found 274.1554.  
1.3.1.2  Applications of Fe-TetraMe PyBox Complex  
 
Complex 3 shows new reactivity in effectively catalyzing intermolecular olefin amino 
hydroxylation, amino halogenation as well as diazidation reactions.     
1.3.2 Results of Fe-TetraPy PyBox Complex 
1.3.2.1 Results of TetraPh PyBox Ligand  
 
2,6-Bis(4,4-diphenyl-4,5-dihydrooxazol-2-yl)pyridine (L2):  white solid (m.p. 213–215 
°C); IR νmax (neat)/cm
-1
: 3059 (w), 3026 (w), 1641 (s), 1570 (m), 1492 (m), 1449 (s), 1380 (s), 
1114 (m), 1077 (s); 
1
H NMR (400 MHz, CDCl3): δ 8.47 (d, J = 7.8 Hz, 2H), 7.92 (t, J = 7.8 Hz, 
1H), 7.40 (d, J = 7.9 Hz, 8H), 7.33 (t, J = 7.5 Hz, 8H), 7.26 (t, J = 7.2 Hz, 4H), 5.09 (s, 4H); 
13
C 
NMR (100 MHz, CDCl3): δ 161.7, 146.9, 145.7, 137.2, 128.5, 127.3, 126.7, 126.7, 80.5, 79.8; 
HRMS (ESI, m/z): calcd for C35H28N3O2
+
, [M + H
+
]: 522.2176, found 522.2178. 
12 
1.3.2.2  Applications of Fe-TetraPh PyBox Complex 
 
Complex 6 is effective to catalyze highly diastereoselective intermolecular diazidation 
reaction for a broad range of olefins. 
1.3.3 Results of Fe-TetraPy Box Complex 
1.3.3.1 Results of TetraPy Box Ligand  
 
2,2-Bis-2-[4(R),5(S)-diphenyl-l,3-oxazolinyl]propane (L3): white solid (m.p. 153–154 
°C); IR νmax (neat)/cm
-1
: 3056 (w), 1674 (s), 1450 (m), 1319 (m), 1140(s), 1119(m); 
1
H NMR 
(400 MHz, CDCl3): δ 7.2–6.96(m, 10H), 5.98 (d, J = 10 Hz, 1H), 5.60 (d, 1H), 1.93 (s, 3H), 0.78 
(d, 3H), nearly identical to the literature data.
12
 
1.3.3.2 Applications of Fe-TetraPh Box Complex 
 
13 
Complex 7 is effective to catalyze highly enantioselective intramolecular amino-
hydroxylation of olefins with functionalized hydroxylamines as well as aminohydroxylation 
reaction for a variety of indoles.  
1.3.4 Results of Fe-Phenanthroline Box Complex 
1.3.4.1 Results of Phenanthroline Box Ligand 
 
4,4-Dimethyl-2-(1,10-phenanthrolin-2-yl)-4,5-dihydrooxazole (L4): ligand L4 was 
further purified by recrystallization from a hexanes/EtOAc mixture as a white solid (m.p. 
106108 °C). IR νmax (neat)/cm
-1
: 3385 (m), 3223 (m), 2966 (w), 1646 (s), 1493 (m), 1400 (s); 
1
H NMR (400 MHz, CDCl3): δ 9.25 (dd, J = 4.3, 1.3 Hz, 1H), 8.43 (d, J = 8.3 Hz, 1H), 8.34 (d, J 
= 8.3 Hz, 1H), 8.29 (d, J = 6.9 Hz, 1H), 7.86 (q, J = 8.8 Hz, 2H), 7.68 (dd, J = 8.1, 4.4 Hz, 1H), 
4.34 (s, 2H), 1.49 (s, 6H); 
13
C NMR (100 MHz, CDCl3): δ 161.7, 150.4, 146.4, 145.9, 145.5, 
136.6, 136.2, 129.4, 128.9, 128.0, 126.1, 123.4, 122.7, 79.8, 68.1, 28.5; HRMS (ESI, m/z): calcd 
for C17H16N3O
+
, [M + H
+
]: 278.1288, found 278.1289.  
1.3.4.2 Applications of Fe-Phenanthroline Box Complex 
 
Complex 8 is effective to catalyze highly diastereo- and enantioselective intermolecular 
aminohydroxylation of olefin with a labile C-H bond as well as the allylic positon of substituted 
indole substrate.  
14 
 
1.4 CONCLUSIONS 
We have successfully synthesized the iron(II) complexes [Fe(tetraMe–PyBox)(OTf)2] 
(3), [Fe(tetraPh–PyBox)(OTf)2] (4), [Fe(tetraPh–Box)(OAc)2] (7) and [Fe(Phen–Box)(NTf2)2] 
(8) by the reaction of iron(II) salt with the corresponding N-based ligand. X-ray crystallographic 
analysis and reactivity studies of these iron complexes were performed. The results indicate that 
the reactivity of the iron complexes is dependent on their unique structures as well as the 
coordination abilities of N-based ligands to the iron center. Therefore, searching for new 
reactivity of those iron catalysts in the fields of total synthesis, new drug discovery, as well as 
novel reaction and methodology studies, show great importance.       
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2 CHAPTER II   IRON(II)-CATALYZED AMINO-OXYGENATION OF ALKENES 
 
2.1 INTRODUCTION  
2.1.1 Naturally Occurring Molecules  
Numerous biologically active alkaloids and pharmaceuticals contain chiral 1,2-amino 
alcohols, and as depicted in Figure 2. However, the synthesis of 1,2-amino alcohol motifs is very 
challenging and synthetic approaches towards this important problem can be summarized in 
Figure 3, including epoxide opening, nucleophilic substitution, imine reduction, aldehyde 
reduction, enamine oxidation, aziridine opening, etc.  
 
Figure 2. Compounds Containing the 1,2-Amino Alcohol Motifs 
From Figure 3 we can see that, research into the simultaneous transfer of nitrogen and 
another heteroatom across a variety of double bonds by organocatalysis or metal catalyzed 
16 
methods show great advantages compared to other methods, because these catalytic reactions 
readily transform commodity chemicals to highly functionalized building blocks valuable to 
medicinal chemistry and pharmaceutical research.  
 
Figure 3. Approaches for the Synthesis of Vicinal 1,2-Amino Alcohols 
We are interested in direct difunctionalization of alkenes with non-precious metal 
catalysts which is among the most utilized methods to introduce stereogenic nitrogen atoms in 
organic synthesis. The application of iron catalyst in organic synthesis is attractive for a few 
reasons.
14
 First and foremost, iron is the most abundant metal in the earth; thus, the price of iron 
is much cheaper than other most often used precious metals. Secondly, considering the 
incorporation of iron compounds in biological systems during the evolutionary process, iron is 
crucial to many integral metabolic parts due to its relatively low toxicity. Last but not the least, 
from the research point of view, although the catalytic efficiency and applicability of iron is still 
behind palladium or some other metals in organic synthesis, publications related to iron in 
catalysis as well as organic synthesis has a tremendous increase just in the last few years, 
demonstrating the coming of the “iron age”. 
17 
2.1.2 Osmium-Mediated Reactions  
The pioneering asymmetric aminohydroxylation (AA) reported by K.B. Sharpless and  
coworkers in 1976 remains a powerful method for the synthesis of enantioenriched syn-vicinal  
amino alcohols.
15
 Different from the well-known dihydroxylation reaction, the unsymmetrical 
addition brings the regioselectivity issue of the reaction affording two possible products, as 
illustrated in Scheme 8. This osmium-catalyzed procedure provides the cis addition of the 
hydroxyl (OH) and arylsulfonamide (ArSO2NH2) moieties across an olefinic linkage with sixteen 
different olefin substrates, and yields ranging from 34% to 96%.
15b
  
 
Scheme 8. Osmium-Catalyzed Sharpless Olefin AA 
The asymmetric induction was first time achieved by using chiral tertiary amine ligands, 
which belongs to cinchona alkaloid family.
15a
 In this case, chirality is transformed from a 
catalytic amount of osmium and an enantiopure ligand to chiral products in good yield and ee, as 
shown in Scheme 9. The advantages of the AA are its simplicity, functional group tolerance as 
well as no requirement for auxiliary functional groups; however, certain barriers still exist such 
as the scope and utility of the reaction, which limits their applications.     
 
Scheme 9. Osmium-Catalyzed Enantioselective AA 
Despite the advances achieved regarding control of the regio- and stereoselectivity in 
osmium-catalyzed aminohydroxylation, the reaction itself is still controlled by the substrates. 
18 
Donohoe
16
 developed an Os-based tethered strategy to solve the regioselectivity problem in 
racemic olefin aminohydroxylation.  
Starting from allylic alcohols, carbamate intermediates can be prepared in high yield by a 
two-step procedure, as shown in Scheme 10. The reaction is stereospecific and proceeds with the 
only catalytic amount of catalyst loading with the application of the Sharpless AA conditions. A 
range of hydroxyl oxazolidinones with complete syn stereospecific the tethered osmium species 
across the alkene were thus achieved.
16f, 16h
 Unfortunately, no ee was observed in the presence of 
(DHQ)2-PHAL.    
 
Scheme 10. Regioselective Aminohydroxylation of Allylic Carbamates 
After illustrating achiral allyl carbamates with regio- and stereoselectivity, substrates 
bearing an allylic stereogenic center were further examined with the optimized reaction 
conditions, affording high syn diastereoselectivity showed in Scheme 11.
16e, 16g
 
 
Scheme 11. Regioselective Aminohydroxylation of Allylic Carbamates with Stereogenic Center 
19 
T o avoid the use of chlorinating agents, Donohoe and others discovered a replacement 
procedure for the synthesis of N-sulfonyloxy and N-carbonyloxy derivatives of a broad range of 
acyclic and cyclic allylic alcohols. The prepared intermediates can thus be converted to the 
corresponding hydroxyl oxazolidinones with higher yields as well as low catalyst loading.
16b-d
 
 
Scheme 12. Improved Aminohydroxylation of Allylic Carbamates 
2.1.3 Copper-Mediated Reactions 
This reaction has also inspired extensive efforts to discover alternative approaches to 
address its inherent limitations. Göttlich
17
 discovered the first radical aminohydroxylation of 
double bonds. N-benzoyl hydroxylamines are reduced by Cu(I) in the presence of a Lewis acid, 
followed by carbon radical oxidized by Cu(II) via a ligand transfer to furnish the cyclized 
products in moderate yields and different regioselectivity for pyrrolidines over piperidines. 
While the formation of piperidine goes through an unusual 6-endo radical cyclization, it might be 
caused by the gem dialkyl groups in the substrates.   
 
Scheme 13. Copper(I)-Catalyzed Cyclization of Unsaturated N-Benzoyloxyamines 
Yoon
18
 firstly reported a novel copper(II)-catalyzed reaction of oxaziridines that affects 
regioselective aminohydroxylation of styrenes and electron-rich olefins in 2007, as shown in 
Scheme 14.
18a
 Cu(II) works as Lewis acid to activate the oxaziridine and nucleophilic attack by 
20 
styrenic olefins, allyl silanes, enol ethers as well as symmetrical dienes, subsequent ring closer 
onto the resultant benzylic cation to furnish highly chemoselective aminals. However, an 
extended reaction, limited substrates scope (only electron rich olefins that can sufficiently 
stabilize the carbon cation intermediate) and poor diastereoselectivity limited their further 
applications.        
 
Scheme 14. Copper(II)-Catalyzed Aminohydroxylation of Styrenic Olefins 
Subsequent reports have revealed this significant use of chiral bisoxazoline copper(II) 
complexes to provide good enantioselectivity for most electron rich styrenic olefins but low 
diastereoselectivity.
18d
   
 
Scheme 15. Copper(II)-Catalyzed Enantioselective Aminohydroxylation 
An important implement for this reaction is the discovery of dimethyloxaziridine with the 
combination of anionic halocuprate(II) complexes that takes care of the diastereoselectivity issue 
as well as reaction time problem for olefinic substrates as summarized in Scheme 16(a).
18c
 In 
most cases, the reaction can finish within 4.5 h with improved yields, and the resulted products 
can be deprotected under milder conditions compared to the reduction conditions required for 
removal of an N-benzenesulfonyl group. Also, the anionic halocuprate(II) complexes show 
advantages over neutral copper(II) salts such as, dramatically increased amount of sterically and 
21 
electronically deactivated styrenes, rate acceleration in most cases with dramatically enhanced 
yields indicated in Scheme 16(b).
18c
 
 
Scheme 16. (a) New Oxaziridines-Mediated Aminohydroxylation 
   (b) Anionic Halocuprate(II) Complex as Enhanced Catalyst 
Chemler
19
 discovered copper can catalyze intramolecular olefin aminooxygenation in the 
presence of TEMPO, as depicted in Scheme 17. This intramolecular process provides efficient 
access to a variety of chiral pyrrolidines and indolines of interest to synthetic organic and 
medicinal chemists.
19a
 Although this methodology gives us another option for the preparation of 
the valuable vicinal amino alcohols directly from olefins, it is limited to terminal olefin systems. 
Besides that, further optimization of the reaction time and temperature is still needed in order to 
broaden its synthetic application.  
 
Scheme 17. Cu(II)-Catalyzed Enantioselective Intramolecular Aminooxygenation of Alkenes 
22 
2.1.4 Palladium-Mediated Reactions 
Bäckvall
20
 in 1975 reported the first direct aminooxygenation of the terminal and internal 
olefins catalyzed by a stoichiometric amount of Pd(II) catalyst.  Alkene was initially activated by 
Pd(II) via nucleophilic attack to afford  Pd(II) intermediate region isomers. The Pd-C bond was 
subsequently oxidized with Pb(OAc)2 to generate vicinal amino motifs. Although highly 
diastereoselective syn addition products were afforded for symmetrically substituted internal 
olefins, only moderate regioselectivity can be achieved for terminal and asymmetrical alkenes.    
An investigation by Sorensen
21
 in 2005 leads to a successful story of Pd(II)-catalyzed 
intramolecular oxyamination of olefins. A possible catalytic mechanism is that Pd(II) catalyzed 
reversible trans-amino metalation of  the alkenes followed by generation of a protonated 
intermediate than can undergo an irreversible deprotonation process. Thus, the addition of base is 
crucial to the reaction rate and regioselectivity. After the alkyl Pd(II) intermediate being oxidized 
by PhI(OAc)2, C-O will be forming through a reductive elimination process to complete the 
catalytic cycle.   
In the same year, Peter Szolcsanyi described a novel method for the preparation of the 6-
oxa-2-azabicyclo[3.2.1]octane skeleton featuring Pd(II)/CuCl2-catalyzed N,O-bicyclization as a 
key step.
22
  
 
Scheme 18. Pd-Catalyzed Aminoacetoxylation of Alkenes 
23 
A significant development came in 2006, Stahl and Liu
23
 demonstrated that simple Pd(II) 
complexes can catalyze intermolecular aminoacetoxylation of terminal alkenes, such as terminal 
allylic, homoallylic and enol ethers, with high levels of regio- and diastereoselectivity. However, 
excess alkene substrate was required to achieve high product yield.     
 
Scheme 19. Pd-Catalyzed Intermolecular Aminoacetoxylation of Alkenes 
The following year, Sanford
24
 enclosed that homoallylic alcohols could be cyclized to 
furnish 3-aminotetrahydrofurans in moderate to high diastereoselectivity. This process involves a 
Pd-catalyzed alkene aminopalladation to generate alkyl Pd species, followed by intramolecular 
oxidative functionalization and reductive elimination to afford stereoselectively tetrahydrofuran 
products.   
 
Scheme 20. Pd-Catalyzed Formation of 3-Aminotetrahydrofuran Derivatives 
 
Recently, Bingfeng Shi
25
 reported that a divergent synthesis of cyclic ureas and isoureas 
via a catalyst controlled aminoacetoxylation of alkenes with PhI(OAc)2 as the oxidant in good 
yields under mild conditions.   
 
Scheme 21. Pd-Catalyzed Aminoacetoxylation 
24 
2.1.5 Platinum-Mediated Reactions 
Kilian Muniz
26
 disclosed that homogeneous Pt can catalyze 1,2 difunctionalizations of 
alkenes to deliver the corresponding bicyclic isoureas in high yields under aerobic conditions. 
More interestingly, the catalytic amount of Cu(II) oxidant is sufficient to turn over the reaction  
without any additives resulting in the formation of 5 or 6 member fused ring system with high 
chemoselectivity, and good diastereoselectivity in the presence of a stereocenter.    
 
Scheme 22. Pt-Catalyzed Aerobic 1,2-Aminoacetoxylation of Alkenes 
2.1.6 Rhodium-Mediated Reactions 
More recently, Albert Padwa
27
 and co-work came up with the iodine (III)-mediated 
aziridination reaction of an indolyl-substituted carbamate which requires a Rh(II) catalyst and 
proceeds by metallonitrene intermediate. A metal-free zwitterion is generated by stepwise 
addition across the indole π-bond followed by Rh (II) detachment, which ultimately furnishes the 
final products, as demonstrated in Scheme 23.  
 
Scheme 23. Iodine(III)-Mediated Aziridination Reaction 
Christian
28
 subsequently came up with the amidoglycosylation reaction of allyl 3-
carbamates catalyzed by rhodium and copper acyl nitrenoids in the presence of iodosobenzene. 
Glycal enol ether π-system will react with the metal nitrenoid leading to the formation of C2-N 
bond; sequential β-selective glycosylation may take place via a metal-complexed glycosyl 
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aziridine to afford highly diastereoselective glycosylation product without activation of Lewis 
acid.   
 
Scheme 24. Rh(II)-Catalyzed Amidoglycosylation 
2.1.7 Gold-Mediated Reactions 
The research group of Cristina Nevado
29
 reported the first gold-catalyzed amino-
oxygenation and aminoamidation of unactivated alkenes. The afforded results are 
complementary to 5-exo palladium-catalyzed process but with expanded substrates scope 
compared to that of copper-mediated reactions. Au(I) can activate the alkene and favor the 6-
endo nitrogen cyclization fashion to form the carbon Au(III) intermediate in a reversible manner. 
Due to the highly electrophilic nature of the Au(III), varying levels of nucleophiles, such as 
water, alcohol, even acetonitrile can be employed in the ligand exchange process, thus the 
reductive elimination will subsequently occur to afford highly diastereoselective desired 
products.  
 
Scheme 25. Gold-Catalyzed Aminooxygenation Reaction of Alkenes 
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Scheme 26. Gold-Catalyzed Aminoamidation Reaction of Alkenes 
2.1.8 Hypervalent Iodine-Mediated Reactions 
K. C. Nicolaou, P. S. Baran and others discovered and subsequently developed a novel 
cyclization reaction of N-aryl amides (anilides) onto internally located unactivated olefins to 
form heterocycles induced by the o-iodoxybenzoic acid (IBX).
30
 It has a great success for the 
synthesis of lactams, cyclic urethanes, hydroxyl amines, amino sugars, et al. Mechanistic 
investigations indicated that an SET (single electron transfer) from the anilide functionality to 
IBX followed by a radical trapping process. The simplicity in terms of operation and substrates 
preparation make this a great method for constructing small molecule libraries for biological and 
pharmaceutical applications.  
In the year 2009, Duncan J. Wardrop
31
 and coworkers showed that when unsaturated o-
alkyl hydroxamates were treated with phenyliodine(III) bis(trifluoroacetate) (PIFA) in pure 
DCM at 0 
o
C, it subsequently underwent an intramolecular cyclization to afford the anti addition 
products in high yield and excellent diastereoselectivity. This alkene oxamidation method 
represents a remarkable method for rapid construction of these pharmaceutically important N-
heterocycles.   
 
Scheme 27. Intramolecular Oxamidation of Unsaturated O-Alkyl Hydroxamates 
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Different from metal or Lewis acid catalyzed reactions, Forrest E. Michael
32
 have 
developed a broadly applicable, high yielding oxyamination reaction promoted by a Brønsted 
acid with high regioselectivity and excellent diastereoselectivity. The oxidant loading is 
decreased without diminished yield for endo cyclization products, and a reaction condition is 
much milder in terms of temperature although with extended reaction time. The showcase total 
synthesis of (-)-Pseudoconhydrine is very concise and interesting.  
 
Scheme 28. Metal-Free Aminotrifluoroacetoxylation of Alkenes 
2.1.9 Hydroxamic Acids-Mediated Reactions 
A significant improved to metal-free alkene oxyamination is described by Erik 
Alexanian
33
 in 2011. This radical-mediated process capitalizes on the unique feature of aminoxyl 
radical in difunctionalizing alkenes using diisopropyl azodicarboxylate (DIAD) as a simple 
radical trap. The furnished high levels of diastereoselective syn cyclic oxyamination products are 
complementary to the previously reported cis-selective process but with single regioisomers. 
Initial extensions of the radical mediated difunctionalization to multibond-forming cascade 
processes are also described. Future work will be focused on applications in complex molecule 
synthesis.   
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Scheme 29. Metal-Free Oxyaminations of Alkenes Using Hydroxamic Acids 
2.1.10 Electrochemical Approach 
Moeller et al.
34
 published an electrochemical approach for the synthesis of proline 
derivatives by oxidative anodic cyclization reactions bearing electron-rich alkenes, as 
demonstrated in Scheme 30. The reactions benefit from the use of a less polar radical cation 
intermediate and the use of more basic reaction conditions, which is complementing to 
previously reported iodine protocols. However, the diastereoselectivity, in this case, is controlled 
by the substrates.   
 
Scheme 30. Intramolecular Anodic Olefin Coupling Reaction 
2.1.11 Iron-Mediated Reactions 
Despite these important achievements above, the direct conversion of a trans-olefin to a 
1,2 anti-amino alcohol remains as an unsolved synthetic problem. In addition, the iron-catalyzed 
aminohydroxylation is a less-explored process. In the year 2010, Yoon
35
 and others established a 
Fe(III)-catalyzed intermolecular aminohydroxylation of a variety of olefins, such as styrenic 
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olefins,  dienes as well as aliphatic olefins, with N-sulfonyl oxaziridine as the N-O sources. More 
interestingly, the afforded product with an amino group on the terminal carbon, this 
regioselectivity is complementary to that observed with their reported Cu(II)-mediated reactions, 
wherein the amino-functional group in at the internal position. Although the mechanism of this 
novel reaction was unclear at that time, this unusual phenomenon indicates the different reaction 
pathway compared to that of the Cu(II)-catalyzed reaction. It turns out to be a useful synthetic 
strategy for the synthesis of 1,2-aminoalcohols.  
 
Scheme 31. Iron-Catalyzed Aminohydroxylation of Olefins with N-Sulfonyl Oxaziridines 
In a more recent publication, Yoon’s group discovered that a novel iron(II) bis(oxazoline) 
complex is capable of catalyzing regioselective and enantioselective oxyamination of alkenes 
with N-sulfonyl oxaziridines.
36
 On one hand, this process furnishes highly enantioenriched and 
synthetically useful 1,2-amino alcohol precursors. On the other hand, the regioselectivity of this 
reaction is also complementary to that obtained from the copper(II)-catalyzed reaction. Thus, this 
method capitalizes on the regio- and stereochemical control of 1,2-amino alcohol motifs. 
 
Scheme 32. Iron-Catalyzed Asymmetric Oxyamination of Olefins 
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2.1.12 Expected Results 
Our group at Georgia State University, we are interested in discovering new iron-
catalyzed olefin amination methods that are unique in organic synthesis, pharmaceutical 
application, and biomedical engineering. Herein, we describe an iron(II)-catalyzed 
diastereoselective aminohydroxylation of an olefin to afford a 1,2 anti-amino alcohol with a 
functionalized hydroxylamine, possibly via an iron nitrenoid
37
 intermediate. The catalysts are 
able to transfer both the N and O groups of the hydroxylamine intramolecularly to a variety of 
olefins, affording amino alcohols with a stereochemical array that is difficult to access with other 
known methods. We envision this discovery offers an appealing alternative for existing 
aminohydroxylation methods. 
 
2.2     EXPERIMENT 
2.2.1 General Procedures 
General procedures. All reactions were performed in oven-dried or flame-dried round-
bottom flasks and vials. Stainless steel syringes and cannula were used to transfer air- and 
moisture-sensitive liquids. Flash chromatography was performed using silica gel 60 (230-400 
mesh) from Sigma–Aldrich. 
Materials. Commercial reagents were purchased from Sigma-Aldrich, Fluka, EM 
Science, and Lancaster and used as received. All solvents were used after being freshly distilled 
unless otherwise noted. 
Instrumentation. Proton nuclear magnetic resonance (
1
H NMR) spectra， carbon 
nuclear magnetic resonance (
13
C NMR) spectra and fluorine nuclear magnetic resonance (
19
F 
NMR) were recorded on Bruker UltraShield-400 (400 MHz). Chemical shifts for protons are 
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reported in parts per million downfield from tetramethylsilane and are referenced to the NMR 
solvent residual peak (CHCl3: δ 7.26). Chemical shifts for carbons are reported in parts per 
million downfield from tetramethylsilane and are referenced to the carbon resonances of the 
NMR solvent (CDCl3: δ 77.0). Chemical shifts for fluorine are reported in parts per million 
downfield and are referenced to the fluorine resonances of CFCl3. Data are represented as 
follows: chemical shift, multiplicity (br = broad, s = singlet, d = doublet, t = triplet, q = quartet, 
m = multiplet), coupling constants in Hertz (Hz), and integration.  
The mass spectroscopic data were obtained at the Georgia State University mass 
spectrometry facility using a Micromass Platform II single quadruple instrument. Infrared (IR) 
spectra were obtained using a Perkin Elmer Spectrum 100 FT-IR spectrometer. Data are 
represented as follows: frequency of absorption (cm
-1
) and absorption strength (s = strong, m = 
medium, w = weak).  
Abbreviations used: EtOH–ethanol, EtOAc–ethyl acetate, THF–tetrahydrofuran, 
MeOH–methanol, Et2O–diethyl ether, CH2Cl2–dichloromethane, TEA–triethylamine, MeCN–
acetonitrile, MS–molecular sieves, CDI–1,1′-carbonyldiimidazole, Troc–2,2,2-
trichloroethoxycarbonyl, DCC–N,N′-dicyclohexylcarbodiimide, TLC–thin layer chromatography 
，Boc2O–di-tert-butyl dicarbonate, DMAP−4-dimethylaminopyridine. 
2.2.2 Relative Stereochemistry Determination of the Product 
2 was hydrolyzed and compared with reported literature data.
16h, 38
   
 
Scheme 33. Hydrolysis of Oxazolidone 
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Comparison of 
1
H NMR data of hydrolysis product of 2 with ones of known 
compounds: 
 
1
H NMR of S1 
1
H NMR of S2 
1
H NMR of hydrolysis products of 2 
7.28-7.54 (5H, m), 4.97 
(1H, brs), 4.69 (1H, d, J 
= 6.0 Hz), 4.44-4.52 (2H, 
m), 3.98-4.03 (1H, m), 
2.47 (1H, br, s) 
7.32-7.44 (5H, m), 5.54 
(1H, br, s), 4.63 (1H, dd, 
J = 7.5, 3.5 Hz), 4.23 
(1H, t, J = 9.0 Hz), 4.12 
(1H, dd, J = 9.0, 5.5 Hz), 
4.05 (1H, m), 2.48 (1H, 
d, J = 3.5 Hz) 
7.30-7.53 (5H, m), 5.09 
(1H, brs), 4.69 (1H, d, J 
= 6.4 Hz), 4.42-4.51 (2H, 
m), 3.98-4.03 (1H, m) 
 
2.2.3 Synthesis and Characterization of Olefin Substrates 
 
Scheme 34. Substrates Preparation 
1,1’-Carbonyldiimidazole (CDI, 1.5 equiv) was added to a solution of alcohol (1.0 equiv) 
in acetonitrile (0.2 M) and stirred at room temperature. The reaction was monitored by TLC, and 
upon its completion, imidazole (4.0 equiv) and hydroxylamine hydrochloride (5.0 equiv) were 
added and stirring continued until TLC analysis indicated the reaction reached completion. After 
removing the solvent, the residue was partitioned between ethyl acetate and 1 M HCl followed 
by extraction of the aqueous phase with ethyl acetate. The organic phase was washed with brine, 
dried (Na2SO4), filtered, and concentrated in vacuo to afford the crude hydroxyl carbamate 
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product, which was purified by flash column chromatography with 40 % ethyl acetate-hexane 
(63-91 % yield). A 25 mL flame-dried round bottom flask was charged with a stirring bar, 
hydroxyl carbamate (1.0 equiv), NEt3 (1.1 equiv) and diethyl ether (0.2 M). After stirring at 0 °C 
for 5 mins, ArCOCl (1.1 equiv) was added dropwise over 10 min. The mixture was stirred for 2-
4 hrs until TLC analysis indicates full conversion of the starting material. The mixture was then 
cooled to 0 °C and cold water was added to quench the reaction. The aqueous layer was extracted 
with ethyl acetate for three times. The organic phase was washed with brine, dried (Na2SO4), 
filtered, and concentrated in vacuo to afford the crude product, which was purified by flash 
column chromatography using 20 % ethyl acetate-hexane (78-98 % yield). 
Allylic alcohol substrates in Table 8 were prepared according to literature methods.
39
 
 
Cinnamyl benzoyloxycarbamate (S3-1): White solid, mp: 95-97 ºC; 
1
H NMR (CDCl3, 
400 MHz): δ ppm 8.40 (1H, s), 8.13 (2H, d, J = 8.4 Hz), 7.69-7.65 (1H, m), 7.53-7.50 (2H, m), 
7.42-7.28 (5H, m), 6.72 (1H, d, J = 16.0 Hz), 6.33 (1H, dt, J = 16.0, 6.4 Hz), 4.90 (1H, d, J = 6.4 
Hz); 
13
C NMR (CDCl3, 100 MHz): δ ppm 165.9, 165.5, 136.0, 135.0, 134.3, 130.0, 128.7, 
128.6, 128.3, 126.8, 126.7, 122.3, 67.3; IR (film) νmax, 3242 (m), 1770 (s), 1759 (s), 1731 (s), 
1600 (m), 1490 (s), 1451 (s), 1389 (s), 1179 (m), 1108 (s), 1038 (m), 1004 (m), 967 (m), 
854(m), 749 (s), 705 (s), 694 (s) cm
-1
; HRMS (ESI-TOF) for C17H14NO4 [M-H
+
] calcd 
296.0923, found 296.0933. 
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(E)-3-(p-tolyl)allyl (4-cyanobenzoyl)oxycarbamate (S3-2): 
1
H NMR (CDCl3, 400 
MHz): δ ppm 8.46 (1H, s), 8.22 (2H, d, J = 8.0 Hz), 7.81 (2H, d, J = 8.0 Hz), 7.30 (2H, d, J = 
7.6 Hz), 7.16 (2H, d, J = 7.2 Hz), 6.68 (1H, d, J = 15.6 Hz), 6.25 (1H, dt, J = 16.0, 6.4 Hz), 4.89 
(1H, d, J = 6.4 Hz); 
13
C NMR (CDCl3, 100 MHz): δ ppm 164.3, 156.1, 138.4, 135.5, 133.1, 
132.5, 130.6, 130.5, 129.4, 129.2, 126.7, 120.8, 117.7, 117.6, 67.8, 21.3; IR (film) νmax, 3235 
(w), 1772 (s), 1732 (w), 1717 (s), 1491 (m), 1234 (s), 1118 (s), 1108 (s), 1040 (m), 1005 (m), 
970 (m), 765 (m), 706 (s) cm
-1
; HRMS (ESI-TOF) for C19H15N2O4 [M-H
+
] calcd 335.1032, 
found 335.1032. 
 
(E)-Methyl 4-(3-(((benzoyloxy)carbamoyl)oxy)prop-1-en-1-yl)benzoate (S3-3): White 
solid, mp: 109-111 
º
C; 
1
H NMR (CDCl3, 400 MHz): δ ppm 8.50 (1H, s), 8.01 (2H, d, J = 8.0 
Hz), 7.67 (2H, d, J = 7.6 Hz), 7.66 (1H, t, J = 7.6 Hz), 7.52 (2H, t, J = 7.6 Hz), 7.44 (2H, d, J = 
8.0 Hz), 6.73 (1H, d, J = 16.0 Hz), 6.41 (1H, dt, J = 16.0, 6.0 Hz), 4.92 (1H, d, J = 6.0 Hz), 3.93 
(3H, s); 
13
C NMR (CDCl3, 100 MHz): δ ppm 166.8, 165.8, 156.3, 140.4, 134.3, 133.5, 129.99, 
129.96, 129.6, 128.8, 126.6, 126.3, 125.0, 66.8, 52.1; IR (film) νmax, 3248 (w), 2953 (w), 1716 
(m), 1606 (m), 1452 (m), 1436 (m), 1278 (s), 1179 (s), 1106 (s), 1041 (m), 1005 (m), 970 (m), 
960 (m), 866 (m), 763 (s), 706 (s) cm
-1
; HRMS (ESI-TOF) for C19H16NO6 [M-H
+
] calcd 
354.0978, found 354.0967. 
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(E)-3-(3-Chlorophenyl)allyl benzoyloxycarbamate (S3-4): White solid, mp: 101-103 
º
C; 
1
H NMR (CDCl3, 400 MHz): δ ppm 8.46 (1H, s), 8.13 (2H, d, J = 8.0 Hz), 7.67 (1H, t, J = 
7.6 Hz), 7.51 (2H, t, J = 7.6 Hz), 7.38 (1H, s), 7.28-7.26 (3H, m), 6.64 (1H, d, J = 16.0 Hz), 6.31 
(1H, dt, J = 16.0, 6.0 Hz), 4.89 (2H, d, J = 6.0 Hz); 
13
C NMR (CDCl3, 100 MHz): δ ppm 165.8, 
156.3, 137.9, 134.6, 134.3, 133.2, 130.0, 129.8, 128.7, 128.2, 126.7, 124.9, 123.9, 66.8; IR (film) 
νmax, 3272 (w), 1733 (s), 1599 (m), 1566 (m), 1452 (s), 1318 (m), 1224 (s), 1179 (m), 1094 (s), 
1004 (s), 964 (s), 885 (m), 765 (s), 682 (s) cm
-1
; HRMS (ESI-TOF) for C17H13NO4Cl [M-H
+
] 
calcd 330.0533, found 330.0533. 
 
(E)-3-(Pyridin-4-yl)allyl benzoyloxycarbamate (S3-5): White solid, mp: 105-107 
º
C;  
1
H NMR (CDCl3, 400 MHz): δ ppm 9.37 (1H, s), 8.57 (1H, s), 8.12 (2H, d, J = 8.0 Hz), 7.71 
(1H, d, J = 8.0 Hz), 7.65 (1H, t, J = 7.6 Hz), 7.50 (2H, t, J = 7.6 Hz), 7.28 (1H, s), 6.67 (1H, d, J 
= 16.0 Hz), 6.37 (1H, dt, J = 16.0, 6.0 Hz), 4.89 (2H, d, J = 6.0 Hz); 
13
C NMR (CDCl3, 100 
MHz): δ ppm 165.8, 156.4, 148.9, 148.3, 134.2, 133.2, 130.6, 130.0, 128.7, 126.8, 125.0, 124.0, 
66.4; IR (film) νmax, 2924 (w), 1745 (s), 1636 (w), 1452 (m), 1363 (w), 1280 (s), 1113 (s), 902 
(w), 750 (m), 706 (m) cm
-1
; HRMS (ESI-TOF) for C16H13N2O4 [M-H
+
] calcd 297.0875, found 
297.0871. 
 
(E)-3-(Naphthalen-1-yl)allyl benzoyloxycarbamate (S3-6): White solid, mp: 75-77 
º
C; 
1
H NMR (CDCl3, 400 MHz): δ ppm 8.41 (1H, s), 8.18-8.10 (3H, m), 7.88 (1H, d, J = 8.8 Hz), 
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7.83 (1H, d, J = 8.4 Hz), 7.67 (1H, t, J = 7.2 Hz), 7.62 (1H, d, J = 7.2 Hz), 7.54-7.47 (6H, m), 
6.36 (1H, dt, J = 16.0, 6.0 Hz), 5.02 (2H, d, J = 6.0 Hz); 
13
C NMR (CDCl3, 100 MHz): δ ppm 
165.9, 156.5, 134.3, 133.8, 133.6, 132.1, 131.1, 130.0, 128.8, 128.6, 126.7, 126.3, 125.9, 125.6, 
125.5, 124.2, 123.7, 67.3; IR (film) νmax, 3268 (w), 1744 (s), 1601 (m), 1452 (m), 1396 (m), 1319 
(m), 1223 (s), 1179 (m), 1108 (m), 1040 (m), 1004 (m), 969 (m), 765 (s), 750 (s) cm
-1
; HRMS 
(ESI-TOF) for C21H16NO4 [M-H
+
] calcd 347.1158, found 347.1155. 
 
(E)-5-Phenylpent-2-en-4-yn-1-yl benzoyloxycarbamate (S3-7): Yellow solid, mp: 62-
64 ºC, 
1
H NMR (CDCl3, 400 MHz): δ ppm 8.83 (1H, s), 8.12 (2H, d, J = 7.2 Hz), 7.62 (1H, t, J = 
7.6 Hz), 7.49-7.45 (4H, m), 7.34-7.32 (3H, m), 6.27 (1H, dt, J = 16.0, 6.0 Hz), 6.03 (1H, d, J = 
16.0 Hz), 4.81 (2H, d, J = 6.0 Hz); 
13
C NMR (CDCl3, 100 MHz): δ ppm 165.8, 156.4, 135.4, 
134.3, 131.6, 130.0, 128.8, 128.5, 128.4, 126.7, 123.0, 114.3, 91.4, 86.8, 66.1; IR (film) νmax, 
3254 (m), 1747 (s), 1489 (m), 1452 (m), 1228 (s), 1179 (m), 1112 (s), 1004 (m), 952 (m), 756 
(s), 706 (m) cm
-1
; HRMS (ESI-TOF) for C19H15NO4Na [M+Na
+
] calcd 344.0899, found 
344.0912. 
 
(E)-But-2-en-1-yl benzoyloxycarbamate (S3-8): White solid, mp: 65-67 
º
C; 
1
H NMR 
(CDCl3, 400 MHz): δ ppm 8.64 (1H, s), 8.08 (2H, d, J = 7.6 Hz), 7.62 (1H, t, J = 7.6 Hz), 7.46 
(1H, d, J = 7.6 Hz), 5.87-5.78 (1H, m), 5.63-5.56 (1H, m), 4.63 (2H, d, J = 6.4 Hz), 1.71 (3H, d, 
J = 6.4 Hz); 
13
C NMR (CDCl3, 100 MHz): δ ppm 165.8, 156.6, 134.2, 132.4, 130.0, 128.7, 
126.8, 124.4, 67.4, 17.8; IR (film) νmax, 3273 (w), 2969 (w), 1733 (s), 1601 (w), 1451 (m), 1319 
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(w), 1275 (m), 1259 (m), 1225 (s), 1178 (m), 1104 (m), 966 (m), 750 (s), 704 (m) cm
-1
; HRMS 
(ESI-TOF) for C12H12NO4 [M-H
+
] calcd 234.0766, found 234.0775. 
 
(Z)-3-Phenylallyl benzoyloxycarbamate (S3-9): Colorless oil, 
1
H NMR (CDCl3, 400 
MHz): δ ppm 8.52 (1H, s), 8.12 (2H, d, J = 7.6 Hz), 7.66 (1H, t, J = 7.4 Hz), 7.51 (2H, t, J = 7.6 
Hz), 7.37 (2H, t, J = 7.6 Hz), 7.30 (1H, t, J = 7.8 Hz), 7.24 (2H, d, J = 7.4 Hz), 6.73 (1H, d, J = 
7.6 Hz), 5.90-5.83 (1H, m), 5.01 (2H, d, J = 6.4 Hz); 
13
C NMR (CDCl3, 100 MHz): δ ppm 165.9, 
165.5, 135.8, 134.3, 133.9, 130.0, 128.7, 128.5, 127.7, 126.7, 124.9, 63.6; IR (film) νmax, 3267 
(m), 1734 (s), 1600 (m), 1451 (m), 1318 (m), 1227 (s), 1119 (m), 1107 (s), 1040 (m), 1004 (m), 
855 (m), 765 (m), 701 (s) cm
-1
; HRMS (ESI-TOF) for C17H16NO4 [M+H
+
] calcd 298.1079, 
found 298.1065. 
 
(Z)-5-Phenylpent-2-en-4-yn-1-yl benzoyloxycarbamate (S3-10): Yellow solid, mp: 45-
47 º C, 
1
H NMR (CDCl3, 400 MHz): δ ppm 8.55 (1H, s), 8.11 (2H, d, J = 7.6 Hz), 7.65 (1H, t, J 
= 7.6 Hz), 7.52-7.46 (4H, m), 7.35-7.33 (3H, m), 6.10 (1H, dt, J = 11.2, 6.0 Hz), 5.95 (1H, d, J = 
11.2 Hz), 5.10 (2H, d, J = 6.4 Hz); 
13
C NMR (CDCl3, 100 MHz): δ ppm 165.8, 156.4, 135.0, 
134.3, 131.6, 130.0, 128.73, 128.66, 128.4, 126.7, 122.8, 113.7, 96.5, 84.3, 64.4; IR (film) νmax, 
3266 (m), 1747 (s), 1490 (m), 1452 (m), 1230 (s), 1180 (m), 1110 (s), 1040 (m), 756 (s), 706 (m) 
cm
-1
; HRMS (ESI-TOF) for C19H15NO4Na [M+Na
+
] calcd 344.0899, found 344.0912. 
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(E)-3-Phenylbut-2-en-1-yl benzoyloxycarbamate (S3-11): White solid, mp: 64-66 
º
C; 
1
H NMR (CDCl3, 400 MHz): δ ppm 8.72 (1H, s), 8.13 (2H, d, J = 7.6 Hz), 7.64 (1H, t, J = 7.6 
Hz), 7.51-7.31 (7H, m), 5.95 (1H, t, J = 7.2 Hz), 4.97 (2H, d, J = 6.8 Hz), 2.14 (3H, s); 
13
C NMR 
(CDCl3, 100 MHz): δ ppm 165.9, 156.8, 142.4, 141.3, 134.2, 130.0, 128.7, 128.4, 127.7, 126.8, 
125.9, 120.5, 63.9, 16.3; IR (film) νmax, 3274 (w), 1733 (s), 1600 (m), 1451 (s), 1346 (m), 1317 
(m), 1225 (s), 1179 (m), 1104 (m), 1039 (m), 1004 (m), 931 (m), 854 (m), 751 (s), 697 (s) cm
-1
; 
HRMS (ESI-TOF) for C18H16NO4 [M-H
+
] calcd 310.1079, found 310.1087. 
 
(E)-2-Methyl-3-phenylallyl benzoyloxycarbamate (S3-12): White solid, mp: 85-87 
º
C;  
1
H NMR (CDCl3, 400 MHz): δ ppm 8.66 (1H, brs), 8.13 (2H, d, J = 7.6 Hz), 7.65 (1H, t, J = 6.8 
Hz), 7.50 (2H, t, J = 6.8 Hz), 7.38-7.25 (5H, m), 6.59 (1H, s), 4.82 (2H, s), 1.93 (3H, s); 
13
C 
NMR (CDCl3, 100 MHz): δ ppm 165.9, 156.7, 136.8, 134.3, 132.0, 130.0, 129.0, 128.8, 128.2, 
126.9, 126.7, 72.3, 15.4; IR (film) νmax, 3274 (w), 2990 (w), 1744 (m), 1600 (m), 1452 (m), 1320 
(m), 1275 (s), 1260 (s), 1228 (s), 1107 (m), 1004 (m), 856 (m), 750 (s), 700 (m) cm
-1
; HRMS 
(ESI-TOF) for C18H16NO4 [M-H
+
] calcd 310.1079, found 310.1087. 
 
Methyl 4-((((((2-phenylallyl)oxy)carbonyl)amino)oxy)carbonyl)benzoate (S3-13): 
White solid, mp: 75-77 
º
C; 
1
H NMR (CDCl3, 400 MHz): δ ppm 8.45 (1H, s), 8.14-8.11 (4H, m), 
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7.44-7.42 (2H, m), 7.37-7.30 (3H, m), 5.60 (1H, s), 5.43 (1H, d, J = 0.8 Hz), 5.15 (2H, d, J = 0.4 
Hz), 3.98 (3H, s); 
13
C NMR (CDCl3, 100 MHz): δ ppm 166.0, 165.0, 156.1, 141.8, 137.6, 135.0, 
130.3, 129.9, 129.8, 128.5, 128.2, 126.0, 116.1, 68.0, 52.6; IR (film) νmax, 3267 (w), 1738 (s), 
1600 (m), 1452 (m), 1318 (m), 1225 (s), 1179 (m), 1095 (m), 1044 (m), 1003 (m), 915 (m), 855 
(m), 828 (w), 764 (s) cm
-1; IR (film) νmax, 3261 (w), 3005 (w), 1722 (s), 1575 (w), 1436 (m), 
1409 (m), 1276 (s), 1261 (s), 1223 (s), 1102 (m), 1009 (m), 872 (m), 750 (s), 723 (m) cm
-1
; 
HRMS (ESI-TOF) for C19H18NO6 [M-H
+
] calcd 354.1056, found 354.1047. 
 
Methyl 4-(((5-methylhex-4-enamido)oxy)carbonyl)benzoate (S3-14): White solid, mp: 
92-94 
º
C; 
1
H NMR (CDCl3, 400 MHz): δ ppm 8.13-8.08 (4H, m), 5.13 (1H, s), 3.96 (3H, s), 2.38 
(4H, s), 1.70 (3H, s), 1.63 (3H, s); 
13
C NMR (CDCl3, 100 MHz): δ ppm 166.0, 164.0, 134.9, 
134.0, 130.4, 129.9, 129.7, 122.0, 52.6, 33.2, 25.7, 23.6, 17.7; IR (film) νmax, 3211 (w), 2918 (w), 
1781 (s), 1729 (s), 1671 (s), 1435 (m), 1280 (s), 1234 (s), 1106 (s), 1073 (m), 1017 (m), 750 (m), 
721 (m) cm
-1
; HRMS (ESI-TOF) for C16H20NO5 [M+H
+
] calcd 306.1341, found 306.1348. 
 
Cyclohex-2-en-1-yl benzoyloxycarbamate (S3-15): White solid, mp: 63-65 
º
C; 
1
H NMR 
(CDCl3, 400 MHz): δ ppm 8.43 (1H, s), 8.10 (2H, d, J = 8.0 Hz), 7.64 (1H, t, J = 7.6 Hz), 7.49 
(2H, t, J = 7.6 Hz), 6.02-5.97 (1H, m), 5.79-5.77 (1H, m), 5.32-5.31 (1H, m), 2.08-1.84 (4H, m), 
1.77-1.63 (2H, m); 
13
C NMR (CDCl3, 100 MHz): δ ppm 165.9, 156.4, 134.2, 133.6,130.0, 128.7, 
126.8, 124.9, 71.0, 28.2, 24.8, 18.6; IR (film) νmax, 3275 (w), 2942 (w), 1733 (s), 1601 (w), 1452 
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(m), 1229 (s), 1179 (m), 1106 (s), 1040 (m), 1003 (m), 909 (m), 750 (m), 706 (m) cm
-1
; HRMS 
(ESI-TOF) for C14H16NO4 [M+H
+
] calcd 262.1079, found 262.1085. 
 
Methyl 4-((((((1-phenylallyl)oxy)carbonyl)amino)oxy)carbonyl)benzoate (S3-16): 
White solid, mp: 39-41 
º
C; 
1
H NMR (CDCl3, 400 MHz): δ ppm 8.86 (1H, s), 8.11 (4H, s), 7.35-
7.28 (5H, m), 6.29 (1H, d, J = 6.0 Hz), 6.08-5.99 (1H, m), 5.39-5.28 (2H, m), 3.95 (3H, s); 
13
C 
NMR(CDCl3, 100 MHz): δ ppm 166.0, 165.0, 164.9, 155.7, 137.9, 135.4, 134.9, 130.5, 129.9, 
129.8, 128.6, 128.5, 127.1, 117.8, 78.9, 52.6; IR (film) νmax, 3266 (w), 2942 (w), 1725 (s), 1436 
(m), 1287 (s), 1270 (m), 1105 (s), 1040 (m), 1003 (m), 909 (m), 725 (m), 700 (m) cm
-1
; HRMS 
(ESI-TOF) for C19H18NO6 [M+H
+
] calcd 356.1134, found 356.1123. 
2.2.4 Procedure for Iron(II)-Catalyzed Olefin Aminohydroxylation 
2.2.4.1 Substrates Screen 
During the optimization process, O-alkyl hydroxycarbamates and O-sulfonyl 
hydroxycarbamates were both screened. It was found that O-alkyl hydroxycarbamates were 
nonreactive under K4Fe(CN)6 (70 ºC), Fe(NTf2)2 and Fe(OAc)2 conditions. Full recovery of 
starting material was obtained in each case. O-sulfonyl hydroxycarbamates displayed a few 
undesired reaction patterns listed below. 
1) K4Fe(CN)6 + phenanthroline (70 ºC) 
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2) Fe(NTf2)2 + phenanthroline/chiral BOX ligands L4 (0 ºC): full recovery of the 
starting material 
3) Fe(OAc)2 + phenanthroline at RT 
 
4) Fe(OAc)2 + chiral BOX ligands L4 at 0 ºC: 
 
2.2.4.2 Diastereoselectivity Optimization of para-Methyl Substituted Substrate  
 
Table 1. T he Diastereoselectivity Optimization of para-Methyl Substituted Substrate 
For K4Fe(CN)6-catalyzed reaction, the major diastereomer from the trans olefin is the 
anti-addition product, which can be obtained through either intramolecular suprafacial ligand 
(benzoate) transfer after C-C sigma bond rotation or intermolecular antarafacial ligand transfer 
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before C-C sigma bond rotation. From the crossover experiment under the K4Fe(CN)6-catalyzed 
conditions, it is possible intermolecular ligand transfer occurs. Therefore, the antarafacial ligand 
transfer before C-C sigma bond rotation might be accountable for a high dr. In principle, para-
methyl-phenyl can further stabilize the radical, and allows for more time of C-C sigma bond 
rotation before the antarafacial ligand transfer, which leads to low dr. 
Presumably, more electron-deficient benzoates will be transferred to benzyl radical faster 
(reminiscent of both Jacobsen and Kochi’s ligand electronic tuning to influence the dr of 
epoxidation), so that it can outcompete the dr erosion effect from the radical stabilizing groups 
on substrates. 
For Fe(OAc)2 and Fe(NTf2)2-catalyzed reactions, totally different mechanism might 
operate. We found the complementary diastereoselectivities were achieved with achiral and 
chiral ligands. 
 
2.2.4.3 General Procedure for Key Reaction Set Up  
To a flame-dried schlenk tube were added K4Fe(CN)6 (0.02 mmol) and phenanthroline 
(0.04 mmol). After evacuation upon oil pump and refill with Ar three times, anhydrous and 
degassed MeCN (3 mL) was added. The obtained suspension was stirred vigorously at room 
temperature for 30 minutes, after which time the substrate (0.2 mmol) was added. The reaction 
mixture was heated at 70 ºC until all the starting material was fully consumed. The reaction 
mixture was cooled and concentrated to a residue, which was chromatographed by using 1:1 
hexane and ethyl acetate as the eluant to give the designed aminohydroxylation product (40-92% 
yield).  
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2-Oxooxazolidin-4-yl)(phenyl)methyl benzoate (S4-1)
38
: 89% yield from E substrate, 
75% yield from Z substrate, Colorless oil, 
1
H NMR (CDCl3, 400 MHz): δ ppm 8.09 (2H, d, J = 
7.6 Hz), 7.63 (1H, t, J = 7.6 Hz), 7.49 (2H, t, J = 7.6 Hz), 7.43-7.39 (5H, m), 6.05 (1H, d, J = 6.0 
Hz), 5.29 (1H, s), 4.49 (2H, d, J = 6.8 Hz), 4.37-4.32 (1H, m); 
13
C NMR (CDCl3, 100 MHz): δ 
ppm 165.4, 159.0, 135.5, 133.7, 129.8, 129.2, 129.1, 128.7, 126.6, 75.9, 66.5, 56.2; IR (film) 
νmax, 3279 (w), 1750 (s), 1745 (s), 1736 (s), 1601 (w), 1451 (m), 1381 (m), 1265 (s), 1178(m), 
1108 (s), 1069 (m), 1025 (s), 939 (m), 710 (s) cm
-1
; HRMS (ESI-TOF) for C17H16NO4 [M+H
+
] 
calcd 298.1079, found 298.1065. 
 
2-Oxooxazolidin-4-yl)(p-tolyl)methyl 4-cyanobenzoate (S4-2): 81% yield, 
1
H NMR 
(CDCl3, 400 MHz): major isomer: δ ppm 8.18 (2H, d, J = 8.0 Hz), 7.78 (1H, t, J = 8.0 Hz), 7.31-
7.22 (4H, m), 6.15 (1H, s), 5.91 (1H, d, J = 4.8 Hz), 4.40-4.36 (2H, m), 4.21-4.19 (1H, m), 2.36 
(3H, s); 
13
C NMR (CDCl3, 100 MHz): δ ppm 163.9, 159.1, 139.7, 133.1, 132.5, 131.9, 130.3, 
130.0, 126.7, 117.8, 78.4, 66.5, 56.2, 21.2; minor isomer: δ ppm 8.18 (2H, d, J = 8.0 Hz), 7.78 
(1H, t, J = 8.0 Hz), 7.31-7.22 (4H, m), 6.03 (1H, d, J = 4.8 Hz), 5.72 (1H, s), 4.48-4.46 (1H, m), 
4.40-4.36 (1H, m), 2.36 (3H, s); 
13
C NMR (CDCl3, 100 MHz): δ ppm 163.9, 158.9, 139.5, 133.1, 
132.4, 131.7, 130.3, 129.9, 126.6, 117.0, 76.7, 66.3, 56.0, 21.2; IR for the mixture of 2 
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diasteromers (film) νmax, 3318 (w), 1730 (s), 1728 (s), 1635 (w), 1450 (m), 1380 (m), 1271 (s), 
1177 (m), 1103 (s), 1018 (m), 910 (m), 737 (s) cm
-1
; HRMS (ESI-TOF) for C19H15N2O4 [M-H
+
] 
calcd 335.1032, found 335.1036. 
 
Methyl 4-((benzoyloxy)((2-oxooxazolidin-4-yl)methyl)benzoate (S4-3): 75% yield, 
Colorless oil, 
1
H NMR (CDCl3, 400 MHz): δ ppm 8.08-8.06 (4H, m), 7.65-7.61 (1H, m), 7.51-
7.48 (4H, m), 6.10 (1H, d, J = 5.2 Hz), 6.00 (1H, s), 4.46-4.42 (2H, m), 4.35-4.30 (1H, m), 3.93 
(3H, s); 
13
C NMR (CDCl3, 100 MHz): δ ppm 166.3, 165.3, 159.1, 140.3, 133.8, 130.9, 130.3, 
129.8, 129.0, 128.7, 126.5, 75.5, 66.1, 56.1, 52.3; IR (film) νmax, 3273 (w), 1752 (s), 1747 (s), 
1560 (w), 1496 (w), 1267 (s), 1149 (w), 1109 (s), 1019 (w), 900 (w), 713 (s) cm
-1
; HRMS (ESI-
TOF) for C19H18NO6 [M+H
+
] calcd 356.1134, found 356.1125. 
 
3-Chlorophenyl-2-oxooxazolidin-4-yl)methyl benzoate (S4-4): 74% yield, Colorless 
oil, 
1
H NMR (CDCl3, 400 MHz): δ ppm 8.10-8.07 (2H, m), 7.65-7.61 (1H, m), 7.49 (2H, d, J = 
8.0 Hz), 7.40-7.26 (4H, m), 6.16 (1H, s), 6.02 (1H, d, J = 5.2 Hz), 4.49-4.42 (2H, m), 4.32-4.28 
(1H, m); 
13
C NMR (CDCl3, 100 MHz): δ ppm 165.3, 159.2, 137.5, 135.2, 133.8, 130.4, 129.9, 
129.3, 129.0, 128.7, 126.7, 124.8, 75.3, 66.3, 56.2; IR (film) νmax, 3274 (w), 1750 (s), 1737 
(s),1560 (w), 1477 (m), 1451 (m), 1407 (m), 1262 (s), 1179 (m), 1107 (s), 1069 (m), 1026 (s), 
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939 (m), 765 (m), 711 (s) cm
-1
; HRMS (ESI-TOF) for C17H15NO4Cl [M+H
+
] calcd 332.0690, 
found 332.0690. 
 
(2-Oxooxazolidin-4-yl)(pyridin-4-yl)methyl benzoate (S4-5): 80% yield, White solid, 
mp: 183-185 
º
C; 
1
H NMR (MeOD-d4, 400 MHz): δ ppm 8.71 (1H, s), 8.56 (1H, s), 8.14-8.12 
(2H, m), 7.99 (1H, d, J = 8.0 Hz), 7.66 (1H, t, J = 7.6 Hz), 7.55-7.48 (3H, m), 6.12 (1H, d, J = 
3.6 Hz), 4.53-4.46 (3H, m); 
13
C NMR (MeOD-d4, 100 MHz): δ ppm 165.2, 160.5, 149.1, 147.7, 
135.6, 133.5, 132.4, 129.4, 129.1, 128.4, 124.1, 74.4, 65.9, 55.7; IR (film) νmax, 3241 (w), 1721 
(s), 1668 (s), 1559 (w), 1461 (m), 1451 (m), 1316 (m), 1261 (s), 1179 (m), 1107 (s), 1069 (s), 
1025 (s), 937 (m), 766 (m) cm
-1
; HRMS (ESI-TOF) for C16H15N2O4 [M+H
+
] calcd 299.1032, 
found 299.1027. 
 
Naphthalen-1-yl(2-oxooxazolidin-4-yl)methyl benzoate (S4-6): 81% yield, White 
solid, mp: 115-117 
º
C; 
1
H NMR (CDCl3, 400 MHz): δ ppm 8.17-8.11 (3H, m), 7.93-7.87 (2H, 
m), 7.68-7.47 (7H, m), 6.91 (1H, d, J = 4.8 Hz), 5.72 (1H, s), 4.64-4.60 (1H, m), 4.55-4.51 (1H, 
m), 4.39-4.35 (1H, m); 
13
C NMR (CDCl3, 100 MHz): δ ppm 165.5, 159.1, 133.9, 133.7, 131.3, 
130.2, 129.9, 129.7, 129.3, 129.2, 128.7, 127.2, 126.3, 125.3, 124.3, 122.4, 72.9, 66.2, 55.6; IR 
(film) νmax, 3298 (w), 1738 (s), 1724 (s), 1600 (w), 1402 (m), 1267 (s), 1178 (w), 1109 (m), 1070 
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(m), 1027 (m), 765 (m), 712 (s) cm
-1
; HRMS (ESI-TOF) for C21H18NO4 [M+H
+
] calcd 348.1236, 
found 348.1247. 
 
1-(2-Oxooxazolidin-4-yl)-3-phenylprop-2-yn-1-yl benzoate (S4-7): 92% yield from E 
substrate, 90% yield from Z substrate, Colorless oil, Major isomer: 
1
H NMR (CDCl3, 400 MHz): 
δ ppm 8.02 (2H, d, J = 8.0 Hz), 7.61-7.59 (1H, m), 7.57-7.44 (4H, m), 7.39-7.26 (3H, m), 6.54 
(1H, s), 5.82 (1H, d, J = 4.2 Hz), 4.61-4.56 (1H, m), 4.53-4.50 (1H, m), 4.33-4.31 (1H, m); 
13
C 
NMR (CDCl3, 100 MHz): δ ppm 165.2, 159.5, 133.8, 132.2, 130.0, 129.4, 128.9, 128.6, 128.4, 
121.1, 87.8, 81.7, 66.5, 66.2, 55.1; minor isomer: 
1
H NMR (CDCl3, 400 MHz): δ ppm 7.99 (2H, 
d, J = 8.0 Hz), 7.61-7.59 (1H, m), 7.57-7.44 (4H, m), 7.39-7.26 (3H, m), 6.48 (1H, s), 5.90 (1H, 
d, J = 2.4 Hz), 4.61-4.56 (1H, m), 4.53-4.50 (1H, m), 4.33-4.31 (1H, m); 
13
C NMR (CDCl3, 100 
MHz): δ ppm 165.3, 159.5, 133.3, 131.6, 130.1, 129.4, 128.9, 128.6, 128.3, 121.1, 88.0, 81.4, 
66.4, 65.9, 55.2; IR for the two isomers (film) νmax, 3264 (w), 1754 (s), 1721 (s), 1601 (m), 1491 
(w), 1406 (m), 1315 (m), 1262 (s), 1178 (w), 1094 (m), 1025 (m), 932 (w), 758 (m), 711 (s), 691 
(s) cm
-1
; HRMS (ESI-TOF) for C19H15NO4Na [M+Na
+
] calcd 344.0899, found 344.0912. 
 
1-(2-Oxooxazolidin-4-yl)ethyl benzoate (S4-8): 85% yield, Colorless oil, Major isomer: 
1
H NMR (CDCl3, 400 MHz): δ ppm 8.03 (2H, d, J = 8.0 Hz), 7.58 (1H, t, J = 7.2 Hz), 7.45 (2H, 
t, J = 7.6 Hz), 6.70 (1H, s), 5.23-5.17 (1H, m), 4.54-4.48 (1H, m), 4.44-4.36 (1H, m), 4.09-4.03 
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(1H, m), 1.37 (3H, d, J = 6.4 Hz); 
13
C NMR (CDCl3, 100 MHz): δ ppm 165.8, 160.0, 133.4, 
129.7, 129.6, 128.5, 71.2, 66.3, 55.7, 15.2; minor isomer: 
1
H NMR (CDCl3, 400 MHz): δ ppm 
8.03 (2H, d, J = 8.0 Hz), 7.58 (1H, t, J = 7.2 Hz), 7.45 (2H, t, J = 7.6 Hz), 6.84 (1H, s), 5.17-5.13 
(1H, m), 4.54-4.48 (1H, m), 4.28-4.25 (1H, m), 4.09-4.03 (1H, m), 1.37 (3H, d, J = 6.4 Hz); 
13
C 
NMR (CDCl3, 100 MHz): δ ppm 165.8, 160.0, 133.4, 129.7, 129.6, 128.5, 71.5, 66.8, 55.7, 15.7; 
IR for the two isomers (film) νmax, 3298 (w), 1755 (s), 1736 (s), 1722 (s), 1541 (w), 1276 (s), 
1150 (w), 1110 (m), 960 (w), 729 (w), 712 (s) cm
-1
; HRMS (ESI-TOF) for C12H14NO4 [M+H
+
] 
calcd 236.0923, found 236.0925. 
 
1-(2-Oxooxazolidin-4-yl)-1-phenylethyl benzoate (S4-9): 81% yield, Colorless oil, 
Major isomer: 
1
H NMR (CDCl3, 400 MHz): δ ppm 8.07 (2H, d, J = 8.0 Hz), 7.61 (1H, t, J = 7.2 
Hz), 7.49 (2H, t, J = 7.2 Hz), 7.42-7.33 (5H, m), 6.32 (1H, s), 4.33-4.31 (2H, m), 4.23-4.20 (1H, 
m), 2.07 (3H, s); 
13
C NMR (CDCl3, 100 MHz): δ ppm 164.6, 159.6, 139.5, 133.4, 129.7, 129.0, 
128.6, 128.4, 125.1, 83.8, 65.7, 61.8, 18.7; IR (film) νmax, 3298 (w), 1755 (s), 1722 (s), 1540 (w), 
1276 (s), 1150 (w), 1110 (m), 957 (w), 735 (w), 712 (s) cm
-1
; HRMS (ESI-TOF) for C18H18NO4 
[M+H
+
] calcd 312.1236, found 312.1243. 
 
(4-Methyl-2-oxooxazolidin-4-yl)(phenyl)methyl benzoate (S4-10): 71% yield, 
Colorless oil, Major isomer: 
1
H NMR (CDCl3, 400 MHz): δ ppm 8.10-7.37 (10H, m), 5.99 (1H, 
s), 5.90 (1H, s), 4.54 (1H, d, J = 8.8 Hz), 4.14 (1H, d, J = 8.8 Hz), 1.39 (3H, s); 
13
C NMR 
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(CDCl3, 100 MHz): δ ppm 165.4, 158.9, 135.2, 133.6, 129.9, 129.3, 128.8, 128.7, 127.2, 79.3, 
73.5, 23.3; minor isomer: 
1
H NMR (CDCl3, 400 MHz): δ ppm 8.10-7.37 (10H, m), 6.22 (1H, s), 
5.99 (1H, s), 4.56 (1H, m), 4.10 (1H, d, J = 8.8 Hz), 1.48 (3H, s); 
13
C NMR (CDCl3, 100 MHz): 
δ ppm 165.4, 158.9, 135.2, 133.3, 129.9, 129.8, 128.8, 128.7, 127.3, 79.0, 72.8, 23.0; IR for the 
two isomers (film) νmax, 3280 (w), 1752 (s), 1721 (s), 1534 (w), 1276 (s), 1130 (w), 1111 (m), 
970 (w), 735 (w), 716 (s) cm
-1
; HRMS (ESI-TOF) for C18H18NO4 [M+H
+
] calcd 312.1236, found 
312.1243. 
 
Methyl ((2-oxo-4-phenyloxazolidin-4-yl)methyl) terephthalate (S4-11): 72% yield, 
White solid, mp: 207-209 
º
C; 
1
H NMR (CDCl3, 400 MHz): δ ppm 8.11-8.05 (4H, m), 7.48-7.36 
(5H, m), 6.48 (1H, s), 4.77 (1H, d, J = 8.8 Hz), 4.70-4.63 (2H, m), 4.78 (1H, d, J = 8.4 Hz), 3.96 
(3H, s); 
13
C NMR (DMSO-d6, 100 MHz): δ ppm 165.9, 165.0, 158.7, 140.9, 134.3, 133.5, 130.1, 
129.9, 129.2, 128.5, 125.8, 72.8, 70.2, 63.1, 53.0; IR (film) νmax, 3279 (w), 1750 (s), 1718 (s), 
1435 (m), 1399 (w), 1267 (s), 1106 (m), 1018 (m), 750 (s), 727 (s) cm
-1
; HRMS (ESI-TOF) for 
C19H18NO6 [M+H
+
] calcd 356.1134, found 356.1123. 
 
Methyl (2-(5-oxopyrrolidin-2-yl)propan-2-yl) terephthalate (S4-12): 76% yield, 
White solid, mp: 160-162 
º
C; 
1
H NMR (CDCl3, 400 MHz): δ ppm 8.10 (d, 2H, J = 8.4 Hz), 8.01 
(2H, d, J = 8.0 Hz), 6.62 (1H, s), 4.08 (1H, t, J = 6.8 Hz), 3.97 (1H, s), 2.43-2.26 (3H, m), 2.04-
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2.01 (1H, m), 1.66 (3H, s), 1.62 (3H, s); 
13
C NMR (CDCl3, 100 MHz): δ ppm 178.3, 166.2, 
164.7, 134.9, 134.0, 129.6, 129.4, 84.8, 61.8, 52.5, 30.0, 22.4, 22.1, 20.4; IR (film) νmax, 2917 
(w), 1695 (s), 1596 (m), 1499 (w), 1457 (w), 1389 (w), 1277(s), 1118 (m), 731 (m), cm
-1
; HRMS 
(ESI-TOF) for C16H20NO5 [M+H
+
] calcd 306.1341, found 306.1348. 
 
2-Oxooctahydrobenzo[d]oxazol-4-yl benzoate (S4-13): 75% yield, White solid, mp: 
158-160 
º
C; 
1
H NMR (CDCl3, 400 MHz): δ ppm 8.03 (d, 2H, J = 8.0 Hz), 7.60 (1H, t, J = 7.2 
Hz), 7.47 (2H, t, J = 7.6 Hz), 6.04 (1H, s), 5.02-4.97 (1H, m), 4.84-4.83 (1H, m), 3.76-3.73 (1H, 
m), 2.24-2.13 (2H, m), 1.80-1.73 (3H, m), 1.58-1.49 (1H, m); 
13
C NMR (CDCl3, 100 MHz): δ 
ppm 166.2, 159.5, 133.5, 129.7, 129.6, 128.5,76.5, 76.3, 56.8, 26.6, 26.2, 17.0; IR (film) νmax, 
2926 (w), 1752 (m), 1275 (w), 1261(s), 1151 (m), 750 (m), cm
-1
; HRMS (ESI-TOF) for 
C14H16NO4 [M+H
+
] calcd 262.1079, found 262.1085. 
 
methyl ((2-oxo-5-phenyloxazolidin-4-yl)methyl) terephthalate (S4-14): 40% yield, 
White solid, mp: 183-185 
º
C; 
1
H NMR (CDCl3, 400 MHz): δ ppm 8.15-8.08 (m, 4H), 7.43 (5H, 
s), 5.77 (1H, s), 5.11 (1H, d, J = 5.6 Hz), 4.65-4.61 (1H, m), 4.49-4.45 (1H, m), 4.16-4.15 (1H, 
m), 3.98 (3H, s); 
13
C NMR (d
6
-DMSO, 100 MHz): δ ppm 166.0, 165.2, 158.5, 139.7, 134.2, 
133.7, 130.2, 129.9, 129.3, 129.2, 126.4, 78.8, 66.4, 58.6, 53.0; IR (film) νmax, 3377 (w), 1757 
50 
(m), 1721 (m), 1403 (m), 1275 (s), 1119 (s), 1019 (m), 730 (m), cm
-1
; HRMS (ESI-TOF) for 
C19H18NO6 [M+H
+
] calcd 356.1134, found 356.1128. 
2.2.5 K4Fe(CN)6-Catalyzed Crossover Experiment 
To a flame-dried Schleck tube was added K4Fe(CN)6 (0.02 mmol) and phenanthroline 
(0.04 mmol). After evacuation upon oil pump and refill with Ar three times, anhydrous and 
degassed MeCN (3 mL) was added. The obtained suspension was stirred vigorously at room 
temperature for 30 minutes, after which time the two substrates with the same equivalence (0.1 
mmol for each) were added. The reaction mixture was heated at 70 ºC until all the starting 
material was fully consumed. The reaction mixture was cooled and concentrated to a residue, 
which was filtered through a very short column. The obtained solution was then concentrated 
upon rotavap and analyzed on chiral HPLC (Chiralcel OD-H, 1.0 mL/min, 210 nm, 20% i-PrOH 
in hexane). 
 
HPLC traces for four possible cyclization products: 
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2.2.6 Iron(II)-Catalyzed Enantioselective Olefin Aminohydroxylation 
2.2.6.1 Procedure for Fe(II)-Catalyzed Racemic Aminohydroxylation Reaction 
To a flame-dried Schleck tube was added K4Fe(CN)6 (0.02 mmol) and phenanthroline 
(0.04 mmol) respectively. After evacuation upon oil pump and refill with Ar three times, 
anhydrous and degassed MeCN (3 mL) was added. The obtained suspension was stirred 
vigorously at room temperature for 30 minutes, after which time the substrate 9a or 9b (0.2 
mmol) was added. The reaction mixture was heated at 70 ºC until all the starting material was 
fully consumed. The reaction mixture was cooled and concentrated to a residue, which was 
chromatographed by using 1:1 hexane and ethyl acetate as the eluant to give the designed 
racemic aminohydroxylation product (85% yield, dr = 3.6:1). 
2.2.6.2 Procedure for Fe(II)-Catalyzed Asymmetric Aminohydroxylation Reaction 
To a flame-dried schlenk tube were added Fe(NTf2)2 (0.01 mmol) and chiral ligand L3 
(0.02 mmol) respectively. After evacuation upon oil pump and refill with Ar gas three times, 
anhydrous and degassed acetonitrile (2 mL) was added. The obtained mixture was stirred 
vigorously at room temperature for 60 minutes. Substrate 9a or 9b (0.1 mmol) in 1 mL of 
anhydrous and degassed MeCN was then added. The reaction mixture was stirred at -10 ºC for 
12 hours. The reaction mixture was then quenched by Sat. NaHCO3, and then extracted with 
ethyl acetate. The organic phase was washed with brine, dried (Na2SO4), filtered, and 
concentrated in vacuo to afford the crude product, which was purified by flash column 
chromatography using 50 % ethyl acetate-hexane (68% yield, dr > 20:1, 82% ee). 
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2-Oxooxazolidin-4-yl)(phenyl)methyl 2,4-dichlorobenzoate (11): 
1
H NMR (CDCl3, 
400 MHz): [𝛼]D
20 = -8.8 (c = 1.3, CH2Cl2); syn-isomer: δ ppm 7.90 (2H, d, J = 8.4 Hz), 7.51 (1H, 
s), 7.43 (5H, s), 7.35 (1H, d, J = 8.4 Hz), 6.04 (1H, s), 5.93 (1H, d, J = 5.6 Hz), 4.35-4.31 (2H, 
m), 4.21-4.20 (1H, m); anti-isomer: δ ppm 7.90 (2H, d, J = 8.4 Hz), 7.51 (1H, s), 7.43 (5H, s), 
7.35 (1H, d, J = 8.4 Hz), 6.04 (1H, d, J = 6.0 Hz), 5.14 (1H, s), 4.52-4.45 (2H, m), 4.38-4.33 
(1H, m); 
13
C NMR (CDCl3, 100 MHz): syn-isomer: δ ppm 163.6, 158.9, 139.2, 135.0, 134.9, 
133.1, 131.2, 129.5, 129.3, 127.4, 127.2, 127.0, 78.6, 66.2, 56.1; anti-isomer: δ ppm 163.6, 
158.9, 139.3, 135.0, 134.9, 133.2, 131.2, 129.5, 129.4, 127.4, 127.3, 127.1, 78.8, 66.2, 56.2; IR 
(film) νmax, 3285 (w), 1738 (m), 1653 (m), 1584 (m), 1455 (m), 1376 (m), 1276 (w), 1231(s), 
1145 (m), 1100 (m), 1045 (m), 733 (m), 696 (s) cm
-1
; HRMS (ESI-TOF) for C17H12Cl2NO4 [M-
H
+
] calcd 364.0143, found 364.0142. 
2.2.6.3 Reaction Optimization of Asymmetric Aminohydroxylation Reaction 
Parameters below were further optimized upon following the procedure of Fe(II)-
catalyzed asymmetric aminohydroxylation reaction. 
1) Ligand screen 
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Table 2. Ligand Screening for Reaction Optimization 
2) Solvent screen 
 
Table 3. Solvent Screening for Reaction Optimization 
3) Temperature screen 
 
Table 4. Temperature Screening for Reaction Optimization 
4) Concentration screen 
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Table 5. Concentration Screening for Reaction Optimization 
2.2.6.4 HPLC Data 
The samples were analyzed by Chiral HPLC analysis (Chiralcel AD-H, 1.0 mL/min, 254 
nm, 20% i-PrOH in hexane). 
Racemic sample: 
 
 
 
Fe
II
-catalyzed tethered asymmetric aminohydroxylation reaction: 
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2.2.6.5 Ligand Effect over Diastereoselectivity 
An anti-amino alcohol was obtained when achiral ligands (including phenanthroline and 
the tridentate L4) was used as a ligand, disregard of iron sources while a syn-amino alcohol was 
obtained when chiral BOX ligands were applied. 
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2.2.7  Iron(II)-Catalyzed Enantioselective Olefin Aziridination 
2.2.7.1 Counter ion Effect 
 
Table 6. Counter Ion Screening for Reaction Optimization 
1) Phenanthroline as a ligand 
 
2) Chiral BOX as a ligand 
 
58 
2.2.7.2 Fe(II)-Catalyzed Enantioselective Olefin Aziridination 
To a flame-dried Schleck tube was added Fe(OAc)2 (0.01 mmol) and chiral ligand L4 
(0.02 mmol) respectively. After evacuation upon oil pump and refill with Ar gas three times, 
anhydrous and degassed toluene/acetonitrile (2 mL, v/v = 4/1) was added. The obtained mixture 
was stirred vigorously at room temperature for 60 minutes. Substrate 9a or 9b (0.1 mmol) in 1 
mL of anhydrous and degassed toluene/acetonitrile (2 mL, v/v = 4/1) was then added. The 
reaction mixture was stirred at 0 ºC for 12 hours. The reaction mixture was then quenched by 
Sat. NaHCO3, and then extracted with ethyl acetate. The organic phase was washed with brine, 
dried (Na2SO4), filtered, and concentrated in vacuo to afford the crude product, which was 
purified by flash column chromatography using 50% ethyl acetate-hexane (38% yield of 
aminohydroxylation product 11 and 46% yield of aziridination product 12). 12:
37d
 [𝛼]D
20 = -1.6 (c 
= 0.2, CH2Cl2); 
1
H NMR (CDCl3, 400 MHz): δ ppm 7.39-7.37 (3H, m), 7.21 (2H, d, J = 8.0 
Hz), 4.65 (1H, d, J = 9.2 Hz), 4.55 (1H, dd, J = 9.2, 5.2 Hz), 3.38 (1H, d, J = 3.2 Hz), 3.26-3.25 
(1H, m)]. 
2.2.7.3 HPLC Data 
The samples were analyzed by Chiral HPLC analysis (Chiralcel AD-H, 1.0 mL/min, 230 
nm, 20% i-PrOH in hexane). 
Racemic sample (Racemic sample, used as a standard for chiral HPLC analysis, was 
synthesized by the identical method except for using 20 mol % phenanthroline instead of chiral 
ligand L4): 
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Fe(II)-catalyzed asymmetric aziridination reaction: 
 
 
2.2.7.4 Control Experiments 
To verify whether or not 11 was obtained through the intermediacy of aziridine 12 in 
Fe(OAc)2-catalzyed reactions, 12 was subjected to the catalytic reaction conditions. The isomeric 
aminohydroxylation product 11' was isolated. 
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To a flame-dried Schleck tube was added Fe(OAc)2 (0.01 mmol) and chiral ligand L4 
(0.02 mmol) respectively. After evacuation upon oil pump and refill with Ar gas three times, 
anhydrous and degassed toluene/acetonitrile (2 mL, v/v = 4/1) was added. The obtained mixture 
was stirred vigorously at room temperature for 60 minutes. Aziridine 12 (0.1 mmol) and 2,4-
dichlorobenzoic acid or its sodium salt (0.1 mmol) in 1 mL of anhydrous and degassed 
toluene/acetonitrile (1 mL, v/v = 4/1) was then added. The reaction mixture was stirred at 0 ºC 
for 12 hours. The reaction mixture with 2,4-dichlorobenzoic acid was then quenched by Sat. 
NaHCO3, and then extracted with ethyl acetate. The organic phase was washed with brine, dried 
(Na2SO4), filtered, and concentrated in vacuo to afford the crude product, which was purified by 
flash column chromatography using 50 % ethyl acetate-hexane: 15% isolated yield of anti-
isomer. 
2.2.7.5 Olefin Aziridination of Tosyl Hydroxyl Carbamate  
 
To a flame-dried Schleck tube was added Fe(OAc)2 (0.01 mmol) and chiral ligand 10 
(0.02 mmol) respectively. After evacuation upon oil pump and refill with Ar gas three times, 
anhydrous and degassed toluene/acetonitrile (2 mL, v/v = 4/1) was added. The obtained mixture 
was stirred vigorously at room temperature for 60 minutes. Substrate 14 (0.1 mmol) in 1 mL of 
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anhydrous and degassed toluene/acetonitrile (2 mL, v/v = 4/1) was then added. The reaction 
mixture was stirred at 0 ºC for 12 hours. The reaction mixture was then quenched by Sat. 
NaHCO3, and then extracted with ethyl acetate. The organic phase was washed with brine, dried 
(Na2SO4), filtered, and concentrated in vacuo to afford the crude product, which was purified by 
flash column chromatography using 50% ethyl acetate-hexane. From HPLC trace, the ee of 
aziridination product 12 was also 65% (Chiralcel AD-H, 1.0 mL/min, 230 nm, 20% i-PrOH in 
hexane). 
 
 
2.2.8  Procedure of Product Derivatization 
 
Procedures:
 40 
A mixture of 11 (37 mg, 0.1 mmol), Boc2O (32 mg, 0.14 mmol), Et3N (21 
µL, 0.15 mmol) and a catalytic amount of DMAP (10% mol) in CH2Cl2 (2 mL) was stirred 1 
hour at room temperature. The reaction was quenched by concentrated in a vacuum. Quick 
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purification of the residue by a short flash chromatography (hexane/ethyl acetate) afforded Boc-
protected product in quantitative yield. The above obtained Boc-protected product was dissolved 
in 1,4-dioxane (2 mL). An aqueous solution of LiOH 2N (0.3 mL, 0.6 mmol) was then added. 
The mixture was stirred at room temperature for 4 h. The solvent was removed. The resulting 
crude was purified by flash chromatography (hexane/ethyl acetate) to give 18.7 mg of compound 
13
41
 (70 %) as a colorless oil. 
1
H NMR (CDCl3, 400 MHz): δ ppm 7.41-7.30 (5H, m), 5.17 (1H, 
brs), 5.01 (1H, s), 3.85-3.79 (3H, m), 3.03 (1H, brs), 2.26 (1H, brs), 1.38 (9H, s); 
13
C NMR 
(CDCl3, 100 MHz): δ ppm 141.1, 128.5, 127.9, 126.1, 79.9, 74.8, 64.2, 57.2, 28.3. HRMS (ESI-
TOF) for C14H22NO4 [M+H
+
] calcd 269.1472, found 269.1469. 
HPLC data of 13: 
The samples were analyzed by Chiral HPLC analysis (Chiralcel AD-H, 1.0 mL/min, 220 
nm, 5% i-PrOH in hexane). 
Racemic Sample (The racemic sample was gotten through the following route): 
 
63 
Enantio-enriched Sample: 
 
2.2.9 Determination  
2.2.9.1 Comparison of Optical Rotation 
Comparison of optical rotation of 13 with literature value:
42
 
 
literature value: [𝛼]D
20 = +51.5 (c = 1.02, CH2Cl2) 
experiment value: [𝛼]D
20 = +31.7 (c = 0.26, CH2Cl2) (82% ee from chiral HPLC) 
2.2.9.2 Stereospecific Epimerization  
To confirm the absolute stereochemistry of the aziridine, the hydrolysis product of 11 
was subjected to the Mitsunobu reaction condition. 
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HPLC trace of 11’: 
 
 
 
 
HPLC trace:  
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2.3     RESULTS 
2.3.1 Catalyst Discovery for the Aminohydroxylation   
We initiated the catalyst discovery with a cinnamyl alcohol derived substrate 1 that 
incorporates both a trans-disubstituted olefin and a functionalized hydroxylamine. A preliminary 
inspection revealed that Fe
II
 salts alone are unable to catalyze the reaction at room temperature; 
however, the reactions are greatly accelerated by a variety of nitrogen-based bidentate and 
tridentate ligands (Table 7): ligands 3 and 4 (with π-acceptor character) facilitate more efficient 
reactions than TMEDA and sparteine (entries 1−4). While FeII/3 complexes are able to catalyze 
the aminohydroxylation, Fe
III
/3 complexes are inactive (entry 5). In addition, we observed a 
significant counterion effect: cyanide (entries 9 and 10) with strong π-acceptor character proves 
to be superior to bromide (entries 3 and 4), triflate (entry 6), carboxylate (entry 7), and triflimide 
(entry 8). Re-examination of Fe
II
 cyanide/ligand combinations revealed that K4Fe(CN)6/3 can 
catalyze a highly diastereoselective aminohydroxylation,
16c, 38
 delivering an anti-amino alcohol 
with a stereochemistry complementary to the one obtained through Os-based methods. We 
discovered that acyl hydroxyl carbamates prove uniquely effective for the desired reaction: both 
alkyl and sulfonyl hydroxyl carbamates are not viable substrates. 
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a
Reactions were carried out under argon at 23 °C unless stated otherwise. 
b
Conversions were determined by 
1
H NMR analysis with 1,3,5-trimethoxybenzene as an internal standard. 
c
Isolated yield. 
d
Catalyst was prepared in 
situ by stirring FeBr2 or K4Fe(CN)6 with freshly prepared potassium salt of the ligand 4. 
e
The reaction was 
performed at 45 °C. 
f
An aziridine was isolated. 
g
The reaction was performed at 70 °C for 4 h. 
h
Conversion was less 
than 5% without ligands. TMEDA = tetramethylethylenediamine, OTf = trifluoromethanesulfonate, NTf2 = 
trifluoromethanesulfonimide. 
 
Table 7. Catalyst Discovery for the Aminohydroxylation 
2.3.2 Substrate Scope of Iron-Catalyzed Aminohydroxylation 
To explore the scope and limitation of this reaction, we have applied the method to a 
variety of olefins (Table 8). trans- Disubstituted styrenyl olefins are excellent substrates (dr > 
20:1) (entries 1−4). Unlike Os-based methods that are not tolerant to basic nitrogen functional 
groups,
43
 the olefin containing a pyridine ring is a viable substrate (entry 4). A para-methyl-
styrenyl substrate suffers from a total loss of dr (entry 5); however, electronic tuning on the 
benzoyl group increased the dr to 3.1:1 (entry 6).
44
 trans-Disubstituted olefins with 1-naphthyl, 
alkyl, and alkynyl substituents can participate in the reaction with acceptable yields but 
diminished diastereoselectivity (entries 7−9, dr varies from 2.5:1 to 5:1). We note that the cis-
disubstituted olefins also afford anti-amino alcohols in this reaction (entries 10−11). The 
stereochemical convergence (entries 1 and 10) and a related crossover experiment suggest the 
stepwise nature of the aminohydroxylation. In addition, trisubstituted olefins (entries 12− 13) are 
suitable substrates (dr varies from 2.2:1 to > 20:1). Disubstituted terminal olefins are decent 
substrates (entry 14), while monosubstituted olefins (entry 15) suffer from lower yields. We also 
67 
discovered a cyclohexanol-derived substrate (entry 16) readily participates in the reaction to 
afford an anti-hydroxyl oxazolidinone that was difficult to access with Os-based strategies.
 
Further investigation reveals that nonallylic alcohol based substrates, including an olefin 
containing hydroxamate, can also undergo smooth reactions (entry 17). 
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a
Combined isolated yield. 
b
Determined by 
1
H NMR. 
c
Phenyl vinyl ketone was also isolated as a side 
product. 
 
Table 8. Substrate Scope of Iron-Catalyzed Aminohydroxylation 
2.3.3 Iron-Catalyzed Asymmetric Aminohydroxylation 
Since the asymmetric synthesis of hydroxyl oxazolidinones by catalytic 
aminohydroxylation has not been reported, we explored the asymmetric induction with 
Fe
II−chiral bisoxazoline (BOX)45 complexes (Scheme 35A). Extensive optimization revealed that 
Fe(NTf2)2 −chiral BOX ligand L4 is effective for enantioinduction. It converts both 9a and 9b to 
syn-hydroxyl oxazolidinone 11 with the same ee and dr (82% ee, dr > 20:1). More synthetically 
useful amino alcohol triad 13 was subsequently obtained without stereochemistry erosion with a 
known method.
40
 To our surprise, the diastereoselectivity observed here is different from the one 
in the K4Fe(CN)6-catalyzed reaction (Table 3). We also observed that the Fe(OAc)2−chiral BOX 
ligand L4 complex catalyzes a convergent aminohydroxylation of both 9a and 9b, affording 11 
with diminished selectivities (71% ee, dr = 5:1). In addition to 11, a chiral aziridine 12 (65% ee, 
dr > 20:1) was obtained from both 9a and 9b. It is important to note that the sense of 
enantioinduction for 11 and 12 is the same, and they cannot interconvert under reaction 
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conditions.
42
 We were curious about this reactivity divergence and explored a series of ligands, 
discovering that the counteranion effect over the product distribution is general. In literature, 
Bolm demonstrated that Fe(OTf)2−chiral BOX can mediate asymmetric styrene aziridination (up 
to 40% ee). Lebel
37d, 37e
 also reported a copper-catalyzed racemic aziridination from tosyl 
hydroxyl carbamate 14. To gain further mechanistic insight, we explored the reactivity of 14 
under the optimized conditions (Scheme 35B): Fe(NTf2)2 is unable to catalyze the cyclization of 
14; Fe(OAc)2 can mediate the aziridination of 14, affording 12 (the same ee with the one 
obtained from 9a and 9b), albeit in a low conversion. These results indicate that the Fe(OAc)2-
catalyzed aziridination of 9a, 9b, and 14 likely go through the same intermediate. 
A) convergent enantioselective aminohydroxylation 
 
B) reactivity of tosyl hydroxyl carbamates 
 
a
Fe(NTf2)2 (10 mol %), 10 (20 mol %), MeCN, 0 °C, 8 h. 
b
Fe(OAc)2 (10 mol %), 10 (20 mol %), 
toluene/MeCN = 4:1, 0 °C, 4 h. 
c
Boc2O, Et3N, DCM, rt, 3 h, then LiOH, dioxane, rt, 4 h, 75% in two steps. Boc2O = 
Di-tert-butyl dicarbonate. 
. 
Scheme 35. Ligand Controlled Asymmetric Induction 
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2.3.4 Mechanistic Working Hypothesis  
The successful asymmetric induction provides further mechanistic insights: (a) 
Fe
II−chiral ligand complexes are involved in both rate- and enantioselectivity-determining steps; 
(b) olefin aziridination is likely a competing pathway from the same intermediate. Presumably, 
two distinct types of mechanistic pathways might operate: (a) Kharasch-type atom transfer 
radical addition
46
 or (b) pathways involving iron nitrenoid
47
 species. Based on the collected 
mechanistic evidence, a working hypothesis that best corroborates the Fe(OAc)2-catalzyed 
enantioselective reaction is shown in Scheme 33. First, the Fe(OAc)2−ligand complex can 
reductively cleave the N−O σ-bond and possibly convert the isomeric cis- and trans-styrenyl 
substrates 9a and 9b to iron nitrenoids A1 and A2, respectively. Then, a stepwise cycloamination 
(from A1 and A2) will presumably occur, affording two carbo-radical species, B1 and B2 that 
are in a fast equilibrium. In principle, the intramolecular aziridination should occur much slower 
than the ligand (OR) transfer from B2, because of the unfavorable A (1,3) interaction 
encountered in the transition state leading to aziridines. In contrast, aziridination can effectively 
compete with the ligand transfer from B1, since the A (1,3) interaction is absent in this 
conformation. Therefore, the aminohydroxylation should occur predominately from intermediate 
B2, leading to an amino alcohol 11, while the cyclization from intermediate B1 will mostly lead 
to a trans-aziridine 12. It is possible that the mechanistic intricacy will vary with different 
counterion/ligand combinations, which will influence the relative stability of B1 vs B2, as well 
as the rates of aziridination (kA) vs aminohydroxylation (kH). Since the diastereoselectivity of 
K4Fe(CN)6-catalyzed reactions is very different from the ones catalyzed by Fe(NTf2)2 and 
Fe(OAc)2, it is less likely this working hypothesis applies for the K4Fe(CN)6-catalyzed racemic 
reactions. 
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Scheme 36. Mechanistic Working Hypothesis 
 
2.4 CONCLUSIONS 
In conclusion, we have discovered a new Fe(II)-catalyzed intramolecular olefin 
aminohydroxylation with functionalized hydroxylamines, where both the N and O functional 
groups are efficiently transferred for olefin aminohydroxylation. Preliminary mechanistic studies 
revealed that an iron nitrenoid is possibly an intermediate that can undergo either olefin 
aziridination or aminohydroxylation. This discovery opens up the possibility of developing a 
unique and general approach for stereoselective olefin amination. Our current effort focuses on 
better understanding the mechanistic details of this process and its application in complex 
molecule synthesis.  
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3 CHAPTER III     IRON(II)-CATALYZED ASYMMETRIC INTRAMOLECULAR 
AMINOHYDROXYLATION OF INDOLES 
 
3.1 INTRODUCTION 
3.1.1 Naturally Occurring Molecules  
Indole chemistry has been extensively explored since its first synthesis by Baeyer et al in 
1866. Due to its prevalence in the structures of numerous medicinal agents and biologically 
active natural products, the study of indole chemistry remains to be appealing in constructing 
those important indole alkaloids as depicted in Figure 4, such as AG-041R, a gastrin/CCK-B 
receptor agonist; SSR-149415, also called Nalivaptan, a medicine for the treatment of anxiety 
and depression;
48
 and natural products psychotrimine, kapakahines, and chaetomin.
49
 More 
interestingly, all of these natural products are bearing either amino oxindoles or amino indolanes 
structural motifs. Much attention has been focused on those well-established reactions, such as 
oxidative (radical) dimerization, or electrophilic cyclization cascades. However, methodologies 
for diastereo- and enantioselectively catalytic functionalization at the C2 and C3 positions for the 
synthesis of amino oxindoles and amino indolanes are less explored.  
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Figure 4. Amino Oxindoles and Amino Indolanes Structural Motifs 
3.1.2 Chiral Substrate-Controlled C(3)-N(1′) Coupling  
Chiral substrate-controlled indole–aniline coupling and stereospecific functional group 
manipulation are among the strategies that have been applied to the asymmetric synthesis of 3-
amino indolanes. Phil S. Baran
49b
 demonstrated a powerful and exceptionally concise gram scale 
synthesis of Psychotrimine with minimal use of protection chemistry and redox steps. The 
proposed coupling reaction was explored using 2-Iodoaniline and L-tryptophan (Scheme 37) 
with a variety of oxidants. Most oxidants afforded a complex mixing system. With exceptionally 
simple halogenating agents such as NCS and NBS, the cyclized C(3)-N(1′) coupling product was 
furnished as the major diastereomer. The key finding in making the reaction robust and scalable 
was using NIS to afford the C3 aminated product in 45% isolated yield along with 40% starting 
material recovered.  
 
Scheme 37. Total Synthesis of Psychotrimine 
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Meanwhile, Rainier
49a
 disclosed another C(3)-N(1′) heterodimeric indolines synthesis. 
Luckily they achieved 28% yield desired product for their first batch as a single diastereoisomer. 
Interestingly, the reaction product bearing a methyl ester functional group could epimerize from 
the exo-position to the thermodynamically more favorable endo-position. Thus, a novel and 
facile entry into the C(3)-N(1′) construction with up to 82% yield for 8 examples and up to 20:1 
dr were thus reported.  
 
Scheme 38. The Synthesis of C(3)-N(1') Dimers 
3.1.3 Organic Molecules and Lewis Acid-Catalyzed Reactions 
An effective approach for the enantio-synthesis of 3-amino-2-oxindoles was discovered 
by Yongjun Chen.
50
 Biscinchona alkaloids catalyzed asymmetric amination of unprotected 
oxindoles with the generation of quaternary chiral carbon center was thus realized by the 
employment of azodicarboxylate as the nitrogen source.  
 
Scheme 39. Organocatalytic Amination of 2-Oxindoles 
Another enantioselective α-amination of aryl oxindoles catalyzed by cinchona alkaloids 
has been developed by Carlos and coworkers.
51
 The reaction is general, broad in substrate scope, 
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and affords the desired products in good yields with good to excellent enantioselectivities. This 
study provides a general organocatalytic method for the creation of nitrogen-containing, 
tetrasubstituted chiral centers at the C3 position of alkyl and aryl oxindoles.  
 
Scheme 40. Expanded Substrate Scope for Amination of 2-Oxindoles 
Recently, a highly enantioselective catalytic synthesis of 3-aminooxindoles with a 
tetrasubstituted carbon stereocenter is reported by Shibasaki’s group.52 1−2 mol % of homo 
bimetallic (R)-Ni2−Schiff base can catalyze the asymmetric amination of 3-substituted oxindoles 
with azodicarboxylates to give (R)-products in 89 to 98% yield and with large than 87% ee. 
While reversed ee was observed when switching to monometallic Schiff base complexes without 
loss of yield and ee. A formal synthesis of the key intermediate for AG-041R from an optically 
active oxindole is also described.  
 
Scheme 41. Catalytic Asymmetric Synthesis of 3-Aminooxindoles 
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Dr. Xiaoming Feng also made a great contribution in this area during the last few years.
53
 
They demonstrated that C2-symmetric N,N’-dioxide amide compounds (as shown in Figure 
5)are effective in a variety of chiral ligand metal-catalyzed or organocatalyzed asymmetric 
reactions under mild reaction conditions. Due to the easy accessibility, extensive versatility, as 
well as other advantages, such as excellent enantioselectivity and reactivity, low price, 
operational simplicity, mild reaction conditions, thus their applications in both traditional and 
new catalytic asymmetric reactions, are promising.  
 
Figure 5. Chiral N,N'-Dioxides 
3.1.4 Intramolecular α-Arylation of Amides 
Peter Kundig developed an asymmetric Pd/NHC-catalyzed intramolecular α-arylation of 
amide enolates to afford optically active 3-alkoxy or 3-aminooxindoles in high yields and 
enantioselectivities.
54
  
 
Scheme 42. Chiral NHC Carbene Catalyzed Oxindole Synthesis 
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Recently, Steven Ley reported an approach for enantioselective 3-amino-2-oxindoles 
through a Pd-catalyzed intramolecular arylation of α-ketimino amides using chiral phosphine 
ligand.
55
  
 
Scheme 43. Pd-Mediated Asymmetric Intramolecular Arylation of Ketimino Amides 
3.1.5 Organic Molecule-Catalyzed Additions 
More interestingly, a highly enantioselective decarboxylative addition of MAHTs to 
ketimines derived from isatins by using novel cinchonidine organocatalysts is described by Norio 
Shibata in 2012.
56
 In the paper, they claimed the first example of decarboxylative addition of 
MAHTs to ketimines, while the afforded product could be further converted to optically active 
(+)-AG-041R. 
 
Scheme 44. Decarboxylative Addition of MAHT to Ketimines 
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3.1.6 Rhodium-Catalyzed Intramolecular Aminohydroxylation of Indoles or Pyrroles 
Despite these key discoveries, a method that can provide both amino oxindoles and 
amino indolanes with synthetically useful ee through catalytic asymmetric indole 
aminohydroxylation has yet to be discovered. Inspired by the pioneering Sharpless asymmetric 
aminohydroxylation,
15
 there has been significant progress in the development of methods for 
selective olefin aminohydroxylation as we discussed in chapter 2.
16a, 16g, 17-18, 19a-c, 21, 23-24, 26, 29, 33-
34
 Albert Padwa
27
 and co-work came up with the iodine (III)-mediated aziridination reaction of 
an indolyl-substituted carbamate which requires a Rh(II) catalyst and proceeds by metallonitrene 
intermediate. A metal-free zwitterion is generated by stepwise addition across the indole π-bond 
followed by Rh (II) detachment, which ultimately furnishes the final products, as demonstrated 
in Scheme 23.  
Chi-ming Che
57
 has found a mild and straightforward enantioselective method for the 
synthesis of optically active indole oxazolidine. Chiral dirhodium complexes can catalyze the 
asymmetric intramolecular aziridination of unsaturated sulfonamides and carbamates giving 
excellent yield and moderate ee. The forming aziridine can be opened in the presence of other 
nucleophiles, such as acetate. Their efforts are currently underway to improve the moderate to 
good ee.  
 
Scheme 45.  Intramolecular Aziridination and Nucleophilic Ring-Opening 
In a stereoselective total synthesis of (+)-Gonyautoxin 3 reported by J. Du Bois
58
 in 2008. 
This important transformation capitalized on the novel reactivity of Rh-bound guanidine nitrene 
79 
that is capable of modifying both C-H bond and π system to afford the pyrrole amination 
product.  
 
Scheme 46. Synthesis of (+)-Gonyautoxin 3 
Recently, Iwabuchi disclosed a chiral Rh-nitrenoid species based oxidative nitrogen atom 
transfer reaction, with a versatile and highly enantioselective synthesis of spiro-β-lactam cores 
and expanded the substrate scope. The further effort towards the total synthesis of chartelline 
alkaloids is now ongoing in his lab.
59
  
 
Scheme 47. Rh-Mediated Intramolecular Aza-spiroannulation 
3.1.7 Previous Indole Aminohydroxylation Reactions  
Y oon has been interested in developing a synthetic methodology for rapid constructing a 
class of pyrroloindoline alkaloids, aiming at C-N bond formation in an enantioselective fashion. 
Later on, they have demonstrated that the copper (II)-catalyzed intermolecular oxyamination of 
indoles affords aminals in high yields and with excellent regioselectivity.
18e
 Based on the 
knowledge of their recently revised mechanistic model,
35
 a radical intermediate is consistent with 
the furnished high regioselective products that can be easily transformed into 3-aminoindoles, 
indolines, pyrroloindolines and other synthetically valuable heterocyclic building blocks. Finally, 
by incorporation of a chiral auxiliary, they subsequently achieved asymmetric oxyamination of 
80 
tryptamine derivatives. This transformation enables the enantioselective construction of 3-
aminopyrroloindolines that is useful in the synthesis of oxidized-indole natural products.  
 
 
Scheme 48. Oxaziridine-Mediated Oxyamination of Indoles 
M ore recently, Dauban
60
 utilized this rhodium nitrene for direct nitrogen atom transfer to 
indolic derivatives. This efficient intermolecular oxyamidation reaction affords access to 2,3-
substituted indolines. Interestingly, its stereoselectivity is controlled by the nucleophile, while 
the regioselectivity is operated by the introduction of a substituent at C3. Moreover, the 
introduction of nitrogen nucleophiles enables the development of the catalytic diamination of 
indoles.  
 
Scheme 49. Catalytic Oxyamidation of Indoles 
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3.2     EXPERIMENT 
3.2.1 General Procedures 
General Procedures. All reactions were performed in oven-dried or flame-dried round-
bottom flasks and vials. Stainless steel syringes and cannula were used to transfer air- and 
moisture-sensitive liquids. Flash chromatography was performed using silica gel 60 (230-400 
mesh) from Sigma-Aldrich. 
Materials. Commercial reagents were purchased from Sigma-Aldrich, Fluka, EM 
Science, and Lancaster and used as received. All solvents were used after being freshly distilled 
unless otherwise noted. 
Instrumentation. Proton nuclear magnetic resonance (
1
H NMR) spectra and carbon 
nuclear magnetic resonance (
13
C NMR) spectra were recorded on Bruker UltraShield-400 (400 
MHz). Chemical shifts for protons are reported in parts per million downfield from 
tetramethylsilane and are referenced to the NMR solvent residual peak (CHCl3:  7.26; DMSO: 
2.50). Chemical shifts for carbons are reported in parts per million downfield from 
tetramethylsilane and are referenced to the carbon resonances of the NMR solvent (CDCl3: 
77.0; DMSO: 39.5). Data are represented as follows: chemical shift, multiplicity (br = broad, 
s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, m = multiplet), coupling constants (J) 
in Hertz (Hz), and integration. 
The mass spectroscopic data were obtained at the Georgia State University mass 
spectrometry facility using a Micromass Platform II single quadrupole instrument. Infrared (IR) 
spectra were obtained by using a Perkin Elmer Spectrum 100 FT-IR spectrometer.  Data are 
represented as follows: frequency of absorption (cm
–1
).Optical rotations were measured using a 1 
mL cell with a 1 dm path length on a Perkin Elmer model 343 at 589 nm, and are reported as [α
82 
]D (concentration ingrams/100 mL solvent). Chiral HPLC analysis was performed with an 
Agilent HPLC instrument. 
Abbreviations used: EtOH–ethanol, EtOAc–ethyl acetate, THF–tetrahydrofuran, 
MeOH–methanol, Et2O–diethyl ether, CH2Cl2–dichloromethane, TEA–triethylamine, MeCN–
acetonitrile, MS–molecular sieves, CDI–1,1′-carbonyldiimidazole, Troc–2,2,2-
trichloroethoxycarbonyl, DCC–N,N′-dicyclohexylcarbodiimide, TLC–thin layer chromatography 
，Boc2O–di-tert-butyl dicarbonate, DMAP−4-dimethylaminopyridine. 
 
Table 9. Catalyst Discovery for the Racemic Indole Aminohydroxylation 
G eneral Procedure: To a flame-dried vial were added Fe(X)n (0.007 mmol) and 1,10-
phenanthroline (0.014 mmol). After evacuation upon oil pump and refill with argon three times, 
anhydrous and degassed MeCN (1.5 mL) was added. The resulting suspension was stirred 
vigorously at room temperature for 30 min; substrate 1 (0.04 mmol) in MeCN (0.5 mL) was 
added afterwards. The reaction was stirred at the indicated temperature for 5 h. Conversions were 
determined by 
1
H NMR analysis with 1, 3, 5-trimethoxybenzene as an internal standard. The 
reaction was quenched with saturated NaHCO3 aqueous solution, and extracted with DCM three 
times. The combined organic phase was dried over anhydrous Na2SO4 and concentrated in vacuo. 
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The residue was purified by silica gel flash column (hexane:THF = 4:1) to afford the racemic 
aminohydroxylation product 2. 
 
(±)-2'-Oxo-1-(phenylsulfonyl)spiro[indoline-3,4'-oxazolidine]-2-yl 2,4-
dichlorobenzoate (2): 
1
H NMR (400 MHz, d6-DMSO, ppm): δ 8.80 (s, 1H), 8.02 (d, J = 7.6 Hz, 
2H), 7.84 (s, 1H), 7.77 (d, J = 8.4 Hz, 1H)， 7.69 (t, J = 6.8 Hz, 1H), 7.57-7.54 (m, 3H), 7.49 (d, 
J = 6.8 Hz, 1H), 7.41 (s, 2H), 7.21 (s, 1H), 6.99 (s, 1H), 4.62 (d, J = 9.2 Hz, 1H), 4.06 (d, J = 8.8 
Hz, 1H);
13
C NMR (100 MHz, d6-DMSO, ppm): δ 162.7, 158.1, 150.4, 139.5, 138.7, 138.0, 
134.9, 134.8, 133.7, 131.4, 131.2, 130.2, 129.7, 128.0, 127.7, 127.0, 125.7, 125.4, 113.5, 89.4, 
73.9, 67.0; IR νmax (neat)/cm
-1
: 3443 (w), 1768 (s), 1238 (m), 1029 (m); HRMS (ESI) calcd for 
C23H15Cl2N2O6S [M-H]
- 
: 517.0028, found 517.0042. 
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3.2.2 General Synthetic Route for Substrates Preparation and Characterization 
 
Table 10. Substrate Scope 
  
 
Scheme 50. General Synthetic Route for Substrates Preparation 
3.2.2.1 Preparation of Indole Alcohols and Product Characterization 
G eneral Procedure for Preparation of Indole Alcohols (IA):
61
 At 0 °C, to a solution 
of indole aldehyde (1 mmol) in DCM (10 mL), was added 
n
Bu4NHSO4 (0.05 mmol, 17 mg) and 
NaOH  (1.1 mmol, 44 mg) subsequently. After stirring for 0.5 h at 0 °C, PhSO2Cl (1.1 mmol, 
194 mg) was added dropwise and stirred for additional 0.5 h at room temperature. Then the 
reaction mixture was diluted with DCM (50 mL) and water (50 mL). The organic layer was 
separated and the aqueous phase was extracted with 50 mL DCM. The combined organic layer 
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was washed with brine (50 mL), dried over anhydrous Na2SO4, and concentrated in vacuo. The 
crude product was purified with flash silica gel column chromatography (20% EtOAc in 
hexanes) to afford the protected indole aldehyde (75–95% yield). To a solution of protected 
indole aldehyde obtained (1 mmol) in methanol (10 mL), NaBH4 (1.1 mmol, 41 mg) was added 
in one portion at 0 °C. After stirring for 30 min, the solvents were removed under vacuum, and 
the residue was extracted by DCM (50 mL). The organic layer was washed by brine, dried over 
anhydrous Na2SO4 and concentrated under vacuum. The residue was purified by silica gel flash 
column chromatography (40% EtOAc in hexanes) to afford the indole alcohol (IA1–IA9, 
8595% yield). 
 
(1-(Phenylsulfonyl)-1H-indol-3-yl)methanol (IA1): IA1 was prepared by following the 
literature procedure and the NMR spectra were in accordance with the previously reported data. 
61 
 
(5-Methyl-1-(phenylsulfonyl)-1H-indol-3-yl)methanol (IA2): white solid, mp: 119–
121 °C;
 1
H NMR (400 MHz, CDCl3, ppm): δ 7.87–7.84 (m, 3H), 7.48–7.44 (m, 2H), 7.38–7.35 
(m, 3H), 7.14 (d, J = 8.4 Hz, 1H), 4.72 (s, 2H), 2.38 (s, 3H), 2.28 (brs, 1H); 
13
C NMR (100 MHz, 
CDCl3, ppm): δ 138.0, 133.7, 133.6, 133.0, 129.6, 129.1, 126.6, 126.3, 123.7, 122.4, 119.7, 
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113.2, 56.9, 21.2; IR νmax (neat)/cm
-1
: 3323 (w), 1447 (m), 1364 (m), 1172 (s), 1118 (s); HRMS 
(ESI) calcd for C16H14NO3S [M-H]
- 
: 300.0704, found 300.0694. 
 
(5-Methoxy-1-(phenylsulfonyl)-1H-indol-3-yl)methanol(IA3): white solid, mp: 105–
107  °C; 
1
H NMR (400 MHz, CDCl3, ppm): δ 7.79 (d, J = 8.0 Hz, 2H), 7.45 (s, 1H), 7.40 (t, J = 
7.2 Hz, 1H), 7.31 (t, J = 7.6 Hz, 1H), 6.96 (s, 1H), 6.90 (d, J = 9.2 Hz, 1H), 4.66 (s, 2H), 3.72 (s, 
3H), 2.85 (brs, 1H); 
13
C NMR (100 MHz, CDCl3, ppm): δ 156.3, 137.7, 133.6, 130.4, 129.8, 
129.0, 126.4, 124.2, 122.7, 114.3, 113.9, 102.2, 56.6, 55.4; IR νmax (neat)/cm
-1
: 3403 (w), 1475 
(m), 1366 (m), 1170 (s), 1029 (s); HRMS (ESI) calcd for C16H14NO4S [M-H]
- 
: 316.0644, found 
316.0649. 
 
(6-Methyl-1-(phenylsulfonyl)-1H-indol-3-yl)methanol (IA4): white solid, mp: 118-120  
°C; 
1
H NMR (400 MHz, CDCl3, ppm): δ 7.86 (d, J = 8.0 Hz, 2H), 7.80 (s, 1H), 7.51-7.38 (m, 
5H), 7.06 (d, J = 8.0 Hz, 1H), 4.73 (s, 2H), 2.47 (s, 3H), 2.07 (s, 1H); 
13
C NMR (100 MHz, 
CDCl3, ppm): δ 138.2, 135.8, 135.2, 133.7, 129.2, 127.1, 126.6, 124.9, 123.0, 122.5, 119.4, 
113.7, 57.0, 21.9; IR νmax (neat)/cm
-1
: 3352 (w), 1448 (m), 1367 (m), 1275 (s), 1173 (s); HRMS 
(ESI) calcd for C16H14NO3S [M+H]
+ 
: 300.0704, found 300.0694. 
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(6-Bromo-1-(phenylsulfonyl)-1H-indol-3-yl)methanol (IA5): white solid, mp: 124-126  
°C; 
1
H NMR (400 MHz, CDCl3, ppm): δ 8.16 (s, 1H), 7.87 (d, J = 7.6 Hz, 2H), 7.55 (t, J = 7.2 
Hz, 1H), 7.49-7.43 (m, 4H), 7.34 (d, J = 8.4 Hz, 1H), 4.76 (s, 2H), 1.90 (s, 1H); 
13
C NMR (100 
MHz, CDCl3, ppm): δ 137.9, 136.0, 134.1, 129.5, 128.2, 126.7, 124.0, 122.3, 121.1, 118.8, 
116.6, 56.9; IR νmax (neat)/cm
-1
: 3370 (w), 1367 (m), 1276 (s), 1174 (s), 1125 (s); HRMS (ESI) 
calcd for C15H11NO3SBr [M-H]
-
: 363.9643, found 363.9645. 
 
(6-Chloro-1-(phenylsulfonyl)-1H-indol-3-yl)methanol(IA6): white solid, mp: 141–143  
°C;
 1
H NMR (400 MHz, CDCl3, ppm): δ 8.03 (s, 1H), 7.91 (d, J = 8.0 Hz, 2H), 7.59 (t, J = 7.2 
Hz, 1H), 7.54-7.47 (m, 4H), 7.25 (d, J = 8.4 Hz, 1H), 4.81 (d, J = 4.4 Hz, 2H), 1.73 (t, J = 4.8 
Hz, 1H); 
13
C NMR (100 MHz, CDCl3, ppm): δ 137.9, 135.8, 134.1, 131.2, 127.9, 126.8, 124.1, 
122.2, 120.8, 113.9, 57.0; IR νmax (neat)/cm
-1
: 3366 (w), 1448 (m), 1370 (m), 1173 (s), 1132 (s); 
HRMS (ESI) calcd for C15H11NO3SCl [M-H]
-
: 320.0148, found 320.0146. 
 
(6-Phenyl-1-(phenylsulfonyl)-1H-indol-3-yl)methanol(IA7): 
1
H NMR (400 MHz, 
CDCl3, ppm): δ 8.26 (s, 1H), 7.92 (d, J = 7.6 Hz, 2H), 7.67–7.60 (m, 4H), 7.50–7.48 (m, 4H), 
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7.43–7.39 (m, 3H), 4.81 (s, 2H), 2.27 (s, 1H); 13C NMR (100 MHz, CDCl3, ppm): δ 141.2, 
138.6, 138.1, 136.1, 134.0, 129.4, 128.9, 128.7, 127.5, 127.4, 126.8, 124.1, 123.1, 122.6, 120.2, 
112.1, 57.0; IR νmax (neat)/cm
-1
: 3371 (w), 1369 (m), 1174 (s), 1122 (m); HRMS (ESI) calcd for 
C21H16NO3S [M-H]
- 
: 362.0851, found 362.0859. 
 
(7-Methyl-1-(phenylsulfonyl)-1H-indol-3-yl)methanol(IA8): white solid, mp: 118–120  
°C;
 1
H NMR (400 MHz, CDCl3, ppm): δ 7.66 (s, 1H), 7.53 (t, J = 7.2 Hz, 1H), 7.47–7.40 (m, 
3H), 7.15 (t, J = 7.2 Hz, 1H), 7.04 (d, J = 7.2 Hz, 1H), 4.82 (s, 2H), 2.51 (s, 3H), 2.06 (brs, 1H); 
13
C NMR (100 MHz, CDCl3, ppm): δ 139.8, 135.4, 133.5, 131.5, 129.3, 128.6, 127.2, 126.3, 
125.0, 123.9, 121.6, 117.6, 57.0, 21.6; IR νmax (neat)/cm
-1
: 3361 (w), 1447 (m), 1354 (s), 1275 
(s), 1083 (s); HRMS (ESI) calcd for C16H15NO3SNa [M+Na]
+ 
: 324.0670, found 324.0670. 
 
(4-Bromo-1-(phenylsulfonyl)-1H-indol-3-yl)methanol (IA9):
 1
H NMR (400 MHz, 
CDCl3, ppm): δ 7.98 (d, J = 6.4 Hz, 2H), 7.73 (s, 1H), 7.69 (t, J = 7.2 Hz, 1H), 7.59 (t, J = 8.0 
Hz, 2H), 7.44 (d, J = 7.6 Hz, 1H), 7.25 (t, J = 8.0 Hz, 1H), 5.31 (t, J = 5.2 Hz, 1H), 4.86 (d, J = 
6.0 Hz, 2H);
 13
C NMR (100 MHz, CDCl3, ppm): δ 136.7, 135.9, 134.8, 129.9, 127.8, 127.4, 
126.7, 126.1, 124.9, 113.7, 112.7, 56.3; IR νmax (neat)/cm
-1
: 3006 (w), 1276 (m), 1173 (w), 978 
(w), 750 (s); HRMS (ESI) calcd for C15H12NO3SBrNa [M+Na]
+ 
: 387.9619, found 387.9626.  
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3.2.2.2 Preparation of Indole Hydroxylamines and Product Characterization 
G eneral Procedure for Preparation of Indole Substrates (IS): To a solution of indole 
alcohol (1 mmol) in MeCN (10 mL), was added CDIHCl (3 mmol, 599 mg) at room 
temperature. After stirring for 1.0 h, NH2OHHCl (4 mmol, 278 mg), imidazole (5 mmol, 340 
mg) were added subsequently and stirred for an additional 4 h at room temperature. Then the 
reaction mixture was diluted with DCM (50 mL) and water (50 mL). The organic layer was 
separated and aqueous phase was extracted with 30 mL DCM three times. The combined organic 
layer was washed with brine (50 mL), dried over anhydrous Na2SO4, and concentrated under 
vacuum. The residue was purified with silica gel flash column chromatography (50% EtOAc in 
hexanes) to afford the hydroxyl carbamate product (7085% yield). To a solution of indole 
hydroxyl carbamate (1.0 mmol) and TEA (1.5 mmol, 152 mg) in THF (10 mL), 2, 4-
dichlorobenzoyl chloride (1.05 mmol, 218 mg) in THF (3.0 mL) was added dropwise at 0 °C. 
After stirring for 1 h, the mixture was quenched by cautiously adding water (0.2 mL). Then the 
reaction mixture was diluted with DCM (50 mL) and water (50 mL). The aqueous phase was 
extracted with DCM (50 mL). The combined organic layer was washed with brine (50 mL), 
dried over anhydrous Na2SO4, and concentrated under vacuum. The residue was purified with 
silica gel flash column chromatography (30% EtOAc in hexanes) to afford the indole substrates 
(1 to IS9) (75–95% yield). 
 
(1-(Phenylsulfonyl)-1H-indol-3-yl)methyl 2,4-dichlorobenzoyloxycarbamate (1) : 
white solid, mp: 165–167 °C; 1H NMR (400 MHz, CDCl3, ppm): δ 8.53 (brs, 1H), 7.99 (d, J = 
90 
8.4 Hz, 1H), 7.90 (d, J = 7.6 Hz, 2H), 7.83 (d, J = 8.4 Hz, 1H), 7.70 (s, 1H), 7.57 (d, J = 7.6 Hz, 
1H), 7.54–7.41 (m, 4H), 7.35 (t, J = 7.6 Hz, 1H), 7.27–7.23 (m, 2H), 5.39 (s, 2H); 13C NMR (100 
MHz, CDCl3, ppm): δ 163.6, 156.2, 139.8, 137.9, 135.6, 135.0, 133.9, 132.7, 131.2, 129.3, 
129.2, 127.2, 126.8, 126.1, 125.2, 124.5, 123.6, 119.6, 116.5, 113.6, 60.0; IR νmax (neat)/cm
-1
: 
3006 (w), 1747 (s), 1585 (m), 1447 (s), 1374 (m), 1275 (s), 1085 (s); HRMS (ESI) calcd for 
C23H15Cl2N2O6S [M-H]
- 
: 517.0028, found 517.0025. 
 
Methyl 4-((((5-methyl-1-(phenylsulfonyl)-1H-indol-3-yl) methoxy) 
carbonylaminooxy) carbonyl) benzoate ( IS2 ): white solid, mp: 121-122 °C;
 1
H NMR (400 
MHz, CDCl3, ppm): δ 8.41 (s, 1H), 8.12 (s, 4H), 7.88–7.84 (m, 3H), 7.62 (s, 1H), 7.53 (t, J = 7.6 
Hz, 1H), 7.43 (t, J = 7.6 Hz, 2H), 7.33 (s, 1H), 7.15 (d, J = 8.4 Hz，1H), 5.35 (s, 2H), 3.96 (s, 
3H), 2.38 (s, 3H); 
13
C NMR (100 MHz, CDCl3, ppm): δ 165.0, 156.2, 138.1, 135.1, 134.0, 133.4, 
133.36, 130.3, 129.9, 129.8, 129.5, 129.4, 126.8, 126.7, 126.3, 119.5, 116.4, 113.4, 60.2, 52.7, 
21.3; IR νmax (neat)/cm
-1
:3266 (w), 1721 (s), 1448 (m), 1370 (m), 1226 (s), 1095 (s); MS(ESI) 
C26H21N2O8S [M-H]
- 
: 521.1. 
 
Methyl 4-((((5-methoxy-1-(phenylsulfonyl)-1H-indol-3-yl) methoxy) 
carbonylaminooxy) carbonyl) benzoate( IS3 ): white solid, mp: 122–124 °C; 1H NMR (400 
MHz, CDCl3, ppm): δ 8.37 (s, 1H), 8.11 (s, 4H), 7.87–7.85 (m, 3H), 7.62 (s, 1H), 7.53 (t, J = 7.2 
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Hz, 1H), 7.43 (t, J = 7.6 Hz, 2H), 6.98 (s, 1H), 6.94 (d, J = 9.2 Hz, 1H), 5.35 (s, 2H), 3.96 (s, 
3H), 3.79 (s, 3H); 
13
C NMR (100 MHz, CDCl3, ppm): δ 166.0, 165.2, 156.8, 156.3, 138.1, 135.3, 
134.1, 130.3, 129.4, 128.3, 126.9, 116.7, 114.8, 114.6, 102.0, 60.2, 55.8, 52.8; IR νmax (neat)/cm
-
1
: 3111 (w), 1718 (s), 1450 (m), 1376 (m), 1216 (s), 1097 (s); MS(ESI) C26H21N2O69S [M-H]
- 
: 
537.0. 
 
(6-Methyl-1-(phenylsulfonyl)-1H-indol-3-yl)methyl 2,4-
dichlorobenzoyloxycarbamate( IS4 ): white solid, mp: 144–146 °C; 1H NMR (400 MHz, d6-
DMSO, ppm): δ 11.52 (brs, 1H), 7.99 (d, J = 7.2 Hz, 2H), 7.88-7.77 (m, 4H), 7.68 (t, J = 6.8 Hz, 
1H), 7.60-7.49 (m, 4H), 7.09 (d, J = 7.2 Hz, 1H), 5.34 (s, 2H), 2.44 (s, 3H); 
13
C NMR (100 MHz, 
d6-DMSO, ppm): δ 163.3, 156.2, 138.5, 137.0, 135.0, 134.8, 133.9, 132.6, 130.8, 129.9, 127.9, 
126.9, 126.7, 125.8, 125.6, 125.0, 119.8, 117.4, 113.1, 58.9, 21.5; IR νmax (neat)/cm
-1
: 3006 (w), 
2250 (w), 1275 (s), 1025 (s), 820 (s); HRMS (ESI) calcd for C24H17Cl2N2O8S [M-H]
-
: 531.0184, 
found 531.0180. 
 
(6-Bromo-1-(phenylsulfonyl)-1H-indol-3-yl)methyl 2,4-
dichlorobenzoyloxycarbamate( IS5 ): white solid, mp: 139–141 °C; 1H NMR (400 MHz, d6-
DMSO, ppm): δ 11.53 (s, 1H), 8.08 (s, 1H), 8.03–8.00 (m, 3H), 7.82 (s, 2H), 7.72 (t, J = 7.6 Hz, 
1H), 7.64–7.55 (m, 4H), 7.45 (d, J = 8.0 Hz, 1H), 5.35 (s, 2H); 13C NMR (100 MHz, d6-DMSO, 
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ppm): δ 163.2, 156.1, 138.5, 136.7, 135.04, 135.0, 133.9, 132.6, 130.8, 130.1, 128.2, 127.9, 
127.3, 126.7, 125.5, 122.1, 118.0, 117.4, 115.6, 58.6; IR νmax (neat)/cm
-1
: 3006 (w), 2251 (w), 
1276 (s), 1025 (s), 820 (s); HRMS (ESI) calcd for C23H14BrCl2N2O8S [M-H]
-
: 594.9133, found 
594.9124. 
 
(6-Chloro-1-(phenylsulfonyl)-1H-indol-3-yl)methyl 2,4-
dichlorobenzoyloxycarbamate( IS6 ): white solid, mp: 160–162 °C; 1H NMR (400 MHz, 
CDCl3, ppm): δ 8.51 (s, 1H), 7.97 (s, 1H), 7.88 (d, J = 7.6 Hz, 2H), 7.82 (d, J = 8.4 Hz, 1H), 7.65 
(s, 1H), 7.55 (t, J = 7.2 Hz, 1H), 7.27 (s, 4H), 7.26 (d, J = 5.2 Hz， 1H)， 7.18 (d, J = 8.0 Hz, 
1H), 5.33 (s, 2H); 
13
C NMR (100 MHz, CDCl3, ppm): δ 163.6, 156.1, 140.0, 137.6, 135.7, 135.3, 
134.2, 132.7, 131.3, 131.2, 129.5, 127.6, 127.2, 126.8, 126.6, 124.4, 124.3, 120.6, 116.4, 113.7, 
59.7; IR νmax (neat)/cm
-1
: 3005 (w), 1752 (s), 1585 (m), 1448 (m), 1375 (s), 1275 (s), 1095 (s);  
HRMS (ESI) calcd for C23H14Cl3N2O7S [M-H]
- 
: 550.9638, found 550.9646. 
 
(6-Phenyl-1-(phenylsulfonyl)-1H-indol-3-yl)methyl 2,4-
dichlorobenzoyloxycarbamate ( IS7 ): 
1
H NMR (400 MHz, CDCl3, ppm): δ 8.39 (s, 1H), 8.22 
(s, 1H), 7.94 (d, J = 7.6 Hz, 2H), 7.88 (d, J = 8.4 Hz, 1H), 7.72 (s, 1H), 7.65–7.63 (m, 3H), 7.58–
7.32 (m, 8H), 7.30–7.29 (m, 1H), 5.42 (s, 2H); 13C NMR (100 MHz, CDCl3, ppm): δ 163.7, 
156.2, 141.1, 140.0, 138.9, 138.0, 135.8., 135.7, 134.1, 132.8, 131.3, 129.4, 128.9, 128.4, 127.5, 
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127.4, 127.3, 126.9, 126.6, 124.6, 123.3, 119.9, 116.4, 112.1, 60.1; IR νmax (neat)/cm
-1
: 3344 (w), 
1725 (w), 1448 (w), 1174 (m), 722 (s); HRMS (ESI) calcd for C29H19Cl2N2O6S [M-H]
-
: 
593.0341, found 593.0329. 
 
(7-Methyl-1-(phenylsulfonyl)-1H-indol-3-yl)methyl 2,4-
dichlorobenzoyloxycarbamate( IS8 ): white solid, mp: 130–132 °C; 1H NMR (400 MHz, 
CDCl3, ppm): δ 8.46 (brs, 1H), 8.15 (s, 4H), 7.93 (s, 1H), 7.70 (d, J = 7.6 Hz, 2H), 7.58 (t, J = 
7.2 Hz, 1H), 7.49-7.45 (m, 3H), 7.16 (t, J = 7.6 Hz, 1H), 7.06 (d, J = 7.2 Hz, 1H), 5.44 (s, 2H), 
3.98 (s, 3H), 2.52 (s, 3H); 
13
C NMR (100 MHz, CDCl3, ppm): δ 165.9, 165.0, 156.2, 139.7, 
135.1, 133.7, 131.2, 130.2, 129.9, 129.8, 129.6, 129.4, 128.8, 126.4, 124.9, 124.0, 117.3, 115.7, 
60.1, 52.6, 21.6; νmax (neat)/cm
-1
: 3260 (w), 1725 (s), 1361 (m), 1227 (s), 1087 (s); HRMS (ESI) 
calcd for C26H21N2O8S [M-H]
- 
: 521.1019, found 521.1030. 
 
(4-Bromo-1-(phenylsulfonyl)-1H-indol-3-yl)methyl 2,4-
dichlorobenzoyloxycarbamate (IS9):
 1
H NMR (400 MHz, CDCl3, ppm): δ 8.58 (s, 1H), 7.97-
7.95 (d, J = 8.4 Hz, 1H), 7.91-7.89 (m, 3H), 7.78 (s, 1H), 7.56 (t, J = 7.2 Hz, 1H), 7.49-7.44 (m, 
3H), 7.39 (d, J = 7.6 Hz, 1H), 7.29 (d, J = 8.0 Hz, 1H), 7.17 (t, J = 8.0 Hz, 1H), 5.60 (s, 2H);
  13
C 
NMR (100 MHz, CDCl3, ppm): δ 163.7, 156.0, 139.8, 137.5, 136.1, 135.7, 134.3, 132.8, 131.2, 
129.4, 127.8, 127.7, 127.2, 126.9, 125.9, 124.6, 116.6, 114.1, 112.7, 60.5; IR νmax (neat)/cm
-1
: 
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3006 (w), 1745 (m), 1374 (m), 983 (s), 722 (s); HRMS (ESI) calcd for C23H14BrCl2N2O6S [M-
H]
- 
: 594.9133, found 594.9149. 
3.2.3 Catalyst Discovery for Enantioselective Intramolecular Indole Aminohydroxylation 
3.2.3.1 General Procedure 
 
 
a
Reactions were carried out under argon in 0.025 M toluene/MeCN (50:1) mixture; catalyst complexes 
were formed by premixing Fe(X)2 and ligands for 40 min.
 b
Isolated yield. 
c
ee was measured by HPLC analysis with 
chiral stationary phase. 
d
The sense of enantioinduction in entry 4 is opposite to that of other entries. 
 
Table 11. Catalyst Discovery for Intramolecular Indole Aminohydroxylation 
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4 Å MS (50 mg), Fe(X)2 (0.007 mmol) and chiral ligand L (0.014 mmol)were added to a 
flame-dried vial. After evacuation upon oil pump and refill with argon three times, anhydrous 
and degassed toluene/MeCN (50:1, 1.5 mL) mixture was added. The obtained suspension was 
stirred vigorously at room temperature for 30 min when the substrate (0.04 mmol) in the 
aforementioned co-solvent (0.5 mL) was added. The reaction mixture was stirred at room 
temperature for 12 h before quenched by saturated NaHCO3 aqueous solution. The aqueous 
phase was extracted with DCM three times. The combined organic phase was dried over 
anhydrous Na2SO4 and concentrated in vacuo. Purification of the residue by silica gel flash 
column (hexane:THF = 4:1) afforded the aminohydroxylation product 2.  
3.2.3.2 Solvent Screening  
A series of toluene and MeCN co-solvent systems have been screened for the asymmetric 
reaction with the aforementioned procedure (Table 12). 
 
Table 12. Solvent Screening for Fe(OTf)2–L9 System 
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3.2.3.3 Temperature Screening  
 
Table 13. Temperature Screening for Fe(OTf)2–L9-Catalyzed Reactions 
 
 
Table 14. Temperature Screening for Fe(OAc)2–L9-Catalyzed Reactions 
 
3.2.3.4 Concentration Screening  
 
Table 15. Concentration Screening for Fe(OAc)2–L9-Catalyzed Reactions 
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3.2.3.5 N-Donor Effect 
General Procedure for N–donor Additive’s Effect: To a flame-dried vial were added 4 
Å MS (50 mg), Fe(OTf)2 (0.007 mmol) and ligand L9 (0.014 mmol). After evacuation upon oil 
pump and refill with argon three times, the anhydrous and degassed toluene was added, followed 
by addition of the N–donor compound (0.04 mmol). The obtained suspension was stirred 
vigorously at room temperature for 30 min when the substrate (0.04 mmol) dissolved anhydrous 
and degassed toluene (600 µL) was added in one portion. The reaction was stirred at room 
temperature for indicated time above and quenched by saturated NaHCO3 aqueous solution. The 
aqueous phase was extracted with DCM three times. The combined organic phase was dried over 
anhydrous Na2SO4. After concentration in vacuo, the residue was purified by silica gel flash 
column chromatography (hexane:THF = 4:1).  
 
Table 16. N-Donor Additive Effect 
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In the presence of lutidine as the N–donor additive, a series of iron (II) salts with different 
counter anions were screened (Table 17).  
 
Table 17. Counter Anion Screening with Lutidine as the N-donor 
Experiments with different quantities of lutidine were performed for ee optimization 
(Table 18). 
 
Table 18. Lutidine Quantity Screening 
The temperature screening showed that the highest enantioselectivity is obtained at -10 
°C (Table 19).  
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Table 19. Temperature Screening for the Additive Effect 
3.2.3.6 General Procedure for Iron(II)-Catalyzed Asymmetric Aminohydroxylation 
To a flame-dried vial were added 4Å MS (50 mg), Fe(OAc)2 (0.007 mmol) together with 
ligand L9 (0.014 mmol). After evacuation upon oil pump and refill with argon three times, 
anhydrous and degassed toluene/MeCN (50:1, 1.5 mL) co-solvent was added. The obtained 
suspension was stirred vigorously at room temperature for 30 min before the substrate (0.04 
mmol) in the aforementioned co-solvent (0.5 mL) was added in one portion. The reaction system 
was stirred at room temperature for 12 h when all the starting material was fully consumed. Sat. 
NaHCO3 aqueous solution was added to quench the reaction, and the aqueous phase was 
extracted with DCM three times. The combined organic phase was dried over anhydrous 
Na2SO4 and concentrated in vacuo. The residue was purified by silica gel flash column 
chromatography (hexane:THF = 4:1) to give the desired aminohydroxylation product 2. 
3.2.3.7 Product Characterization 
        
(2R, 3S)-2'-Oxo-1-(phenylsulfonyl)spiro[indoline-3,4'-oxazolidine]-2-yl 2,4-
100 
dichlorobenzoate (2): by following the general procedure (0.04 mmol scale), the title compound 
2 was obtained from 1 and isolated by a silica gel flash column as white foam (14 mg, 67% 
yield). The sample was analyzed by Chiral HPLC analysis and determined to be 90% ee 
(Chiralcel AD-H, 1.0 mL/min, 272 nm, 20% i-PrOH in hexane, tr (minor) = 19.99 min, tr (major) 
= 32.33 min). [𝛼]D
20 = 62.0
o
 (c = 1.0, DCM). 
1
H NMR (400 MHz, d6-DMSO, ppm): δ 8.80 (s, 
1H), 8.02 (d, J = 7.6 Hz, 2H), 7.84 (s, 1H), 7.77 (d, J = 8.4 Hz, 1H)， 7.69 (t, J = 6.8 Hz, 1H), 
7.57-7.54 (m, 3H), 7.49 (d, J = 6.8 Hz, 1H), 7.41 (s, 2H), 7.21 (s, 1H), 6.99 (s, 1H), 4.62 (d, J = 
9.2 Hz, 1H), 4.06 (d, J = 8.8 Hz, 1H); 
13
C NMR (100 MHz, d6-DMSO, ppm): δ 162.7, 158.1, 
150.4, 139.5, 138.7, 138.0, 134.9, 134.8, 133.7, 131.4, 131.2, 130.2, 129.7, 128.0, 127.7, 127.0, 
125.7, 125.4, 113.5, 89.4, 73.9, 67.0; HRMS (ESI) calcd for C23H15Cl2N2O6S [M-H]
- 
: 517.0028, 
found 517.0042. 
 
Methyl (2R,3S)-5-ethyl-2'-oxo-1-(phenylsulfonyl)spiro[indoline-3,4'-oxazolidine]-2-
yl terephthalate (P2): by following the general procedure (0.04 mmol scale), the title compound 
P2 was obtained from IS2 and isolated by a silica gel flash column as white foam (16 mg, 72% 
yield). The sample was analyzed by Chiral HPLC analysis and determined to be 94% ee 
(Chiralcel AD-H, 1.0 mL/min, 254 nm, 20% i-PrOH in hexane, tr (minor) = 18.86 min, tr (major) 
= 24.41 min). [𝛼]D
20 = 32.0
o
 (c = 1.1, DCM). 
1
H NMR (400 MHz, d6-DMSO, ppm): δ 8.80 (s, 
1H), 8.08 (d, J = 8.0 Hz, 2H), 7.97 (d, J = 7.6 Hz, 4H), 7.69 (t, J = 7.2 Hz, 1H), 7.55 (t, J = 7.6 
Hz, 2H), 7.35 (d, J = 8.0 Hz, 1H), 7.29 (s, 1H), 7.25 (d, J = 8.0 Hz, 1H), 6.97 (s, 1H), 4.52 (d, J = 
9.2 Hz, 1H), 4.01 (d, J = 9.2 Hz, 1H), 3.90 (s, 3H); 
13
C NMR (100 MHz, d6-DMSO, ppm): δ 
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165.9, 164.3, 158.2, 138.1, 137.3, 135.1, 134.9, 134.6, 132.5, 131.8, 130.7, 130.3, 129.9, 129.8, 
127.5, 125.8, 113.6, 89.5, 73.8, 67.1, 53.1, 20.9; IR νmax (neat)/cm
-1
: 3324 (w), 1767 (s), 1276 
(m), 1176 (m); HRMS (ESI) calcd for C24H18Cl2N2O6S [M-H]
- 
: 531.0184, found 531.0192. 
 
(2R,3S)-5-methoxy-2'-oxo-1-(phenylsulfonyl)spiro[indoline-3,4'-oxazolidine]-2-yl 
methyl terephthalate (P3): the title compound P3 was obtained from IS3 by following the 
general procedure with lutidine as the additive. To a flame-dried vial were added 4 Å MS (50 
mg), Fe(OTf)2 (0.007 mmol) and ligand L9 (0.014 mmol). After evacuation upon oil pump and 
refill with argon three times, anhydrous and degassed toluene (1.4 mL) was added, followed by 
addition of lutidine (0.04 mmol). The obtained suspension was stirred vigorously at room 
temperature for 30 min and then IS3 (0.04 mmol) dissolved anhydrous and degassed toluene 
(600 µL) was added in one portion. The reaction was stirred at room temperature for 1 h and 
quenched by saturated NaHCO3 aqueous solution. The aqueous phase was extracted with DCM 
three times and the combined organic phase was dried over anhydrous Na2SO4. After 
concentration in vacuo, the title compound was isolated by a silica gel flash column as white 
foam (17 mg, 75% yield). The sample was analyzed by Chiral HPLC analysis and determined to 
be 93% ee (Chiralcel AD-H, 1.0 mL/min, 272 nm, 20% i-PrOH in hexane, tr (minor) = 20.03 
min, tr (major) = 21.67 min). [𝛼]D
20 = 30.5
o
 (c = 1.3, DCM). 
1
H NMR (400 MHz, d6-DMSO, 
ppm): δ 8.81 (s, 1H), 8.03 (AB, 4H), 7.94 (d, J = 7.6 Hz, 2H), 7.70 (t, J = 7.2 Hz, 1H), 7.56 (t, J 
= 8.0 Hz, 2H), 7.40 (d, J = 8.8 Hz, 1H), 7.09 (d, J = 2.0 Hz, 1H), 7.01 (dd, J = 8.4 Hz, 2.0 Hz, 
1H), 6.93 (s, 1H), 4.36 (d, J = 9.2 Hz, 1H), 4.03 (d, J = 8.8 Hz, 1H), 3.90 (s, 3H), 3.75 (s, 3H); 
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13
C NMR (100 MHz, d6-DMSO, ppm): δ 165.9, 164.3, 158.1, 157.6, 137.9, 134.9, 134.6, 132.8, 
132.5, 131.4, 130.7, 130.3, 129.8, 127.5, 117.0, 115.1, 110.9, 89.7, 73.5, 67.3, 56.2, 53.1; IR νmax 
(neat)/cm
-1
: 3330 (w), 1771 (s), 1275 (m), 1033 (s); MS(ESI) C26H22N2O9S [M-H]
- 
: 537.1. 
 
(2R, 3S)-6-methyl-2'-oxo-1-(phenylsulfonyl)spiro[indoline-3,4'-oxazolidine]-2-yl 2,4-
dichlorobenzoate(P4): by following the general procedure (0.04 mmol scale), the title 
compound P4 was obtained from IS4 and isolated by a silica gel flash column as white foam (14 
mg, 65% yield). The sample was analyzed by Chiral HPLC analysis and determined to be 94% 
ee (Chiralcel AD-H, 1.0 mL/min, 254 nm, 20% i-PrOH in hexane, tr (minor) = 17.02 min, tr 
(major) = 28.59 min). [𝛼]D
20 = 25.9
o
 (c = 1.1, DCM). 
1
H NMR (400 MHz, CDCl3, ppm): δ 8.75 
(s, 1H), 8.01 (d, J = 7.6 Hz, 2H), 7.84 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.68 (d, J = 7.2 Hz, 1H), 
7.57–7.55 (m, 3H), 7.35 (d, J = 7.6 Hz, 1H), 7.24 (s, 1H), 7.02 (d, J = 8.0 Hz, 1H), 6.94 (s, 1H), 
4.53 (d, J = 9.2 Hz, 1H), 4.01 (d, J = 9.2 Hz, 1H), 3.17 (s, 3H); 
13
C NMR (100 MHz, CDCl3, 
ppm): δ 162.2, 157.6, 141.1, 139.3, 138.2, 137.6, 134.4, 134.3, 133.2, 130.7, 129.8, 127.5, 127.2, 
126.5, 126.4, 125.7, 124.8, 13.6, 89.2, 73.4, 66.4, 21.3; IR νmax (neat)/cm
-1
: 3342 (w), 1634 (w), 
1276 (m), 750 (s); HRMS (ESI) calcd for C24H18Cl2N2O6S [M-H]
- 
: 531.0184, found 531.0193. 
 
(2R, 3S)-6-bromo-2'-oxo-1-(phenylsulfonyl)spiro[indoline-3,4'-oxazolidine]-2-yl 2,4-
dichlorobenzoate (P5): by following the general procedure (0.04 mmol scale), the title 
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compound P5 was obtained from IS5 and isolated by a silica gel flash column as white foam (16 
mg, 64% yield). The sample was analyzed by Chiral HPLC analysis and determined to be 98% 
ee (Chiralcel AD-H, 1.0 mL/min, 272 nm, 20% i-PrOH in hexane, tr (minor) = 20.19 min, tr 
(major) = 28.35 min). [𝛼]D
20 = 13.1
o
 (c = 0.87, DCM). 
1
H NMR (400 MHz, d6-DMSO, ppm): δ 
8.83 (s, 1H), 8.04 (d, J = 7.6 Hz, 2H), 7.83 (d, J = 1.6 Hz, 1H), 7.77–7.71 (m, 2H), 7.61–7.55 (m, 
3H), 7.49–7.43 (m, 3H), 7.00 (s, 1H), 4.64 (d, J = 9.2 Hz, 1H), 4.10 (d, J = 9.2 Hz, 1H);13C 
NMR (100 MHz, d6-DMSO, ppm): δ 162.0, 157.5, 140.5, 138.3, 137.4, 134.8, 134.4, 133.3, 
130.8, 130.0, 128.9, 127.8, 127.6, 127.2, 126.3, 123.5, 115.5, 89.0, 73.1, 66.2; IR νmax (neat)/cm
-
1
: 3290 (m), 1647 (w), 1276 (w), 1016 (s), 750 (s); HRMS (ESI) calcd for C23H14BrCl2N2O6S 
[M-H]
- 
: 594.9133, found 594.9147. 
 
(2R, 3S)-6-chloro-2'-oxo-1-(phenylsulfonyl)spiro[indoline-3,4'-oxazolidine]-2-yl 2,4-
dichlorobenzoate (P6): by following the general procedure (0.04 mmol scale), the title 
compound P6 was obtained from IS6 and isolated by a silica gel flash column as white foam (16 
mg, 70% yield). The sample was analyzed by Chiral HPLC analysis and determined to be 99% 
ee (Chiralcel AD-H, 1.0 mL/min, 272 nm, 20% i-PrOH in hexane, tr (minor) = 18.39 min, tr 
(major) = 26.10 min). [𝛼]D
20 = 10.1
o
 (c = 0.67, DCM). 
1
H NMR (400 MHz, d6-DMSO, ppm): δ 
8.82 (s, 1H), 8.05 (d, J = 7.6 Hz, 2H), 7.83 (d, J = 1.6 Hz, 1H), 7.76–7.70 (m, 2H), 7.61–7.54 (m, 
4H), 7.35 (s, 1H), 7.29 (d, J = 7.6 Hz, 1H), 7.01 (s, 1H), 4.65 (d, J = 9.2 Hz, 1H), 4.10 (d, J = 9.2 
Hz, 1H);
13
C NMR (100 MHz, d6-DMSO, ppm): δ 162.0, 157.5, 140.4, 138.3, 137.4, 135.2, 
134.7, 134.4, 133.2, 130.8, 130.0, 128.4, 127.5, 127.2, 126.9, 126.3, 124.9, 112.8, 89.1, 73.1, 
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66.2; IR νmax (neat)/cm
-1
: 3260 (w), 1767 (s), 1586 (m), 1376 (m), 1027 (s);  HRMS (ESI) calcd 
for C23H14Cl3N2O6S [M-H]
- 
: 550.9638, found 550.9640. 
 
(2R, 3S)-2'-oxo-6-phenyl-1-(phenylsulfonyl)spiro[indoline-3,4'-oxazolidine]-2-yl 2,4-
dichlorobenzoate (P7): by following the procedure for preparation of P3 (0.04 mmol scale), the 
title compound P7 was obtained from IS7 and isolated by a silica gel flash column as white foam 
(16 mg, 65% yield).The sample was analyzed by Chiral HPLC analysis and determined to be 
91% ee (Chiralcel AD-H, 1.0 mL/min, 272 nm, 20% i-PrOH in hexane, tr (minor) = 20.43 min, tr 
(major) = 27.22 min). [𝛼]D
20 = 17.5
o
 (c = 0.6, DCM). 
1
H NMR (400 MHz, d6-DMSO, ppm): δ 
8.83 (brs, 1H), 8.06 (d, J = 7.6 Hz, 2H), 7.84 (s, 1H), 7.80 (d, J = 8.4 Hz, 1H), 7.71 (t, J = 7.2 
Hz, 1H), 7.62–7.44 (m, 11H), 7.03 (s, 1H), 4.62 (d, J = 9.2 Hz, 1H), 4.12 (d, J = 9.2 Hz, 1H); 13C 
NMR (100 MHz, d6-DMSO, ppm): δ 162.6, 158.1, 143.7, 140.4, 139.8, 138.7, 138.0, 135.1, 
134.8, 133.7, 131.2, 130.4, 129.7, 128.9, 128.7, 128.0, 127.7, 127.4, 127.0, 126.2, 124.3, 111.5, 
89.7, 73.8, 66.8;  IR νmax (neat)/cm
-1
: 3354 (w), 1765 (s), 1376 (m), 1172 (m), 763 (m); HRMS 
(ESI) calcd for C29H20Cl2N2O6SNa [M+Na]
+
: 617.0317, found 617.0311. 
 
Methyl (2R, 3S)-7-methyl-2'-oxo-1-(phenylsulfonyl)spiro[indoline-3,4'-oxazolidine]-
2-yl terephthalate (P8): by following the general procedure (0.04 mmol scale), the title 
compound P8 was obtained from IS8 and isolated by a silica gel flash column as white foam (13 
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mg, 62% yield). The sample was analyzed by Chiral HPLC analysis and determined to be 88% 
ee (Chiralcel AD-H, 1.0 mL/min, 254 nm, 20% EtOH in hexane, tr (minor) = 20.81 min, tr 
(major) = 23.31 min). [𝛼]D
20 = -19.1
o
 (c = 0.8, DCM). 
1
H NMR (400 MHz, CDCl3, ppm): δ 8.07 
(d, J = 8.0 Hz, 2H), 7.96 (d, J = 7.6 Hz, 2H), 7.92 (d, J = 8.0 Hz, 2H), 7.64 (t, J = 7.6 Hz, 1H), 
7.52 (t, J = 7.2 Hz, 2H), 7.28 (s, 2H), 7.20 (d, J = 3.6 Hz, 1H), 7.05 (s, 1H), 5.95 (s, 1H), 4.46 (d, 
J = 9.6 Hz, 1H), 4.03 (d, J = 9.2 Hz, 1H), 3.94 (s, 3H), 2.36 (s, 3H); 
13
C NMR (100 MHz, 
CDCl3, ppm): δ 165.9, 139.0, 134.9, 133.9, 133.8, 131.8, 131.0, 130.0, 129.7, 129.3, 127.8, 
127.5, 121.0, 89.7, 73.9, 68.0, 52.6, 20.2; IR νmax (neat)/cm
-1
: 2922 (w), 1727 (s), 1279 (s), 1116 
(m); HRMS (ESI) calcd for C26H22N2O8S [M-H]
- 
: 521.1019, found 521.1014.  
 
(2R, 3S)-4-bromo-2'-oxo-1-(phenylsulfonyl)spiro[indoline-3,4'-oxazolidine]-2-yl 2,4-
dichlorobenzoate (P9): by following the general procedure (0.04 mmol scale), the title 
compound P9 was obtained from IS9 and isolated by a silica gel flash column as white foam (16 
mg, 67% yield). The sample was analyzed by Chiral HPLC analysis and determined to be 74% 
ee (Chiralcel AD-H, 1.0 mL/min, 254 nm, 20% i-PrOH in hexane, tr (minor) = 13.59 min, tr 
(major) = 27.94 min). [𝛼]D
20 = 14.3
o
 (c = 0.35, DCM). 
1
H NMR (400 MHz, d6-DMSO, ppm): δ 
8.81 (s, 1H), 8.04 (d, J = 7.6 Hz, 2H), 7.86 (d, J = 8.0 Hz, 1H), 7.85 (s, 1H), 7.72 (t, J = 7.2 Hz, 
1H), 7.60-7.55 (m, 3H), 7.43-7.33 (m, 3H), 7.04 (s, 1H), 4.83 (d, J = 9.2 Hz, 1H), 7.24 (d, J = 9.2 
Hz, 1H);
  13
C NMR (100 MHz, CDCl3, ppm): δ 162.2, 157.5, 141.4, 138.3, 137.4, 134.6, 134.3, 
133.2, 132.7, 130.7, 129.8, 128.9, 127.5, 127.3, 126.5, 126.48, 119.6, 112.4, 89.9, 71.4, 67.1; IR 
νmax (neat)/cm
-1
: 3241 (w), 1759 (m), 1582 (m), 1026 (s), 728 (s); HRMS (ESI) calcd for 
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C23H14BrCl2N2O6S [M-H]
- 
: 594.9133, found 594.9140. 
3.2.3.8 HPLC Data 
 
Racemic sample: 
 
 
 
90% ee 
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Racemic sample: 
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Racemic sample: 
 
 
94% ee 
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Racemic sample: 
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Racemic sample: 
 
 
99% ee 
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Racemic sample: 
 
 
 
91% ee 
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Racemic sample: 
 
 
88% ee 
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Racemic sample: 
 
 
 
74% ee 
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3.2.4 Product Derivatization and its Synthetic Applications 
3.2.4.1 Amino Indolane and Amino Oxindole Synthesis 
 
Scheme 51. Synthesis of Amino Indolane 
Procedure for Amino Indolane (3) Synthesis: 2 (0.04 mmol, 21 mg) was dissolved in 
2mL DCM, to which Et3SiH (0.4 mmol, 63.0 µL) was then added, followed by addition of 
BF3Et2O (0.12 mmol, 15µL) at -78 ℃. The mixture was stirred overnight and allowed to warm 
to room temperature. Then DCM was added and the organic phase was washed with water. The 
organic layer was washed with brine and dried over anhydrous Na2SO4. After filtration, the 
solvent was removed under vacuum and the residue was used in the next step directly without 
further purification.  
At room temperature, to a solution of the crude product obtained from the previous step 
in THF (2.0 mL), TEA (0.15 mmol, 21.0 µL) and DMAP (0.01 mmol, 1.2 mg) were added, 
followed by addition of Boc2O (0.2 mmol, 13 mg). After stirring for 1.0h at rt, the reaction was 
quenched with water and extracted with DCM three times. The combined organic phase was 
dried over anhydrous Na2SO4 and concentrated in vacuo. The protected indolane product was 
dissolved in MeOH (2.0 mL), to which Cs2CO3 (0.04 mmol, 13 mg) was added. The reaction 
mixture was stirred at room temperature for 1.0 h and quenched by water. DCM was added and 
the organic phase was washed with water. The combined organic layers were dried over 
anhydrous Na2SO4. After filtration and concentration under vacuum, the residue was purified by 
silica gel flash column chromatography (hexane/EtOAc = 2:1) to afford the 3-amino indolane  
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(11 mg, 64% overall yield). 
 
(R)-tert-Butyl (3-(hydroxymethyl)-1-(phenylsulfonyl)indolin-3-yl) carbamate(3): The 
sample was analyzed by Chiral HPLC analysis and determined to be 90% ee (Chiralcel AD-H, 
1.0 mL/min, 254 nm, 10% i-PrOH in hexane, tr (minor) = 25.91 min, tr (major) = 19.08 min). 
[𝛼]D
20= 4.4
o
 (c = 1.4, DCM). 
1
H NMR (400 MHz, CDCl3, ppm): δ 7.84 (d, J = 7.6 Hz, 2H), 7.70 
(d, J = 8.0 Hz, 1H), 7.56 (t, J = 7.2 Hz, 1H), 7.46 (t, J = 7.2 Hz, 2H), 7.31 (t, J = 7.6 Hz, 1H), 
7.17 (d, J = 7.2 Hz, 1H), 7.04 (t, J = 7.2 Hz, 1H), 4.14 (AB, 2H), 3.73-3.68 (m, 1H), 3,48 (s, 1H), 
1.32 (s, 9H);
13
C NMR (100 MHz, CDCl3, ppm): δ 155.2, 141.7, 137.4, 133.3, 132.5, 130.0, 
129.1, 127.2, 124.0, 123.5, 115.0, 80.8, 67.2, 63.24, 63.15, 57.7; IR νmax (neat)/cm
-1
: 3428 (w), 
1697 (m), 1358 (m), 1168 (s); MS(ESI) calcd for C20H25N2O5S [M+H]
+ 
: 405.1, found: 405.2. 
 
Scheme 52. Synthesis of Amino Oxindoles 
Procedure for Synthesis of Amino Oxindoles (4): At room temperature, Boc2O (0.11 
mmol, 24 mg) was added to a solution of 2 (0.1 mmol), TEA (0.15 mmol, 20.9 µL) and DMAP 
(0.01 mmol, 1.2 mg) in THF (4 mL). After stirring for 1.0h, the reaction was quenched with 
water and extracted with DCM three times. The combined organic phase was dried over 
anhydrous Na2SO4 and concentrated in vacuo. Quick purification of the residue by a short flash 
chromatography (hexane/EtOAc) affords the crude N-Boc protected intermediate. 
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The obtained N-Boc protected intermediate was dissolved in 2mL MeOH, to which 2 N 
aqueous Cs2CO3 solution (0.02 mmol, 10 µL) was added. The mixture was stirred at room 
temperature for 1 h before the solvent was removed in vacuo. The residue was dissolved in DCM 
and washed with water for three times. The combined organic layers were washed with brine (50 
mL) and dried over anhydrous Na2SO4. After filtration, the solvent was removed to afford the 
crude product, which was directly subjected to next step without further purification.  
To a solution of the crude product obtained above in DCM, DMP (0.12 mmol, 51 mg) 
was added and the mixture was stirred for 1.0 h at room temperature before water was added. 
The resulting mixture was extracted with DCM three times, and the combined organic layers 
were washed with brine (50 mL) and dried over anhydrous Na2SO4. After being concentrated in 
vacuo, the residue was purified by silica gel flash column chromatography (hexane/EtOAc) to 
afford the 3-amino oxindole product 4 (36 mg, 61% overall yield). 
 
(S)-(3-((tert-butoxycarbonyl)amino)-2-oxo-1-(phenylsulfonyl)indolin-3-yl)methyl 2,4-
dichlorobenzoate (4) : The sample was analyzed by Chiral HPLC analysis and determined to be 
90% ee (Chiralcel AD-H, 1.0 mL/min, 254 nm, 20% i-PrOH in hexane, tr (minor) = 18.18 min, tr 
(major) = 31.45 min). [𝛼]D
20  = -23.5
o
 (c = 1.2, DCM). 
1
H NMR (400 MHz, CDCl3, ppm): δ 8.16 
(d, J = 7.6 Hz, 2H), 7.99 (d, J = 8.0 Hz, 1H), 7.79 (s, 1H), 7.67 (t, J = 7.2 Hz, 1H), 7.55 (t, J = 
7.6 Hz, 2H), 7.43–7.37 (m, 3H), 7.30 (t, J = 7.6 Hz, 1H), 7.25–7.18 (m, 2H), 4.39 (AB, 2H), 1.49 
(s, 9H); 
13
C NMR (100 MHz, CDCl3, ppm): δ 171.0, 163.9, 153.2, 139.2, 137.7, 137.5, 134.4, 
132.0, 131.8, 130.5, 130.2, 130.1, 128.9, 128.2, 127.5, 126.1, 125.1, 123.9, 113.7, 84.0, 67.5, 
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62.2, 27.6; IR νmax (neat)/cm
-1
: 3009 (w), 1754 (s), 1681 (w), 1370 (m), 1253 (s); MS (ESI) 
calculated for C27H25Cl2N2O7S [M + H]
+
: 591.1, found: 591.1. 
3.2.4.2 HPLC Data 
 
Racemic sample: 
 
 
 
90% ee 
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Racemic sample: 
 
 
90% ee 
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3.2.5 Asymmetric Aminohydroxylation of an N-Boc Indole and Product Derivatization 
3.2.5.1  Asymmetric Aminohydroxylation of an N-Boc Indole  
 
Scheme 53. Asymmetric Aminohydroxylation of an N-Boc Indole 
Procedure for asymmetric aminohydroxylation of an N-Boc indole: To a flame-dried 
vial were added 4Å MS (50 mg), Fe(OAc)2 (0.004 mmol) together with ligand L9 (0.004 mmol). 
After evacuation upon oil pump and refill with argon three times, anhydrous and degassed 
toluene/MeCN (50:1, 1.5 mL) co-solvent was added. The obtained suspension was stirred 
vigorously at room temperature for 30 min before the substrate 5 (19 mg, 0.04 mmol) in the 
aforementioned co-solvent (0.5 mL) was added in one portion. The reaction system was stirred 0 
o
C for 12 h when all the starting material was fully consumed. Saturated NaHCO3 aqueous 
solution was added to quench the reaction, and the aqueous phase was extracted with DCM three 
times. The combined organic phase was dried over anhydrous Na2SO4 and concentrated in vacuo. 
The residue was purified by silica gel flash column chromatography (hexane: THF = 4:1) to give 
the desired aminohydroxylation product 6 (16 mg, 85% yield). 
 
tert-Butyl 3-(((((2,4-dichlorobenzoyl)oxy)carbamoyl)oxy)methyl)-1H-indole-1-
carboxylate (5): 
1
H NMR (400 MHz, CDCl3, ppm): δ 8.44 (s, 1H), 8.17 (d, J = 8.0 Hz, 1H), 
7.87 (d, J = 8.4 Hz, 1H), 7.71 (s, 1H), 7.62 (d, J = 8.0 Hz, 1H), 7.52 (s, 1H), 7.39-7.25 (m, 3H), 
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5.43 (s, 2H), 1.69 (s, 9H); 
13
C NMR (100 MHz, CDCl3, ppm): δ 163.7, 156.3, 149.4, 139.9, 
135.7, 132.8, 131.2, 129.0, 127.2, 126.2, 124.9, 124.6, 122.9, 119.1, 115.3, 114.5, 84.1, 60.5, 
28.1; IR νmax (neat)/cm
-1
: 3255 (w), 1733 (s), 1370 (m), 1087 (s), 731 (m); HRMS (ESI) 
calculated for C22H19Cl2N2O6 [M - H]
-
: 477.0620, found: 477.0610. 
 
tert-Butyl (2R,3S)-2-((2,4-dichlorobenzoyl)oxy)-2'-oxospiro[indoline-3,4'-
oxazolidine]-1-carboxylate (6): The sample was analyzed by Chiral HPLC analysis and 
determined to be 87% ee (Chiralcel AD-H, 1.0 mL/min, 254 nm, 20% i-PrOH in hexane, tr 
(minor) = 4.58 min, tr (major) = 8.56 min). [𝛼]D
20 = 44.7
o
 (c = 2.1, DCM). 
1
H NMR (400 MHz, 
CDCl3, ppm): δ 7.81 (d, J = 8.4 Hz, 1H), 7.47 (s, 1H), 7.39 (d, J = 8.4 Hz, 2H), 7.32 (dd, J = 1.2 
Hz, 8.4 Hz, 1H), 7.17 (t, J = 7.2 Hz, 1H), 6.96 (s, 1H), 6.36 (s, 1H), 4.71 (d, J  = 9.2 Hz, 1H), 
4.29 (d, J = 9.2 Hz, 1H), 1.52 (t, J = 9H); 
13
C NMR (100 MHz, CDCl3, ppm): δ 163.2, 158.3, 
150.8, 140.9, 139.2, 135.1, 133.0, 131.2, 127.2, 126.8, 124.4, 123.5, 115.2, 87.2, 83.4, 75.3, 
28.2; IR νmax (neat)/cm
-1
: 3256 (w), 1765 (s), 1721 (s), 1379 (m), 765 (m); HRMS (ESI) 
calculated for C22H19Cl2N2O6 [M - H]
-
: 477.0620, found: 477.0625. 
3.2.5.2 N-Boc Indole Product Derivatization  
 
Scheme 54. Synthesis of Amino Indolane 
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Procedure for Amino Indolane (6) Synthesis: 6 (0.04 mmol, 19 mg) was dissolved in 
DCM (2 ml), to which Et3SiH (0.4 mmol, 63.0 µL) was then added, followed by addition of 
BF3Et2O (0.12 mmol, 15µL) at -78 ℃. The mixture was stirred overnight and allowed to warm 
to 0 
o
C. Then DCM was added and the organic phase was washed with water. The organic layer 
was washed with brine and dried over anhydrous Na2SO4. After filtration, the solvent was 
removed under vacuum and the residue was purified by silica gel flash column chromatography 
(hexane/EtOAc = 1:1) to afford the 3-amino indolane S1 (13 mg, 66% overall yield). 
 
(R)-Spiro [indoline-3,4'-oxazolidin]-2'-one (S1): The sample was analyzed by Chiral 
HPLC analysis and determined to be 86% ee (Chiralcel AD-H, 1.0 mL/min, 254 nm, 10% EtOH 
in hexane, tr (minor) = 51.76 min, tr (major) = 72.76 min). [𝛼]D
20 = -52.1
o
 (c = 0.19, DCM). 
1
H 
NMR (400 MHz, CDCl3, ppm): δ 7.31 (d, J = 7.6 Hz, 1H), 7.18 (t, J = 7.2 Hz, 1H), 6.86 (t, J = 
7.2 Hz, 1H), 6.75 (d, J = 8.0 Hz, 1H), 4.50 (AB, 2H), 3.65 (AB, 2H); 
13
C NMR (100 MHz, 
CDCl3, ppm): δ 159.7, 150.6, 129.7, 129.3, 122.9, 119.7, 110.9, 76.2, 65.7, 58.3; IR νmax 
(neat)/cm
-1
: 3331 (w), 1740 (s), 1609 (m), 1387 (m), 754 (w).  
3.2.5.3 Synthesis of Amino Oxindoles  
 
Scheme 55. Synthesis of Amino Oxindoles 
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Procedure for Synthesis of Amino Oxindoles (S2): At room temperature, LiOH (0.11 
mmol, 2.46mg) was added to a solution of 5 (0.1 mmol) in THF/MeOH/H2O (8/1/1, 2.0 mL). 
After stirring for 1.0 h, the reaction was concentrated in vacuo. Quick purification of the residue 
by a short flash chromatography (hexane/EtOAc) affords the crude hydroxyl oxazolidinone 
intermediate. 
To a solution of the hydroxyl oxazolidinone intermediate obtained above in DessMartin 
Periodinane (0.22 mmol, 93 mg), NaHCO3 (1.0 mmol, 84 mg) were added and the mixture was 
stirred for 10 h at room temperature before water was added. The resulting mixture was extracted 
with DCM three times, and the combined organic layers were washed with brine (50 mL) and 
dried over anhydrous Na2SO4. After being concentrated in vacuo, the residue was purified by 
silica gel flash column chromatography (hexane/EtOAc) to afford the oxindole intermediate. 
To a solution of the oxindole intermediate obtained above in DCM (1.0 mL), TFA (1.0 
mmol, 76 uL) was added and the mixture was stirred for 2 h at 0 
o
C before saturated NaHCO3 
aqueous solution was added. The resulting mixture was extracted with DCM for three times, and 
the combined organic layers were washed with brine (50 mL) and dried over anhydrous Na2SO4. 
After being concentrated in vacuo, the residue was purified by silica gel flash column 
chromatography (hexane/EtOAc) to afford the amino oxindole product S2 (11 mg, 56% overall 
yield). 
 
(S)-Spiro [indoline-3,4'-oxazolidine]-2,2'-dione (S2): The sample was analyzed by 
Chiral HPLC analysis and determined to be 87% ee (Chiralcel AD-H, 1.0 mL/min, 254 nm, 20% 
i-PrOH in hexane, tr (minor) = 13.12 min, tr (major) = 7.08 min). [𝛼]D
20 = 6.0
o
 (c = 0.05, DCM). 
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1
H NMR (400 MHz, CDCl3, ppm): δ 7.48 (d, J = 7.6 Hz, 1H), 7.35 (t, J = 8.0 Hz, 1H), 7.14 (t, J 
= 7.6 Hz, 1H), 6.94 (d, J = 8.0 Hz, 1H), 4.55 (AB, 2H); 
13
C NMR (100 MHz, CDCl3, ppm): δ 
130.3, 128.1, 124.0, 123.0, 110.3, 72.7; IR νmax (neat)/cm
-1
: 3250 (w), 1725 (s), 1620 (m), 1471 
(m), 752 (m); HRMS (ESI) calculated for C10H7N2O3 [M - H]
-
: 203.0457, found: 203.0451. 
3.2.5.4 HPLC Data 
 
Racemic sample: 
 
 
87% ee 
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Racemic sample: 
 
 
 
86% ee 
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Racemic sample: 
 
 
 
87% ee 
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3.2.6 Iron-Catalyzed Aminohydroxylation of Functionalized Tryptophan 
3.2.6.1 Preparation of Tryptophan Substrate  
 
Scheme 56. Preparation of Tryptophan Substrate 5 
Procedure for Substrate S4 Synthesis: LiOH (5.0 mmol) was added to a solution of L-
tryptophan methyl ester S3 (1.0 mmol)
 2 
in THF/H2O (10 mL) and the mixture was stirred at 
room temperature for 10 h until the starting material was completely consumed. THF was 
removed under reduced pressure and the resulting residue was dissolved in DCM and washed 
with water three times. The combined organic phase was dried over anhydrous Na2SO4 and 
concentrated in vacuo. The crude product was purified by silica gel flash column 
chromatography (DCM/MeOH) to afford S4 (423 mg, 86% yield). 
 
(S)-Methyl 2-(((benzyloxy)carbonyl)amino)-3-(1-(phenylsulfonyl)-1H-indol-3-
yl)propanoate (S4) : 
1
H NMR (400 MHz, CDCl3, ppm): δ 9.88 (brs, 1HA + 1HB), 7.99 (d, J = 
8.4 Hz, 1HA + 1HB), 7.55 (s, 1HA), 7.51–7.39 (m, 4H), 7.31–7.29 (m, 11H), 7.20–7.14 (m, 3H), 
6.87 (d, J = 7.6 Hz, 1HB), 5.50 (d, J = 7.6 Hz, 1HA), 5.12 (AB, 2HA), 4.91 (AB, 2HB), 4.79–4.74 
(m, 1HA), 4.61–4.60 (m, 1HB), 3.36–3.06 (m, 2HA + 2HB) ;
13
C NMR (100 MHz, CDCl3, ppm): δ 
175.5, 155.9, 137.8, 135.9, 135.0, 133.7, 130.7, 130.4, 129.1, 128.5, 128.2, 128.0, 127.9, 126.6, 
124.9, 124.6, 123.4, 119.4, 119.2, 117.2, 116.9, 113.6, 67.7, 67.2, 54.0, 53.7, 28.4, 27.4; IR νmax  
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(neat)/cm
-1
: 3067 (w), 1716 (s), 1367 (m), 1175 (s), 1047 (w). 
Procedure for Substrate Tryptophan 7 Synthesis: At room temperature, CDI (2 mmol) 
was added to a solution of protected L-tryptophan S4 (1.0 mmol) in DMF (10 mL). The reaction 
mixture was stirred for 30 min and then NH2OHHCl (4 mmol) was added. After being stirred for 
an additional 1.0 h at room temperature, H2O (5 mL) was added and the reaction system was 
stirred for another 30 min, and then diluted with DCM (50 mL) and water (50 mL). The aqueous 
phase was extracted with DCM (50 mL) three times and the combined organic phase was dried 
over anhydrous Na2SO4 and concentrated in vacuo. The crude product was purified by short 
silica gel flash column chromatography (10% MeOH in DCM) to afford the hydroxyl carbamate 
intermediate (420 mg, 85% yield). 
To a solution of the obtained hydroxyl carbamate (1.0 mmol) and 2, 4-dichlorobenzoyl 
acid (1.0 mmol) in DCM (10 mL), DCC (1.0 mmol) in DCM (3.0 mL) was added dropwise at 0 
°C. After being stirred for 1.0 h, the reaction mixture was diluted by Et2O (15 mL).The 
byproduct precipitated out and was removed by filtration. DCM was removed under vacuum and 
the residue was purified by silica gel flash column chromatography (30% EtOAc in hexanes) to 
afford 7 (480 mg, 72% yield). 
 
(S)-Benzyl (1-(((2,4-dichlorobenzoyl)oxy)amino)-1-oxo-3-(1-(phenylsulfonyl)-1H-
indol-3-yl)propan-2-yl)carbamate (7) : 
1
H NMR (400 MHz, CDCl3, ppm): δ 10.44 (brs, 1H), 
7.97 (d, J = 8.4 Hz, 1H), 7.85 (d, J = 7.6 Hz, 3H), 7.58 (s, 1H), 7.49–7.41 (m, 3H), 7.35–7.21 (m, 
9H), 7.16 (t, J = 7.6 Hz, 1H), 5.79 (d, J = 7.6 Hz, 1H), 5.02 (s, 2H), 4.76 (s, 1H), 3.22 (AB, 
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2H);
13
C NMR (100 MHz, CDCl3, ppm): δ 162.2, 139.9, 138.0, 135.7, 135.6, 135.1, 133.7, 132.9, 
131.2, 130.4, 129.2, 128.5, 128.2, 128.0, 127.2, 126.7, 125.0, 124.4, 123.4, 119.3, 116.9, 113.7, 
67.5, 52.2, 27.4; IR νmax (neat)/cm
-1
: 3285 (w), 1683 (s), 1374 (m), 1176 (s), 1081 (m); HRMS 
(ESI) calcd for C32H26Cl2N3O7S [M+H]
+ 
: 666.0869, found 666.0865. 
3.2.6.2 Reaction Discovery for Aminohydroxylation of Tryptophan Substrate  
 
Table 20. Reaction Conditions Screening for Aminohydroxylation of Tryptophan 
Procedure for Aminohydroxylation of 7: Fe(NTf2)2 (0.007 mmol) and 1,10-
phenanthroline (0.014 mmol) were added to a flame-dried vial. After evacuation upon oil pump 
and refill with argon three times, anhydrous and degassed DCM (1.0 mL) was added. The 
resulting suspension was stirred vigorously at room temperature for 30 min and cooled down to -
130 
10 
o
C. 7 (0.04 mmol) dissolved in anhydrous and degassed DCM (1.0 mL) was added dropwise 
to the reaction system, which was stirred at -10 
o
C for 4 h when all the starting material was fully 
consumed. Saturated NaHCO3 aqueous solution was added to quench the reaction, and the 
aqueous phase was extracted with DCM three times. The combined organic layers were dried 
over anhydrous Na2SO4 and concentrated in vacuo. The residue was purified by silica gel flash 
column chromatography (hexane: EtOAc = 2:1) to give 8 and 9 respectively.  
 
(2S,2'S,4'S)-4'-(Benzyloxycarbonylamino)-5'-oxo-1-(phenylsulfonyl)spiro[indoline-
3,2'-pyrrolidine]-2-yl 2,4-dichlorobenzoate (8): by following the procedure above (0.04 mmol 
scale), the title compound 8 was obtained from 7 and isolated by a silica gel flash column as 
white foam (13 mg, 46% yield). [𝛼]D
20 = -36.3
o
 (c = 0.8, DCM). 
1
H NMR (400 MHz, CDCl3, 
ppm): δ 7.69-7.57 (m, 3H), 7.49–7.34 (m, 9H), 7.24–7.16 (m, 4H), 6.74 (s, 1H), 5.96 (s, 1H), 
5.35 (d, J = 8.4 Hz, 1H), 5.09 (s, 2H), 4.49-4.44 (m, 1H), 2.44–2.39 (m, 1H), 2.16–2.10 (m, 1H); 
13
C NMR (100 MHz, CDCl3, ppm): δ 163.4, 155.8, 139.5, 139.48, 138.2, 136.0, 135.6, 134.0, 
133.0, 131.5, 131.2, 130.9, 129.6, 128.6, 128.3, 128.1, 127.1, 126.9, 126.3, 125.5, 124.1, 114.4, 
88.9, 67.1, 64.9, 51.3, 42.0. IR νmax (neat)/cm
-1
: 3362 (w), 1710 (s), 1366 (m), 1238 (m), 1173 
(s); HRMS (ESI) calcd for C32H26Cl2N3O7S [M+H]
+ 
: 666.0869, found 666.0868. 
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(S)-Benzyl 3-oxo-4-((1-(phenylsulfonyl)-1H-indol-3-yl)methyl)-1,2-diazetidine-1- 
carboxylate (9): by following the general procedure (0.04 mmol scale), the title 
compound 9 was obtained from 7 and isolated by a silica gel flash column as white foam (5 mg, 
25% yield). [𝛼]D
20  = -38.2
o
 (c = 1.6, DCM). 
1
H NMR (400 MHz, d6-acetone, ppm): δ 8.02 (d, J = 
8.4 Hz, 1H), 7.97-7.93 (m, 2H), 7.78 (s, 1H), 7.70 (d, J = 7.6 Hz, 1H), 7.63–7.59 (m, 1H), 7.52–
7.47 (m, 3H), 7.39–7.26 (m, 6H), 5.69 (q, J = 7.6 Hz, 1H), 5.15–5.08 (m, 2H), 3.29 (d, J = 6.8 
Hz, 2H); 
13
C NMR (100 MHz, d6-acetone, ppm): δ 137.9, 135.1, 134.2, 130.8, 129.5, 128.4, 
128.0, 127.9, 126.7, 124.9, 123.5, 119.8, 117.6, 113.6, 66.3, 63.2, 31.6. IR νmax (neat)/cm
-1
: 3306 
(w), 2246 (s), 1716 (m), 1174 (s); MS (ESI) calcd for C25H21N3NaO5S [M+Na]
+ 
: 498.1, found 
498.1. 
3.2.6.3 Reaction Discovery for Aminohydroxylation of Tryptophan Substrate  
 
 
Table 21. Reaction Discovery for Aminohydroxylation of Tryptophan Substrate 10 
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Procedure for Aminohydroxylation of 10: Fe(NTf2)2 (0.007 mmol) and 1,10-
phenanthroline (0.014 mmol) were added to a flame-dried vial. After evacuation with a vacuum 
pump and refill with argon three times, anhydrous and degassed CH3CN (1.0 mL) was added. 
The resulting suspension was stirred vigorously at room temperature for 30 min and cooled down 
to 0 
o
C. 10 (0.04 mmol) dissolved in anhydrous and degassed CH3CN (1.0 mL) was added 
dropwise to the reaction system, which was stirred at 0 
o
C for 8 h when all the starting material 
was fully consumed. Saturated NaHCO3 aqueous solution was added to quench the reaction, and 
the aqueous phase was extracted with DCM three times. The combined organic layers were dried 
over anhydrous Na2SO4 and concentrated in vacuo. The residue was purified by silica gel flash 
column chromatography (hexane: EtOAc = 2:1) to give 11.  
 
(S)-tert-Butyl 3-(3-(((2,4-dichlorobenzoyl)oxy)amino)-2-(1,3-dioxoisoindolin-2-yl)-3-
oxopropyl)-1H-indole-1-carboxylate (10): white solid (mp: 155-157
 o
C) 
1
H NMR (400 MHz, 
CDCl3, ppm): δ 10.47 (brs, 1H), 8.05 (d, J = 7.6 Hz, 1H), 7.93 (d, J = 8.4 Hz, 1H), 7.79-7.76 (m, 
2H), 7.69-7.66 (m, 2H), 7.56 (d, J = 8.0 Hz, 2H), 7.46 (s, 1H), 7.42 (s, 1H), 7.31-7.16 (m, 3H), 
5.42 (t, J = 8.0 Hz, 1H), 3.74 (d, J = 8.0 Hz, 2H), 1.58 (s, 9H); 
13
C NMR (100 MHz, CDCl3, 
ppm): δ 167.9, 162.4, 149.4, 139.9, 135.8, 134.5, 133.0, 131.4, 129.7, 127.3, 124.7, 124.5, 124.3, 
123.8, 122.7, 118.7, 115.3, 115.0, 83.6, 52.8, 33.7, 28.1. IR νmax (neat)/cm
-1
: 3350 (w), 1717 (s), 
1372 (m), 878 (m); HRMS (ESI) calcd for C31H25Cl2N3O7Na [M+Na]
+
: 644.0967, found 
644.0958. 
133 
 
(2S, 2'S, 4'S)-tert-Butyl 2-((2,4-dichlorobenzoyl)oxy)-4'-(1,3-dioxoisoindolin-2-yl)-5'-
oxospiro[indoline-3,2'-pyrrolidine]-1-carboxylate (11): by following the procedure above 
(0.04 mmol scale), the title compound 11 was obtained from 10 and isolated by a silica gel flash 
column as white solid (mp: 183-185
 o
C, 19 mg, 76% yield). 
1
H NMR (400 MHz, CDCl3, ppm): δ 
7.78-7.76 (m, 8H), 7.68 (d, J = 7.6 Hz, 1H), 7.47 (s, 1H), 7.40-7.30 (m, 4H), 7.20 (t, J = 8.0 Hz, 
1H), 6.91 (s, 1H), 6.46 (s, 1H) (6.38 (s, 1H, minor diastereomer)), 5.39 (d, J = 10.0 Hz, 1H) 
(5.28 (d, J = 10.0 Hz, 1H, minor diastereomer)), 2.91 (t, J = 8.0 Hz, 1H) (3.14 (t, J = 8.4 Hz, 1H, 
minor diastereomer)), 2.76 (t, J = 12.8 Hz, 1H) (2.61 (t, J = 9.6 Hz, 1H, minor diastereomer)), 
1.52 (s, 9H) (1.55 (s, 5H, minor diastereomer)); 
13
C NMR (100 MHz, CDCl3, ppm): δ 172.0, 
171.9, 171.5, 167.3, 163.8, 162.6, 151.0, 139.9, 139.3, 139.1, 135.2, 135.0, 133.2, 132.9, 131.24, 
131.2, 130.6, 130.4, 127.3, 124.6, 124.2, 123.9, 123.8, 123.7, 122.1, 115.4, 114.8, 88.9, 88.1, 
83.3, 64.1, 63.8, 48.6, 48.1, 39.0, 38.8, 28.2. IR νmax (neat)/cm
-1
: 3340 (w), 1717 (s), 1040 (m), 
880 (m); HRMS (ESI) calcd for C31H25Cl2N3O7Na [M+Na]
+ 
: 644.0967, found 644.0959. 
3.2.7 X-ray Crystallographic Analysis for Product Absolute Stereochemistry Determination 
Please refer to Appendix E for further details.  
 
3.3     RESULTS 
Despite these important achievements, the catalytic asymmetric aminohydroxylation of 
indoles with synthetically useful ee has remained a challenge.
57
 Likewise, iron-catalyzed olefin 
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aminohydroxylation is also a less-explored process;
14b, 14d, 14e, 62
 however, Yoon recently 
discovered an iron-catalyzed olefin aminohydroxylation with sulfonyl oxaziridines.
35-36
 We have 
recently reported an iron-catalyzed intramolecular olefin aminohydroxylation and the 
mechanistic studies revealed that an iron-nitrenoid is a possible intermediate in the selective 
atom transfer reaction.
63
 Herein, we describe our latest discovery: an iron(II)-catalyzed 
asymmetric intramolecular aminohydroxylation of indoles. In this reaction, the iron catalyst 
diastereo- and enantioselectively transfer the N and O group of the hydroxylamine to a variety of 
indoles (dr > 20:1, ee up to 99%). Simple product derivatization provides both amino oxindoles 
and amino indolanes in their enantioenriched forms. 
3.3.1 Iron Catalyst Discovery  
3.3.1.1  Iron(II)-Catalyzed Racemic Reaction 
We initiated the catalyst discovery with a model substrate 1 and extensive optimization 
revealed that the FeSO4–1,10-phenanthroline complex catalyzes an efficient racemic indole 
aminohydroxylation reaction affording product 2 as a single diastereomer (Table 9). 
3.3.1.2 Iron(II)-Catalyzed Asymmetric Reaction 
With the optimized racemic reaction in hand, we set out to search for chiral ligands that 
effectively promote enantioselective indole aminohydroxylation with iron(II) complexes (Table 
22). Since FeSO4 is poorly soluble in nonpolar solvents such as toluene, we selected Fe(OTf)2 as 
the iron salt for chiral ligand discovery. Extensive experimentation revealed that a toluene–
MeCN (50:1) mixture is crucial for high enantioselectivity. Under these conditions, we 
systematically inspected a series of chiral bisoxazoline (BOX) and pyridine–oxazoline (PyBOX) 
hybrid ligands.
37b, 45a, 45b, 45d, 64
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a
Reactions were carried out under argon in 0.025 M toluene/MeCN (50:1) mixture; catalyst complexes 
were formed by premixing Fe(X)2 and ligands for 40 min. 
b
Isolated yield. 
c
ee was measured by HPLC analysis with 
chiral stationary phase. 
d
The sense of enantioinduction in entry 4 is opposite to that of other entries. 
 
Table 22. Catalyst Discovery for the Asymmetric Indole Aminohydroxylation 
We observed that the Fe(OTf)2–iPrBOX L1 complex fails to induce any 
enantioselectivity (entry 1); however, the Fe(OTf)2–tBuBOX L2 complex is capable of 
asymmetric induction (entry 2, 31% ee). The change from L2 to PhBOX L3 correlates with both 
enhanced reactivity and enantioselectivity (entry 3, 58% yield, 77% ee). Surprisingly, a relatively 
minor modification to the ligand’s structure (from PhBOX L3 to BnBOX L4) leads to 
asymmetric induction in the opposite sense (entry 4, 48% yield, −86% ee). We, therefore, tested 
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PyBOX and pyridine-oxazoline hybrid ligands L5–L8 and determined that they are inferior to 
L3 and L4 (entries 5–8, ee up to 61%). Further screening of tetrasubstituted chiral BOX ligands 
(L9–L10) revealed that the Fe(OTf)2–L9 complex catalyzes the indole aminohydroxylation with 
further enhanced ee (entry 9, 65% yield, 87% ee). Knowing that aromatic interaction may be 
important for asymmetric induction,
65
 we carried out electronic tuning experiments on the 
benzoyl protecting group. We discovered that the 4-Cl, 4-CF3, and 3,5-(CF3)2 substituents result 
in decreased ee while the 4-CO2Me group maintains the similar ee (entries 11–14 compared with 
entry 9). We also observed that hydrolytically more robust Fe(NTf2)2
45e
 promotes the reaction 
with a slightly increased yield yet decreased ee (entry 15, 67% yield, 79% ee). Concordantly, we 
discovered that both FeCl2 and FeBr2 promote less selective reactions with L9 (entries 16–17); 
however, the Fe(OAc)2–L9 complex manages to increase the ee to 90% in 12 h (entry 18). 
3.3.1.3 N-Donor Effect 
 
Scheme 57. Iron(II)-Catalyzed Indole Aminohydroxylation Accelerated by 2,6-Lutidine 
In order to search for a more reactive yet highly selective catalyst, we inspected a variety 
of additives with bulky N-donor ability.
66
 Extensive optimization revealed that 2,6-lutidine (1.0 
equiv) significantly accelerates the Fe(OTf2)–L9 catalyzed reaction in toluene with a slight 
increase in enantioselectivity (Scheme 57, full conversion in 45 min at −10 °C, 65% yield, 88% 
ee). This discovery offers us an opportunity to expand the substrate scope and includes substrates 
that have low reactivity in Fe(OAc)2-catalyzed reactions. 
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3.3.2 Substrate Scope 
To explore the scope and limitation of the aforementioned method, we applied the 
optimized reaction conditions to a variety of substituted indoles (Table 23). We observed that 5-
methylindole is an excellent substrate for Fe(OAc)2-catalyzed asymmetric aminohydroxylation 
(AA) (entry 2, 94% ee). Likewise, the Fe(OTf)2–L9–lutidine complex enantioselectively 
converts a 5-methoxy indole to its corresponding hydroxyl oxazolidinone (entry 3, 93% ee). We 
also discovered that 6-methyl-, bromo-, and chloro-substituents are all well-tolerated in the 
Fe(OAc)2-catalyzed indole AA, which thereby offers versatile handles for further transformation 
(entries 4–6, 91–99% ee). Further exploration revealed that 6-phenyl indole is an excellent 
substrate for Fe(OTf)2-catalyzed AA (entry 7, 91% ee) and that 7-methyl indole participates in 
the Fe(OAc)2-catalyzed AA with acceptable ee (entry 8, 88% ee). However, we observed that the 
ee for aminohydroxylation of 4-bromo indole is significantly lower than other substrates (entry 9, 
74% ee), which suggests that 4-H may be important for asymmetric induction. 
 
a
Reactions were carried out under argon in 0.025 M toluene/MeCN (50:1) mixture unless stated otherwise. 
b
Isolated yield, and 3-indole aldehydes were isolated (ca. 15%) as the side product. 
c
ee was measured by HPLC 
analysis with chiral stationary phase. 
d
R
1
 = 4-CO2Mebenzoyl. 
e
Reactions were carried out under argon at 0.025 M 
toluene at 10 °C for 4 h. Fe(OTf)2 (15 mol %) and L9 (30 mol %) were applied as the catalyst and 2,6-lutidine (1.0 
equiv) was used as the additive. 
 
Table 23. Substrate Scope for the Asymmetric Indole Aminohydroxylation 
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3.3.3 Synthetic Transformations 
The enantio-enriched hydroxyl oxazolidinone 2 can be readily converted to either amino 
indolane 3 or amino oxindole 4 without erosion of the ee with three-step procedures (Scheme 
58A). The N-sulfonyl protected amino oxindole motif is of interest in medicinal chemistry 
because it is present in SSR-149415, a medicine for the treatment of anxiety and depression. In 
order to develop an easy entry to both unprotected amino indolanes and oxindoles, we explored 
the aminohydroxylation of an N-Boc protected indole 5 (Scheme 58B). We observed that 
Fe(OAc)2–L9 complex catalyzes the efficient aminohydroxylation of 5 with an even lower 
catalyst loading, affording product 6 with excellent yield (10 mol% catalyst, 85% yield, dr > 
20:1, 87% ee). 
We further observed that the Fe(NTf2)2–phenanthroline complex catalyzes the 
aminohydroxylation of a protected tryptophan 7 to afford a single diastereomeric hydroxyl 
oxazolidinone 8 (full conversion, 46% yield, Scheme 58C); interestingly, the 
aminohydroxylation occurs from the α face of tryptophan. In addition, we also isolated 
diazetidinone 9 (25% yield), a side product that is possibly derived from an N–H insertion 
reaction of the putative iron-nitrenoid intermediate. We, therefore, applied the same catalyst to 
another fully protected tryptophan 10 and observed the efficient aminohydroxylation afford 11. 
A) synthetic transformation of the product: amino indolanes and amino oxindoles 
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B) asymmetric aminohydroxylation of an N-Boc indole 
 
C) aminohydroxylation of tryptophan 
 
Scheme 58. Product Synthetic Transformation and the Iron(II)-Catalyzed AA of Tryptophan 
 
3.4 CONCLUSIONS 
In conclusion, we have discovered an asymmetric intramolecular indole 
aminohydroxylation catalyzed by iron(II)–chiral BOX complexes. This enantioselective process 
enables the facile asymmetric synthesis of biologically relevant 3-amino oxindoles and 3-amino 
indolanes. Our current research focuses on the application of this method in medicinal agent 
synthesis and a better understanding of the origin for asymmetric induction. 
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4 CHAPTER IV     IRON CATALYZED DIRECT DIAZIDATION FOR A BROAD 
RANGE OF OLEFINS 
 
4.1 INTRODUCTION  
4.1.1 Naturally Occurring Molecules  
Since the first discovery of organic azides more than 140 years by Peter Grieß,
67
 it has 
been broadly applied in numerous syntheses of important classes of organic compounds. 
Particularly in more recent years, a varied utility of organic azides was developed due to its good 
accessibility, such as organic functional group transformations in industrial and pharmaceutical 
areas, the synthesis of heterocycles and the well-known “Click Chemistry”. In spite of the 
explosive property of azide compounds, a vast utility of azido group in a late stage 
diversification of commercially available drug candidates, biomedical probes, as well as 
molecule libraries received considerable attentions.
68
 
 
Figure 6. Important Transformations of Organic Azides 
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More importantly, we have witnessed the power and achievements of selective nitrogen-
atom-transfer for olefin functionalization due to their generation of high-value chemicals from 
readily available hydrocarbons or petrochemicals. Among the blossoming of C-H activations as 
well as olefin functionalization processes by azido-group transfer, catalytic olefin diazidation has 
emerged with unique value for a few reasons.
67-69
 First and foremost, vicinal diamines are 
important structural motifs that widely exist in naturally occurring molecules as shown in Figure 
7. Thus, this reaction provides an easy access to affording synthetically important vicinal 
primary diamines which are difficult to obtain with the currently existing olefin diamination 
methods.
70
 Next, it can also rapidly convert olefins into a variety of probes for the robust azide–
alkyne click chemistry, which has given organic azides irreplaceable roles in biological and 
material sciences.
69a
 Therefore, searching for a general, yet novel selective olefin diazidation 
method has been an attracting research area and a variety of methods for certain limited types of 
olefins have been developed.
71
   
 
Figure 7.   Compounds Containing the Vicinal Diamine Motif 
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4.1.2 Fe(II)/Fe(III)-Mediated Reactions 
Minisci developed a Fe(II)/Fe(III)-mediated stoichiometric approach, with hydrogen 
peroxide and NaN3, specifically for styrenyl olefins. In his case, the yield of diazide product is 
significantly affected by the oxidant type. However, this method is incompatible with 
nonstyrenyl olefins.
71i
 
 
Scheme 59. Fe(II)/Fe(III)-Mediated Diazidonation of Alkenes 
4.1.3 Mn(III)-Mediated Reactions 
Fristad and co-workers reported a Mn(III)-mediated stoichiometric method only for 
nonfunctionalized aliphatic olefins with a large excess of NaN3 in acetic acid at 110 °C. The rate 
enhancement evidences that ligand transfer oxidation happened in the presence of alkenes rather 
than the participation of the free azido radical.
71c
  
 
Scheme 60. Mn(III)-Mediated Diazidation of Alkenes 
Later on, Snider subsequently reported a key improvement of Fristad’s procedure by 
using a mixture of MeCN/TFA at −20 °C.71l This modified procedure is effective for acid-
sensitive substrates, such as glycal; however, it is unsuitable for acyclic aliphatic olefins. 
 
Scheme 61. Modified Mn(III)-Mediated Diazidation of Alkenes 
143 
4.1.4 Aryl-λ3-Iodanes Mediated Reactions 
The group of Arimoto reported (PhIO)n/TMSN3-mediated method specifically for 
electron-rich allyl silanes in DCM at −78 °C to room temperature to afford vicinal diazide in the 
absence of BF3▪Et2O with good yields.
71a
  
 
Scheme 62. (PhIO)n-Mediated Diazidation of Alkenes 
More recently, Magnus discovered that treatment of silyl enol ether with (PhIO)n/TMSN3 
with the addition of catalytic amount of the stable radical TEMPO can boost the high yield of the 
corresponding diazide product.
71h
  
 
Scheme 63. TEMPO-Mediated Diazidation of Alkenes 
These methods have been valuable for synthetic chemistry; however, significant gaps still 
exist for this important transformation. First, a general and selective catalytic method that is 
compatible with a broad range of both unfunctionalized and highly functionalized olefins has yet 
to be developed. Second, a diastereoselective method for internal olefins has not yet been 
reported. Furthermore, a new diazidation reaction which proceeds through a new selective 
pathway under mild reaction conditions (thus avoiding both heating and cryogenic cooling) has 
yet to be discovered. 
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4.2     EXPERIMENT 
4.2.1 General Procedure 
General Procedures. All reactions were performed in oven-dried or flame-dried round-
bottom flasks and vials.  Stainless steel syringes and cannula were used to transfer air- and 
moisture-sensitive liquids. Flash chromatography was performed using silica gel 60 (230−400 
mesh) from SigmaAldrich. 
Materials. Commercial reagents were purchased from SigmaAldrich, Fluka, EM 
Science, and Lancaster and used as received. All solvents were used after being freshly distilled 
unless otherwise noted. 
Instrumentation. Proton nuclear magnetic resonance (
1
H NMR) spectra and carbon 
nuclear magnetic resonance (
13
C NMR) spectra were recorded on Bruker UltraShield400 (400 
MHz). Chemical shifts for protons are reported in parts per million downfield from 
tetramethylsilane and are referenced to the NMR solvent residual peak (CHCl3 δ 7.26). Chemical 
shifts for carbons are reported in parts per million downfield from tetramethylsilane and are 
referenced to the carbon resonances of the NMR solvent (CDCl3 δ 77.0). Data are represented as 
follows: chemical shift, multiplicity (br = broad, s = singlet, d = doublet, t = triplet, q = quartet, 
m = multiplet), coupling constants in Hertz (Hz), and integration. The mass spectroscopic data 
were obtained at the Georgia State University mass spectrometry facility using a Micromass 
Platform II single quadrupole instrument. Infrared (IR) spectra were obtained using a Perkin 
Elmer Spectrum 100 FT-IR spectrometer. Data are represented as follows: frequency of 
absorption (cm
-1
) and absorption strength (s = strong, m = medium, w = weak ).  
Abbreviations Used: EtOH–ethanol, EtOAc–ethyl acetate, THF–tetrahydrofuran, 
MeOH–methanol, Et2O–diethyl ether, CH2Cl2–dichloromethane, TEA–triethylamine, MeCN–
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acetonitrile, MS–molecular sieves, CDI–1,1′-carbonyldiimidazole, Troc–2,2,2-
trichloroethoxycarbonyl, DCC–N,N′-dicyclohexylcarbodiimide, TLC–thin layer 
chromatography, Boc2O–di-tert-butyl dicarbonate, DMAP−4-dimethylaminopyridine, TBAN3–
tetra-n-butylammonium azide, HATU−1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-
b]pyridinium 3-oxid hexafluorophosphate. 
4.2.2 Catalyst Discovery and Procedures for the Diazidation  
4.2.2.1 Catalyst Discovery for the Iron-Catalyzed Indene Diazidation 
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a
Reactions were carried out under N2 and then quenched with a saturated NaHCO3 solution unless stated 
otherwise. Standard precautions with regard to handling TMSN3 should be taken during the reaction workup. 
Reduction condition: PPh3 (2.5 equiv), H2O (5.0 equiv), THF, 50 C, 2 h, then TsOH (2.5 equiv). 
b
Conversion is < 
5%. 
c
Isolated yield; dr was measured by 
1
H NMR analysis. OTf: trifluoromethanesulfonate, NTf2: 
trifluoromethanesulfonimide. 
e
No significant ee was observed (ee <5%). 
 
Table 24. Catalyst Discovery for the Iron-Catalyzed Indene Diazidation
a
 
4.2.2.2 General Procedure for the Iron-Catalyzed Indene Diazidation 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added an  
iron salt (0.02 mmol) and a ligand (0.02 mmol). After the vial was evacuated and backfilled with 
N2 three times, anhydrous CH2Cl2 (0.8 mL) and MeCN (0.2 mL) were added via a syringe and 
the mixture was stirred at room temperature for 10 min. To another flame-dried 3-dram vial (vial 
B) equipped with a stir bar was added 2a or 2b (0.48 mmol). This vial was evacuated and 
backfilled with N2 three times and then anhydrous CH2Cl2 (3.0 mL) was added. Both vials were 
degassed with brief evacuation and then backfilled with N2 twice. Subsequently, freshly distilled 
TMSN3 (79 L, 0.6 mmol or 190 L, 1.44 mmol) and indene 1 (47 L, 0.4 mmol) were added to 
vial B, followed by drop-wise addition of the catalyst solution in vial A at room temperature.  
The reaction was kept at the same temperature for the indicated time and then quenched with 
saturated NaHCO3 solution (0.1 mL) and then further diluted with hexanes (5 mL). The mixture 
was stirred vigorously for 10 min and filtered through a short silica gel pad. The filtrate was 
further concentrated in vacuo and directly subject to dr analysis by 
1
H NMR. The residue was 
further purified through a silica gel flash column (hexanes/Et2O: from 200:1 to 50:1) to afford 
the indene diazide 3a as colorless oil.  
Warning: Standard precautions with regard to handling TMSN3 should be taken during 
the reaction workup since an extra equivalent of TMSN3 is used when 2b is directly used as the 
terminal oxidant. 
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Since the C/N ratios for indene diazide are between 1 and 3, careful isolation and 
characterization of diazides was carried out under small-scale (<100 mg) conditions. 
 
trans-1,2-Diazido-2,3-dihydro-1H-indene (trans-3a). The major diastereomer trans-3a 
is a known compound: both the 
1
H NMR and 
13
C NMR data are in accordance with the literature  
data.
72
  
1
H NMR (400 MHz, CDCl3): δ 7.67–6.68 (m, 4H), 4.77 (d, J = 5.6 Hz, 1H), 4.17 (dd, J = 
12.8, 6.7 Hz, 1H), 3.35 (dd, J = 16.0, 7.3 Hz, 1H), 2.94 (dd, J = 16.0, 6.6 Hz, 1H); 
13
C NMR 
(100 MHz, CDCl3): δ 139.2, 137.8, 129.5, 127.8, 125.2, 124.6, 70.3, 67.7, 36.2; IR νmax 
(neat)/cm
-1
: 2104 (s), 1743(w), 1478 (w), 1247 (s). 
Note: it was challenging to obtain HRMS analysis of indene diazides 3a and most of 
other diazides through ESI analysis; therefore, the HRMS analysis was performed with the 
corresponding diaminium salts after derivatization. Additionally, diazides 3d and 3f were both 
derived to bistriazole compounds through the click-reaction with phenylacetylene to confirm the 
structure (vide infra). 
 
cis-1,2-Diazido-2,3-dihydro-1H-indene (cis-3a): The minor diastereomer cis-3a is also 
a known compound: both the 
1
H NMR and 
13
C NMR data are in accordance with the literature 
data.
73
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1
H NMR (400 MHz, CDCl3): δ 7.45–7.27 (m, 4H), 4.84 (d, J = 5.6 Hz, 1H), 4.29 (dd, J = 
12.3, 6.5 Hz, 1H), 3.25–3.06 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 139.8, 137.6, 129.8, 
127.8, 125.5, 125.0, 67.1, 64.2, 35.7; IR νmax (neat)/cm
-1
: 2096 (s), 1742 (w), 1322 (m), 1242 (s). 
 
Scheme 64. Staudinger Reduction of Azides 
The indene diazides 3a (trans- and cis-) were both converted to diaminium salts 4a  
through a 2-step procedure. To a 3-dram vial equipped with a stir bar were added trans-/cis-3a 
(60.0 mg, 0.3 mmol), THF (3 mL) and H2O (27 L, 1.5 mmol). After the vial was evacuated and 
backfilled with N2 three times, a solution of PPh3 (196.8 mg, 0.75 mmol) in THF (1.5 mL) was 
added drop-wise at 0 °C. The mixture was warmed up to 50 °C and stirred for 5 h (the reaction 
was monitored by IR until the absorption of azido groups disappeared). The mixture was then 
concentrated in vacuo and the residue was further dissolved in Et2O (5 mL). This solution was 
added drop-wise to a solution of TsOH∙H2O (142.7 mg, 0.75 mmol) in Et2O (3 mL). The reaction 
was kept stirring for 30 min and the white precipitate was collected by filtration, washed with 
Et2O (5 mL × 3) and dried in vacuo.   
 
(±)-(1R,2R)-2,3-Dihydro-1H-indene-1,2-diaminium ditosylate (trans-4a). trans-4a was 
prepared through the aforementioned reduction/protonation procedure and it was isolated as a 
white solid (94% yield, m.p. 276–279 °C). IR νmax (neat)/cm
-1
: 3036 (s), 2920 (s), 1599 (m), 
1437 (w), 1166 (s), 1119 (s), 1032 (s), 1009 (s), 812 (m), 723 (m), 679 (s); 
1
H NMR (400 MHz, 
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DMSO-d6): δ 8.37 (brs, 6H), 7.58 (d, J = 7.7 Hz, 1H), 7.48 (d, J = 8.0 Hz, 4H), 7.45–7.34 (m, 
3H), 7.12 (d, J = 7.9 Hz, 4H), 4.82 (d, J = 4.9 Hz, 1H), 3.99 (dd, J = 13.7, 5.6 Hz, 1H), 3.47 (dd, 
J = 16.8, 8.3 Hz, 1H), 3.01 (dd, J = 16.8, 5.9 Hz, 1H), 2.29 (s, 6H); 
13
C NMR (100 MHz, 
DMSO-d6): δ 144.9, 140.1, 138.3, 136.0, 130.0, 128.3, 127.8, 125.6, 125.2, 125.0, 58.5, 54.4, 
35.5, 20.9; HRMS (ESI, m/z): calcd for C9H13N2
+
, [M + H
+
], 149.1073, found 149.1067. 
 
(±)-(1R,2S)-2,3-Dihydro-1H-indene-1,2-diaminium ditosylate (cis-4a). cis-4a was 
prepared through the aforementioned reduction/protonation procedure and it was isolated as a 
white solid (94% yield, m.p. 268–270 ˚C). IR νmax (neat)/cm
-1
: 2870 (s), 1634 (w), 1547 (w), 
1218 (s), 1187 (s), 1153 (m), 1125 (s), 1038 (s), 1012 (s), 817 (m), 682 (s); 
1
H NMR (400 MHz, 
DMSO-d6): δ 8.47 (brs, 6H), 7.58 (d, J = 7.5 Hz, 1H), 7.53 (d, J = 8.0 Hz, 4H), 7.43–7.32 (m, 
3H), 7.15 (d, J = 7.8 Hz, 4H), 4.85 (d, J = 6.1 Hz, 1H), 4.18 (dd, J = 13.7, 7.1 Hz, 1H), 3.24 
(ddd, J = 31.5, 16.0, 7.5 Hz, 2H), 2.30 (s, 6H); 
13
C NMR (100 MHz, DMSO-d6): δ 144.6, 140.1, 
138.5, 136.0, 130.2, 128.4, 127.7, 125.9, 125.6, 125.4, 54.9, 52.0, 34.1, 20.9; HRMS (ESI, m/z): 
calcd for C9H13N2
+
, [M + H
+
], 149.1073, found 149.1067. 
4.2.2.3 Optical Resolution of the Indene-(trans)-1,2-Diamine  
 
Scheme 65. Optical Resolution of the Indene-(trans)-1,2-Diamine 
To a 3-dram vial equipped with a stir bar were added trans-3a (2.6 g, 13.0 mmol), THF 
(40 mL) and H2O (1.2 mL, 65.0 mmol). After the vial was evacuated and backfilled with N2 three 
150 
times, a solution of PPh3 (8.18 g, 31.2 mmol) in THF (20 mL) was added drop-wise at 0 °C. The 
mixture was warmed up to 50 °C and stirred for 4 h (the reaction was monitored by IR until the 
absorption of azido groups disappeared). L-(+)-tartaric acid (1.47 g, 9.8 mmol) was dissolved in 
MeOH (5 mL) and added to the reaction mixture drop-wise at 50 °C. The White precipitate was 
formed and the whole mixture was kept stirring for another 10 min. Then AcOH (0.37 mL, 6.5 
mmol) was added via a syringe. After refluxing for 2 min, the reaction was cooled down to room 
temperature without stirring. The resulting white precipitate was collected by filtration, washed 
with MeOH (5 mL × 2), EtOAc (10 mL × 2) and dried in vacuo. The white solid was dissolved 
in hot water (10 mL), and hot MeOH (11 mL) was added subsequently. The resulting solution 
was cooled down to room temperature and crystalline white solids precipitated out in 12 h. The 
solids were collected (1.09 g) by filtration and washed with a mixture of MeOH/H2O (2:1, 5 
mL), and then MeOH (5 mL). Another portion of white solids (220 mg) precipitated out of the 
filtrate, and they were also collected by filtration and dried in vacuo. Both solids were dissolved 
in NaOH solution (1 M), extracted with CH2Cl2 for four times and dried over anhydrous K2CO3 
separately. Evaporation of the solvent afforded the chiral diamine S1 as white solids (533 mg and 
107 mg, 35% combined yield from diazide trans-3a). The ee of both solids was determined to be 
97% by HPLC analysis after derivatization. Its configuration was determined as (1R,2R) by 
comparison of the optical rotation of the diamine S1 ([𝛼]D
20 = –20.3° (c=0.7 in CHCl3)) with the 
one reported in literature ([𝛼]D
25 = –20.4° (c=0.7 in CHCl3)).
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N,N'-((1R,2R)-2,3-dihydro-1H-indene-1,2-diyl)diacetamide (S2): Diamine S1 (14.8 
mg, 0.1 mmol) was dissolved in anhydrous CH2Cl2 (2 mL) in a flame-dried vial under N2.  The 
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reaction was cooled to 0 °C and Et3N (35 μL, 0.25 mmol) were added followed by dropwise 
addition of Ac2O (23 μL, 0.24 mmol). The reaction was then warmed up to room temperature 
and kept stirring for 2 hours. After quenching with the saturated NaHCO3 solution under 
vigorous stirring, the mixture was extracted with CH2Cl2 (2 mL × 3) and then concentrated in 
vacuo. The residue was purified through a silica gel flash column (hexanes/acetone from 2:1 to 
1:2) to afford S2 as a white solid (19.5 mg, 84% yield, m.p. decomposed at 250 ˚C). IR νmax 
(neat)/cm
-1
: 3271 (m), 3068 (w), 2937 (w), 1641 (s), 1542 (s), 1371 (m), 1295 (m); 
 1
H NMR 
(400 MHz, CDCl3, 318 K): δ 7.25–7.08 (m, 4H), 6.74 (d, J = 5.5 Hz, 1H), 6.36 (d, J = 8.0 Hz, 
1H), 5.34 (t, J = 8.7 Hz, 1H), 4.34–4.21 (m, 1H), 3.31 (dd, J = 15.5, 7.7 Hz, 1H), 2.63 (dd, J = 
15.4, 9.8 Hz, 1H), 2.08 (s, 3H), 1.99 (s, 3H); 
13
C NMR (100 MHz, CDCl3, 318 K): δ 171.5, 
171.0, 139.9, 139.7, 128.3, 127.1, 124.9, 122.9, 59.8, 59.5, 36.8, 23.20, 23.15; HRMS (ESI, 
m/z): calcd for C13H17N2O2
+
, [M + H
+
], 233.1285, found 233.1283; [𝛼]D
20  = –44.2 (c=1.0 in 
CHCl3, 97% ee); The ee was determined by Chiral HPLC analysis (Chiral S.S. Whelk, 1.0 
mL/min, 254 nm, 10% EtOH in hexanes, tr (major) = 12.49 min, tr (minor) = 16.98 min, 97% ee). 
Racemic S2 
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Enantio-enriched S2 (97% ee) 
 
 
4.2.2.4 Procedure for the Iron-Catalyzed Olefin Diazidation and Product Characterization 
 
Warning: Standard precautions with regard to handling TMSN3 should be taken during 
the reaction workup since an extra equivalent of TMSN3 is used when 2b is directly used as the 
terminal oxidant. 
For safely handling TMSN3, see the MSDS sheet at:  
http://www.sigmaaldrich.com/catalog/product/aldrich/155071. 
Since the C/N ratios for these synthetically valuable diazides generally vary from 1 to 3, 
careful isolation and characterization of diazides was carried out under small-scale (<100 mg) 
conditions.  Also, direct reduction of diazides to diamines without further concentration is 
carried out for most substrates. 
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For safely handling organic azides, see: 
https://web.stanford.edu/dept/EHS/prod/researchlab/lab/safety_sheets/08-203.pdf. 
3.6 equiv. of TMSN3 is sufficient for high yields with anhydrous 2b that is stored in a 
glove-box. Alternatively, 4.0 equiv. of TMSN3 is used to achieve the same yield with 2b that is 
stored out of a glove-box. 
Allylbenzene is commercially available and was distilled before usage. 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added 
Fe(OTf)2 (1.8 mg, 0.005 mmol) and L2 (1.4 mg, 0.005 mmol). After the vial was evacuated and 
backfilled with N2 three times, anhydrous CH2Cl2 (0.8 mL) and MeCN (0.2 mL) were added via 
a syringe and the mixture was stirred at room temperature for 10 min. To another flame-dried 3-
dram vial (vial B) equipped with a stir bar was added 2b (158.4 mg, 0.60 mmol). This vial was 
evacuated and backfilled with N2 three times and anhydrous CH2Cl2 (4.0 mL) was added. Both 
vials were degassed with brief evacuation and backfilled with N2 twice. Freshly distilled 
allylbenzene (66 L, 0.5 mmol), TMSN3 (263 L, 2.0 mmol) were added successively to vial B 
and followed by drop-wise addition of the catalyst solution in vial A at room temperature. The 
reaction was kept at room temperature for 2 h and then quenched with a saturated NaHCO3 
solution (0.1 mL) and further diluted with hexanes (5 mL). The mixture was stirred vigorously 
for 10 min and filtered through a short silica gel pad. The filtrate was concentrated in vacuo.  The 
residue was subsequently purified through a silica gel flash column (hexanes/Et2O: from 200:1 to 
50:1) as a colorless oil (72.8 mg, 72% yield).   
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(2,3-Diazidopropyl)benzene (3b): IR νmax (neat)/cm
-1
: 2932 (w), 2100 (s), 1205 (m), 743 
(w); 
1
H NMR (400 MHz, CDCl3): δ 7.36–7.32 (m, 2H), 7.30–7.27 (m, 1H), 7.25–7.17 (m, 2H), 
3.79–3.66 (m, 1H), 3.40 (dd, J = 12.7, 3.9 Hz, 1H), 3.29 (dd, J = 12.7, 6.9 Hz, 1H), 2.88 (d, J = 
7.0 Hz, 2H); 
13
C NMR: (100 MHz, CDCl3) δ 136.5, 129.4, 129.0, 127.3, 63.0, 54.0, 38.1. 
 
3-Phenylpropane-1,2-diaminium ditosylate (4b). To a 3-dram vial equipped with a stir 
bar were added diazidation product 3b (60.7 mg, 0.3 mmol), THF (3 mL) and H2O (27 L, 1.5 
mmol).  After the vial was evacuated and backfilled with N2 three times, a solution of PPh3 
(196.8 mg, 0.75 mmol) in THF (1.5 mL) was added drop-wise at 0 °C. The mixture was warmed 
up to 50 °C and stirred for 6 h (the reaction was monitored by IR until the absorption of azido 
groups disappeared). The mixture was then concentrated in vacuo and the residue was further 
dissolved in Et2O (5 mL). This solution was added drop-wise to a solution of TsOH∙H2O (142.7 
mg, 0.75 mmol) in Et2O (3 mL). The reaction was kept stirring for 30 min and the white 
precipitate was collected by filtration, washed with Et2O (5 mL × 3) and dried in vacuo. 4b was 
obtained as a white solid (138 mg, 93% yield, m.p. 217–219 ˚C). IR νmax (neat)/cm
-1
: 3059 (s), 
2917 (m), 1496 (m), 1176 (s), 1120 (s), 1034 (m), 1010 (m), 812 (w), 723 (m), 679 (s); 
1
H NMR 
(400 MHz, CD3OD): δ 7.72 (d, J = 8.1 Hz, 4H), 7.40–7.27 (m, 5H), 7.24 (d, J = 7.9 Hz, 4H), 
3.86 (m, 1H), 3.33 (dd, J = 13.9, 7.2 Hz, 1H), 3.23 (dd, J = 13.9, 5.4 Hz, 1H), 3.08 (dd, J = 14.2, 
6.9 Hz, 1H), 2.99 (dd, J = 14.2, 6.9 Hz, 1H), 2.37 (s, 6H); 
13
C NMR: (100 MHz, CD3OD) δ 
143.2, 142.0, 135.6, 130.5, 130.3, 130.0, 128.9, 126.9, 52.2, 42.0, 37.6, 21.3; HRMS (ESI, m/z): 
calcd for C9H15N2
+
, [M + H
+
], 151.1230, found 151.1224. 
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(1,2,3-Triazidopropyl)benzene (S4). A pair of tri-azidation products were isolated as 
side products as a colorless oil (17.0 mg, 14% yield, dr = 1.8:1). S4 was generated presumably 
through the addition/elimination/addition sequence. Their structures were further corroborated 
through the analysis of the corresponding tri-amine. IR νmax (neat)/cm
-1
: 2922 (w), 2091 (s), 1454 
(w), 1247 (s); 
1
H NMR (400 MHz, CDCl3): δ 7.50–7.30 (m, 5H), 4.63 (d, J = 8.0 Hz, 1H), 4.62 
(d, J = 7.6 Hz, 1H, minor), 3.70 (ddd, J = 7.6, 6.9, 3.9 Hz, 1H, minor), 3.65 (ddd, J = 8.0, 6.5, 3.7 
Hz, 1H), 3.54–3.44 (m, 2H, minor), 3.31 (dd, J = 12.8, 3.7 Hz, 1H), 3.09 (dd, J = 12.8, 6.5 Hz, 
1H); 
13
C NMR (100 MHz, CDCl3): δ 135.4, 135.1 (minor), 129.5, 129.4 (minor), 129.4, 129.2 
(minor), 127.8 (minor), 127.4, 67.3, 66.0 (minor), 65.7, 65.1 (minor), 51.8, 51.7 (minor). 
 
N,N',N''-(1-Phenylpropane-1,2,3-triyl)triacetamide (S5). The structure of S4 was 
further confirmed after derivatization. To a 2-dram vial equipped with a stir bar was added Pd/C 
(1.5 mg, 10 wt%). After the vial was evacuated and backfilled twice with N2, a solution of 
triazide S4 (14.6 mg, 0.06 mmol, dissolved in 1 mL MeOH) was added. The mixture was 
degassed with brief evacuation and backfilled twice with N2 and then three times with H2. The 
reaction was vigorously stirred under H2 at room temperature until the reduction completed (the 
reaction was monitored by IR until the absorption of azido groups disappeared). The solution 
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was filtered through Celite, washed with MeOH (3 mL) and the filtrate was concentrated in 
vacuo. Subsequently, the residue was dissolved in CH2Cl2 (2 mL) and cooled to 0 °C. Et3N (42 
L, 0.3 mmol) was then added followed by dropwise addition of Ac2O (23 L, 0.24 mmol).  The 
reaction was warmed up to room temperature and stirred for additional 4 h and quenched with a 
saturated NaHCO3 solution (1 mL). After the organic layer was separated, the aqueous phase was 
extracted with CH2Cl2 (2 mL × 6). The combined organic layers were dried over anhydrous 
Na2SO4 and concentrated in vacuo. The residue was purified through a silica gel flash column 
(CH2Cl2/MeOH: from 20:1 to 5:1) to afford S5 as a colorless oil (dr = 6:1).  IR νmax (neat)/cm
-1
: 
3281 (m), 3068 (w), 1641 (s), 1530 (s), 1371 (s), 1279 (m), 1118 (w); 
1
H NMR (400 MHz, 
CDCl3): δ 7.37–7.27 (m, 6H), 7.11 (d, J = 6.9 Hz, 1H), 6.68 (d, J = 7.2 Hz, 1H, minor), 6.34 (t, J 
= 5.3 Hz, 1H, minor), 6.01 (t, J = 5.3 Hz, 1H), 5.14 (dd, J = 7.9, 3.7 Hz, 1H, minor), 4.85 (dd, J 
= 10.3, 7.5 Hz, 1H), 4.42–4.34 (m, 1H, minor), 4.33–4.25 (m, 1H), 3.51–3.42 (m, 1H, minor), 
3.38–3.29 (m, 1H, minor), 3.16 (t, J = 5.7 Hz, 2H), 2.07 (s, 3H, minor), 2.01 (s, 3H), 1.97 (s, 
3H), 1.94 (s, 3H, minor), 1.93 (s, 3H), 1.85 (s, 3H, minor); 
13
C NMR: (100 MHz, CDCl3) δ 
172.9, 172.3, 170.5, 139.3, 129.2, 128.3, 127.2, 57.1, 55.5, 41.7, 23.4, 23.3, 23.1; HRMS (ESI, 
m/z): calcd for C15H20N3O3
–
, [M - H
+
], 290.1510, found 290.1501. 
 Allyl triisopropylsilane S6 was prepared through a literature procedure.
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To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added 
Fe(OTf)2 (5.3 mg, 0.015 mmol) and L2 (4.1 mg, 0.015 mmol). After the vial was evacuated and 
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backfilled with N2 three times, anhydrous CH2Cl2 (0.8 mL) and MeCN (0.2 mL) were added via 
a syringe and the mixture was stirred at room temperature for 10 min. To another flame-dried 3-
dram vial (vial B) equipped with a stir bar was added 2b (158.4 mg, 0.60 mmol). This vial was 
evacuated and backfilled with N2 three times and anhydrous CH2Cl2 (4.0 mL) was added. Both 
vials were degassed with brief evacuation and backfilled with N2 twice. Allyl triisopropylsilane 
S6 (148 L, 0.5 mmol), TMSN3 (263 L, 2.0 mmol) were added successively to vial B and 
followed by dropwise addition of the catalyst solution in vial A at room temperature. The 
reaction was kept at room temperature for 2 h and then quenched with a saturated NaHCO3 
solution (0.1 mL) and further diluted with hexanes (5 mL). The mixture was stirred vigorously 
for 10 min and filtered through a short silica gel pad. The filtrate was concentrated in vacuo. The 
residue was subsequently purified through a silica gel flash column (hexanes/Et2O: from 200:1 to  
50:1) as a colorless oil (125.7 mg, 89% yield).   
 
 (2,3-Diazidopropyl)triisopropylsilane (3c): IR νmax (neat)/cm
-1
: 2942 (m), 2103 (s), 
1463 (w), 1261 (m), 764 (s); 
1
H NMR (400 MHz, CDCl3): δ 3.69–3.58 (m, 1H), 3.42 (dd, J = 
12.5, 4.0 Hz, 1H), 3.35 (dd, J = 12.5, 7.6 Hz, 1H), 1.07 (s, 21H), 0.91 (dd, J = 15.0, 8.9 Hz, 1H), 
0.84 (dd, J = 15.0, 5.6 Hz, 1H); 
13
C NMR: (100 MHz, CDCl3) δ 59.8, 58.0, 18.87, 18.84, 12.9, 
11.4. 
 
3-(Triisopropylsilyl)propane-1,2-diaminium ditosylate (4c). To a 3-dram vial 
equipped with a stir bar were added diazidation product 3c (84.8 mg, 0.3 mmol), THF (3 mL) 
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and H2O (27 L, 1.5 mmol). After the vial was evacuated and backfilled with N2 three times, a 
solution of PPh3 (196.8 mg, 0.75 mmol) in THF (1.5 mL) was added drop-wise at 0 °C. The 
mixture was warmed up to 50 °C and stirred for 6 h (the reaction was monitored by IR until the 
absorption of azido groups disappeared). The mixture was then concentrated in vacuo and the 
residue was further dissolved in Et2O (5 mL). This solution was added drop-wise to another 
solution of TsOH∙H2O (142.7 mg, 0.75 mmol) in Et2O (3 mL). The reaction was kept stirring for 
30 min and the white precipitate was collected by filtration, washed with Et2O (5 mL × 3) and 
dried in vacuo. 4c was obtained as a white solid (155.2 mg, 90% yield, m.p. 246–248 ˚C). IR 
νmax (neat)/cm
-1
: 2942 (s), 1531 (m), 1171 (s), 1126 (s), 1035 (s), 1012 (s), 813 (m), 679(s); 
1
H 
NMR (400 MHz, CD3OD): δ 7.71 (d, J = 8.1 Hz, 4H), 7.24 (d, J = 8.0 Hz, 4H), 3.92–3.69 (m, 
1H), 3.28 (d, J =14.3, 9.8 Hz, 1H), 3.21 (dd, J = 14.3, 3.0 Hz, 1H), 2.37 (s, 6H), 1.14 (d, J = 7.6 
Hz, 2H), 1.08 (s, 21H); 
13
C NMR (100 MHz, CD3OD): δ 143.1, 142.0, 130.0, 126.9, 49.8, 44.2, 
21.3, 19.18, 19.17, 14.4, 12.5; HRMS (ESI, m/z): calcd for C12H31N2Si
+
, [M + H
+
], 231.2251, 
found 231.2247. 
 
Styrene is commercially available and was distilled before usage. 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added 
Fe(OTf)2 (5.3 mg, 0.015 mmol) and L2 (4.1 mg, 0.015 mmol). After the vial was evacuated and 
backfilled with N2 three times, anhydrous CH2Cl2 (0.8 mL) and MeCN (0.2 mL) were added via 
a syringe and the mixture was stirred at room temperature for 10 min. To another flame-dried 3-
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dram vial (vial B) equipped with a stir bar was added 2b (158.4 mg, 0.60 mmol). This vial was 
evacuated and backfilled with N2 three times and anhydrous CH2Cl2 (4.0 mL) was added. Both 
vials were degassed with brief evacuation and backfilled with N2 twice. Freshly distilled styrene 
(57 L, 0.5 mmol), TMSN3 (263 L, 2.0 mmol) were added successively to vial B and followed 
by drop-wise addition of the catalyst solution in vial A at room temperature. The reaction was 
kept at room temperature for 2 h and then quenched with saturated NaHCO3 solution (0.1 mL) 
and further diluted with hexanes (5 mL). The mixture was stirred vigorously for 10 min and 
filtered through a short silica gel pad. The filtrate was concentrated in vacuo. The residue was 
subsequently purified through a silica gel flash column (hexanes/Et2O: from 200:1 to 50:1) as 
colorless oil (80.0 mg, 85% yield).   
 
(1,2-Diazidoethyl)benzene (3d): IR νmax (neat)/cm
-1
: 2927 (w), 2099 (s), 1456 (w), 1152 
(m); 
1
H NMR (400 MHz, CDCl3): δ  7.47–7.38 (m, 3H), 7.38–7.27 (m, 2H), 4.68 (dd, J = 8.2, 
5.0 Hz, 1H), 3.51 (dd, J = 12.7, 8.3 Hz, 1H), 3.45 (dd, J = 12.7, 5.0 Hz, 1H); 
13
C NMR (100 
MHz, CDCl3): δ 136.5, 129.2, 129.2, 127.1, 65.6, 56.1. 
 
1-Phenylethane-1,2-diaminium ditosylate (4d). To a 3-dram vial equipped with a stir  
bar were added diazidation product 3d (56.5 mg, 0.3 mmol), THF (3 mL) and H2O (27 L, 1.5 
mmol). After the vial was evacuated and backfilled with N2 three times, a solution of PPh3 (196.8 
mg, 0.75 mmol) in THF (1.5 mL) was added drop-wise at 0 °C. The mixture was warmed up to 
50 °C and stirred for 6 h (the reaction was monitored by IR until the absorption of azido groups 
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disappeared). The mixture was then concentrated in vacuo and the residue was further dissolved 
in Et2O (5 mL). This solution was added drop-wise to another solution of TsOH∙H2O (142.7 mg, 
0.75 mmol) in Et2O (3 mL). The reaction was kept stirring for 30 min and the white precipitate 
was collected by filtration, washed with Et2O (5 mL × 3) and dried in vacuo. 4d was obtained as 
a white solid (126.9 mg, 88% yield, m.p. 245–247 ˚C). IR νmax (neat)/cm
-1
: 3053 (s), 2918 (s), 
1620 (w), 1515 (m), 1193 (s), 1172 (s), 1126 (s), 1036 (s), 1011 (s), 812 (m), 759 (m), 697 (m), 
680 (s); 
1
H NMR (400 MHz, CD3OD): δ 7.72 (d, J = 8.1 Hz, 4H), 7.59–7.54 (m, 2H), 7.54–7.48 
(m, 3H), 7.25 (d, J = 8.0 Hz, 4H), 4.68 (dd, J = 9.4, 5.7 Hz, 1H), 3.66 (dd, J = 13.0, 5.7 Hz, 1H), 
3.57 (dd, J = 13.0, 9.4 Hz, 1H), 2.38 (s, 6H); 
13
C NMR (100 MHz, DMSO-d6): δ 144.8, 138.5, 
133.8, 129.8, 129.2, 128.4, 128.1, 125.6, 52.2, 41.6, 20.9; HRMS (ESI, m/z): calcd for C8H13N2
+
,  
[M + H
+
], 137.1073, found 137.1067. 
 
1,1'-(1-Phenylethane-1,2-diyl)bis(4-phenyl-1H-1,2,3-triazole) (S7): Diazido compound 
3d (37.6 mg, 0.2 mmol) was dissolved in a 2:1 mixture of 
t
BuOH and water (0.6 mL).  
Phenylacetylene (48 µL, 0.44 mmol), CuSO4·5H2O (10.0 mg, 0.04 mol), sodium ascorbate (15.9 
mg, 0.08 mmol) and TBTA (tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine) (2.1 mg, 0.004 
mmol) were added and the solution was stirred at room temperature for 1 h. The reaction mixture 
was diluted with water (20 mL) and extracted with CH2Cl2 (5 × 20 mL). The combined organic 
phases were dried over MgSO4 and the solvent was evaporated. The resulting solid was washed 
with ether (2 × 3 mL) and bistriazole S7 was isolated as a white solid (71.4 mg, 91%). IR νmax 
(neat)/cm
-1
: 3091 (m), 1464 (s), 1231 (m), 1020 (m) 1081 (m), 1044 (w), 838 (w); 
1
H NMR (400 
MHz, DMSO-d6, 323K): δ 8.79 (s, 1H), 8.52 (s, 1H), 7.80 (d, J = 7.3 Hz, 2H), 7.75 (d, J = 7.4 
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Hz, 2H), 7.58 (d, J = 7.0 Hz, 2H), 7.48 – 7.39 (m, 7H), 7.36 – 7.28 (m, 2H), 6.55 (dd, J = 9.7, 5.8 
Hz, 1H), 5.62 (dd, J = 14.2, 9.9 Hz, 1H), 5.35 (dd, J = 14.2, 5.6 Hz, 1H); 
13
C NMR (100 MHz, 
DMSO-d6, 323K): δ 147.0, 146.7, 136.6, 131.0, 130.9, 129.5, 129.33, 129.32, 128.5, 128.4, 
127.8, 125.7, 125.6, 122.3, 121.5, 64.0, 52.7; HRMS (ESI, m/z): calcd for C24H20N6Na
+
, [M + 
Na
+
], 415.1642, found 415.1636. 
 
α-Methylstyrene is commercially available and was distilled before usage. 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added 
Fe(OTf)2 (5.3 mg, 0.015 mmol) and L2 (4.1 mg, 0.015 mmol). After the vial was evacuated and 
backfilled with N2 three times, anhydrous CH2Cl2 (0.8 mL) and MeCN (0.2 mL) were added via 
a syringe and the mixture was stirred at room temperature for 10 min. To another flame-dried 3-
dram vial (vial B) equipped with a stir bar was added 2b (158.4 mg, 0.60 mmol). This vial was 
evacuated and backfilled with N2 three times and anhydrous CH2Cl2 (4.0 mL) was added. Both 
vials were degassed with brief evacuation and backfilled with N2 twice. Freshly distilled α-
methylstyrene (65 L, 0.5 mmol), TMSN3 (263 L, 2.0 mmol) were added successively to vial B 
and followed by drop-wise addition of the catalyst solution in vial A at room temperature. The 
reaction was kept at room temperature for 2 h and then quenched with a saturated NaHCO3 
solution (0.1 mL) and further diluted with hexanes (5 mL). The mixture was stirred vigorously 
for 10 min and filtered through a short silica gel pad. The filtrate was concentrated in vacuo. The 
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residue was subsequently purified through a silica gel flash column (hexanes/Et2O: from 200:1 to 
50:1) as a colorless oil (83.9 mg, 83% yield).   
 
(1,2-Diazidopropan-2-yl)benzene (3e): IR νmax (neat)/cm
-1
: 2934 (m), 2097 (s), 1298 
(m), 699 (m); 
1
H NMR (400 MHz, CDCl3): δ 7.46–7.40 (m, 4H), 7.38–7.31 (m, 1H), 3.50 (d, J = 
12.6 Hz, 1H), 3.41 (d, J = 12.6 Hz, 1H), 1.78 (s, 3H); 
13
C NMR (100 MHz, CDCl3): δ 140.7, 
129.0, 128.4, 125.9, 66.7, 61.1, 22.4. 
 
2-Phenylpropane-1,2-diaminium ditosylate (4e). To a 3-dram vial equipped with a stir  
the bar was added Pd/C (6.0 mg, 10 wt%). After the vial was evacuated and backfilled twice with 
N2, a solution of diazidation product 3e (60.7 mg, 0.3 mmol, dissolved in 3 mL MeOH) was 
added to the vial. The mixture was degassed with brief evacuation and backfilled twice with N2 
and then three times with H2. The reaction was vigorously stirred under H2 at room temperature 
until the reduction completed (the reaction was monitored by IR until the absorption of azido 
groups disappeared). The solution was filtered through Celite and washed with MeOH (3 mL). 
To the filtrate was added a solution of TsOH∙H2O (114.2 mg, 0.60 mmol) in methanol (3 mL). 
The mixture was concentrated in vacuo (to ca. 0.5 mL solvent left), then diluted with Et2O (10 
mL).  The white precipitate was collected by filtration, washed with Et2O (5 mL × 3) and dried in 
vacuo. 4e was obtained as a white solid (133.5 mg, 90% yield, m.p. 187–188 ˚C). IR νmax 
(neat)/cm
-1
: 3307 (s), 2944 (m), 2832 (w), 1449 (w), 1415 (w), 1260 (w), 1022 (s), 765 (m), 750 
(m); 
1
H NMR (400 MHz, CD3OD ): δ 7.74 (d, J = 8.0 Hz, 4H), 7.67–7.61 (m, 2H), 7.61–7.50 (m, 
3H), 7.27 (d, J = 8.0 Hz, 4H), 3.74 (d, J = 13.5 Hz, 1H), 3.64 (d, J = 13.5 Hz, 1H), 2.41 (s, 6H), 
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1.95 (s, 3H); 
13
C NMR (100 MHz, CD3OD): δ 143.2, 141.9, 138.6, 130.7, 130.5, 129.9, 126.9, 
126.8, 58.0, 48.7, 23.6, 21.3; HRMS (ESI, m/z): calcd for C9H15N2
+
, [M + H
+
], 151.1230, found 
151.1228. 
 1-Octene is commercially available and was distilled before usage. 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added 
Fe(OTf)2 (5.3 mg, 0.015 mmol) and L2 (4.1 mg, 0.015 mmol). After the vial was evacuated and 
backfilled with N2 three times, anhydrous CH2Cl2 (0.8 mL) and MeCN (0.2 mL) were added via 
a syringe and the mixture was stirred at room temperature for 10 min. To another flame-dried 3-
dram vial (vial B) equipped with a stir bar was added 2b (158.4 mg, 0.60 mmol). This vial was 
evacuated and backfilled with N2 three times and anhydrous CH2Cl2 (4.0 mL) was added. Both 
vials were degassed with brief evacuation and backfilled with N2 twice. Freshly distilled octene 
(79 L, 0.5 mmol), TMSN3 (263 L, 2.0 mmol) were added successively to vial B and followed 
by drop-wise addition of the catalyst solution in vial A at room temperature. The reaction was 
kept at room temperature for 2 h and then quenched with saturated NaHCO3 solution (0.1 mL) 
and further diluted with hexanes (5 mL). The mixture was stirred vigorously for 10 min and 
filtered through a short silica gel pad.  The filtrate was concentrated in vacuo. The residue was 
subsequently purified through a silica gel flash column (hexanes/Et2O: from 200:1 to 50:1) as 
colorless oil (76.5 mg, 78% yield). 
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1,2-Diazidooctane (3f): IR νmax (neat)/cm
-1
: 2930 (m), 2099 (s), 1152 (s), 820 (w); 
1
H 
NMR (400 MHz, CDCl3): δ 3.50–3.41 (m, 1H), 3.38 (dd, J = 12.6, 3.8 Hz, 1H), 3.31 (dd, J = 
12.6, 7.4 Hz, 1H), 1.59–1.50 (m, 2H), 1.50–1.41 (m, 1H), 1.41–1.20 (m, 7H), 0.89 (t, J = 5.9 Hz, 
3H); 
13
C NMR (100 MHz, CDCl3): δ 62.2, 55.0, 31.9, 31.7, 29.1, 26.0, 22.7, 14.2. 
 
Octane-1,2-diaminium ditosylate (4f). To a 3-dram vial equipped with a stir bar were 
added diazidation product 3f (58.9 mg, 0.3 mmol), THF (3 mL) and H2O (27 L, 1.5 mmol).  
After the vial was evacuated and backfilled with N2 three times, a solution of PPh3 (196.8 mg, 
0.75 mmol) in THF (1.5 mL) was added drop-wise at 0 °C. The mixture was warmed up to 50 °C 
and stirred for 6 h (the reaction was monitored by IR until the absorption of azido groups 
disappeared). The mixture was then concentrated in vacuo and the residue was further dissolved 
in Et2O (5 mL). This solution was added drop-wise to another solution of TsOH∙H2O (142.7 mg, 
0.75 mmol) in Et2O (3 mL). The reaction was kept stirring for 30 min and the white precipitate 
was collected by filtration, washed with Et2O (5 mL × 3) and dried in vacuo.  4f was obtained as 
a white solid (124.6 mg, 85% yield, m.p. 311–312 ˚C). IR νmax (neat)/cm
-1
: 2922 (s), 2857 (s), 
1532 (w), 1168 (s), 1123 (s), 1035 (s), 1010 (s), 813 (m), 679 (s); 
1
H NMR (400 MHz, CD3OD): 
δ 7.71 (d, J = 8.1 Hz, 4H), 7.25 (d, J = 7.9 Hz, 4H), 3.53 (dt, J = 12.6, 6.2 Hz, 1H), 3.26 (dd, J = 
12.5, 3.9 Hz, 1H), 3.22 (dd, J = 12.5, 5.2 Hz, 1H), 2.37 (s, 6H), 1.81–1.55 (m, 2H), 1.50–1.19 
(m, 8H), 0.90 (t, J = 6.1 Hz, 3H); 
13
C NMR (100 MHz, CD3OD): δ 154.3, 147.8, 137.8, 135.0, 
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58.5, 50.1, 40.5, 39.3, 37.9, 33.7, 31.5, 30.3, 23.5; HRMS (ESI, m/z): calcd for C8H21N2
+
, [M + 
H
+
], 145.1699, found 145.1694. 
 
1,1'-(Octane-1,2-diyl)bis(4-phenyl-1H-1,2,3-triazole) (S8): Diazido compound 3f (39.2 
mg, 0.2 mmol) was dissolved in a 2:1 mixture of 
t
BuOH and water (0.6 mL). Phenylacetylene 
(48 µL, 0.44 mmol), CuSO4·5H2O (10.0 mg, 0.04 mol), sodium ascorbate (15.9 mg, 0.08 mmol) 
and TBTA (tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine) (2.1 mg, 0.004 mmol) were 
added and the solution was stirred at room temperature for 2 h. The reaction mixture was diluted 
with water (20 mL) and extracted with CH2Cl2 (3 × 20 mL). The combined organic phases were 
dried over MgSO4 and the solvent was evaporated. The residue was then purified through a silica 
gel flash column (hexanes/acetone: from 10:1 to 3:1). Bistriazole S8 was isolated as a white solid 
(74.4 mg, 93%). IR νmax (neat)/cm
-1
: 3083 (m), 2924 (m), 2857 (w), 1464 (m), 1226 (m), 1075 
(w), 1044 (w); 
1
H NMR (400 MHz, CDCl3): δ 7.77–7.69 (m, 2H), 7.69–7.61 (m, 2H), 7.49 (s, 
1H), 7.41–7.26 (m, 6H), 7.30 (s, 1H), 5.04–4.88 (m, 3H), 2.31–2.15 (m, 1H), 2.11–1.98 (m, 1H), 
1.40–1.20 (m, 8H), 0.86 (t, J = 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 147.9, 147.6, 130.0, 
129.9, 128.8, 128.8, 128.4, 128.3, 125.74, 125.73, 120.72, 120.68, 62.2, 53.8, 32.7, 31.4, 28.7, 
25.7, 22.5, 14.0; HRMS (ESI, m/z): calcd for calcd for C24H29N6
+
, [M + H
+
], 401.2448, found 
401.2450. 
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 2-Methyl-1-nonene is commercially available and was distilled before usage. 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added 
Fe(OTf)2 (5.3 mg, 0.015 mmol) and L2 (4.1 mg, 0.015 mmol). After the vial was evacuated and 
backfilled with N2 three times, anhydrous CH2Cl2 (0.8 mL) and MeCN (0.2 mL) were added via 
a syringe and the mixture was stirred at room temperature for 10 min. To another flame-dried 3-
dram vial (vial B) equipped with a stir bar was added 2b (158.4 mg, 0.60 mmol). This vial was 
evacuated and backfilled with N2 three times and anhydrous CH2Cl2 (4.0 mL) was added. Both 
vials were degassed with brief evacuation and backfilled with N2 twice. Freshly distilled 2-
methylnon-1-ene (94.1 μl, 0.5 mmol), TMSN3 (263 L, 2.0 mmol) were added successively to 
vial B and followed by drop-wise addition of the catalyst solution in vial A at room temperature.  
The reaction was kept at room temperature for 2 h and then quenched with a saturated NaHCO3 
solution (0.1 mL) and further diluted with hexanes (5 mL). The mixture was stirred vigorously 
for 10 min and filtered through a short silica gel pad. The filtrate was concentrated in vacuo. The 
residue was subsequently purified through a silica gel flash column (hexanes/Et2O: from 200:1 to 
50:1) as a colorless oil (98.7 mg, 88% yield). 
 
1,2-Diazido-2-methylnonane (3g): IR νmax (neat)/cm
-1
: 2929 (s), 2857 (w), 2094 (s), 
1603 (m), 1460 (m), 1256 (s), 1152 (s), 1069 (w); 
1
H NMR (400 MHz, CDCl3): δ 3.28 (d, J = 
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12.4 Hz, 1H), 3.23 (d, J = 12.5 Hz, 1H), 1.54 (m, 2H), 1.30 (m, 13H), 0.89 (t, J = 6.4 Hz, 3H); 
13
C NMR (100 MHz, CDCl3): δ 64.0, 59.2, 37.5, 31.9, 29.9, 29.3, 23.8, 22.8, 21.4, 14.2. 
 
2-Methylnonane-1,2-diaminium ditosylate (4g). To a 3-dram vial equipped with a stir 
bar was added Pd/C (6.7 mg, 10 wt%). After the vial was evacuated and backfilled twice with N2, 
a solution of diazidation product 3g (67.3 mg, 0.3 mmol, dissolved in 3 mL MeOH) was added to 
the vial. The mixture was degassed with brief evacuation and backfilled twice with N2 and then 
three times with H2. The reaction was vigorously stirred under H2 at room temperature until the 
reduction completed (the reaction was monitored by IR until the absorption of azido groups 
disappeared). The solution was filtered through Celite and washed with MeOH (3 mL). To the 
filtrate was added a solution of TsOH∙H2O (114.2 mg, 0.60 mmol) in methanol (3 mL). The 
mixture was concentrated in vacuo (to ca. 0.5 mL solvent left), then diluted with Et2O (10 mL).  
The white precipitate was collected by filtration, washed with Et2O (5 mL × 3) and dried in 
vacuo. 4g was obtained as a white solid (147.3 mg, 95% yield, m.p. 236–237 ˚C). IR νmax 
(neat)/cm
-1
: 2921 (s), 2854 (s), 2271 (w), 1531 (w), 1190 (s), 1125 (s), 1036 (s), 1012 (s), 816 
(m), 679 (s); 
1
H NMR (400 MHz, CD3OD): δ 7.72 (d, J = 8.1 Hz, 4H), 7.24 (d, J = 7.9 Hz, 4H), 
3.28 (d, J = 13.8 Hz, 1H), 3.24 (d, J = 13.8 Hz, 1H), 2.37 (s, 6H), 1.71 (m, 2H), 1.43 (s, 3H), 
1.40–1.20 (m, 10H), 0.90 (t, J = 6.8 Hz, 3H); 13C NMR (100 MHz, CD3OD): δ 143.1, 142.0, 
130.0, 126.9, 56.3, 46.4, 37.2, 32.9, 30.6, 30.1, 23.7, 23.6, 21.5, 21.3, 14.4; HRMS (ESI, m/z): 
calcd for C10H25N2
+
, [M + H
+
], 173.2012, found 173.2010. 
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Indene is commercially available and was distilled before usage. 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stirring bar were added 
Fe(OAc)2 (4.4 mg, 0.025 mmol) and L3 (13.1 mg, 0.025 mmol). After the vial was evacuated 
and backfilled with N2 three times, anhydrous CH2Cl2 (0.8 mL) and MeCN (0.2 mL) were added 
via a syringe and the mixture was stirred at room temperature for 10 min. To another flame-dried 
3-dram vial (vial B) equipped with a stirring bar was added 2b (158.4 mg, 0.60 mmol). This vial 
was evacuated and backfilled with N2 three times and anhydrous CH2Cl2 (4.0 mL) was added.  
Both vials were degassed with brief evacuation and backfilled with N2 twice. Freshly distilled 
indene (58 μl, 0.5 mmol), TMSN3 (237 μl, 1.8 mmol) were added successively to vial B and 
followed by drop-wise addition of the catalyst solution in vial A at room temperature. The 
reaction was kept at room temperature for 4 h and then quenched with a saturated NaHCO3 
solution (0.1 mL) and further diluted with hexanes (5 mL). The mixture was stirred vigorously 
for additional 10 min and filtered through a short silica gel pad. The filtrate was concentrated in 
vacuo. The residue was subsequently purified through a silica gel flash column (hexanes/Et2O: 
from 200:1 to 10:1) as a colorless oil (87.1 mg, 87 % yield, dr > 20:1). 
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1,2-Dihydronaphthalene is commercially available and was distilled before usage. 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stirring bar were added 
Fe(OAc)2 (4.4 mg, 0.025 mmol) and L3 (13.1 mg, 0.025 mmol). After the vial was evacuated 
and backfilled with N2 three times, anhydrous CH2Cl2 (0.8 mL) and MeCN (0.2 mL) were added 
via a syringe and the mixture was stirred at room temperature for 10 min. To another flame-dried 
3-dram vial (vial B) equipped with a stirring bar was added 2b (158.4 mg, 0.60 mmol). This vial 
was evacuated and backfilled with N2 three times and anhydrous CH2Cl2 (4.0 mL) was added.  
Both vials were degassed with brief evacuation and backfilled with N2 twice. Freshly distilled 
1,2-dihydronaphthalene (65 μl, 0.5 mmol), TMSN3 (263 μl, 2.0 mmol) were added successively 
to vial B and followed by drop-wise addition of the catalyst solution in vial A at room 
temperature. The reaction was kept at room temperature for 4 h and then quenched with saturated 
NaHCO3 solution (0.1 mL) and further diluted with hexanes (5 mL). The mixture was stirred 
vigorously for additional 10 min and filtered through a short silica gel pad. The filtrate was 
concentrated in vacuo. The residue was subsequently purified through a silica gel flash column  
(hexanes/Et2O: from 200:1 to 10:1) as colorless oil (84.6 mg, 79 % yield, dr = 12:1). 
 
trans-1,2-Diazido-1,2,3,4-tetrahydronaphthalene (trans-3h): IR νmax (neat)/cm
-1
: 2927 
170 
(w),  2094 (s), 1256(m), 748 (w); 
1
H NMR (400 MHz, CDCl3): δ 7.37 (d, J = 3.4 Hz, 1H), 7.31–
7.22 (m, 2H), 7.15 (d, J = 3.0 Hz, 1H), 4.43 (d, J = 6.6 Hz, 1H), 3.87 (ddd, J = 8.9, 6.6, 3.1 Hz, 
1H), 3.00–2.82 (m, 2H), 2.29–2.19 (m, 1H), 2.04–1.91 (m, 1H); 13C NMR (100 MHz, CDCl3): δ 
135.8, 131.7, 129.15, 129.13, 128.7, 126.9, 63.6, 61.7, 26.1, 25.3. 
 
cis-1,2-Diazido-1,2,3,4-tetrahydronaphthalene (cis-3h): IR νmax (neat)/cm
-1
: 2937 (w),  
2095 (s), 1252(m), 767 (w); 
1
H NMR (400 MHz, CDCl3): δ 7.35–7.28 (m, 1H), 7.28–7.23 (m, 
2H), 7.19 (d, J = 7.3 Hz, 1H), 4.65 (d, J = 3.2 Hz, 1H), 3.81 (dt, J = 11.4, 3.4 Hz, 1H), 3.07 (ddd, 
J = 17.4, 6.1, 3.4 Hz, 1H), 2.90 (ddd, J = 17.4, 10.6, 6.6 Hz, 1H), 2.30–2.15 (m, 1H), 2.15–2.02 
(m, 1H); 
13
C NMR (100 MHz, CDCl3): δ 135.5, 131.8, 129.8, 129.5, 129.3, 126.7, 62.7, 59.9, 
27.5, 23.0.  
The relative stereochemistry was determined by comparison of 
1
H NMR with literature 
data.
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1
H NMR 
 
1
H NMR (400 MHz, 
CDCl3): δ 4.43 (d, J = 
6.6 Hz, 1H), 3.87 (ddd, 
J = 8.9, 6.6, 3.1 Hz, 
1H), 3.00–2.82 (m, 
2H), 2.29–2.19 (m, 
1H), 2.04–1.91 (m, 
1H). 
1
H NMR (400 MHz, 
CDCl3): δ 4.65 (d, J = 
3.2 Hz, 1H), 3.81 (dt, J 
= 11.4, 3.4 Hz, 1H), 
3.07 (ddd, J = 17.4, 6.1, 
3.4 Hz, 1H), 2.90 (ddd, 
J = 17.4, 10.6, 6.6 Hz, 
1H), 2.30–2.15 (m, 1H), 
2.15–2.02 (m, 1H). 
1
H NMR (300MHz, 
CDCl3): δ 4.65 (d, J = 
2.3 Hz, 1H); 3.80 (ddd, 
J = 10.4, 4.6, 2.3 Hz, 
1H), 3.09 (ddd, J = 16.1, 
4.0, 5.8 Hz, 1H), 2.88 
(ddd, J = 16.1, 10.4, 5.8 
Hz, 1H), 2.18 (m, 2H).  
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(±)-(1S,2S)-1,2,3,4-Tetrahydronaphthalene-1,2-diaminium ditosylate (trans-4h). To a 
3-dram vial equipped with a stir bar were added trans-diazidation product trans-3h (64.3 mg, 0.3 
mmol), THF (3 mL) and H2O (27 L, 1.5 mmol). After the vial was evacuated and backfilled 
with N2 three times, a solution of PPh3 (196.8 mg, 0.75 mmol) in THF (1.5 mL) was added drop-
wise at 0 °C. The mixture was warmed up to 50 °C and stirred for 6 h (the reaction was 
monitored by IR until the absorption of azido groups disappeared). The mixture was then 
concentrated in vacuo and the residue was further dissolved in Et2O (5 mL). This solution was 
added drop-wise to another solution of TsOH∙H2O (142.7 mg, 0.75 mmol) in Et2O (3 mL). The 
reaction was kept stirring for 30 min and the white precipitate was collected by filtration, washed 
with Et2O (5 mL × 3) and dried in vacuo. trans-4h was obtained as a white solid (136.7 mg, 86 
% yield, decomposed at 280 ˚C). IR νmax (neat)/cm
-1
: 3026 (s), 2919 (s), 1610 (m), 1497 (w), 
1163 (s), 1125 (s), 1036 (s), 1011 (s), 814 (m), 685 (s); 
1
H NMR (400 MHz, CD3OD): δ 7.70 (d, 
J = 8.1 Hz, 4H), 7.48 (d, J = 7.6 Hz, 1H), 7.42 (t, J = 7.1 Hz, 1H), 7.38–7.28 (m, 2H), 7.24 (d, J 
= 7.9, 4H), 4.69 (d, J = 3.1 Hz, 1H), 4.07–3.95 (m, 1H), 3.04 (dt, J = 18.0, 5.5 Hz, 1H), 2.99–
2.88 (m, 1H), 2.37 (s, 6H), 2.35–2.27 (m, 1H), 2.20–2.09 (m, 1H); 13C NMR (100 MHz, DMSO-
d6): δ 144.9, 138.3, 136.6, 129.9, 129.4, 129.3, 128.8, 128.4, 127.0, 125.6, 50.0, 48.5, 23.9, 22.2, 
20.9; HRMS (ESI, m/z): calcd for C10H15N2
+
, [M + H
+
], 163.1230, found 163.1223.  
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(±)-(1R,2S)-1,2,3,4-Tetrahydronaphthalene-1,2-diaminium ditosylate (cis-4h). To a 
2-dram vial equipped with a stir bar was added Pd/C (2.1 mg, 10 wt%). After the vial was 
evacuated and backfilled twice with N2, a solution of diazidation product cis-3h (21.4 mg, 0.1 
mmol, dissolved in 1.5 mL MeOH) was added to the vial. The mixture was degassed with brief 
evacuation and backfilled twice with N2 and then three times with H2. The reaction was 
vigorously stirred under H2 at room temperature until the reduction completed (the reaction was 
monitored by IR until the absorption of azido groups disappeared). The solution was filtered 
through Celite and washed with MeOH (3 mL). To the filtrate was added a solution of 
TsOH∙H2O (114.2 mg, 0.60 mmol) in methanol (3 mL). The mixture was concentrated in vacuo 
(to ca. 0.5 mL solvent left), then diluted with Et2O (10 mL). The white precipitate was collected 
by filtration, washed with Et2O (5 mL × 3) and dried in vacuo. cis-4h was obtained as a white 
solid (46.0 mg, 90% yield, decomposed at 280 ˚C). IR νmax (neat)/cm
-1
: 3401 (s), 1652 (m), 1048 
(w), 994 (s), 824 (m), 762 (w); 
1
H NMR (400 MHz, DMSO-d6): δ 8.32 (brs, 6H), 7.51 (d, J = 
7.9 Hz, 4H), 7.44–7.33 (m, 2H), 7.31–7.21 (m, 2H), 7.14 (d, J = 7.8 Hz, 4H), 4.61 (d, J = 2.3 Hz, 
1H), 3.79 (d, J = 12.4 Hz, 1H), 3.07–2.83 (m, 2H), 2.29 (s, 6H), 2.22–2.09 (m, 1H), 2.08–1.98 
(m, 1H); 
13
C NMR (100 MHz, DMSO-d6): δ 145.0, 138.2, 136.0, 130.3, 129.9, 129.7, 129.3, 
128.3, 126.4, 125.6, 50.0, 48.7, 26.8, 20.9, 20.7; HRMS (ESI, m/z): calcd for C10H15N2 [M +  
H
+
], 163.1230, found 163.1223. 
 
2,2,2-Trichloroethyl quinoline-1(2H)-carboxylate (S9). To a solution of 3,4-
dihydroquinoline (234.4 mg, 2.0 mmol) in CH2Cl2 (10 mL) cooled in an ice-water bath, Et3N 
(831 µL, 6.0 mmol) and DMAP (12.2 mg, 0.1 mmol) were added, followed by drop-wise 
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addition of 2,2,2-trichlorethoxycarbonyl chloride (0.41 mL, 3.0 mmol). The reaction was kept 
stirring in an ice-water bath for 6 h until starting material was consumed. Then the reaction 
mixture was diluted with water (50 mL) and extracted with CH2Cl2 (25 mL × 3). The combined 
organic layer was washed with brine (25 mL), dried over anhydrous Na2SO4, and concentrated in 
vacuo.  The crude product was purified through a silica gel flash column (hexanes/EtOAc = 
10:1) to afford S9 as a white solid (466.0 mg, 76% yield). IR νmax (neat)/cm
-1
: 3049 (w), 2850 
(w), 1715 (s), 1940 (m), 1387 (s), 1334 (m), 1223 (s), 1130 (s), 754 (m); 
1
H NMR (400 MHz, 
CD3CN): δ 7.67 (d, J = 8.1 Hz, 1H), 7.29–7.21 (m, 1H), 7.18–7.12 (m, 2H), 6.58 (d, J = 9.6 Hz, 
1H), 6.14–6.06 (m, 1H), 4.90 (s, 2H), 4.45 (dd, J = 4.1, 1.6 Hz, 2H); 13C NMR (100 MHz, 
CD3CN): δ 152.2, 135.6, 128.3, 127.4, 126.4, 126.0, 125.1, 123.9, 117.3, 95.4, 75.1, 43.6; 
HRMS (ESI, m/z): calcd for C12H11Cl3NO2
+
, [M + H
+
], 305.9850, found 305.9860. 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stirring bar were added 
Fe(NTf2)2 (30.8 mg, 0.05 mmol) and L3 (26.1 mg, 0.05 mmol). After the vial was evacuated and 
backfilled with N2 three times, anhydrous CH2Cl2 (0.8 mL) and MeCN (0.2 mL) were added via 
a syringe and the mixture was stirred at room temperature for 10 min. To another flame-dried 3-
dram vial (vial B) equipped with a stirring bar were added 2b (158.4 mg, 0.60 mmol) and S9 
(153.3 mg, 0.5 mmol). This vial was evacuated and backfilled with N2 three times and anhydrous 
CH2Cl2 (4.0 mL) was added. Both vials were degassed with brief evacuation and backfilled with 
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N2 twice. TMSN3 (263 μl, 2.0 mmol) was added to vial B and followed by drop-wise addition of 
the catalyst solution in vial A at room temperature. The reaction was kept at room temperature 
for 2.5 h and then quenched with saturated NaHCO3 solution (0.1 mL), and further diluted with 
hexanes (5 mL). The mixture was stirred vigorously for 10 min and filtered through a short silica 
gel pad.  The filtrate was concentrated in vacuo. The residue was subsequently purified through a 
silica gel flash column (hexanes/Et2O: from 200:1 to17:1) as colorless oil (128.9 mg, 66% yield, 
dr > 20:1). 
 
2,2,2-Trichloroethyl-trans-3,4-diazido-3,4-dihydroquinoline-1(2H)-carboxylate (3i): 
The relative stereochemistry was determined by comparison of its 
1
H NMR spectra with the one 
obtained from 3h. IR νmax (neat)/cm
-1
: 2956 (w), 2098 (s), 1722 (s), 1492 (s), 1391 (m), 1206 
(m), 1146 (m), 760 (m); 
1
H NMR (400 MHz, CDCl3): δ 7.90 (d, J = 6.9 Hz, 1H), 7.45–7.33 (m, 
2H), 7.26–7.19 (m, 1H), 4.89 (s, 2H), 4.51 (d, J = 4.9 Hz, 1H), 4.15 (dd, J = 13.5, 5.8, 1H), 4.06–
3.92 (m, 2H); 
13
C NMR (100 MHz, CDCl3): δ 152.7, 136.5, 129.5, 129.3, 125.3, 124.1, 123.6, 
95.1, 75.7, 61.0, 59.2, 45.2; HRMS (ESI, m/z): calcd for C12H10Cl3N7O2Na
+
, [M + Na
+
], 
418.9854, found 418.9854. 
 
(±)-(3S,4S)-1-((2,2,2-Trichloroethoxy)carbonyl)-1,2,3,4-tetrahydroquinoline-3,4-
diaminium ditosylate (4i). To a 3-dram vial equipped with a stir bar were added Pd/C (11.7 mg, 
10 wt%) and TsOH∙H2O (142.7 mg, 0.75 mmol). After the vial was evacuated and backfilled 
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twice with N2, a solution of diazidation product 3i (117.2 mg, 0.3 mmol, dissolved in 5 mL 
MeOH) was added to the vial. The mixture was degassed with brief evacuation and backfilled 
twice with N2 and then three times with H2. The reaction was vigorously stirred under H2 at room 
temperature until the reduction completed (the reaction was monitored by IR until the absorption 
of azido groups disappeared). The solution was filtered through Celite and washed with MeOH.  
The filtrate was concentrated in vacuo, dissolved in minimum amount of MeOH (about 0.5 mL), 
and then diluted with Et2O (10 mL). The white precipitate was collected by filtration, washed 
with Et2O (5 mL × 3) and dried in vacuo. 4i was obtained as a white solid (182.4 mg, 89% yield, 
dr > 20:1, m.p. 249–251 ˚C). IR νmax (neat)/cm
-1
: 2951 (brs), 1721 (m), 1498 (m), 1399 (m), 
1170 (s), 1033 (m), 1011 (m), 686 (m); 
1
H NMR (400 MHz, CD3OD): δ 8.10 (d, J = 8.5 Hz, 1H), 
7.71 (d, J = 8.1 Hz, 4H), 7.59 (d, J = 7.7 Hz, 1H), 7.55–7.48 (m, 1H), 7.32 (t, J = 7.6 Hz, 1H), 
7.25 (d, J = 8.0 Hz, 4H), 5.00–4.92 (m, 2H), 4.86 (d, J = 2.6 Hz, 1H), 4.38 (dd, J = 15.5, 5.9 Hz, 
1H), 4.27–4.19 (m, 2H), 2.39 (s, 6H); 13C NMR (100 MHz, CD3OD): δ 152.2, 141.8, 140.6, 
137.1, 130.3, 129.9, 128.6, 125.6, 125.5, 123.9, 120.0, 94.9, 75.5, 48.9, 47.7, 42.8, 19.9; HRMS 
(ESI, m/z): calcd for C12H15Cl3N3O2
+
, [M + H
+
], 338.0224, found 338.0230. 
 
2,2,2-Trichloroethyl-1H-indole-1-carboxylate (S10). To a solution of indole (234.4 mg, 
2.0 mmol) in CH2Cl2 (10 mL) cooled in an ice-water bath, Bu4NHSO4 (34 mg, 0.1 mmol) and 
NaOH (320 mg, 8.0 mmol) were added, followed by drop-wise addition of 2,2,2-
trichlorethoxycarbonyl chloride (0.41 mL, 3.0 mmol). The reaction was allowed to warm up to 
room temperature gradually, and stirred for 2 h until indole was consumed. Then the reaction 
mixture was diluted with water (50 mL) and extracted with CH2Cl2 (25 mL × 3). The combined 
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organic layer was washed with brine (25 mL), dried over anhydrous Na2SO4, and concentrated in 
vacuo. The crude product was purified through a silica gel flash column (hexanes/EtOAc = 10:1) 
to afford the N-Troc indole S10 as a white solid (514.8 mg, 88% yield). IR νmax (neat)/cm
-1
: 2961 
(w), 1739 (s), 1536 (w), 1455 (s), 1391 (s), 1343 (m), 1326 (s), 1236 (s), 1211 (m), 1120 (s) 753 
(s), 715 (s); 
1
H NMR (400 MHz, 310 K, CDCl3): δ 8.28 (d, J = 8.1 Hz, 1H), 7.70 (d, J = 3.7 Hz, 
1H), 7.62 (d, J = 7.7 Hz, 1H), 7.51–7.37 (m, 1H), 7.32 (td, J = 7.7, 0.9 Hz, 1H), 6.69 (d, J = 3.7 
Hz, 1H), 5.07 (s, 2H); 
13
C NMR (100 MHz, CDCl3): δ 149.3, 135.3, 130.8, 125.4, 125.1, 123.7, 
121.3, 115.4, 109.4, 94.6, 77.4, 75.8; HRMS (ESI, m/z): calcd for C11H9Cl3NO2
+
, [M + H
+
], 
291.9693, found 291.9699. 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stirring bar were added 
Fe(OTf)2 (8.9 mg, 0.025 mmol) and L3 (13.1 mg, 0.025 mmol). After the vial was evacuated and 
backfilled with N2 three times, anhydrous CH2Cl2 (0.8 mL) and MeCN (0.2 mL) were added via 
a syringe and the mixture was stirred at room temperature for 10 min. To another flame-dried 3-
dram vial (vial B) equipped with a stirring bar were added 2b (158.4 mg, 0.60 mmol) and N-Troc 
indole S10 (146.0 mg, 0.5 mmol). This vial was evacuated and backfilled with N2 three times 
and anhydrous CH2Cl2 (1.5 mL) was added. Both vials were degassed with brief evacuation and 
backfilled with N2 twice. TMSN3 (263 μl, 2.0 mmol) was added to vial B and followed by drop-
wise addition of the catalyst solution in vial A at room temperature. The reaction was kept at 
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room temperature for 3 h and then quenched with saturated NaHCO3 solution (0.1 mL), and 
further diluted with hexanes (5 mL). The mixture was stirred vigorously for 10 min and filtered 
through a short silica gel pad. The filtrate was concentrated in vacuo. The residue was 
subsequently purified through a silica gel flash column (hexanes/Et2O: from 200:1 to 15:1) as 
white solid (151.8 mg, 81% yield, dr > 20:1). 
 
2,2,2-Trichloroethyl-trans-2,3-diazidoindoline-1-carboxylate (3j): IR νmax (neat)/cm
-1
: 
2102 (s), 1737(w), 1605 (m), 753 (s); 
1
H NMR (400 MHz, CD3CN, 318 K): δ 7.85 (d, J = 8.0 
Hz, 1H), 7.56–7.46 (m, 2H), 7.24 (t, J = 7.5 Hz, 1H), 5.87 (s, 1H), 5.10 (d, J = 12.2 Hz, 1H), 
4.98 (d, J = 12.1 Hz, 1H), 4.83 (s, 1H); 
13
C NMR (100 MHz, DMSO-d6, 318 K): δ 150.4, 139.9, 
131.1, 131.0, 126.3, 124.5, 115.2, 94.9, 79.8, 74.8, 64.2; HRMS (ESI, m/z): calcd for 
C11H8Cl3N7O2Na
+
, [M + Na
+
], 397.9697, found 397.9691. 
 
(±)-(2S,3S)-1-((2,2,2-Trichloroethoxy)carbonyl)indoline-2,3-diaminium ditosylate 
(4j). To a 3-dram vial equipped with a stir bar were added Pd/C (11.3 mg, 10 wt%) and 
TsOH∙H2O (142.7 mg, 0.75 mmol). After the vial was evacuated and backfilled twice with N2, a 
solution of diazidation product 3j (113.0 mg, 0.3 mmol, dissolved in 5 mL MeOH) was added to 
the vial. The mixture was degassed with brief evacuation and backfilled twice with N2 and then 
three times with H2. The reaction was vigorously stirred under H2 at room temperature until the 
reduction completed (the reaction was monitored by IR until the absorption of azido groups 
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disappeared). The solution was filtered through Celite and washed with MeOH. The filtrate was 
concentrated in vacuo, dissolved in minimum amount of MeOH (ca. 0.5 mL), and then diluted 
with Et2O (10 mL). The white precipitate was collected by filtration, washed with Et2O (5 mL × 
3) and dried in vacuo. 4j was obtained as a white solid (180.1 mg, 90% yield, dr > 20:1, m.p. 
145–146 ˚C).  IR νmax (neat)/cm
-1
: 2923 (s), 1721 (s), 1599 (m), 1489 (s), 1409 (m), 1328 (m), 
1164 (s), 1125 (s), 1035 (s), 1010 (s), 683 (s); 
1
H NMR (400 MHz, DMSO-d6, 318 K): δ 8.64 
(brs, 3H), 7.74 (d, J = 7.6 Hz, 1H), 7.70 (d, J = 7.5 Hz, 1H), 7.57 (m, 1H), 7.52 (d, J = 8.0 Hz, 
4H), 7.28 (t, J = 7.5 Hz, 1H), 7.13 (d, J = 7.8 Hz, 4H), 5.62 (s, 1H), 5.23 (d, J = 12.1 Hz, 1H), 
5.01 (brs, 1H), 4.87 (s, 1H), 2.30 (s, 6H); 
13
C NMR (100 MHz, DMSO-d6, 318 K): δ 150.6, 
148.8, 144.5, 141.0, 140.2, 138.2, 131.4, 128.2, 127.1, 126.9, 125.4, 124.7, 124.3, 115.6, 114.9, 
94.5, 75.4, 74.4, 68.8, 54.0, 53.4, 20.7; HRMS (ESI, m/z): calcd for C11H13N3O2Cl3
+
, [M + H
+
], 
324.0068, found 324.0057. 
4j was converted to S11 for NOE analysis for relative stereochemistry determination. 
 
(±)-2,2,2-Trichloroethyl (2S,3S)-2,3-diacetamidoindoline-1-carboxylate (S11).  
Diaminium tosylate 4j (66.9 mg, 0.1 mmol) was suspended in anhydrous CH2Cl2 (3 mL) in a 
flame-dried vial under N2. The reaction was cooled to 0 °C under stirring. Et3N (56 μL, 0.4 
mmol) was added via a syringe followed by dropwise addition of Ac2O (23.6 μL, 0.25 mml).  
The reaction was then warmed up to room temperature and kept stirring for 2 hours. After 
quenching with saturated NaHCO3 solution under vigorous stirring, the mixture was extracted 
with CH2Cl2 (2 mL × 3) and concentrated in vacuo. The crude product was purified through a 
silica gel column (hexanes/acetone for 3:1 to 1:1) to afford S11 as a white solid (31.9 mg, 78% 
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yield). IR νmax (neat)/cm
-1
: 2921 (s), 2851 (s), 1732 (w), 1555 (m), 1463 (m); 
1
H NMR (400 
MHz, CD3CN, 318 K): δ 7.83 (d, J = 8.4 Hz, 1H), 7.42–7.33 (m, 2H), 7.14 (t, J = 7.5 Hz, 1H), 
7.06 (brd, J = 5.8 Hz, 1H), 6.84 (brd, J = 5.8 Hz, 1H), 5.87 (d, J = 7.7 Hz, 1H), 5.18 (d, J = 7.9 
Hz, 1H), 5.09 (d, J = 12.2 Hz, 1H), 4.89 (d, J = 11.9 Hz, 1H), 1.89 (s, 3H), 1.86 (s, 3H); 
13
C 
NMR (100 MHz, CD3CN, 318 K): δ 170.4, 170.0, 152.0, 142.9, 131.4, 130.6, 126.7, 125.1, 
116.1, 96.4, 75.9, 73.3, 58.0, 23.4, 23.2; HRMS (ESI, m/z): calcd for C15H17N3O4Cl3
+
, [M + H
+
], 
408.0279, found 408.0273.  
 
A strong NOE was observed between H(a) and H(b); however, there is no significant 
NOE observed between H(c) and H(d). Additionally, NOEs between H(a) and H(d), and between 
H(b) and H(c) were also observed.  
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2,2,2-Trichloroethyl-3-methyl-1H-indole-1-carboxylate (S12). To a solution of 3-
methyl indole (262.4 mg, 2.0 mmol) in CH2Cl2 (10 mL) cooled in an ice-water bath, Bu4NHSO4 
(34 mg, 0.1 mmol) and NaOH (320 mg, 8.0 mmol) were added, followed by dropwise addition 
of 2,2,2-trichlorethoxycarbonyl chloride (0.41 mL, 3.0 mmol). The reaction was allowed to 
warm up to room temperature gradually, and stirred for 2 h until 3-methyl indole was consumed.  
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Then the reaction mixture was diluted with water (50 mL) and extracted with CH2Cl2 (25 mL × 
3). The combined organic layer was washed with brine (25 mL), dried over anhydrous Na2SO4, 
and concentrated in vacuo. The crude product was purified through a silica gel flash column 
(hexanes/EtOAc = 10:1) to afford S12 as a white solid (527.4 mg, 86% yield). IR νmax (neat)/cm
-
1
: 2956 (w), 1739 (s), 1612 (w), 1456 (s), 1397 (s), 1348 (m), 1305 (s), 1233 (s), 1152 (m), 1099 
(s), 753 (s), 713 (s); 
1
H NMR (400 MHz, CDCl3): δ 8.24 (d, J = 5.1 Hz, 1H), 7.54 (d, J = 7.5 Hz, 
1H), 7.44 (s, 1H), 7.44–7.37 (m, 1H), 7.36–7.29 (m, 1H), 5.05 (s, 2H), 2.31 (s, 3H); 13C NMR 
(100 MHz, CDCl3): δ 149.1, 135.6, 131.8, 125.0, 123.4, 122.0, 119.3, 118.6, 115.3, 94.7, 75.6, 
9.7; HRMS (ESI, m/z): calcd for C12H11Cl3NO2
+
, [M + H
+
], 305.9850, found 305.9861. 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stirring bar were added 
Fe(OTf)2 (8.9 mg, 0.025 mmol) and L3 (13.1 mg, 0.025 mmol). After the vial was evacuated and 
backfilled with N2 three times, anhydrous CH2Cl2 (0.8 mL) and MeCN (0.2 mL) were added via 
a syringe and the mixture was stirred at room temperature for 10 min. To another flame-dried 3-
dram vial (vial B) equipped with a stirring bar were added 2b (158.4 mg, 0.60 mmol) and N-
Troc-3-methyl indole S12 (153 mg, 0.5 mmol). This vial was evacuated and backfilled with N2 
three times and anhydrous CH2Cl2 (1.5 mL) was added. Both vials were degassed with brief 
evacuation and backfilled with N2 twice. TMSN3 (263 μl, 2.0 mmol) was added to vial B and 
followed by drop-wise addition of the catalyst solution in vial A at room temperature. The 
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reaction was kept at room temperature for 3 h and then quenched with saturated NaHCO3 
solution (0.1 mL), and further diluted with hexanes (5 mL). The mixture was stirred vigorously 
for 10 min and filtered through a short silica gel pad. The filtrate was concentrated in vacuo. The 
residue was subsequently purified through a silica gel flash column (hexanes/Et2O: from 200:1 to 
15:1) as a white solid (160.0 mg, 82% yield, dr > 20:1). The relative stereochemistry was 
determined through NOE analysis of a derivatization product of S13.  
 
2,2,2-Trichloroethyl-trans-2,3-diazido-3-methylindoline-1-carboxylate (S13): IR νmax 
(neat)/cm
-1
: 2113 (s), 1736 (s), 1483 (m), 1403 (m), 1256 (w), 753 (w); 
1
H NMR (400 MHz, 
CD3CN, 318 K): δ 7.86 (d, J = 7.9 Hz, 1H), 7.57–7.44 (m, 2H), 7.28 (td, J = 7.6, 0.8 Hz, 1H), 
5.81 (s, 1H), 5.14 (d, J = 12.2 Hz, 1H), 5.02 (d, J = 12.1 Hz, 1H), 1.79 (s, 3H); 
13
C NMR (100 
MHz, DMSO-d6, 318 K): δ 150.3, 139.1, 130.9, 129.6, 124.4, 123.5, 115.1, 94.9, 82.6, 74.7, 
69.5, 16.8. 
 
(±)-(2S,3S)-1-((2,2,2-Trichloroethoxy)carbonyl)indoline-3-methyl-2,3-diaminium 
ditosylate ditosylate (S14). To a 3-dram vial equipped with a stir bar were added Pd/C (11.7 
mg, 10 wt%) and TsOH∙H2O (142.7 mg, 0.75 mmol). After the vial was evacuated and backfilled 
twice with N2, a solution of diazidation product S13 (117.2 mg, 0.3 mmol, dissolved in 5 mL 
MeOH) was added to the vial. The mixture was degassed with brief evacuation and backfilled 
twice with N2 and then three times with H2. The reaction was vigorously stirred under H2 at room 
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temperature until the reduction completed (the reaction was monitored by IR until the absorption 
of azido groups disappeared). The solution was filtered through Celite and washed with MeOH.  
The filtrate was concentrated in vacuo, dissolved in minimum amount of MeOH (ca. 0.5 mL), 
and then diluted with Et2O (10 mL). The white precipitate was collected by filtration, washed 
with Et2O (5 mL × 3) and dried in vacuo. S14 was obtained as a white solid (171.2 mg, 83% 
yield, dr > 20:1, decomposed at 234˚C). IR νmax (neat)/cm
-1
: 2855 (s), 1731 (s), 1532 (w), 1484 
(m), 1398 (w), 1325 (w), 1192 (s), 1124 (s), 1039 (s), 1010 (s), 762 (m), 682 (s); 
1
H NMR (400 
MHz, DMSO-d6, 318 K): δ 8.71 (brs, 3H), 7.76 (d, J = 7.3 Hz, 1H), 7.64–7.55 (m, 2H), 7.52 (d, 
J = 8.0 Hz, 4H), 7.32 (t, J = 7.6 Hz, 1H), 7.14 (d, J = 7.9 Hz, 4H), 5.58 (s, 1H), 5.24 (d, J = 12.1 
Hz, 1H), 5.01 (d, J = 12.0 Hz, 1H), 2.32 (s, 6H), 1.84 (s, 3H); 
13
C NMR (100 MHz, DMSO-d6, 
318 K): δ 150.3, 144.9, 139.4, 138.0, 131.5, 128.5, 128.0, 125.4, 125.0, 124.8, 115.6, 94.7, 75.2, 
71.9, 60.3, 20.6, 16.9; HRMS (ESI, m/z): calcd for C12H15O2N3Cl3
+
, [M + H
+
], 338.0224, found 
338.0209. 
 
(±)-2,2,2-Trichloroethyl (2S,3S)-2,3-diacetamidoindoline-1-carboxylate (S15).  
Diaminium tosylate S14 (66.9 mg, 0.1 mmol) was suspended in anhydrous CH2Cl2 (3 mL) in a 
flame-dried vial under N2. The reaction was cooled to 0 °C under stirring. Et3N (56 μL, 0.4 
mmol) was added via a syringe followed by drop-wise addition of Ac2O (23.6 μL, 0.25 mml).  
The reaction was then warmed up to room temperature and kept stirring for 2 hours. After 
quenching with saturated NaHCO3 solution under vigorous stirring, the mixture was extracted 
with CH2Cl2 (2 mL × 3) and concentrated in vacuo. The crude product was purified through a 
silica gel flash column (hexanes/acetone from 3:1 to 1:1) to afford S15 as a white solid (22.0 mg, 
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52% yield). IR νmax (neat)/cm
-1
: 3275 (m), 2922 (m), 1726 (s), 1653 (s), 1543 (s), 1485 (s), 1403 
(s);
 1
H NMR (400 MHz, CD3CN): δ 7.80 (d, J = 8.1 Hz, 1H), 7.36–7.30 (m, 2H), 7.17–7.10 (m, 
1H), 6.89 (d, J = 8.2 Hz, 1H), 6.76 (s, 1H), 6.40 (d, J = 8.8 Hz, 1H), 5.15 (d, J = 12.4 Hz, 1H), 
4.79 (s, 1H), 1.88 (s, 3H), 1.79 (s, 3H), 1.52 (s, 3H); 
13
C NMR (100 MHz, CD3CN): δ 169.4, 
169.1, 151.0, 141.5, 134.2, 129.1, 123.7, 123.5, 114.8, 95.2, 74.6, 72.9, 61.9, 22.4, 22.1, 20.3; 
HRMS (ESI, m/z): calcd for C16H19N3O4Cl3
+
, [M + H
+
], 422.0436, found: 422.0426. 
 
A strong NOE was observed between H(c) and H(b); however, there is no significant 
NOE observed between H(c) and H(d). Additionally, NOEs between H(a) and H(d), and between 
H(c) and H(b) were also observed.  
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trans-Stilbene 10b is commercially available and it was further purified upon 
recrystallization before usage. 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stirring bar were added 
Fe(OTf)2 (8.9 mg, 0.025 mmol) and L3 (13.1 mg, 0.025 mmol). After the vial was evacuated and 
backfilled with N2 three times, anhydrous CH2Cl2 (0.8 mL) and MeCN (0.2 mL) were added via 
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a syringe and the mixture was stirred at room temperature for 10 min. To another flame-dried 3-
dram vial (vial B) equipped with a stirring bar were added 2b (158.4 mg, 0.60 mmol) and trans-
stilbene 10b (90.1 mg, 0.5 mmol). This vial was evacuated and backfilled with N2 three times 
and anhydrous CH2Cl2 (4.0 mL) was added. Both vials were degassed with brief evacuation and 
backfilled with N2 twice. TMSN3 (263 µL, 2.0 mmol) was added to vial B and followed by drop-
wise addition of the catalyst solution in vial A at room temperature. The reaction was kept at 
room temperature for 3 h and then quenched with a saturated NaHCO3 solution (0.1 mL) and 
further diluted with hexanes (5 mL). The mixture was stirred vigorously for additional 10 min 
and filtered through a short silica gel pad. The filtrate was concentrated in vacuo. The residue 
was subsequently purified through a silica gel flash column (hexanes/Et2O: from 200:1 to 50:1) 
as a colorless oil (113.6 mg, 86% yield, dr = 2.5:1). Lower dr (1.5:1) was obtained when the 
Fe(OAc)2L3 complex was used as the catalyst.   
 
1,2-Diazido-1,2-diphenylethane (11): IR νmax (neat)/cm
-1
: 2959 (w), 2100 (s), 1252(m), 
1116 (w), 842 (m); 
1
H NMR (400 MHz, CDCl3): δ 7.41 (m, 6H, minor), 7.35–7.19 (m, 4H, 
minor and m, 6H, major), 7.10 (m, 4H, major), 4.72 (s, 2H, minor), 4.67 (s, 2H, major); 
13
C 
NMR (100 MHz, CDCl3): δ 136.0 (minor), 135.9 (major), 129.1 (minor), 128.83 (minor), 128.79 
(major), 128.7 (major), 128.1 (minor), 127.8 (major), 70.9 (major), 69.8 (minor). 
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1,2-Diphenylethane-1,2-diaminium ditosylate (S16). To a 3-dram vial equipped with a 
stir bar were added diazidation product 11 (79.3 mg, 0.3 mmol), THF (3 mL) and H2O (27 L, 
1.5 mmol). After the vial was evacuated and backfilled with N2 three times, a solution of PPh3 
(196.8 mg, 0.75 mmol) in THF (1.5 mL) was added drop-wise at 0 °C. The mixture was warmed 
up to 50 °C and stirred for 6 h (the reaction was monitored by IR until the absorption of azido 
groups disappeared). The mixture was then concentrated in vacuo and the residue was further 
dissolved in Et2O (5 mL). This solution was added drop-wise to another solution of TsOH∙H2O 
(142.7 mg, 0.75 mmol) in Et2O (3 mL).  The reaction was kept stirring for 30 min and the white 
precipitate was collected by filtration, washed with Et2O (5 mL × 3) and dried in vacuo. S16 was 
obtained as a white solid (138.6 mg, 83% yield, dr = 2.5:1, m.p. 251–253 ˚C). IR νmax (neat)/cm
-
1
: 2911 (s), 2662 (m), 1599 (w), 1538 (m), 1171 (s), 1157 (s), 1123 (s), 1032 (s), 1007 (s), 811 
(m), 698 (m), 679 (s); 
1
H NMR (400 MHz, DMSO-d6): δ 8.83 (s, 6H, major), 8.43 (s, 6H, 
minor), 7.72–7.67 (m, 4H, minor), 7.55 (d, J = 8.0 Hz, 4H), 7.57–7.42 (m, 6H, minor), 7.36–7.27 
(m, 6H, major), 7.27–7.22 (m, 4H, minor), 7.18 (d, J = 7.8 Hz, 4H), 4.92 (s, 2H, major), 4.77 (s, 
2H, minor), 2.31 (s, 6H);
 13
C NMR (100 MHz, DMSO-d6): δ 144.8, 138.4, 133.2, 132.6, 130.0, 
129.38, 129.35, 128.69, 128.65, 128.62, 128.4, 125.6, 56.9 (major), 56.7 (minor), 20.9; HRMS 
(ESI, m/z): calcd for C14H17N2
+
, [M + H
+
], 213.1386, found 213.1382. 
The relative stereochemistry of the major diastereomer was determined by comparison of 
the 
1
H NMR spectrum of the synthetic diamines with the one obtained from commercially 
available (1R,2R)-(+)-1,2-diphenylethylenediamine (Aldrich 364010).   
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trans-2-Octene is commercially available and it was distilled before usage. 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stirring bar were added 
Fe(OTf)2 (8.9 mg, 0.025 mmol) and L3 (13.1 mg, 0.015 mmol). After the vial was evacuated and 
backfilled with N2 three times, anhydrous CH2Cl2 (0.8 mL) and MeCN (0.2 mL) were added via 
a syringe and the mixture was stirred at room temperature for 10 min. To another flame-dried 3-
dram vial (vial B) equipped with a stirring bar was added 2b (158.4 mg, 0.60 mmol). This vial 
was evacuated and backfilled with N2 three times and anhydrous CH2Cl2 (4.0 mL) was added.  
Both vials were degassed with brief evacuation and backfilled with N2 twice. Freshly distilled 
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trans-2-octene (78 µL, 0.5 mmol), TMSN3 (263 µL, 2.0 mmol) were added successively to vial 
B and followed by drop-wise addition of the catalyst solution in vial A at room temperature. The 
reaction was kept at room temperature for 2 h and then quenched with saturated NaHCO3 
solution (0.1 mL) and further diluted with hexanes (5 mL). The mixture was stirred vigorously 
for additional 10 min and filtered through a short silica gel pad. The filtrate was concentrated in 
vacuo. The residue was subsequently purified through a silica gel flash column (hexanes/Et2O: 
from 200:1 to 50:1) as colorless oil (74.6 mg, 76% yield, dr = 1.4:1). anti- and syn-3k were 
separated through a silica gel flash column (hexanes/Et2O: from 200:1 to 50:1). 
 
anti-2,3-Diazidooctane (anti-3k): IR νmax (neat)/cm
-1
: 2931 (m), 2097 (s), 1251 (m), 
1153 (m), 744 (w); 
1
H NMR (400 MHz, CDCl3): δ 3.63–3.48 (m, 1H), 3.31 (dt, J = 9.0, 4.6 Hz, 
1H), 1.55–1.48  (m, 3H), 1.41–1.25 (m, 8H), 0.91 (t, J = 6.7 Hz, 3H); 13C NMR (100 MHz, 
CDCl3): δ 66.5, 60.4, 31.6, 30.9, 26.1, 22.6, 14.6, 14.1. 
 
syn-2,3-Diazidooctane (syn-3k): IR νmax (neat)/cm
-1
: 2932 (m), 2091 (s), 1454 (w), 1249 
(m), 1055 (m), 1009 (m); 
1
H NMR (400 MHz, CDCl3): δ 3.56–3.47 (m, 1H), 3.21–3.13 (m, 1H), 
1.68–1.55 (m, 2H), 1.55–1.43 (m, 2H), 1.37–1.29 (m, 7H), 0.91 (t, J = 6.8 Hz, 3H); 13C NMR 
(100 MHz, CDCl3): δ 66.5, 60.3, 31.6, 31.1, 25.9, 22.6, 16.5, 14.1. 
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anti-Octane-2,3-diaminium ditosylate (anti-4k). To a 3-dram vial equipped with a stir 
bar were added diazidation product anti-3k (58.9 mg, 0.3 mmol), THF (3 mL) and H2O (27 L, 
1.5 mmol). After the vial was evacuated and backfilled with N2 three times, a solution of PPh3 
(196.8 mg, 0.75 mmol) in THF (1.5 mL) was added drop-wise at 0 °C. The mixture was warmed 
up to 50 °C and stirred for 6 h (the reaction was monitored by IR until the absorption of azido 
groups disappeared). The mixture was then concentrated in vacuo and the residue was further 
dissolved in Et2O (5 mL). This solution was added drop-wise to another solution of TsOH∙H2O 
(142.7 mg, 0.75 mmol) in Et2O (3 mL). The reaction was kept stirring for 30 min and the white 
precipitate was collected by filtration, washed with Et2O (5 mL × 3) and dried in vacuo. anti-4k 
was obtained as a white solid (139.3 mg, 95% yield, m.p. 278–279 ˚C). IR νmax (neat)/cm
-1
: 2951 
(s), 2923 (s), 2866 (s), 1622 (m), 1532 (m), 1172 (s), 1122 (s), 1035 (s), 1010 (s), 813 (m), 677 
(s); 
1
H NMR (400 MHz, CD3OD): δ 7.71 (d, J = 8.2 Hz, 4H), 7.25 (d, J = 8.0 Hz, 4H), 3.64 (qd, 
J = 6.9, 4.8 Hz, 1H), 3.47 (dt, J = 8.1, 5.0 Hz, 1H), 2.37 (s, 6H), 1.81–1.57 (m, 2H), 1.54–1.43 
(m, 1H), 1.39 (d, J = 6.9 Hz, 3H), 1.35–1.31 (m, 5H), 0.91 (t, J = 6.8 Hz, 3H); 13C NMR (100 
MHz, CD3OD): δ 143.2, 141.9, 129.9, 126.9, 55.1, 49.8, 32.5, 30.5, 25.8, 23.4, 21.3, 14.5, 14.3; 
HRMS (ESI, m/z): calcd for C8H21N2
+
, [M + H
+
], 145.1699, found 145.1695. 
 
syn-Octane-2,3-diaminium ditosylate (syn-4k). By following the same reduction 
procedure, the diamine salt syn-4k was also obtained as a white solid (139.3 mg, 95% yield, m.p. 
278–279 ˚C). IR νmax (neat)/cm
-1
: 2951 (s), 2923 (s), 2866 (s), 1622 (m), 1532 (m), 1172 (s), 
1122 (s), 1035 (s), 1010 (s), 813 (m), 677 (s); 
1
H NMR (400 MHz, CD3OD): δ 7.71 (d, J = 8.1 
Hz, 4H), 7.24 (d, J = 7.9 Hz, 4H), 3.84–3.67 (m, 1H), 3.55 (dt, J = 7.5, 3.5 Hz, 1H), 2.37 (s, 6H), 
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1.77–1.66 (m, 1H), 1.66–1.55 (m, 1H), 1.55–1.42 (m, 1H), 1.40–1.27 (m, 8H), 0.91 (t, J = 6.6 
Hz, 3H); 
13
C NMR (100 MHz, CD3OD): δ 143.3, 141.9, 129.9, 126.9, 54.0, 49.5, 32.6, 27.7, 
26.1, 23.4, 21.3, 14.3, 13.1; HRMS (ESI, m/z): calcd for C8H21N2
+
, [M + H
+
], 145.1699, found 
145.1695. 
The relative stereochemistry of two isomers of 4k was determined by NOE analysis of 
their corresponding ureas after derivatization.   
 
cis-4-Methyl-5-pentylimidazolidin-2-one (cis-S17). Octane-2,3-diamonium ditosylate 
anti-4k (24.5 mg, 0.05 mmol) was suspended in anhydrous CH2Cl2 (2 mL) in a flame-dried vial 
under N2. The mix was cooled to 0 °C under stirring. Et3N (42 μL, 0.3 mmol) was added via a 
syringe followed by drop-wise addition of a phosgene toluene solution (57.1 μL, 0.08 mmol, 15 
wt%). The reaction was then warmed up to room temperature and kept stirring for 3 hours. After 
quenching with the saturated NaHCO3 solution under vigorous stirring, the mixture was 
extracted with CH2Cl2 (2 mL × 3) and concentrated in vacuo. The crude product was purified 
through a silica gel column (hexanes/acetone from 2:1 to 1:1) to afford the product cis-S17 as a 
solid (7.2 mg, 84% yield). IR νmax (neat)/cm
-1
: 3205 (m), 2926 (m), 2856 (m), 1697 (s), 1454 
(m), 1373 (w), 1254 (m); 
1
H NMR (400 MHz, CDCl3): δ 4.54 (brs, 1H), 4.38 (brs, 1H), 3.89–
3.79 (m, 1H), 3.75–3.66 (m, 1H), 1.54–1.41 (m, 2H), 1.39–1.26 (m, 6H), 1.14 (d, J = 6.5 Hz, 
3H), 0.90 (t, J = 6.4 Hz, 3H); 
13
C NMR (100 MHz, CDCl3): δ 163.0, 56.1, 51.4, 31.7, 29.6, 26.2, 
22.5, 15.8, 14.0; HRMS (ESI, m/z): calcd for C9H19N2O
+
, [M + H
+
], 171.1492, found 171.1484. 
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The strong NOE between the methyl H(c) and the methylene H(d) was observed. 
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trans-4-Methyl-5-pentylimidazolidin-2-one (trans-S17). By following the same 
procedure, trans-S17 was prepared through syn-4k and isolated as colorless oil (6.9 mg, 81% 
yield). IR νmax (neat)/cm
-1
: 3206 (m), 2926 (m), 2855 (m), 1697 (s), 1454 (m), 1374 (w), 1254 
(m); 
1
H NMR (400 MHz, CDCl3): δ 4.62 (brs, 1H), 4.53 (brs, 1H), 3.56–3.43 (m, 1H), 3.33–3.23 
(m, 1H), 1.60–1.46 (m, 2H), 1.35 (d, J = 15.7 Hz, 6H), 1.26 (d, J = 6.2 Hz, 3H), 0.92 (t, J = 6.7 
Hz, 3H); 
13
C NMR (100 MHz, CDCl3): δ 162.4, 60.5, 54.3, 35.1, 31.7, 25.4, 22.5, 21.2, 14.0; 
HRMS (ESI, m/z): calcd for C9H19N2O
+
, [M + H
+
], 171.1492, found 171.1484. 
 
There is absence of NOE between H(c) and H(d) and the NOE between H(b) and H(d) 
was observed instead.  
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Methyl trans-cinnamate is commercially available and it was used directly. 
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To a flame-dried sealable 2-dram vial (vial A) equipped with a stirring bar were added 
Fe(OTf)2 (8.9 mg, 0.025 mmol) and L3 (13.1 mg, 0.025 mmol). After the vial was evacuated and 
backfilled with N2 three times, anhydrous CH2Cl2 (0.8 mL) and MeCN (0.2 mL) were added via 
a syringe and the mixture was stirred at room temperature for 10 min. To another flame-dried 3-
dram vial (vial B) equipped with a stirring bar was added 2b (158.4 mg, 0.60 mmol) and trans-
methyl trans-cinnamate (81.1 mg, 0.5 mmol). This vial was evacuated and backfilled with N2 
three times and anhydrous CH2Cl2 (4.0 mL) was added. Both vials were degassed with brief 
evacuation and backfilled with N2 twice. TMSN3 (263 μl, 2.0 mmol) was added to vial B and 
followed by drop-wise addition of the catalyst solution in vial A at room temperature. The 
reaction was kept at room temperature for 3 h and then quenched with saturated NaHCO3 
solution (0.1 mL), and further diluted with hexanes (5 mL). The mixture was stirred vigorously 
for 10 min and filtered through a short silica gel pad. The filtrate was concentrated in vacuo. The 
residue was subsequently purified through a silica gel flash column (hexanes/Et2O: from 200:1 
to10:1). The major diastereomer anti-3l and minor diastereomer syn-3l were both isolated as 
colorless oil (70.5 mg, 57% yield and 41.5 mg, 34% yield respectively). 
 
anti-Methyl-2,3-diazido-3-phenylpropanoate (anti-3l): IR νmax (neat)/cm
-1
: 2099 (s), 
1744(m), 1275 (w), 764 (m); 
1
H NMR (400 MHz, CDCl3): δ 7.48–7.40 (m, 3H), 7.40–7.33 (m, 
2H), 4.90 (d, J = 8.0 Hz, 1H), 4.10 (d, J = 8.0 Hz, 1H), 3.83 (s, 3H); 
13
C NMR (100 MHz, 
CDCl3): δ 168.4, 134.6, 129.7, 129.2, 128.0, 65.7, 65.6, 53.2. 
 
196 
syn-Methyl-2,3-diazido-3-phenylpropanoate (syn-3l): IR νmax (neat)/cm
-1
: 2105 (s), 
1747(m), 1275 (w), 764 (m); 
1
H NMR (400 MHz, CDCl3): δ 7.56–7.31 (m, 5H), 5.05 (d, J = 5.7 
Hz, 1H), 4.03 (d, J = 5.7 Hz, 1H), 3.74 (s, 3H); 
13
C NMR (100 MHz, CDCl3): δ 168.1, 135.0, 
129.4, 129.1, 127.6, 66.44, 66.40, 53.1.   
 
anti-3-Methoxy-3-oxo-1-phenylpropane-1,2-diaminium ditosylate (anti-4l). To a 3-
dram vial equipped with a stir bar were added diazidation product anti-3l (73.9 mg, 0.3 mmol), 
THF (3 mL) and H2O (27 L, 1.5 mmol). After the vial was evacuated and backfilled with N2 
three times, a solution of PPh3 (196.8 mg, 0.75 mmol) in THF (1.5 mL) was added drop-wise at 
0 °C.  The mixture was warmed up to 50 °C and stirred for 6 h (the reaction was monitored by IR 
until the absorption of azido groups disappeared). The mixture was then concentrated in vacuo 
and the residue was further dissolved in Et2O (5 mL). This solution was added drop-wise to 
another solution of TsOH∙H2O (142.7 mg, 0.75 mmol) in Et2O (3 mL). The reaction was kept 
stirring for 30 min and the white precipitate was collected by filtration, washed with Et2O (5 mL 
× 3) and dried in vacuo. anti-4l was obtained as a white solid (147.5 mg, 91% yield, m.p. 217–
219 ˚C).  IR νmax (neat)/cm
-1
: 2859 (s), 2681 (m), 1758 (s), 1552 (w), 1211 (s), 1175 (s), 1125 (s), 
1036 (s), 1010 (s), 812 (m), 680 (s); 
1
H NMR (400 MHz, DMSO-d6): δ 8.64 (brs, 6H), 7.61–7.41 
(m, 9H), 7.15 (d, J = 7.7 Hz, 4H), 4.71 (d, J = 8.0 Hz, 1H), 4.51 (d, J = 8.0 Hz, 1H), 3.80 (s, 3H), 
2.30 (s, 6H); 
13
C NMR (100 MHz, DMSO-d6): δ 166.7, 145.0, 138.2, 132.1, 130.1, 129.4, 
128.33, 128.29, 125.6, 54.7, 53.8, 53.6, 20.9; HRMS (ESI, m/z): calcd for C10H15O2N2
+
 [M + 
H
+
], 195.1128, found 195.1123.  
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syn-3-Methoxy-3-oxo-1-phenylpropane-1,2-diaminium ditosylate (syn-4l). By 
following the same reduction procedure, the syn-diamine salt syn-4l was obtained as a white 
solid (153.3 mg, 95% yield, m.p. 172–174 ˚C). IR νmax (neat)/cm
-1
: 3482 (w), 2954 (s), 1756 (s), 
1601 (w), 1530 (w), 1172 (s), 1124 (s), 1034 (s), 1010 (s), 816 (m), 683 (s); 
1
H NMR (400 MHz, 
DMSO-d6): δ 8.72 (brs, 6H), 7.52–7.47 (m, 3H), 7.49 (d, J = 7.9 Hz, 4H), 7.37 (dd, J = 6.5, 2.8 
Hz, 2H), 7.13 (d, J = 7.9 Hz, 4H), 4.75 (d, J = 4.9 Hz, 1H), 4.61 (d, J = 4.5 Hz, 1H), 3.72 (s, 3H), 
2.30 (s, 6H); 
13
C NMR (100 MHz, CD3OD): 167.2, 143.3, 141.9, 131.9, 130.94, 130.90, 129.9, 
129.2, 126.9, 55.6, 55.5, 54.5, 21.3; HRMS (ESI, m/z): calcd for C10H15O2N2
+
, [M + H
+
], 
195.1128, found 195.1122. 
The relative stereochemistry of both diastereomers was determined by comparing the 
1
H 
NMR spectra of diamines S18 with the ones obtained from the literature.
76,77,78
 The free diamines 
were obtained by dissolving the diammonium salts in 2 N NaOH solution and extraction with 
CH2Cl2 for three times.  
  
     
1
H NMR 
 
1
H NMR (400 
MHz, CDCl3): δ 
7.37–7.24 (m, 5H), 
4.27 (d, J = 5.8 
Hz, 1H), 3.72 (d, J 
= 5.8 Hz, 1H), 
3.70 (s, 3H), 1.83 
(brs, 4H). 
1
H NMR (200 
MHz, CDCl3): δ 
7.40–7.20 (m, 5H), 
4.24 (d, J = 5.9, 
1H), 3.70 (d, J = 
5.9, 1H), 3.68 (s, 
3H), 1.95 (brs, 
4H). 
1
H NMR (400 
MHz, CDCl3): δ 
7.40–7.23 (m, 5H), 
4.30 (d, J = 4.5 
Hz, 1H), 3.67 (s, 
3H), 3.65 (d, J = 
4.5 Hz, 1H), 1.65 
(brs, 4H). 
1
H NMR (500 
MHz, CDCl3): δ 
7.38–7.25 (m, 5H), 
4.30 (d, J = 4.5 
Hz, 1H), 3.67 (s, 
3H), 3.65 (d, J = 
4.8 Hz, 1H). 
 
198 
1-Vinyl-2-pyrrolidinone is commercially available and was distilled before usage. 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added 
Fe(OTf)2 (5.3 mg, 0.015 mmol) and L2 (4.1 mg, 0.015 mmol). After the vial was evacuated and 
backfilled with N2 three times, anhydrous CH2Cl2 (0.8 mL) and MeCN (0.2 mL) were added via 
a syringe and the mixture was stirred at room temperature for 10 min. To another flame-dried 3-
dram vial (vial B) equipped with a stir bar was added 2b (158.4mg, 0.60 mmol). This vial was 
evacuated and backfilled with N2 three times and anhydrous CH2Cl2 (4.0 mL) was added. Both 
vials were degassed with brief evacuation and backfilled with N2 twice. Freshly distilled1-vinyl-
2-pyrrolidinone (53.4 μL, 0.5 mmol), TMSN3 (263 L, 2.0 mmol) were added successively to 
vial B and followed by drop-wise addition of the catalyst solution in vial A at room temperature.  
The reaction was kept at room temperature for 3 h and then quenched with a saturated NaHCO3 
solution (0.1 mL) and further diluted with hexanes (5 mL). The mixture was stirred vigorously 
for additional 10 min and filtered through a short silica gel pad. The filtrate was concentrated in 
vacuo. The residue was subsequently purified through a silica gel flash column (hexanes/EtOAc: 
from 20:1 to 5:1) as a colorless oil.  
 
1-(1,2-Diazidoethyl)pyrrolidin-2-one (3m): The titled compound was isolated through a 
silica gel flash column (hexanes/acetone: from 20:1 to 4:1) as a colorless oil (78.1 mg, 80% 
199 
yield).  IR νmax (neat)/cm
-1
: 2932 (m), 2107 (s), 1698 (s); 
1
H NMR (400 MHz, CDCl3): δ 5.81 (t, 
J = 6.6 Hz, 1H), 3.51 (dt, J = 9.2, 7.4 Hz, 1H), 3.46 – 3.31 (m, 3H), 2.47 (td, J = 8.1, 1.6 Hz, 
2H), 2.17 – 2.05 (m, 2H); 13C NMR (101 MHz, CDCl3): δ 176.2, 67.0, 51.4, 42.6, 30.8, 18.4. 
HRMS (ESI, m/z): calcd for C6H9Cl3N7ONa
+
, [M + Na
+
], 218.0761, found 218.0757. 
 
1-(1,2-Diaminoethyl)pyrrolidin-2-one (4m): To a flame-dried sealable 2-dram vial 
equipped with a stir bar was added diazidation product 3m (84.1 mg, 0.3 mmol). After the vial 
was evacuated and backfilled with N2 three times, THF (6 mL) and H2O (27 µL, 1.5 mmol) were 
added via syringes. The solution was cooled to 0 °C under stirring.  PMe3 (0.66 mL, 1M solution 
in THF) was added dropwise through a syringe. The reaction was then warmed up to room 
temperature for 15 min and further warmed up to 50 °C for additional 10 h (the reaction was 
monitored by IR until the absorption of azido groups disappeared). The whole mixture was 
concentrated in vacuo and the residue was then dissolved in Et2O (5 mL). This solution was 
added drop-wise to another solution of TsOH∙H2O (142.7 mg, 0.75 mmol) in Et2O (3 mL). The 
reaction was kept stirring for 30 min and the white precipitate was collected by filtration, washed 
with Et2O (5 mL × 3) and dried in vacuo. 4m was obtained as a white solid (105.3 mg, 72% 
yield, m.p. 145–146 ˚C).  IR νmax (neat)/cm
-1
: 3020 (s), 2921 (s), 1743 (w), 1699 (s), 1496 (w), 
1173 (s), 1123 (s), 1035 (s), 1010 (s), 812 (m), 680 (s); 
1
H NMR (400 MHz, DMSO-d6): δ 8.29 
(br, 6H), 7.52 (d, J = 7.9 Hz, 4H), 7.15 (d, J = 7.8 Hz, 4H), 5.35 (dd, J = 10.5, 3.0 Hz, 1H), 3.40 
– 3.30 (m, 3H), 3.22 – 3.11 (m, 1H), 2.38-2.18 (m, 8H), 2.09 – 1.73 (m, 2H); 13C NMR (100 
MHz, DMSO-d6): δ 176.3, 144.9, 138.3, 128.4, 125.6, 55.9, 41.8, 37.5, 30.4, 20.9, 17.4; HRMS 
(ESI, m/z): calcd for C6H14N3O
+
, [M + H
+
], 144.1131, found 144.1125. 
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 Geranyl acetate S19 was prepared according to a literature procedure.
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To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(OTf)2 (8.9 
mg, 0.025 mmol) and L2 (6.8 mg, 0.025 mmol). After the vial was evacuated and backfilled with 
N2 three times, anhydrous CH2Cl2 (0.8 mL) and MeCN (0.2 mL) were added via a syringe and 
the mixture was stirred at room temperature for 10 min. To another flame-dried 3-dram vial (vial 
B) equipped with a stirring bar was added 2b (158.4 mg, 0.60 mmol) and compound S19 (98.0 
mg, 0.5 mmol). This vial was evacuated and backfilled with N2 three times and anhydrous 
CH2Cl2 (4.0 mL) was added. Both vials were degassed with brief evacuation and backfilled with 
N2 twice. TMSN3 (263 µL, 2.0 mmol) was added successively to vial B and followed by drop-
wise addition of the catalyst solution in vial A at 0 °C. The reaction was kept at 0 °C for 10 h and 
then quenched with a saturated NaHCO3 solution (0.1 mL) and further diluted with hexanes (5 
mL). The mixture was stirred vigorously for additional 10 min and filtered through a short silica 
gel pad. The filtrate was concentrated in vacuo. The residue was subsequently purified through a 
silica gel flash column (hexanes/Et2O: from 20:1 to 5:1) as  a colorless oil (112.1 mg, 80% 
yield). 
 
(E)-6,7-Diazido-3,7-dimethyloct-2-en-1-yl acetate (3n): IR νmax (neat)/cm
-1
: 2971 (m), 
2099 (s), 1740 (m), 1458 (w), 1368 (w), 1259 (s), 1140 (w), 1037 (w); 
1
H NMR (400 MHz, 
201 
CDCl3): δ 5.40 (t, J = 7.0 Hz, 1H), 4.59 (d, J = 7.0 Hz, 2H), 3.04 (dd, J = 11.1, 2.0 Hz, 1H), 
2.37–2.21 (m, 1H), 2.18–2.08 (m, 1H), 2.04 (s, 3H), 1.83–1.73 (m, 1H), 1.71 (s, 3H), 1.56–1.41 
(m, 1H), 1.32 (s, 3H), 1.28 (s, 3H); 
13
C NMR (100 MHz, CDCl3): δ 171.1, 140.4, 120.1, 70.1, 
64.7, 61.3, 36.8, 27.5, 23.0, 22.9, 21.1, 16.4.  
 
(E)-6,7-diamino-3,7-dimethyloct-2-en-1-yl acetate (S20). To a flame-dried sealable 2-
dram vial equipped with a stir bar was added diazidation product 3n (84.1 mg, 0.3 mmol). After 
the vial was evacuated and backfilled with N2 three times, THF (6 mL) and H2O (27 µL, 1.5 
mmol) were added via syringes. The solution was cooled to 0 °C under stirring. PMe3 (0.66 mL, 
1M solution in THF) was added dropwise through a syringe. The reaction was then warmed up 
to room temperature for 15 min and further warmed up to 50 °C for additional 10 h (the reaction 
was monitored by IR until the absorption of azido groups disappeared). The whole mixture was 
concentrated in vacuo and diamine S20 was isolated through a silica gel flash column 
(CH2Cl2/MeOH = 10:1) as a colorless oil (63.0mg, 92% yield). IR νmax (neat)/cm
-1
: 2964 (brs), 
1734 (s), 1568 (m), 1446 (m), 1366 (m), 1223 (s), 1022 (m); 
1
H NMR (400 MHz, CDCl3): δ 5.36 
(t, J = 7.1 Hz, 1H), 4.57 (d, J = 7.1 Hz, 2H), 2.34 (dd, J = 10.7, 1.9 Hz, 1H), 2.32–2.21 (m, 1H), 
2.09–1.98 (m, 4H), 1.78–1.65 (m, 4H), 1.35 (brs, 4H), 1.20–1.09 (m, 1H), 1.07 (s, 3H), 1.02 (s, 
3H); 
13
C NMR (100 MHz, CDCl3): δ 171.1, 142.2, 118.6, 61.3, 60.3, 52.5, 37.5, 30.2, 28.2, 25.5, 
21.1, 16.5; HRMS (ESI, m/z): calcd for C12H25N2O2
+
, [M + H
+
], 229.1911, found 229.1914. 
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4.2.3 Procedures for the Diazidation of Acetyl Quinine and Glycals 
 
Scheme 66. Procedures for the Diazidation of Acetyl Quinine 
Acetyl quinine 5 was prepared according to a literature procedure.
80
  
To a flame-dried sealable 2-dram vial (vial A) equipped with a stirring bar were added 
Fe(OTf)2 (17.7 mg, 0.05 mmol) and L2 (13.7 mg, 0.05 mmol). After the vial was evacuated and 
backfilled with N2 three times, anhydrous CH2Cl2 (0.75 mL) and MeCN (0.25 mL) were added 
via a syringe and the mixture was stirred at room temperature for 10 min. To another flame-dried 
3-dram vial (vial B) equipped with a stirring bar were added 2b (198.0 mg, 0.75 mmol) and 5 
(183.3 mg, 0.5 mmol). This vial was evacuated and backfilled with N2 three times and anhydrous 
CH2Cl2 (1.5 mL) was added. Both vials were degassed with brief evacuation and backfilled with 
N2 twice. TMSN3 (395 μl, 3.0 mmol) was added to vial B and followed by drop-wise addition of 
the catalyst solution in vial A at room temperature. The reaction was kept at room temperature 
for 2 h and then quenched with saturated NaHCO3 solution (0.1 mL), and further diluted with 
hexanes (5 mL). The mixture was stirred vigorously for 10 min and filtered through a short silica 
gel pad.  The filtrate was concentrated in vacuo. The residue was subsequently purified through a 
silica gel flash column (CH2Cl2/MeOH: from 50:1 to 20:1) as white foam (184.7 mg, 82% yield, 
dr = 3:1).  
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(R)-((1S,2S,4S,5R)-5-((R)-1,2-diazidoethyl)quinuclidin-2-yl)(6-methoxyquinolin-4-
yl)methyl acetate (6a): IR νmax (neat)/cm
-1
: 3364 (w), 2928 (m), 2871 (w), 2102 (s), 1744 (s), 
1622 (m), 1508 (m), 1229 (s), 1030 (m); 
1
H NMR (400 MHz, CDCl3): δ 8.75 (d, J = 4.5 Hz, 1H), 
8.02 (d, J = 9.0 Hz, 1H), 7.44–7.36 (m, 2H), 7.34 (d, J = 4.5 Hz, 1H), 6.49 (d, J = 7.1 Hz, 1H), 
3.96 (s, 3H), 3.57 (dd, J = 15.6, 6.4 Hz, 1H), 3.44–3.31 (m, 3H), 3.15–3.06 (m, 1H), 3.02 (dd, J 
= 14.1, 9.9 Hz, 1H), 2.72–2.58 (m, 2H), 2.13 (s, 3H), 1.82 (s, 1H), 1.78–1.64 (m, 3H), 1.63–1.44 
(m, 2H); 
13
C NMR (100 MHz, CDCl3): δ 170.3, 158.4, 147.8, 145.2, 143.6, 132.3, 127.3, 122.1, 
119.1, 101.7, 73.9, 65.8, 59.3, 56.0, 55.2, 54.4, 42.6, 37.4, 28.4, 24.6, 24.5, 21.4. 
 
(R)-((1S,2S,4S,5R)-5-((S)-1,2-diazidoethyl)quinuclidin-2-yl)(6-methoxyquinolin-4-
yl)methyl acetate (6b): IR νmax (neat)/cm
-1
: 3364 (w), 2929 (m), 2103 (s), 1744 (s), 1620 (m), 
1508 (m), 1230 (s), 1029 (m); 
1
H NMR (400 MHz, CDCl3): δ 8.75 (d, J = 4.5 Hz, 1H), 8.03 (d, J 
= 9.1 Hz, 1H), 7.42 (d, J = 2.5 Hz, 1H), 7.38 (dd, J = 9.1, 2.6 Hz, 1H), 7.34 (d, J = 4.5 Hz, 1H), 
6.48 (d, J = 7.2 Hz, 1H), 3.96 (s, 3H), 3.50–3.39 (m, 1H), 3.35–3.19 (m, 3H), 3.14–3.04 (m, 1H), 
2.99 (dd, J = 13.8, 10.0 Hz, 1H), 2.68–2.55 (m, 1H), 2.29 (dd, J = 13.6, 3.3 Hz, 1H), 2.14 (s, 
3H), 2.15–2.09 (m, 1H), 1.85–1.72 (m, 2H), 1.69–1.59 (m, 2H), 1.56–1.45 (m, 1H); 13C NMR 
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(100 MHz, CDCl3): δ 170.4, 158.3, 147.8, 145.2, 143.7, 132.3, 127.3, 122.0, 119.2, 101.9, 73.9, 
65.3, 59.9, 56.0, 55.1, 53.7, 42.6, 37.7, 28.0, 24.5, 23.8, 21.4. 
 
Scheme 67. Reduction of Acetyl Quinine 
To a flame-dried sealable 2-dram vial equipped with a stir bar was added diazidation 
product 6 (135.2 mg, 0.3 mmol, dr = 3:1). After the vial was evacuated and backfilled with N2 
three times, THF (6 mL) and H2O (27 µL, 1.5 mmol) were added via syringes. The solution was 
cooled to 0 °C under stirring. PMe3 (0.75 mL, 1M solution in THF) was added drop-wise via a 
syringe. The reaction was then warmed up to room temperature and kept stirring for additional 4 
h (the reaction was monitored by IR until the absorption of azido groups disappeared). The 
whole mixture was then concentrated and dried in vacuo. The crude product was dissolved in 
anhydrous CH2Cl2 (3 mL) under N2. This solution was cooled to 0 °C and Et3N (125 L, 0.9 
mmol) was then added followed by drop-wise addition of Ac2O (71 L, 0.75 mmol). The 
reaction was gradually warmed up to room temperature, stirred for 4 h and quenched with a 
saturated NaHCO3 solution (2 mL). After the organic layer was separated, the aqueous phase was 
extracted with CH2Cl2 (5 mL × 4). The combined organic layers were dried over anhydrous 
Na2SO4 and concentrated in vacuo. The residue was then purified through a silica gel flash 
column (from CH2Cl2/MeOH 10:1 to CH2Cl2/MeOH (buffered with 5% NH4OH aq.) 2:1) to 
afford the protected product S21 as a viscous oil (88.3 mg, 61% yield, dr = 3:1). IR νmax 
(neat)/cm
-1
: 3270(w), 2937 (m), 1742 (m), 1652 (s) 1228 (s), 1027 (m), 912 (m); 
1
H NMR (400 
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MHz, CDCl3): δ 8.73 (d, J = 4.6 Hz, 1H), 8.00 (d, J = 9.2 Hz, 1H, minor), 7.99 (d, J = 9.2 Hz, 
1H), 7.44 (d, J = 2.7 Hz, 1H, minor), 7.43 (d, J = 2.6 Hz, 1H), 7.39–7.32 (m, 2H), 6.48 (d, J = 
8.0 Hz, 1H), 6.44 (d, J = 7.7 Hz, 1H, minor), 6.18–6.09 (m, 1H), 5.96 (d, J = 9.0 Hz, 1H, minor), 
5.78 (d, J = 9.0 Hz, 1H), 4.05 (ddd, J = 13.0, 9.7, 3.8 Hz, 1H), 3.96 (s, 3H), 3.94–3.88 (m, 1H, 
minor), 3.47 (q, J = 8.1 Hz, 1H), 3.34 (ddd, J = 14.1, 9.7, 7.1 Hz, 1H), 3.24 (dt, J = 13.8, 3.8 Hz, 
1H), 3.13–3.00 (m, 1H), 2.85 (dd, J = 13.9, 9.8 Hz, 1H), 2.62–2.47 (m, 2H), 2.36 (dd, J = 13.7, 
4.1 Hz, 1H, minor), 2.10 (s, 3H), 1.95 (s, 3H), 1.94 (s, 3H), 1.92–1.82 (m, 2H), 1.78–1.68 (m, 
1H), 1.58–1.37 (m, 3H); 13C NMR (100 MHz, CDCl3): δ 171.7, 171.4 (minor), 171.2, 170.8 
(minor), 170.19, 170.17 (minor), 158.0, 157.95 (minor), 147.42, 147.39 (minor), 144.72 (minor), 
144.66, 143.6 (minor), 143.5, 131.7 (minor), 131.6, 127.3, 127.1 (minor), 121.9, 121.8 (minor), 
119.1, 101.7 (minor), 101.5, 73.6 (minor), 73.3, 59.5 (minor), 58.6, 55.7 (minor), 55.65, 54.5, 
52.6, 52.5 (minor), 43.8, 42.9 (minor), 42.2, 42.1 (minor), 38.4 (minor), 38.3, 28.0 (minor), 27.9, 
24.6, 24.5 (minor), 23.9, 23.4 (minor), 23.3 (minor), 23.2, 23.14, 23.10 (minor), 21.1; HRMS 
(ESI, m/z): calcd for C26H35N4O5
+
, [M + H
+
], 483.2602, found 483.2586. 
 
Scheme 68. Procedures for the Diazidation of Glycals 
Glycal 7 was prepared according to a literature procedure.
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To a flame-dried sealable 3-dram vial equipped with a stir bar were added Fe(NTf2)2 
(153.7 mg, 0.25 mmol) and L2 (68.3 mg, 0.25 mmol). After the vial was evacuated and 
backfilled with N2 three times, anhydrous CH2Cl2 (4 mL) and MeCN (1 mL) were added via a 
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syringe and the mixture was stirred at room temperature for 10 min. To a flame-dried round-
bottom flask (100 mL) equipped with a stirring bar were added 2b (1.72 mg, 6.5 mmol) and 
compound 7 (1.50 g, 5 mmol). The flask was evacuated and backfilled with N2 three times and 
anhydrous CH2Cl2 (45 mL) was added. Both the vial and the flask were degassed with brief 
evacuation and backfilled with N2 twice. After the flask was cooled to 0 °C, TMSN3 (3.95 ml, 30 
mmol) was added into it and followed by drop-wise addition of the catalyst solution in the vial.  
The reaction was kept at 0 °C for 5 h and then quenched with saturated NaHCO3 solution (1 
mL).  The mixture was transferred to an Erlenmeyer flask (200 mL) and diluted with hexanes 
(100 mL).  The mixture was stirred vigorously for 10 min and filtered through a short silica gel 
pad. The filtrate was concentrated in vacuo and the residue was subsequently purified through a 
silica gel flash column (hexanes/Et2O: from 60:1 to 25:1). Three diastereomers were isolated as 
colorless oil (288 mg, 15% yield for S22, 385 mg, 20% yield for 8a and 615 mg, 32% yield for 
8b). 
 
tert-Butyl(((4aR,6S,7S,8R,8aR)-6,7-diazido-2,2-dimethylhexahydropyrano[3,2-
d][1,3]dioxin -8-yl)oxy)dimethylsilane (S22): IR νmax (neat)/cm
-1
: 2927 (w), 2856 (w), 2105 (s), 
1473 (s), 1374 (w), 1247 (m), 1122 (m), 1096 (s); 
1
H NMR (400 MHz, CDCl3): δ 5.26 (d, J = 1.4 
Hz, 1H), 4.04 (dd, J = 9.4, 3.8 Hz, 1H), 3.89 (t, J = 9.4 Hz, 1H), 3.86 (dd, J = 10.4, 5.1 Hz, 1H), 
3.79 (t, J = 10.2 Hz, 1H), 3.75–3.69 (m, 1H), 3.68 (dd, J = 3.7, 1.4 Hz, 1H), 1.51 (s, 3H), 1.40 (s, 
3H), 0.90 (s, 9H), 0.11 (s, 3H), 0.10 (s, 3H); 
13
C NMR (100 MHz, CDCl3): δ 99.9, 89.2, 71.1, 
70.3, 67.0, 64.5, 61.9, 29.1, 25.7, 19.2, 18.3, -4.4, -4.9.  
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N,N'-((4aR,6R,7S,8R,8aR)-8-((tert-Butyldimethylsilyl)oxy)-2,2-
dimethylhexahydropyrano [3,2-d][1,3]dioxine-6,7-diyl)diacetamide (S23): To a 3-dram vial 
equipped with a stir bar was added Pd/C (3.4 mg, 10 wt%). After the vial was evacuated and 
backfilled twice with N2, a solution of diazidation product S22 (76.9 mg, 0.2 mmol, dissolved in 
3 mL MeOH) was added to the vial. The mixture was degassed by brief evacuation and 
backfilled twice with N2 and then three times with H2. The reaction was vigorously stirred under 
H2 at room temperature until the reduction completed (the reaction was monitored by IR until the 
absorption of azido groups disappeared). The solution was filtered through Celite, washed with 
MeOH (3 mL). The filtrate was concentrated in vacuo and the residue was re-dissolved in 
CH2Cl2 (3 mL). This solution was cooled to 0 °C and Et3N (68 L, 0.5 mmol) was then added 
followed by drop-wise addition of Ac2O (46 L, 0.48 mmol). The reaction was gradually 
warmed up to room temperature, stirred for 4 h and quenched with saturated NaHCO3 solution (1 
mL). After the organic layer was separated, the aqueous phase was extracted with CH2Cl2 (5 mL 
× 3). The combined organic layers were dried over anhydrous Na2SO4 and concentrated in 
vacuo. The residue was purified through a silica gel flash column (hexanes/acetone from 4:1 to 
2:1) to afford S23 as colorless oil (63.3 mg, 76% yield). IR νmax (neat)/cm
-1
: 3281 (w), 2932 (w), 
1661 (s), 1540 (m), 1371 (m), 1257 (m), 1090 (s); 
1
H NMR (400 MHz, CDCl3): δ 7.42 (d, J = 
7.7 Hz, 1H), 5.73 (d, J = 6.6 Hz, 1H), 5.21 (dd, J = 7.7, 1.4 Hz, 1H), 4.24 (t, J = 6.0 Hz, 1H), 
3.96 (dd, J = 10.7, 5.0 Hz, 1H), 3.89 (dd, J = 9.1, 5.1 Hz, 1H), 3.70 (t, J = 10.5, 1H), 3.45 (t, J = 
9.4 Hz, 1H), 3.42–3.35 (m, 1H), 2.14 (s, 3H), 2.00 (s, 3H), 1.48 (s, 3H), 1.40 (s, 3H), 0.86 (s, 
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9H), 0.08 (s, 3H), 0.07 (s, 3H); 
13
C NMR (100 MHz, CDCl3): δ 173.3, 170.4, 99.9, 79.1, 72.0, 
70.5, 70.0, 62.0, 55.1, 29.0, 25.5, 23.6, 23.4, 19.3, 18.1, -4.6, -5.2; HRMS (ESI, m/z): calcd for 
C19H37N2O6Si
+
, [M + H
+
], 417.2415, found 417.2425. 
 
The stereochemistry of S23 was determined through NOE analysis. Strong NOEs were 
observed between H(a) and H(c), and H(a) and H(e). Additionally, a significant NOE was 
observed between H(d) and H(2).   
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tert-Butyl(((4aR,6R,7R,8R,8aR)-6,7-diazido-2,2-dimethylhexahydropyrano[3,2-
d][1,3]dioxin -8-yl)oxy)dimethylsilane (8a): IR νmax (neat)/cm
-1
: 2108 (s), 1371 (w), 1248 (m), 
1094 (s); 
1
H NMR (400 MHz, C6D6): δ 3.87 (d, J = 9.1 Hz, 1H), 3.63 (dd, J = 10.7, 5.3 Hz, 1H), 
3.40 (t, J = 10.5 Hz, 1H), 3.24 (t, J = 8.9 Hz, 1H), 3.15 (t, J = 9.2 Hz, 1H), 2.86 (t, J = 9.0 Hz, 
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1H), 2.73 (td, J = 9.9, 5.3 Hz, 1H), 1.34 (s, 3H), 1.13 (s, 3H), 1.03 (s, 9H), 0.21 (s, 3H), 0.15 (s, 
3H); 
13
C NMR (100 MHz, C6D6): δ 99.2, 89.2, 73.7, 73.3, 69.1, 68.2, 61.4, 28.7, 25.6, 18.4, 18.1, 
-4.5, -5.1. 
 
The stereochemistry of 8a was determined through NOE analysis. Strong NOEs were 
observed between H(a) and H(c), and H(a) and H(e). Additionally, a significant NOE was 
observed between H(b) and H(d). 
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tert-Butyl(((4aR,6S,7R,8R,8aR)-6,7-diazido-2,2-dimethylhexahydropyrano[3,2-
d][1,3]dioxin -8-yl)oxy)dimethylsilane (8b): IR νmax (neat)/cm
-1
: 2106 (s), 1249 (m), 1130 (s), 
1097 (s); 
1
H NMR (400 MHz, C6D6): δ 4.54 (d, J = 4.3 Hz, 1H), 3.80 (t, J = 9.1 Hz, 1H), 3.69–
3.58 (m, 2H), 3.47–3.36 (m, 1H), 3.21–3.11 (m, 1H), 2.76 (dd, J = 9.5, 4.3 Hz, 1H), 1.37 (s, 3H), 
1.18 (s, 3H), 1.03 (s, 9H), 0.22 (s, 3H), 0.15 (s, 3H); 
13
C NMR (100 MHz, C6D6): δ 99.6, 88.9, 
74.2, 70.6, 65.7, 64.8, 61.8, 28.8, 25.6, 18.5, 18.1, -4.3, -5.6. 
 
The stereochemistry of 8b was determined through NOE analysis. No NOE was observed 
between H(a) and H(c), and H(a) and H(e). However, a significant NOE was observed between 
H(b) and H(d). 
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(4aR,6R,7R,8R,8aR)-7-Azido-8-((tert-butyldimethylsilyl)oxy)-2,2-
dimethylhexahydropyrano [3,2-d][1,3]dioxin-6-amine (S24). To a flame-dried sealable 2-
dram vial equipped with a stir bar was added a mixture of 8b and 8a (153.8 mg, 0.4 mmol, dr = 
1.5:1). The vial was evacuated and backfilled with N2 three times and THF (4 mL) was added 
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through a syringe. After the solution was cooled to -60 °C under stirring, PMe3 (0.42 mL, 1M 
solution in THF) was added drop-wise through a syringe and the reaction was kept at -60 °C for 
4 h and warmed up gradually to room temperature.  Subsequently, water (144 uL) was added, the 
reaction mixture was further warmed up to 40 °C and stirred for additional 5 h. The whole 
mixture was concentrated in vacuo and S24 was isolated through a silica gel flash column 
(hexanes/EtOAc: from 10:1 to 2:1) as colorless oil (109 mg, 76% yield, dr > 20:1). IR νmax 
(neat)/cm
-1
: 2106 (s), 1370 w), 1264 (m), 1128 (m), 1090 (s); 
1
H NMR (400 MHz, CDCl3): δ 
4.04 (d, J = 8.7 Hz, 1H), 3.87 (dd, J = 10.7, 5.4 Hz, 1H), 3.68 (t, J = 10.5 Hz, 1H), 3.51–3.41 (m, 
2H), 3.24–3.13 (m, 1H), 3.03–2.93 (m, 1H), 1.99 (s, 2H), 1.46 (s, 3H), 1.39 (s, 3H), 0.91 (s, 9H), 
0.13 (s, 3H), 0.09 (s, 3H); 
13
C NMR (100 MHz, CDCl3): δ 99.4, 85.9, 74.3, 74.1, 70.5, 68.4, 
62.2, 29.0, 25.8, 18.9, 18.3, -4.3, -4.9; HRMS (ESI, m/z): calcd for C15H31N4O4Si
+
, [M + H
+
], 
359.2109, found 359.2116. 
 
The stereochemistry of S24 was determined through NOE analysis. Strong NOEs were 
observed between H(a) and H(c), and H(a) and H(e).   
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Boc-Asp(OBz)-Phe-OEt (S27): To a stirred solution of L-aspartic acid β-benzyl ester 
S25 (647 mg, 2.0 mmol) and L-phenylalanine ethyl ester hydrochloride S26 (466 mg, 2.6 mmol) 
in DCM were added 1-hydroxybenzotriazole hydrate (HOBt) (505 mg, 2.8 mmol) and 1-ethyl-3-
(3-(dimethylamino)propyl)carbodiimide hydrochloride (EDC) (498 mg, 2.6 mmol) at 0
 
°C. The 
mixture was stirred at room temperature for 18 h. After the solvent was removed in vacuo, the 
residue was dissolved in EtOAc and washed successively with 5% citric acid, 5% sodium 
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bicarbonate and brine (5 mL each). The combined organic layers were dried over Na2SO4 and 
concentrated in vacuo. The residue was purified through a silica gel flash column (hexane/EtOAc 
= 4:1) to give amide S27 as colorless oil (748 mg, 75% yield). IR νmax (neat)/cm
-1
: 3335 (w), 
2979 (w), 1734 (s), 1674 (s), 1497 (s), 1367 (m); 
1
H NMR (400 MHz, CDCl3): δ 7.38–7.32 (m, 
5H), 7.31–7.27 (m, 2H), 7.26–7.21 (m, 1H), 7.18–7.12 (m, 2H), 6.95 (d, J = 6.8 Hz, 1H), 5.64 (d, 
J = 8.0 Hz, 1H), 5.21–5.05 (m, 2H), 4.78 (dd, J = 13.5, 6.0 Hz, 1H), 4.54 (s, 1H), 4.13 (q, J = 7.1 
Hz, 2H), 3.09 (d, J = 5.9 Hz, 2H), 3.05 (dd, J =17.2, 2.7 Hz, 1H), 2.71 (dd, J = 17.2, 6.0 Hz, 1H), 
1.42 (s, 9H), 1.20 (t, J = 7.1 Hz, 3H); 
13
C NMR (100 MHz, CDCl3): δ 171.8, 170.9, 170.3, 155.4, 
135.8, 135.4, 129.4, 128.6, 128.5, 128.4, 128.3, 127.1, 80.5, 66.9, 61.5, 53.5, 50.5, 37.9, 36.1, 
28.3, 14.1; HRMS (ESI, m/z): calcd for C27H35N2O7
+
, [M + H
+
], 499.2439, found 499.2449. 
 
Boc-Asp-Phe-OEt (S28): To a round bottom flask equipped with a stirring bar was 
added Pd/C (50 mg, 10 wt%). After the flask was evacuated and backfilled twice with N2, a 
solution of dipeptide S27 (499 mg, 1.0 mmol, dissolved in 10 mL methanol) and MeOH (10 mL) 
was added. The mixture was degassed by brief evacuation and backfilled twice with N2 and then 
three times with H2. The reaction was then vigorously stirred under H2 at room temperature for 2 
h (the reaction was monitored by TLC until S27 was fully consumed). The reaction mixture was 
filtered through Celite.  The filtrate was concentrated in vacuo, dissolved in minimum amount of 
EtOH (ca. 0.5 mL), and then diluted with Et2O (10 ml). The resulting white precipitate was 
collected by filtration and washed with Et2O (5 ml × 3) to give acid S28 as a white solid (372 
mg, 91% yield, m.p. 128–129 °C). IR νmax (neat)/cm
-1
: 3316 (w), 2977 (m), 1711 (s) 1664 (s), 
1517 (m), 1497 (m), 1368 (m), 1161 (s); 
1
H NMR (400 MHz, CDCl3) δ 8.39 (brs, 1H), 7.34–7.18 
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(m, 3H), 7.13 (d, J = 6.7 Hz, 2H), 7.02 (s, 1H), 5.62 (s, 1H), 4.78 (dd, J = 13.5, 6.1 Hz, 1H), 4.49 
(s, 1H), 4.12 (q, J = 7.1 Hz, 2H), 3.08 (d, J = 5.8 Hz, 2H), 2.95 (dd, J = 16.8, 4.6 Hz, 1H), 2.71 
(dd, J = 16.8, 5.9 Hz, 1H), 1.42 (s, 9H), 1.19 (t, J = 7.1 Hz, 3H); 
13
C NMR (100 MHz, CDCl3): δ 
175.4, 171.1, 170.8, 155.6, 135.8, 129.4, 128.5, 127.1, 80.7, 61.6, 53.6, 50.4, 37.8, 36.0, 28.2, 
14.0; HRMS (ESI, m/z): calcd for C20H29N2O7
+
, [M + H
+
], 409.1969, found 409.1979. 
 
Ethyl N
4
-((4aR,6R,7R,8R,8aR)-7-azido-8-((tert-butyldimethylsilyl)oxy)-2,2-
dimethylhexahy-dropyrano[3,2-d][1,3]dioxin-6-yl)-N
2
-(tert-butoxycarbonyl)-L-asparaginyl-
L-phenylalaninate (9). To a flame-dried sealable 2-dram vial charged with a stir bar was added 
dipeptide S28 (102.1 mg, 0.25 mmol).  After the vial was evacuated and backfilled with N2 three 
times, anhydrous DMF (2 mL) was added via a syringe. HATU and DIPEA were added to the 
reaction successively at 0 °C and it was stirred for 10 min before a DMF solution of amine S24 
(71.7 mg, 0.2 mmol, 1 mL) was added. The reaction was then warmed up to room temperature 
and stirred for 16 h. After quenching with saturated NaHCO3 solution (2 mL), the mixture was 
further diluted with water (20 mL) and extracted with EtOAc (10 mL × 4). The combined 
organic layers were concentrated in vacuo and subsequently purified through a silica gel flash 
column (hexanes/EtOAC: from 10:1 to 1:1). 9 was isolated as white foam (128.8 mg, 86% 
yield).  IR νmax (neat)/cm
-1
: 3311 (w), 3260 (w), 3068 (w), 2110 (s), 1739 (m), 1653 (s), 1545 (s);  
1
H NMR (400 MHz, CDCl3): δ 7.54 (d, J = 7.8 Hz, 1H), 7.35–7.21 (m, 3H), 7.20–7.10 (m, 3H), 
6.01 (d, J = 6.8 Hz, 1H), 5.00 (t, J = 9.4 Hz, 1H), 4.74 (dd, J = 13.5, 6.0 Hz, 1H), 4.50 (d, J = 5.7 
Hz, 1H), 4.12 (q, J = 7.1 Hz, 2H), 3.86 (dd, J = 10.7, 5.3 Hz, 1H), 3.65 (t, J = 10.5 Hz, 1H), 3.56 
(t, J = 8.9 Hz, 1H), 3.45 (t, J = 9.2 Hz, 1H), 3.34–3.20 (m, 2H), 3.16–3.02 (m, 2H), 2.85 (dd, J = 
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15.2, 3.0 Hz, 1H), 2.64 (dd, J = 15.4, 5.7 Hz, 1H), 1.43 (s, 3H), 1.41 (s, 9H), 1.38 (s, 3H), 1.18 (t, 
J = 7.1 Hz, 3H), 0.90 (s, 9H), 0.13 (s, 3H), 0.09 (s, 3H); 
13
C NMR (100 MHz, CDCl3): δ 171.3, 
171.2, 171.0, 155.8, 135.7, 129.4, 128.6, 127.1, 99.5, 80.5, 78.8, 74.6, 73.7, 69.3, 67.7, 61.9, 
61.5, 53.7, 51.2, 37.8, 37.6, 28.9, 28.3, 25.7, 18.9, 18.2, 14.1, -4.3, -4.9; HRMS (ESI, m/z): calcd 
for C35H57N6O10Si
+
, [M + H
+
], 749.3900, found 749.3915. 
4.2.4 Mechanistic Investigation of the Iron-Catalyzed Olefin Diazidation 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added 
Fe(OTf2)2 (3.5 mg, 0.01 mmol) and L3 (5.2 mg, 0.01 mmol). After the vial was evacuated and 
backfilled with N2 three times, anhydrous CH2Cl2 (0.4 mL) and MeCN (0.1 mL) were added via 
a syringe and the mixture was stirred at room temperature for 10 min. To another flame-dried 3-
dram vial (vial B) equipped with a stirring bar was added 2a (69.4 mg, 0.24 mmol). This vial was 
evacuated and backfilled with N2 three times and anhydrous CH2Cl2 (1.5 mL) was added. Both 
vials were degassed with brief evacuation and backfilled with N2 twice. cis-Stilbene 10a (36 µL, 
0.2 mmol) was added via a syringe to vial B and followed by drop-wise addition of the catalyst 
solution in vial A, the reaction was kept at room temperature for 2 h and then quenched with 
saturated NaHCO3 solution (0.1 mL), and further diluted with hexanes (3 mL). The mixture was 
stirred vigorously for 10 min and filtered through a short silica gel pad. The filtrate was 
concentrated in vacuo and the crude product was analyzed by 
1
H NMR with trimethoxybenzene 
as an internal standard. cis-Stilbene was almost fully recovered (>95% NMR yield). 
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To a flame-dried sealable 3-dram vial equipped with a stir bar was added 2a (69.4 mg, 
0.24 mmol). After this vial was evacuated and backfilled with N2 three times, anhydrous CH2Cl2 
(1.9 mL) and MeCN (0.1) were added. cis-Stilbene 10a (36 µL, 0.2 mmol) and TMSN3 (40 μl, 
0.3 mmol) were then added into the reaction successively via syringes at room temperature. The 
reaction was kept stirring at room temperature for 2 h and then quenched with a saturated 
NaHCO3 solution (0.1 mL), and further diluted with hexanes (3 mL). The mixture was stirred 
vigorously for 10 min and filtered through a short silica gel pad. The filtrate was concentrated in 
vacuo and the crude product was analyzed by 
1
H NMR with trimethoxybenzene as an internal 
standard.  cis-Stilbene 10a was fully converted to trans-stilbene 10b (75% NMR yield). 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added 
Fe(OTf2)2 (3.5 mg, 0.01 mmol) and L3 (5.2mg, 0.01 mmol). After the vial was evacuated and 
backfilled with N2 three times, anhydrous CH2Cl2 (0.4 mL) and MeCN (0.1 mL) were added via 
a syringe and the mixture was stirred at room temperature for 10 min. To another flame-dried 3-
dram vial (vial B) equipped with a stirring bar was added 2a (69.4 mg, 0.24 mmol). This vial was 
evacuated and backfilled with N2 three times and anhydrous CH2Cl2 (1.5 mL) was added. Both 
vials were degassed with brief evacuation and backfilled with N2 twice. cis-Stilbene 10a (36 µL, 
0.2 mmol) and TMSN3 (40 μl, 0.3 mmol) were added successively to vial B and followed by 
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drop-wise addition of the catalyst solution in vial A at room temperature, the reaction was kept at 
room temperature for 2 h and then quenched with saturated NaHCO3 solution (0.1 mL), and 
further diluted with hexanes (3 mL). The mixture was stirred vigorously for 10 min and filtered 
through a short silica gel pad. The filtrate was concentrated in vacuo and the crude product was 
analyzed by 
1
H NMR with trimethoxybenzene as an internal standard (86% yield, and dr = 2.5). 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added 
Fe(OTf2)2 (3.5 mg, 0.01 mmol) and L3 (5.2 mg, 0.01 mmol). After the vial was evacuated and 
backfilled with N2 three times, anhydrous CH2Cl2 (0.4 mL) and MeCN (0.1 mL) were added via 
a syringe and the mixture was stirred at room temperature for 10 min. To another flame-dried 3-
dram vial (vial B) equipped with a stirring bar were added 2a (69.4 mg, 0.24 mmol) and TEMPO 
(31.3 mg, 0.2 mmol). This vial was evacuated and backfilled with N2 three times and anhydrous 
CH2Cl2 (1.5 mL) was added. Both vials were degassed with brief evacuation and backfilled with 
N2 twice.  cis-Stilbene 10a (36 µL, 0.2 mmol) and TMSN3 (40 μl, 0.3 mmol) were added to vial 
B successively and followed by drop-wise addition of the catalyst solution in vial A. The 
reaction was kept at room temperature for 2 h and then quenched with saturated NaHCO3 
solution (0.1 mL), and further diluted with hexanes (3 mL). The mixture was stirred vigorously 
for 10 min and filtered through a short silica gel pad. The filtrate was concentrated in vacuo and 
the crude product was analyzed by 
1
H NMR with trimethoxybenzene as an internal standard. The 
azido-oxygenation product 12 was identified (75% yield, dr = 2.3).
82
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(±)-1-((1R,2S)-2-Azido-1,2-diphenylethoxy)-2,2,6,6-tetramethylpiperidine (12a): IR 
νmax (neat)/cm
-1
: 2933 (s), 2100 (s), 1455 (m), 1258 (m), 1133 (w), 757 (w), 698 (m); 
1
H NMR 
(400 MHz, CDCl3): δ 7.26–7.14 (m, 6H), 7.10–7.01 (m, 4H), 5.18 (d, J = 8.0 Hz, 1H), 5.07 (d, J 
= 8.0 Hz, 1H), 1.91–0.88 (m, 16H), 0.65–0.18 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 138.9, 
136.8, 129.7, 128.14, 128.08, 127.9, 127.8, 127.4, 89.2, 69.3, 61.1, 59.6, 41.0, 34.8, 34.1, 20.7, 
17.2. 
 
(±)1-((1S,2S)-2-Azido-1,2-diphenylethoxy)-2,2,6,6-tetramethylpiperidine (12b): IR 
νmax (neat)/cm
-1
: 2932 (s), 2100 (s), 1452 (m), 1361 (w), 1133 (w), 1025 (m), 709 (s); 
1
H NMR 
(400 MHz, CDCl3): δ 7.25–7.12 (m, 6H), 7.00–6.88 (m, 4H), 5.62 (d, J = 3.5 Hz, 1H), 4.89 (d, J 
= 3.5 Hz, 1H), 1.70–1.20 (m, 12H), 1.19–0.95 (m, 3H), 0.83–0.34 (m, 3H); 13C NMR (100 MHz, 
CDCl3): δ 137.3, 137.2, 129.3, 128.2, 127.7, 127.5, 127.4, 127.1, 91.6, 68.1, 60.3, 40.8, 35.3, 
34.3, 20.4, 17.2. 
 
To a flame-dried 3-dram vial equipped with a stirring bar were added 2a (69.4 mg, 0.24 
mmol) and TEMPO (37.5 mg, 0.24 mmol). The vial was evacuated and backfilled with N2 three 
times and anhydrous CH2Cl2 (1.5 mL) was added. After the vial was degassed with brief 
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evacuation and backfilled with N2 twice, cis-stilbene 10a (36 µL, 0.2 mmol) and TMSN3 (40 μl, 
0.3 mmol) were added successively to this vial at room temperature. The reaction was kept at 
room temperature for 2 h and then quenched with a saturated NaHCO3 solution (0.1 mL), and 
further diluted with hexanes (3 mL). The mixture was stirred vigorously for 10 min and filtered 
through a short silica gel pad. The filtrate was concentrated in vacuo and the crude product was 
analyzed by 
1
H NMR with trimethoxybenzene as an internal standard. 12 was also identified 
(69% yield, dr: 2.3:1). 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added 
Fe(OTf2)2 (3.5 mg, 0.01 mmol) and L3 (5.2 mg, 0.01 mmol). After the vial was evacuated and 
backfilled with N2 three times, anhydrous CH2Cl2 (0.4 mL) and MeCN (0.1 mL) were added via 
a syringe and the mixture was stirred at room temperature for 10 min. To another flame-dried 3-
dram vial (vial B) equipped with a stirring bar was added 2a (69.4 mg, 0.24 mmol). This vial was 
evacuated and backfilled with N2 three times and anhydrous CH2Cl2 (1.5 mL) was added. Both 
vials were degassed with brief evacuation and backfilled with N2 twice and they were cooled to -
15 C. cis-Stilbene 10a (36 µL, 0.2 mmol) and a stock solution of TBAN3 (1.0 M in CH2Cl2, 300 
μl, 0.3 mmol) were added to vial B successively and followed by drop-wise addition of the 
catalyst solution in vial A. The reaction was then kept at room temperature for 2 h and then 
quenched with saturated NaHCO3 solution (0.1 mL), and further diluted with hexanes (3 mL).  
The mixture was stirred vigorously for 10 min and filtered through a short silica gel pad. The 
filtrate was concentrated in vacuo and the crude product was analyzed by 
1
H NMR with  
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trimethoxybenzene as an internal standard. cis-Stilbene was almost fully recovered. 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added 
Fe(OTf2)2 (3.5 mg, 0.01 mmol) and L2 (2.7 mg, 0.01 mmol). After the vial was evacuated and 
backfilled with N2 three times, anhydrous CH2Cl2 (0.4 mL) and MeCN (0.1 mL) were added via 
a syringe and the mixture was stirred at room temperature for 10 min. To another flame-dried 3-
dram vial (vial B) equipped with a stirring bar was added 2a (69.4 mg, 0.24 mmol). This vial was 
evacuated and backfilled with N2 three times and anhydrous CH2Cl2 (1.5 mL) was added. Both 
vials were degassed with brief evacuation and backfilled with N2 twice and they were cooled to -
15 C. cis-Stilbene 10a (36 µL, 0.2 mmol), a stock solution of TBAN3 (1.0 M in CH2Cl2, 300 μl, 
0.3 mmol) and TMSN3 (40 μl, 0.3 mmol) were added to vial B successively and followed by 
drop-wise addition of the catalyst solution in vial A. The reaction was kept at room temperature 
for 2 h and then quenched with saturated NaHCO3 solution (0.1 mL), and further diluted with 
hexanes (3 mL). The mixture was stirred vigorously for 10 min and filtered through a short silica 
gel pad. The filtrate was concentrated in vacuo and the crude product was analyzed by 
1
H NMR 
with trimethoxybenzene as an internal standard.  trans-stilbene was obtained in 75% yield. 
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Scheme 69. Radical Clock of the Iron-Catalyzed Olefin Diazidation 
Two isomeric vinyl-cyclopropane substrates were evaluated in order to determine 
whether a radical species is involved in the olefin diazidation. trans-2-Phenyl-1-
vinylcyclopropane trans-S29 was synthesized according to a literature procedure.
10, 83
 cis-2-
Phenyl-1-vinylcyclopropane cis-29 was obtained according to another literature procedure.
10, 83b, 
84
   
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added 
Fe(OTf)2 (5.3 mg, 0.015 mmol) and L2 (4.1 mg, 0.015 mmol). After the vial was evacuated and 
backfilled with N2 three times, anhydrous CH2Cl2 (0.8 mL) and MeCN (0.2 mL) were added via 
a syringe and the mixture was stirred at room temperature for 10 min. To another flame-dried 3-
dram vial (vial B) equipped with a stir bar was added 2b (158.4 mg, 0.60 mmol). This vial was 
evacuated and backfilled with N2 three times and anhydrous CH2Cl2 (4.0 mL) was added. Both 
vials were degassed with brief evacuation and backfilled with N2 twice. S29 (72.1 mg, 0.5 
mmol), TMSN3 (263 L, 2.0 mmol) were added successively to vial B and followed by drop-
wise addition of the catalyst solution in vial A at room temperature. The reaction was kept at 
room temperature for 2 h and then quenched with a saturated NaHCO3 solution (0.1 mL) and 
further diluted with hexanes (5 mL). The mixture was stirred vigorously for 10 min and filtered 
through a short silica gel pad. The filtrate was concentrated in vacuo. The residue was 
subsequently purified through a silica gel flash column (hexanes/Et2O: from 200:1 to 50:1) and  
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S30 was isolated as a colorless oil (76.4 mg, 67% yield). 
S30 was obtained with essentially the same yield through the same procedure with cis-2-
Phenyl-1-vinylcyclopropane cis-S29. Isomerization product trans-S29 was not identified.   
 
(1,5-Diazidopent-3-en-1-yl)benzene (S30): IR νmax (neat)/cm
-1
: 2920 (w), 2096 (s), 1245 
(m), 974 (w), 700 (w); 
1
H NMR (400 MHz, CDCl3): δ 7.43–7.28 (m, 5H), 5.74–5.53 (m, 2H), 
4.54–4.45 (m, 1H), 3.71 (d, J = 5.9 Hz, 2H), 2.69–2.49 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 
139.0, 131.3, 129.0, 128.6, 127.0, 126.9, 65.9, 52.6, 39.2. 
 
N,N'-(5-Phenylpent-2-ene-1,5-diyl)diacetamide (S31). To a 3-dram vial equipped with 
a stir bar were added diazidation product S30 (45.6 mg, 0.2 mmol), THF (2 mL) and H2O (18 
L, 1.0 mmol). After the vial was evacuated and backfilled with N2 three times, a solution of 
PPh3 (131.2 mg, 0.5 mmol) in THF (1 mL) was added drop-wise at 0 °C. The mixture was 
warmed up to 50 °C and stirred for 6 h (the reaction was monitored by IR until the absorption of 
azido groups disappeared). The mixture was then concentrated in vacuo and the residue was 
dissolved in CH2Cl2 (3 mL). This solution cooled to 0 °C and Et3N (68 L, 0.5 mmol) was then 
added via a syringe followed by drop-wise addition of acetyl chloride (32 L, 0.44 mmol). The 
reaction was kept stirring for 1 h and quenched with saturated NH4Cl solution (1 mL). After the 
organic layer was separated, the aqueous phase was extracted with CH2Cl2 (5 mL × 3). The 
combined organic layers were dried over anhydrous Na2SO4 and concentrated in vacuo to afford 
S31 as colorless oil (31 mg, 60% yield). IR νmax (neat)/cm
-1
: 3288 (s), 1650 (s), 1549 (s), 1433 
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(w), 1374 (m), 1297 (m), 970 (w), 700 (w); 
1
H NMR (400 MHz, CDCl3): δ 7.39–7.18 (m, 5H), 
6.08 (d, J = 7.0 Hz, 1H), 5.59–5.38 (m, 3H), 5.09 (dd, J = 14.6, 6.9 Hz, 1H), 3.73 (t, J = 4.0 Hz, 
2H), 2.51 (t, J = 5.4 Hz, 2H), 2.00 (s, 3H), 1.96 (s, 3H); 
13
C NMR (100 MHz, CDCl3): δ 170.2, 
169.6, 141.6, 129.6, 128.8, 128.5, 127.6, 126.7, 52.7, 41.5, 39.0, 23.5, 23.4; HRMS (ESI, m/z): 
calcd for C15H21N2O2
+
, [M + H
+
], 261.1598, found 261.1603. 
 
4.3     RESULTS 
Herein, we describe an iron-catalyzed diastereoselective olefin diazidation at room 
temperature with low catalyst loading (Scheme 70).
83b, 85
 This new method tolerates a broad 
range of olefins, including those that are incompatible with existing methods. Notably, the anti-
selectivity can be modulated by iron catalysts (d.r. up to >20:1). This method also provides a 
convenient approach to a variety of nitrogen-containing molecules, including vicinal primary 
diamines and 2-azido glycosyl azides, which are valuable for N-linked glycoprotein synthesis. 
Furthermore, preliminary mechanistic studies suggest that this reaction may proceed through a 
new selective pathway, which has the promise to become a general strategy for selective olefin 
difunctionalization. 
 
Scheme 70. Iron-Catalyzed Olefin Diazidation 
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4.3.1 Iron Catalyst Discovery 
Indene (1) was selected as a model substrate for catalyst discovery since it is 
incompatible with existing diastereoselective olefin diazidation methods. Azidoiodinane (2a) and 
Fe(OTf)2 were initially selected as the azido-transfer reagent and the catalyst, respectively. We 
observed that Fe(OTf)2 was ineffective for the azido-group transfer in the absence of TMSN3 and 
both 1 and 2a were fully recovered (Table 25, entry 1). However, in the presence of TMSN3, a 
catalytic amount of Fe(OTf)2 was sufficient to turn over the catalytic cycle, thus affording the 
indene diazide 3 in high yields (entries 2, 4, and 5). Notably, in the absence of iron catalysts, no 
desired product was observed and 1 was fully recovered (entry 3). These observations suggest 
that TMSN3 is necessary to activate 2a for the azido-group transfer and that iron catalysts are 
also necessary for the olefin diazidation.  
Although the Fe(OTf)2/L1 complex catalyzed a moderately diastereoselective reaction 
(entry 2), the d.r. value was significantly improved when the ligand L2 was used (entry 4). 
Notably, a bulkier ligand (L3) induced a higher d.r. value (entry 5). Since 2a is prepared from 
bench-stable benziodoxole (2b) with an excess amount of TMSN3, and 2b is barely soluble 
under the olefin diazidation conditions,
86
 we explored using 2b as the terminal oxidant under 
heterogeneous conditions (entry 6). To our pleasure, 3 was obtained with essentially the same 
yield and d.r. value under these new reaction conditions. This observation suggests that 2a may 
be rapidly derived from 2b in situ. Note that precautions with regard to handling TMSN3 should 
be taken during the reaction workup. 
We thereby evaluated the counterion effect and discovered that Fe(NTf2)2 was equally 
effective (Table 25, entry 7). Surprisingly, the Fe(OAc)2/L3 complex catalyzed highly 
diastereoselective anti-diazidation of 1 with an excellent yield (entry 8). Since 3 is a convenient 
227 
precursor for the indene diamine, it is further converted into the anti-indene diaminium salt 4 in a 
high yield by a mild reduction/protonation sequence. Furthermore, standard resolution with 
tartaric acid readily provided the indene diamine essentially in its enantiopure form (97 % ee). 
 
a
Reactions were carried out under N2 and then quenched with a saturated NaHCO3 solution unless stated 
otherwise.
 b
Reaction condition: PPh3 (2.5 equiv), H2O (5.0 equiv), THF, 50 °C, 2 h, then TsOH (2.5 equiv). 
c
Conversion and dr were measured by 
1
H NMR analysis. 
d
Isolated yield. OTf: trifluoromethanesulfonate, NTf2: tri-
fluoromethanesulfonimide. 
 
Table 25. Catalyst Discovery for the Diastereoselective Indene Diazidation 
4.3.2 Substrate Scope 
To examine the scope of this new iron-catalyzed olefin diazidation, we explored the 
reactivity with a broad range of olefins (Table 26). Since the C/N ratios for these diazides 
generally vary from 1 to 3, careful isolation was executed strictly under small-scale (<100 mg) 
conditions. Additionally, direct diazide reduction without solvent concentration conveniently 
affords a variety of vicinal primary diamines. First, olefins with labile C-H bonds, including allyl 
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benzene and an allyl silane, were evaluated because they have been challenging substrates for the 
existing diazidation methods. For synthetic convenience, L2, with a lower molecular weight, was 
selected as the ligand for terminal olefins, and we discovered that the Fe(OTf)2/L2 complex 
catalyzed the efficient diazidation: the amount of competing direct C-H azidation product is less 
than 5% (entries 1 and 2). Mild derivatization converted the diazides into functionalized 
diaminium salts with excellent yields. Styrenyl and aliphatic terminal olefins are also excellent 
substrates: the corresponding diazides were isolated with good yields (entries 3–6). Next, we 
evaluated a range of cyclic olefins and discovered that the Fe(OAc)2/L3 complex is effective for 
highly diastereoselective diazidation of indene, dihydronaphthalene, dihydroquinoline, and 
indole (entries 7–10). Standard derivatization afforded a range of valuable anti-vicinal diamines, 
which are challenging to synthesize with existing diazidation or diamination methods. Further 
evaluation of acyclic internal olefins revealed that trans-2-octene is an excellent substrate for the 
diazidation yet with a low dr value (entry 11). Fortunately, the diastereomers were separable and 
the straightforward derivatization converted them into vicinal primary diamines, which are 
difficult to obtain with the existing olefin diamination methods. We also observed that an 
electron-deficient cinnamate ester is an excellent substrate, and an electron-rich enamide is also 
compatible with this method (entries 12 and 13). We further evaluated geranyl acetate and 
observed that the diazidation occurred regioselectively at the distal position with a more 
electron-rich olefin (entry 14). 
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a
TMSN3 (3.6 4.0 equiv) was used. 
b
Isolated yield. 
c
Fe(OTf)2·L2 (1 mol %), 2 h. 
d
PPh3, H2O, 50 °C, then 
TsOH. 
e
Pd/C, H2 22 °C, then TsOH. 
f
Fe(OAc)2·L3 (5 mol %), 4 h. 
g
Fe(NTf2)2·L3 (10 mol %), 4 h. 
h
Fe(OTf)2·L3 (5 
mol %). 
i
PMe3, H2O, 50 °C, then TsOH. 
j
0 °C, 10 h. 
k
92% yield for reduction. 
 
Table 26. Substrate Scope for the Iron-Catalyzed Olefin Diazidation 
4.3.3 Late Stage Functionalization 
Furthermore, we explored this new method with densely functionalized olefins (Scheme 
71). Acetyl quinine (5) smoothly participates in the diazidation to afford diazide 6, which adds a 
new structural motif for organocatalysis. Additionally, glycal 7 is also a reasonable substrate, 
which affords 2-azido glycosyl azides 8. Interestingly, both diastereomers were elaborated to 2-
azido N-linked glycopeptide 9 as a single diastereomer via a reduction/ligation procedure. 
Notably, 9 is also a valuable building block for N-linked glycoprotein synthesis.
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a
Fe(OTf)2·L2 (10 mol %), 2b, TMSN3, 22 °C; 82% yield, dr: 3:1. 
b
Fe(OTf)2·L2 (5 mol %), 2b, TMSN3, 0 
°C; 52% yield, dr: 1.5:1. 
c
PMe3 in THF, -60-22 °C; then H2O in THF, 40 °C; 76% yield, dr>20:1; then HATU, 
DIPEA, the corresponding peptide acid, DMF, 22 °C, 86% yield for the ligation step. 
 
Scheme 71. Iron-Catalyzed Diazidation of Acetyl Quinine and Glycals for N-Linked Glycopeptide Synthesis 
4.3.4 Mechanistic Working Hypothesis  
The observed catalyst-controlled diastereoselectivity is mechanistically important 
because it suggests that iron catalysts are involved in the dr-determining step. Therefore, we 
selected cis-stilbene 10a as a probe for several control experiments (Scheme 72). First, when 
TMSN3 is absent, no reaction was observed and both 10a and 2a were fully recovered (equation 
72a). Next, under an iron-free condition yet in the presence of TMSN3, 10a was isomerized to 
trans-stilbene 10b and no diazidation product was observed (equation 72b). We further 
discovered that 10a was converted to diazide 11 under a standard condition and essentially the 
same dr was observed compared with the one obtained from 10b (equation 72c). Furthermore, 12 
was obtained in the presence of TEMPO (equations 72d and 72e). These experiments provided 
several mechanistic insights. First, TMSN3 is crucial to activate 2a. Next, an azido-radical 
species is possibly involved in the olefin diazidation and a reversible radical addition may 
convert 10a to a carbo-radical species under both standard and iron-free conditions. Additionally, 
this radical can be captured by TEMPO. Moreover, stereo-convergent diazidation of cis/trans 
stilbenes suggest that the second azido-group transfer may be rate-limiting. 
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a
Fe(OTf)2·L3 (5 mol %). 
b
TMSN3. 
c
Fe(OTf)2·L3 (5 mol %), TMSN3. 
d
Fe(OTf)2·L3 (5 mol %), TMSN3, 
TEMPO. 
e
TMSN3, TEMPO. 
f
Fe(OTf)2·L3 (5 mol %), TBAN3, 2a, -15-22 °C. 
g
Fe(OTf)2·L3 (5 mol %), TBAN3, 
TMSN3, 2a, -15-22 °C. Other reactions were carried out at 22 °C. 
 
Scheme 72. Control Experiments for Mechanistic Insights of the Iron-Catalyzed Olefin Diazidation 
In order to probe for the role of TMSN3, it was further replaced by TBAN3 (equation 
72f). Surprisingly, no diazidation was observed and 10a was fully recovered. However, in the 
presence of both TMSN3 and TBAN3, 10a was isomerized to 10b and no diazidation was 
observed (equation 72g). These observations suggest that the Lewis-acidic TMS group is crucial 
for the activation of 2a and that an excess amount of azide anion may deactivate iron catalysts. 
Based on the collective evidence from the aforementioned control experiments and key 
observations in catalyst discovery (Table 10), we propose a mechanistic working hypothesis that 
is supported by the experimental data (Scheme 73). First, TMSN3 reacts with 2b and possibly 
converts 2b to 2a in situ. Next, 2a may be further activated by TMSN3 to reversibly generate 
intermediate A. In the absence of iron catalysts, A may react with cis-stilbene 10a, presumably 
through reversible azido-radical addition, affording a carbo-radical species B and 
azidoiodobenzene C. Nevertheless, B may not be further oxidized in the absence of iron and the 
elimination from B will afford more stable 10b and regenerate A. However, in the presence of an 
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iron catalyst, it may reductively cleave the IN3 bond of A, which presumably generates a high-
valent iron species and an azido-radical. The azido-radical may thereby react with 10a to afford 
another carbo-radical species E that is associated with the iron catalyst. Since the dr of olefin 
diazidation can be modulated both by the ligand and counter ion of the catalyst, it is likely that 
the high-valent iron species may further oxidize E through inner-sphere azido ligand-transfer to 
afford the diazide 11.
46
 
 
Scheme 73. Mechanistic Working Hypothesis for the Iron-Catalyzed Olefin Diazidation Using 
Benziodoxole and TMSN3 
 
4.4 CONCLUSIONS 
In conclusion, we have discovered a new iron-catalyzed diastereoselective olefin 
diazidation method which tolerates a broad range of olefins, including those that are 
incompatible with the existing methods. It can also afford a variety of synthetically valuable 
building blocks that are difficult to prepare with alternative methods. Our mechanistic studies 
suggest that the reaction may proceed through a new pathway in which Lewis-acid activation is 
indispensable for the first azido-group transfer and that iron catalysts are crucially involved with 
the second azido-group transfer. Our current efforts focus on the mechanistic understanding of 
this new reaction and achieving effective asymmetric induction through new catalyst discovery. 
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H and 
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Appendix E X-ray Crystallographic Analysis for Product Absolute Stereochemistry 
Determination 
 
 
Table 1. Crystal data and structure refinement for B302_0m 
 
Identification code  B302_0m  
Empirical formula  C26H22Cl2N2O7S  
Formula weight  577.41  
Temperature/K  173(2)  
Crystal system  orthorhombic  
Space group  P212121 
a/Å  9.6790(7)  
b/Å  11.8883(8)  
c/Å  22.4824(16)  
α/°  90  
β/°  90  
γ/°  90  
Volume/Å
3
 2587.0(3)  
Z  4  
386 
ρcalcmg/mm
3
 1.483  
m/mm
-1
 0.382  
F(000)  1192.0  
Crystal size/mm
3
 0.698 × 0.309 × 0.23  
2Θ range for data collection  3.624 to 61.158°  
Index ranges  -13 ≤ h ≤ 13, -16 ≤ k ≤ 17, -28 ≤ l ≤ 32  
Reflections collected  20608  
Independent reflections  7834[R(int) = 0.0289]  
Data/restraints/parameters  7834/1/349  
Goodness-of-fit on F
2
 1.033  
Final R indexes [I>=2σ (I)]  R1 = 0.0482, wR2 = 0.1153  
Final R indexes [all data]  R1 = 0.0572, wR2 = 0.1218  
Largest diff. peak/hole / e Å
-3
 0.77/-0.42  
Flack parameter 0.012(18) 
 
Table 2. Fractional Atomic Coordinates (×10
4
) and Equivalent Isotropic Displacement 
Parameters (Å
2
×10
3
) for B302_0m. Ueq is defined as 1/3 of of the trace of the orthogonalised UIJ 
tensor. 
 
Atom x y z U(eq) 
S1 -3467.1(8) -6310.7(7) -3791.5(3) 28.52(17) 
Cl2 -2358.9(8) -7597.4(6) -7753.5(3) 31.40(17) 
Cl1 -4886.0(12) -4143.1(9) -6739.3(4) 53.7(3) 
O2 -2651(2) -5279.5(17) -5088.2(8) 23.5(4) 
O3 -2056(2) -1889.3(19) -4968.4(9) 28.9(5) 
O1 -3946(2) -3947.3(19) -5525.3(9) 29.7(5) 
O5 -4628(3) -6284(2) -4184.8(10) 40.3(6) 
O4 -792(2) -2090(2) -5804.8(10) 34.5(5) 
N2 -2383(3) -5384(2) -4066(1) 27.1(5) 
O7 -8934(3) -5021(2) -5587.2(10) 40.0(6) 
O6 -2724(3) -7335(2) -3698.5(12) 45.2(6) 
N1 -957(2) -3498(2) -5107(1) 23.9(5) 
C3 -2683(3) -6833(2) -7111.8(12) 23.2(5) 
C18 -3989(3) -5812(3) -3090.3(12) 25.3(6) 
C7 -3316(3) -4817(3) -5560.3(12) 22.8(5) 
C5 -3802(3) -5279(3) -6640.2(13) 26.9(6) 
C12 -603(3) -4115(2) -4071.7(12) 21.9(5) 
C9 -1605(3) -3683(2) -4536.0(11) 20.4(5) 
387 
C10 -1211(3) -2469(3) -5338.1(12) 24.9(5) 
C2 -2018(3) -7107(3) -6588.1(13) 26.6(6) 
C4 -3595(3) -5943(3) -7143.1(12) 27.8(6) 
C6 -3138(3) -5526(2) -6103.0(11) 21.5(5) 
C8 -2747(3) -4623(2) -4547.3(11) 22.3(5) 
C17 -1075(3) -5103(2) -3815.8(12) 23.1(5) 
C1 -2246(3) -6452(2) -6090.2(12) 24.1(5) 
C16 -302(3) -5688(3) -3401.4(12) 27.2(6) 
C25 -8230(4) -5681(3) -5311.6(15) 35.2(7) 
C11 -2185(3) -2489(3) -4413.8(12) 25.4(5) 
C19 -3594(4) -6395(3) -2582.7(14) 34.3(7) 
C13 669(3) -3674(3) -3923.5(13) 28.4(6) 
C23 -4869(3) -4895(3) -3062.9(14) 32.8(7) 
C22 -5364(4) -4565(4) -2508.7(17) 42.0(8) 
C14 1459(3) -4242(3) -3500.4(14) 33.0(7) 
C15 984(3) -5227(3) -3248.0(13) 31.6(6) 
C20 -4123(4) -6055(4) -2038.0(14) 44.3(9) 
C21 -5009(4) -5152(4) -2003.5(15) 45.2(10) 
C26 -8877(6) -6438(4) -4858.2(18) 57.9(12) 
C24 -6713(4) -5759(4) -5408(2) 60.1(13) 
 
 
    
Table 3. Anisotropic Displacement Parameters (Å
2
×10
3
) for B302_0m. The Anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+...+2hka×b×U12] 
 
Atom U11 U22 U33 U23 U13 U12 
S1 38.2(4) 26.5(4) 20.8(3) -3.5(3) 4.5(3) -10.9(3) 
Cl2 38.6(4) 29.8(4) 25.8(3) -9.0(3) 2.2(3) 1.1(3) 
Cl1 74.9(6) 58.7(6) 27.5(4) -11.9(4) -17.4(4) 45.3(5) 
O2 30.3(9) 26(1) 14.3(8) -0.9(7) -1.8(7) 0.1(8) 
O3 37.8(11) 25.4(11) 23.5(10) 2.8(8) -0.9(8) 4.7(9) 
O1 34.7(10) 30.6(12) 23.9(10) -3.8(8) -2.7(8) 7.2(9) 
O5 45.3(13) 52.5(16) 23(1) -4.4(11) -0.4(9) -23.7(12) 
O4 42.0(12) 35.7(13) 25.8(10) 8.8(9) 1.4(9) -1.7(10) 
N2 31.1(12) 34.1(13) 16.1(10) 4.7(9) 0.9(9) -11.1(11) 
O7 44.2(13) 45.6(15) 30.4(12) -5.8(10) -6.4(10) 15.7(12) 
O6 63.2(16) 24.5(11) 48.0(15) -5(1) 13.3(13) -3.9(11) 
N1 25.1(11) 29.1(13) 17.4(10) 2.5(9) 4.2(8) 2.1(9) 
C3 25.2(12) 23.8(13) 20.6(12) -5.2(10) 1.8(10) -1.2(11) 
388 
C18 31.0(13) 28.0(14) 16.9(11) -0.7(10) 2.8(10) -9.9(11) 
C7 23.9(12) 27.4(14) 17.1(11) -0.6(10) -0.5(9) -1.6(10) 
C5 30.9(13) 27.0(14) 22.8(13) 0.5(11) -4.0(11) 12.1(11) 
C12 23.8(12) 24.8(13) 17.2(11) 0(1) -0.3(9) 2.6(10) 
C9 22.1(11) 24.1(13) 15(1) -0.3(10) 1.0(9) 0.8(10) 
C10 23.5(12) 29.0(15) 22.3(12) 0.4(11) -3.1(9) -2.9(11) 
C2 26.4(12) 24.2(14) 29.3(14) -1.2(11) -3.3(11) 6.8(10) 
C4 31.1(13) 34.2(15) 18.0(12) -1.8(11) -4.6(10) 5.3(12) 
C6 23.8(12) 24.7(13) 16.1(11) -0.1(10) -0.7(9) 0.9(10) 
C8 24.5(12) 27.6(14) 14.9(11) -1.5(10) -0.7(9) -1.8(10) 
C17 27.0(12) 27.3(14) 14.9(11) -0.7(10) 2.5(10) 0.4(10) 
C1 27.0(12) 25.8(13) 19.3(12) 2.8(10) -4.3(10) 1.8(11) 
C16 36.5(15) 28.0(15) 17.1(12) 2.8(11) 3.8(10) 3.6(12) 
C25 42.0(17) 33.3(18) 30.4(15) -12.9(13) -11.0(13) 8.3(14) 
C11 27.7(12) 28.0(14) 20.5(12) -0.8(11) 0.9(10) 3.4(11) 
C19 37.8(16) 36.5(17) 28.7(14) 8.1(13) -1.1(12) -8.8(14) 
C13 24.8(13) 33.0(16) 27.5(14) 3.4(12) -1.3(10) -2.8(11) 
C23 35.9(16) 34.6(17) 27.9(14) -1.5(12) -0.9(12) -1.8(13) 
C22 35.4(17) 46(2) 44.1(19) -17.1(17) 8.0(15) -3.9(15) 
C14 23.8(13) 46.1(19) 29.1(14) 2.9(13) -4.6(11) 1.0(13) 
C15 30.5(14) 42.6(18) 21.8(13) 5.2(13) 0.1(11) 11.6(13) 
C20 48.4(19) 65(3) 19.7(14) 8.5(15) -3.1(13) -25.1(19) 
C21 43.3(19) 67(3) 25.1(15) -14.1(16) 9.4(14) -21.6(19) 
C26 92(3) 47(2) 34.4(19) -1.3(18) 6(2) 14(2) 
C24 37.3(19) 50(3) 93(4) -26(2) -19(2) 7.6(18) 
 
Table 4. Bond Lengths for B302_0m. 
Atom            Atom              Length/Å            Atom            Atom              Length/Å 
S1 O5 1.430(3)   C7 C6 1.493(4) 
S1 N2 1.642(2)   C5 C4 1.394(4) 
S1 O6 1.429(3)   C5 C6 1.400(4) 
S1 C18 1.758(3)   C12 C9 1.514(4) 
Cl2 C3 1.734(3)   C12 C17 1.386(4) 
Cl1 C5 1.724(3)   C12 C13 1.379(4) 
O2 C7 1.358(3)   C9 C8 1.573(4) 
O2 C8 1.448(3)   C9 C11 1.551(4) 
389 
O3 C10 1.354(4)   C2 C1 1.381(4) 
O3 C11 1.442(3)   C6 C1 1.399(4) 
O1 C7 1.203(4)   C17 C16 1.383(4) 
O4 C10 1.212(4)   C16 C15 1.403(5) 
N2 C8 1.454(3)   C25 C26 1.497(6) 
N2 C17 1.425(4)   C25 C24 1.487(5) 
O7 C25 1.210(4)   C19 C20 1.387(5) 
N1 C9 1.445(3)   C13 C14 1.394(4) 
N1 C10 1.352(4)   C23 C22 1.391(5) 
C3 C2 1.381(4)   C22 C21 1.377(6) 
C3 C4 1.380(4)   C14 C15 1.380(5) 
C18 C19 1.388(4)   C20 C21 1.376(6) 
C18 C23 1.386(5)         
 
Table 5. Bond Angles for B302_0m. 
 
Atom Atom Atom Angle/˚ Atom Atom Atom Angle/˚ 
O5 S1 N2 104.78(14) C12 C9 C11 114.8(2) 
O5 S1 C18 108.74(15) C11 C9 C8 113.5(2) 
N2 S1 C18 107.13(13) O4 C10 O3 122.9(3) 
O6 S1 O5 120.29(17) O4 C10 N1 127.5(3) 
O6 S1 N2 107.74(15) N1 C10 O3 109.6(2) 
O6 S1 C18 107.49(16) C3 C2 C1 118.9(3) 
C7 O2 C8 114.1(2) C3 C4 C5 119.0(2) 
C10 O3 C11 109.3(2) C5 C6 C7 122.2(2) 
C8 N2 S1 122.8(2) C1 C6 C7 119.9(2) 
C17 N2 S1 125.23(19) C1 C6 C5 117.8(2) 
C17 N2 C8 111.3(2) O2 C8 N2 105.9(2) 
C10 N1 C9 113.6(2) O2 C8 C9 110.6(2) 
C2 C3 Cl2 120.1(2) N2 C8 C9 105.1(2) 
C4 C3 Cl2 118.4(2) C12 C17 N2 109.2(2) 
C4 C3 C2 121.5(3) C16 C17 N2 129.0(3) 
C19 C18 S1 119.3(3) C16 C17 C12 121.8(3) 
C23 C18 S1 118.8(2) C2 C1 C6 121.7(2) 
C23 C18 C19 121.7(3) C17 C16 C15 116.7(3) 
O2 C7 C6 110.8(2) O7 C25 C26 120.2(4) 
O1 C7 O2 122.5(3) O7 C25 C24 121.5(4) 
390 
O1 C7 C6 126.7(3) C24 C25 C26 118.4(4) 
C4 C5 Cl1 115.2(2) O3 C11 C9 105.5(2) 
C4 C5 C6 121.0(3) C20 C19 C18 118.6(3) 
C6 C5 Cl1 123.8(2) C12 C13 C14 118.0(3) 
C17 C12 C9 111.3(2) C18 C23 C22 118.3(3) 
C13 C12 C9 127.5(3) C21 C22 C23 120.6(4) 
C13 C12 C17 121.1(3) C15 C14 C13 120.6(3) 
N1 C9 C12 112.7(2) C14 C15 C16 121.7(3) 
N1 C9 C8 113.5(2) C21 C20 C19 120.4(3) 
N1 C9 C11 100.1(2) C20 C21 C22 120.3(3) 
C12 C9 C8 102.7(2) 
    
 
Table 6. Hydrogen Bonds for B302_0m. 
 
D H A d(D-H)/Å d(H-A)/Å d(D-A)/Å D-H-A/° 
N1 H1 O7
1
 0.985(7) 1.909(11) 2.877(3) 167(3) 
1
1+X,+Y,+Z 
 
Table 7. Hydrogen Atom Coordinates (Å×10
4
) and Isotropic Displacement Parameters 
(Å
2
×10
3
) for B302_0m.  
Atom x y z U(eq) 
H2 -1427 -7723 -6571 32 
H4 -4065 -5789 -7495 33 
H8 -3674 -4307 -4494 27 
H1A -1794 -6631 -5738 29 
H16 -618 -6354 -3233 33 
H11A -3144 -2529 -4291 30 
H11B -1658 -2119 -4103 30 
H19 -2988 -7000 -2607 41 
H13 991 -3018 -4101 34 
H23 -5122 -4509 -3406 39 
H22 -5940 -3941 -2479 50 
H14 2313 -3955 -3387 40 
H15 1531 -5594 -2969 38 
H20 -3877 -6441 -1694 53 
391 
H21 -5369 -4937 -1637 54 
H26A -8508 -6268 -4472 87 
H26B -8681 -7207 -4956 87 
H26C -9859 -6323 -4855 87 
H24A -6475 -5389 -5773 90 
H24B -6446 -6536 -5429 90 
H24C -6240 -5403 -5083 90 
H1 -370(30) -4050(20) -5318(15) 31(9) 
     
Experimental  
Single crystals of C26H22Cl2N2O7S [B302_0m] were []. A suitable crystal was selected 
and [] on a apex2_Mo diffractometer. The crystal was kept at 173(2) K during data collection. 
Using Olex2 [1], the structure was solved with the Superflip [2] structure solution program using 
Charge Flipping and refined with the ShelXL [3] refinement package using Least Squares 
minimisation. 
1. O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard and H. Puschmann, 
OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Cryst. 
(2009). 42, 339-341. 
2. SHELXS-97 (Sheldrick, 2008) 
3. SHELXL-97 (Sheldrick, 2008) 
Crystal structure determination of [B302_0m]  
Crystal Data for C26H22Cl2N2O7S (M =577.41): orthorhombic, space group P212121 (no. 
19), a = 9.6790(7) Å, b = 11.8883(8) Å, c = 22.4824(16) Å, V = 2587.0(3) Å
3
, Z = 4, T = 
173(2) K, μ(MoKα) = 0.382 mm-1, Dcalc = 1.483 g/mm3, 20608 reflections measured (3.624 ≤ 
2Θ ≤ 61.158), 7834 unique (Rint = 0.0289) which were used in all calculations. The final R1 was 
0.0482 (I >2σ(I)) and wR2 was 0.1218 (all data).  
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Table 8. Crystal data and structure refinement for trypt 
Identification code  trypt 
Empirical formula  C33H26Cl5N3O7S  
Formula weight  785.88  
Temperature/K  172.3  
Crystal system  orthorhombic  
Space group  P212121 
a/Å  9.6220(13)  
b/Å  18.082(2)  
c/Å  19.975(3)  
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α/°  90  
β/°  90  
γ/°  90  
Volume/Å
3
 3475.4(8)  
Z  4  
ρcalcmg/mm
3
 1.502  
m/mm
-1
 0.530  
F(000)  1608.0  
Crystal size/mm
3
 0.928 × 0.331 × 0.19  
2Θ range for data collection  4.078 to 63.784°  
Index ranges  -14 ≤ h ≤ 13, -26 ≤ k ≤ 18, -28 ≤ l ≤ 25  
Reflections collected  30478  
Independent reflections  11170[R(int) = 0.0350]  
Data/restraints/parameters  11170/158/476  
Goodness-of-fit on F
2
 1.030  
Final R indexes [I>=2σ (I)]  R1 = 0.0561, wR2 = 0.1352  
Final R indexes [all data]  R1 = 0.0706, wR2 = 0.1451  
Largest diff. peak/hole / e Å
-3
 0.65/-0.53  
Flack parameter -0.01(7) 
 
Table 9. Fractional Atomic Coordinates (×10
4
) and Equivalent Isotropic Displacement 
Parameters (Å
2
×10
3
) for trypt. Ueq is defined as 1/3 of of the trace of the orthogonalised UIJ 
tensor. 
Atom x y z U(eq) 
N3B -4670(9) -8722(3) -4607(5) 31(2) 
C24B -3588(10) -9184(6) -4559(8) 26.8(10) 
O6B -2523(6) -9171(4) -4891(3) 27.6(9) 
O7B -3834(5) -9676(3) -4064(4) 35.7(14) 
C25B -2702(6) -10190(4) -3954(3) 39.4(14) 
C26B -3009(9) -10611(3) -3316(3) 28.2(15) 
C27B -3103(6) -11379(3) -3349(3) 36.4(11) 
C28B -3319(7) -11785(3) -2767(3) 46.5(14) 
C29B -3456(9) -11422(4) -2168(4) 49.2(14) 
C30B -3411(7) -10662(5) -2125(3) 50.2(13) 
C31B -3185(13) -10261(4) -2715(3) 41.2(13) 
N3A -4580(20) -8805(8) -4729(14) 31(2) 
394 
C24A -3610(20) -9300(15) -4522(17) 26.8(10) 
O6A -2406(14) -9268(10) -4728(7) 27.6(9) 
O7A -4114(13) -9848(7) -4142(9) 35.7(14) 
C25A -3127(14) -10437(7) -3971(6) 39.4(14) 
C26A -3280(30) -10624(6) -3242(6) 28.2(15) 
C27A -3299(14) -11352(6) -3026(6) 36.4(11) 
C28A -3310(20) -11544(7) -2355(6) 46.5(14) 
C29A -3306(14) -10964(6) -1903(6) 49.2(14) 
C30A -3257(15) -10230(7) -2098(6) 50.2(13) 
C31A -3230(30) -10060(7) -2774(6) 41.2(13) 
S1 -2949.4(8) -6225.1(4) -7293.1(4) 24.94(16) 
Cl1 -3177.4(12) -5698.9(6) -3673.0(4) 45.5(2) 
Cl2 -4927.1(14) -2953.5(6) -4139.6(6) 55.3(3) 
Cl3 -3677(2) -11782.6(13) -5566.1(7) 99.3(7) 
Cl4 -5967.1(16) -11143.8(11) -4841.5(7) 85.2(5) 
Cl5 -4615(3) -10310.4(10) -5859.4(8) 107.6(7) 
O2 -4086(2) -6043.8(11) -5829.8(10) 23.2(4) 
O4 -3285(3) -6384.0(14) -7979.1(12) 35.9(5) 
N1 -4122(3) -6671.1(14) -6844.3(12) 20.8(5) 
O3 -1628(2) -6429.3(14) -7021.8(14) 35.7(6) 
O5 -5847(3) -7425.0(15) -4183.2(11) 33.3(5) 
O1 -2767(2) -6415.7(15) -4962.9(12) 34.7(5) 
N2 -5748(3) -7039.0(15) -5275.6(12) 22.4(5) 
C7 -3912(3) -6768.1(16) -6130.7(13) 18.9(5) 
C23 -5431(3) -7480.3(18) -4757.6(15) 25.2(6) 
C13 -6178(3) -7158.9(16) -6486.8(14) 20.9(5) 
C20 -5172(3) -7265.7(15) -5914.1(13) 19.0(5) 
C14 -3169(3) -5265.3(17) -7161.0(15) 24.6(6) 
C6 -3484(3) -5952.8(18) -5219.7(15) 24.5(6) 
C12 -7569(3) -7353.9(18) -6518.9(16) 26.0(6) 
C8 -5534(3) -6805.8(15) -7018.3(14) 20.4(5) 
C21 -4757(3) -8081.2(16) -5772.9(15) 23.6(6) 
C22 -4445(3) -8068.1(18) -5020.2(16) 27.0(6) 
C10 -7662(4) -6833.0(19) -7626.2(17) 31.1(7) 
C3 -3850(3) -5214.5(18) -4940.9(16) 26.7(6) 
C11 -8317(3) -7179.7(19) -7095.1(17) 31.2(7) 
C9 -6258(4) -6641.9(17) -7602.4(15) 27.4(6) 
C1 -4669(4) -3963(2) -5130(2) 38.1(8) 
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C4 -3720(4) -5053(2) -4258.2(16) 31.5(7) 
C2 -4329(4) -4657.1(19) -5366.5(17) 30.5(7) 
C19 -2063(4) -4859.1(19) -6907.5(17) 31.9(7) 
C15 -4395(4) -4927.8(18) -7356.5(18) 31.6(7) 
C1D -4529(4) -3827(2) -4447.0(19) 38.0(8) 
C16 -4521(4) -4164(2) -7287(2) 39.4(8) 
C5 -4078(4) -4362(2) -4014.5(18) 36.6(8) 
C17 -3419(5) -3754(2) -7038(2) 42.6(9) 
C18 -2199(5) -4098(2) -6855.8(19) 41.6(9) 
C1L -5119(6) -11183(3) -5618(2) 57.0(12) 
 
Table 10. Anisotropic Displacement Parameters (Å
2
×10
3
) for trypt. The Anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+...+2hka×b×U12] 
Atom U11 U22 U33 U23 U13 U12 
N3B 21.3(16) 41(2) 29(5) 20(3) 4.8(17) 2.8(14) 
C24B 27.8(14) 26(4) 26(2) 8(2) -3.7(11) -0.9(18) 
O6B 29.0(14) 24(2) 30(3) 11.3(18) -1.8(18) 2.8(13) 
O7B 22(2) 37(3) 49(2) 24(2) 1.3(18) 3.3(17) 
C25B 28(3) 41(3) 49(2) 24(2) 6(2) 10(2) 
C26B 16(4) 24.6(14) 43.8(19) 14.4(13) 0.3(18) -1.7(14) 
C27B 34(2) 27.6(17) 48(3) 15(2) -7(2) -2.6(16) 
C28B 42(3) 40(3) 58(3) 26(2) -6(2) -3(2) 
C29B 37(3) 59(3) 52(3) 21(2) -5(2) 0(2) 
C30B 39(3) 61(3) 50(2) 10(2) -1(2) -3(3) 
C31B 32(2) 39(3) 53(2) 4(2) -1.2(19) -1(3) 
N3A 21.3(16) 41(2) 29(5) 20(3) 4.8(17) 2.8(14) 
C24A 27.8(14) 26(4) 26(2) 8(2) -3.7(11) -0.9(18) 
O6A 29.0(14) 24(2) 30(3) 11.3(18) -1.8(18) 2.8(13) 
O7A 22(2) 37(3) 49(2) 24(2) 1.3(18) 3.3(17) 
C25A 28(3) 41(3) 49(2) 24(2) 6(2) 10(2) 
C26A 16(4) 24.6(14) 43.8(19) 14.4(13) 0.3(18) -1.7(14) 
C27A 34(2) 27.6(17) 48(3) 15(2) -7(2) -2.6(16) 
C28A 42(3) 40(3) 58(3) 26(2) -6(2) -3(2) 
C29A 37(3) 59(3) 52(3) 21(2) -5(2) 0(2) 
C30A 39(3) 61(3) 50(2) 10(2) -1(2) -3(3) 
C31A 32(2) 39(3) 53(2) 4(2) -1.2(19) -1(3) 
S1 24.0(3) 27.0(3) 23.8(3) 3.3(3) 7.1(3) -1.0(3) 
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Cl1 60.3(6) 53.2(6) 23.1(3) -3.0(4) -5.4(4) 2.9(5) 
Cl2 72.3(7) 34.0(5) 59.7(6) -19.4(4) 18.1(6) -8.8(5) 
Cl3 93.4(11) 155.1(17) 49.4(7) 17.6(9) 23.7(7) 66.0(12) 
Cl4 71.4(9) 127.9(14) 56.4(7) 8.2(8) 12.6(7) 50.4(10) 
Cl5 188(2) 82.3(11) 52.8(8) -10.8(7) -8.5(11) -30.9(13) 
O2 25.6(10) 21.9(10) 22.0(9) -1.4(8) -3.6(8) -2.2(8) 
O4 45.5(14) 37.9(13) 24.3(11) 0.3(9) 11.5(10) -2.9(11) 
N1 20.9(11) 23.9(12) 17.7(10) 3.6(9) 1.2(8) -4.8(9) 
O3 23.9(11) 37.1(13) 46.1(14) 7.3(11) 8.8(10) 2.9(9) 
O5 32.2(12) 50.0(15) 17.7(9) 1.7(9) 1.5(9) -9.2(11) 
O1 29.7(12) 44.9(14) 29.5(11) -6.3(10) -7.3(10) 8.6(10) 
N2 19.6(11) 29.5(13) 18(1) 0.6(9) 2.4(8) 2.4(9) 
C7 19.7(12) 21.5(13) 15.6(11) 0.8(9) -0.5(9) 0.5(10) 
C23 17.7(12) 34.6(16) 23.3(13) 2.0(11) -0.2(10) -7.2(11) 
C13 23.3(13) 20.2(13) 19.1(12) -1.1(10) -2.7(10) 2(1) 
C20 18.2(12) 21.9(12) 16.8(11) 0.7(9) 2.3(9) -1(1) 
C14 25.6(14) 24.4(14) 23.7(13) 4.5(10) 4.2(11) -4.4(11) 
C6 19.1(12) 32.3(15) 21.9(13) -3.5(11) 1.1(10) -6.0(11) 
C12 22.8(13) 29.8(15) 25.6(13) -1.6(11) 0.6(11) -0.2(11) 
C8 22.3(13) 18.9(12) 20.1(12) -0.7(10) -2(1) -0.8(10) 
C21 24.6(13) 22.1(13) 24.1(13) 4.3(10) 0.3(11) 1.7(11) 
C22 22.2(13) 33.3(16) 25.6(14) 10.6(12) -1.8(11) -2.1(12) 
C10 35.2(17) 29.2(15) 29.1(15) -1.8(12) -13.8(13) 0.5(13) 
C3 24.8(14) 30.4(16) 24.7(13) -5.7(11) 1.5(11) -8.1(12) 
C11 24.1(15) 31.4(16) 38.1(17) -4.2(13) -7.3(13) -1.4(12) 
C9 37.2(16) 22.9(14) 22.1(13) 1.5(11) -5.7(12) -1.9(12) 
C1 40.5(19) 33.7(18) 40.2(19) -5.6(14) 3.8(15) -4.8(15) 
C4 31.8(16) 37.8(18) 24.9(14) -4.6(13) -0.5(12) -7.5(14) 
C2 33.9(17) 30.8(16) 26.9(15) -3.2(12) -0.1(12) -6.5(13) 
C19 29.3(15) 34.3(17) 32.1(15) 4.2(13) -1.2(13) -8.0(13) 
C15 31.1(15) 27.9(15) 35.8(16) 1.6(13) -1.1(13) -1.9(12) 
C1D 40.3(18) 32.2(17) 41.4(19) -14.0(15) 9.4(15) -10.6(15) 
C16 39.7(19) 30.1(17) 48(2) 7.7(15) 6.6(16) 3.0(14) 
C5 38.4(18) 42.0(19) 29.6(16) -12.4(14) 4.1(14) -9.8(15) 
C17 57(2) 23.3(16) 48(2) 3.6(15) 11.7(18) -8.3(16) 
C18 49(2) 38(2) 37.3(18) -1.4(14) 1.6(17) -19.8(17) 
C1L 63(3) 74(3) 33.5(19) 0(2) -10.2(19) 15(3) 
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Table 11. Bond Lengths for trypt. 
 
Atom Atom Length/Å   Atom Atom Length/Å 
N3B C24B 1.338(8)   O2 C7 1.451(3) 
N3B C22 1.459(4)   O2 C6 1.359(4) 
C24B O6B 1.221(8)   N1 C7 1.450(3) 
C24B O7B 1.352(8)   N1 C8 1.424(4) 
O7B C25B 1.447(7)   O5 C23 1.219(4) 
C25B C26B 1.515(7)   O1 C6 1.200(4) 
C26B C27B 1.393(7)   N2 C23 1.342(4) 
C26B C31B 1.367(8)   N2 C20 1.450(4) 
C27B C28B 1.390(8)   C7 C20 1.570(4) 
C28B C29B 1.372(10)   C23 C22 1.518(5) 
C29B C30B 1.376(11)   C13 C20 1.511(4) 
C30B C31B 1.400(9)   C13 C12 1.386(4) 
N3A C24A 1.357(15)   C13 C8 1.385(4) 
N3A C22 1.460(5)   C20 C21 1.553(4) 
C24A O6A 1.234(16)   C14 C19 1.389(4) 
C24A O7A 1.338(14)   C14 C15 1.385(5) 
O7A C25A 1.466(13)   C6 C3 1.489(5) 
C25A C26A 1.503(13)   C12 C11 1.394(4) 
C26A C27A 1.386(6)   C8 C9 1.390(4) 
C26A C31A 1.385(6)   C21 C22 1.533(4) 
C27A C28A 1.385(6)   C10 C11 1.384(5) 
C28A C29A 1.385(6)   C10 C9 1.396(5) 
C29A C30A 1.383(6)   C3 C4 1.400(4) 
C30A C31A 1.385(6)   C3 C2 1.397(5) 
S1 O4 1.437(3)   C1 C2 1.380(5) 
S1 N1 1.651(2)   C1 C1D 1.394(5) 
S1 O3 1.430(3)   C4 C5 1.385(5) 
S1 C14 1.768(3)   C19 C18 1.386(5) 
Cl1 C4 1.732(4)   C15 C16 1.394(5) 
Cl2 C1D 1.738(4)   C1D C5 1.368(6) 
Cl3 C1L 1.764(5)   C16 C17 1.386(6) 
Cl4 C1L 1.754(5)   C17 C18 1.377(6) 
Cl5 C1L 1.720(6)         
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Table 12. Bond Angles for trypt. 
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
  
C24B N3B C22 115.5(5)   C8 C13 C12 120.9(3) 
  
N3B C24B O7B 109.1(7)   N2 C20 C7 112.1(2) 
  
O6B C24B N3B 127.1(6)   N2 C20 C13 112.6(2) 
  
O6B C24B O7B 123.8(6)   N2 C20 C21 102.0(2) 
  
C24B O7B C25B 113.7(5)   C13 C20 C7 102.3(2) 
  
O7B C25B C26B 107.7(5)   C13 C20 C21 115.1(2) 
  
C27B C26B C25B 118.3(6)   C21 C20 C7 113.3(2) 
  
C31B C26B C25B 122.0(5)   C19 C14 S1 118.8(3) 
  
C31B C26B C27B 119.7(6)   C15 C14 S1 119.5(2) 
  
C28B C27B C26B 119.7(6)   C15 C14 C19 121.5(3) 
  
C29B C28B C27B 119.5(6)   O2 C6 C3 110.1(3) 
  
C28B C29B C30B 121.9(7)   O1 C6 O2 122.9(3) 
  
C29B C30B C31B 118.0(7)   O1 C6 C3 127.0(3) 
  
C26B C31B C30B 121.2(6)   C13 C12 C11 118.7(3) 
  
C24A N3A C22 131.4(15)   C13 C8 N1 108.6(2) 
  
O6A C24A N3A 120.9(13)   C13 C8 C9 121.2(3) 
  
O6A C24A O7A 124.3(13)   C9 C8 N1 130.3(3) 
  
O7A C24A N3A 114.4(13)   C22 C21 C20 102.3(2) 
  
C24A O7A C25A 115.9(11)   N3B C22 C23 106.2(4) 
  
O7A C25A C26A 109.0(12)   N3B C22 C21 120.9(6) 
  
C27A C26A C25A 121.2(10)   N3A C22 C23 116.4(8) 
  
C31A C26A C25A 119.0(9)   N3A C22 C21 111.1(13) 
  
C31A C26A C27A 119.4(10)   C23 C22 C21 103.1(2) 
  
C28A C27A C26A 122.7(10)   C11 C10 C9 121.8(3) 
  
C29A C28A C27A 116.2(11)   C4 C3 C6 122.0(3) 
  
C30A C29A C28A 122.9(11)   C2 C3 C6 119.8(3) 
  
C29A C30A C31A 119.3(11)   C2 C3 C4 118.2(3) 
  
C30A C31A C26A 119.6(10)   C10 C11 C12 120.0(3) 
  
O4 S1 N1 105.48(14)   C8 C9 C10 117.4(3) 
  
O4 S1 C14 108.17(15)   C2 C1 C1D 118.1(4) 
  
N1 S1 C14 108.46(13)   C3 C4 Cl1 123.0(3) 
  
O3 S1 O4 120.61(16)   C5 C4 Cl1 116.5(3) 
  
O3 S1 N1 105.98(14)   C5 C4 C3 120.5(3) 
  
O3 S1 C14 107.64(16)   C1 C2 C3 121.8(3) 
  
C6 O2 C7 115.6(2)   C18 C19 C14 118.7(3) 
  
C7 N1 S1 119.87(19)   C14 C15 C16 118.9(3) 
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C8 N1 S1 127.1(2)   C1 C1D Cl2 119.0(3) 
  
C8 N1 C7 110.6(2)   C5 C1D Cl2 119.3(3) 
  
C23 N2 C20 115.0(3)   C5 C1D C1 121.7(3) 
  
O2 C7 C20 108.3(2)   C17 C16 C15 119.9(4) 
  
N1 C7 O2 106.4(2)   C1D C5 C4 119.7(3) 
  
N1 C7 C20 103.5(2)   C18 C17 C16 120.4(4) 
  
O5 C23 N2 127.0(3)   C17 C18 C19 120.6(4) 
  
O5 C23 C22 126.0(3)   Cl4 C1L Cl3 109.8(3) 
  
N2 C23 C22 107.0(2)   Cl5 C1L Cl3 111.0(3) 
  
C12 C13 C20 128.4(3)   Cl5 C1L Cl4 110.0(3) 
  
C8 C13 C20 110.7(2)           
  
 
 
Table 13. Hydrogen Atom Coordinates (Å×10
4
) and Isotropic Displacement  
Parameters (Å
2
×10
3
) for trypt.  
Atom x y z U(eq) 
H3B -5464 -8807 -4402 37 
H25A -1814 -9918 -3911 47 
H25B -2626 -10536 -4336 47 
H27B -3020 -11625 -3768 44 
H28B -3370 -12309 -2784 56 
H29B -3586 -11702 -1771 59 
H30B -3530 -10418 -1708 60 
H31B -3153 -9737 -2697 49 
H3A -5446 -8954 -4678 37 
H25C -2166 -10269 -4063 47 
H25D -3315 -10880 -4248 47 
H27A -3301 -11735 -3352 44 
H28A -3331 -12046 -2213 56 
H29A -3335 -11074 -1438 59 
H30A -3244 -9848 -1772 60 
H31A -3173 -9559 -2915 49 
H2 -6268 -6641 -5231 27 
H7 -2993 -6997 -6022 23 
H12 -8004 -7601 -6155 31 
H21A -5529 -8424 -5877 28 
H21B -3926 -8226 -6034 28 
H22A -3468 -7894 -4953 32 
H22 -3468 -7894 -4953 32 
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H10 -8183 -6722 -8018 37 
H11 -9277 -7299 -7123 37 
H9 -5813 -6409 -7971 33 
H1 -4990 -3588 -5426 46 
H2A -4424 -4759 -5831 37 
H19 -1229 -5098 -6772 38 
H15 -5139 -5212 -7535 38 
H16 -5360 -3924 -7412 47 
H5 -4010 -4260 -3549 44 
H17 -3507 -3234 -6991 51 
H18 -1444 -3811 -6693 50 
H1L -5782 -11383 -5959 68 
 
Experimental  
Single crystals of C33H26Cl5N3O7S [trypt] were []. A suitable crystal was selected and [] 
on a apex2_Mo diffractometer. The crystal was kept at 172.3 K during data collection. Using 
Olex2 [1], the structure was solved with the Superflip [2] structure solution program using 
Charge Flipping and refined with the ShelXL [3] refinement package using Least Squares 
minimisation. 
1. O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard and H. Puschmann, 
OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Cryst. 
(2009). 42, 339-341. 
2. SHELXS-97 (Sheldrick, 2008) 
3. SHELXL-97 (Sheldrick, 2008) 
Crystal structure determination of [trypt]  
Crystal Data for C33H26Cl5N3O7S (M =785.88): orthorhombic, space group P212121 (no. 
19), a = 9.6220(13) Å, b = 18.082(2) Å, c = 19.975(3) Å, V = 3475.4(8) Å
3
, Z = 4, T = 172.3 K, 
μ(MoKα) = 0.530 mm-1, Dcalc = 1.502 g/mm3, 30478 reflections measured (4.078 ≤ 2Θ ≤ 
401 
63.784), 11170 unique (Rint = 0.0350) which were used in all calculations. The final R1 was 
0.0561 (I >2σ(I)) and wR2 was 0.1451 (all data).  
 
 
 
 
 
 
 
 
 
 
 
 
 
